background
aim
recurr
clostridium
difficil
associ
diarrhea
cdad
associ
lack
protect
immun
c
difficil
toxin
paremer
c
difficil
vaccin
contain
toxoid
toxoid
b
report
previous
safe
immunogen
healthi
volunt
kotloff
et
al
infect
immun
aim
stuy
examin
whether
vaccin
also
well
toler
immunogen
patient
recurr
c
difficil
associ
diarrhea
cdad
method
subject
receiv
four
microgram
intramuscular
inocul
c
difficil
toxoid
vaccin
week
period
serum
antibodi
purifi
toxin
toxin
b
measur
toxin
neutral
activ
sera
evalu
use
tissu
cultur
cytotoxni
assay
result
three
patient
multipl
episod
recurr
cdad
vaccin
two
three
show
increas
serum
igg
antitoxin
antibodi
increas
day
compar
baselin
increas
serum
igg
antitoxin
b
antibodi
respect
also
develop
cytotoxin
neutral
activ
toxin
toxin
b
sera
prior
vaccin
subject
requir
nearli
continu
treatment
oral
vancumycin
month
respect
treat
recurr
episod
cdad
vaccin
three
subject
discontinu
treatment
oral
vancomycin
without
recurr
conclus
c
difficil
toxoid
vaccin
induc
immun
respons
toxin
b
associ
resolut
recurr
cdad
first
report
use
c
difficil
vaccin
patient
cdad
result
studi
support
feasibl
activ
immun
c
difficil
toxin
high
risk
individu
must
valid
larger
control
trial
effect
enteropathogen
e
coli
epec
infect
mice
c
rodentium
genet
similar
epec
propos
model
studi
epec
form
lesion
increas
cytokin
express
util
type
iii
secret
system
deliv
effector
molecul
host
cell
aim
studi
compar
effect
epec
c
rodentium
cultur
murin
bacteri
adher
actin
rearrang
inflammatori
respons
transepitbeh
electr
resist
ter
tight
junction
tj
morpholog
respons
epec
c
rodentium
examin
adher
epec
c
rodentium
cell
compar
h
cfuwel
resp
greater
epec
h
x
cfuwel
resp
lesion
format
epec
occur
h
requir
h
c
rodentium
epec
c
rodentium
induc
inflammatori
cascad
includ
nuclear
tranaloc
phosphoryl
pkc
transloc
within
h
suggest
respons
independ
ae
lesion
format
fact
steril
supernat
pathogen
stimul
tmnslocat
indic
type
ili
secret
involv
contrast
human
iec
ter
monolay
alter
either
pathogen
unless
centrifug
rain
onto
monolay
case
epec
h
p
control
c
rodentium
h
p
significantli
decreas
ter
local
tj
protein
assess
immuuofluoresc
microscopi
disrupt
monolay
infect
epec
follow
centrifug
correl
decreas
ter
conclus
bacteri
adher
lesion
format
disrupt
tj
barrier
significantli
greater
epec
c
rodentium
inflammatori
respons
host
cell
similar
despit
genet
similar
pathogen
function
alter
induc
host
cell
significantli
differ
variabl
physiolog
respons
exert
two
pathogen
murin
iec
suggest
caution
exercis
extrapol
inform
regard
c
rodenflum
infect
epec
clinic
applic
polymeras
chain
reaction
diagnos
clostridium
difficil
hospit
patient
diarrhea
michael
morefli
jr
susan
rouster
ralph
giarmella
kenneth
e
sherman
background
aim
clostridium
difficil
common
caus
diarrhea
hospit
patient
associ
signific
morbid
cost
current
diagnost
standard
enzym
immunoassay
eia
suffer
low
sensit
lead
repetit
test
empir
treatment
sought
demonstr
util
costeffect
polymeras
chain
reaction
pcr
amplif
toxin
b
gene
diagnosi
clostridium
difficileinduc
diarrhea
addit
analyz
practic
physician
regard
test
treatment
clostridium
difficil
compar
practic
guidelin
recommend
method
stool
sampl
academ
communitybas
hospit
sent
eia
test
prospect
evalu
presenc
toxin
b
gene
pcr
result
compar
eia
regard
sensit
specif
predict
valu
pcr
serv
gold
standard
likelihood
ratio
calcul
medic
chart
review
determin
number
eia
sent
per
admiss
b
number
sent
within
time
period
c
caregiv
react
eia
result
result
mean
age
subject
year
eia
pcr
posit
eia
sensit
specif
posit
neg
predict
valu
posit
likelihood
ratio
eia
neg
likelihood
ratio
cost
pcr
total
turnaround
time
sampl
hour
empir
treatment
clostridiam
difficil
given
unnecessarili
elaneg
patient
eia
sent
hospit
admiss
patient
multipl
sampl
sent
one
sent
period
conclus
mani
physician
conform
practic
guidehn
regard
recommend
diagnosi
empir
treatment
clostridium
difficil
may
due
low
confid
test
reliabl
toxin
b
gene
pcr
repres
sensit
potenti
costeffect
method
diagnos
clostridium
difficileinduc
diarrhea
eia
consid
use
altern
diagnost
standard
explor
role
bismuth
thiol
control
bacteri
infect
associ
biliari
stent
occlus
hong
un
zhang
jevon
tang
xiangwen
meng
jacki
tsang
tatkin
tsang
background
aim
bacteri
infect
biofilm
format
surfac
biliari
stent
believ
one
main
factor
stent
occlus
effect
longterra
prophylact
antibiot
incorpor
antibacteri
agent
stent
proven
satisfactori
studi
aim
explor
role
new
reagent
bismuth
thiol
prevent
bacteri
adher
bacteri
biofilm
format
surfac
biliari
stent
method
modifi
flow
cell
system
use
polyethylen
straight
stent
built
steril
porcin
bile
infect
separ
escherichia
coli
klebsiella
pneumonia
enterobact
enterococcn
use
perfus
medium
bacteri
growth
bile
bacteri
adher
surfac
stent
test
bismuth
dimercaptopropanol
bisbal
dilut
perfnsion
medium
amount
bacteria
adher
surfac
stent
well
amount
bacteria
perfnsion
medium
measur
use
platecount
method
hour
time
point
respect
result
result
demonstr
bisbal
inhibit
growth
test
bacteri
speci
howev
significantli
decreas
amount
bacteria
adher
surfac
stent
except
eseherichia
coil
bisbal
significantli
inhibit
growth
escherichia
coil
klebsiella
pneumonia
enterobact
therebi
significantli
decreas
bacteria
adher
surfac
stent
conclus
result
indic
low
concentr
bismuth
thiol
present
bile
may
inhibit
adher
surfac
biliari
stentt
retard
bacteri
biofilm
format
high
dose
bismuth
thiol
intestin
tract
may
eras
bacteri
sourc
prevent
infect
reflux
sinc
uniqu
bactericid
antibiofilm
properti
bismuth
thiol
may
contribut
delay
process
biliari
stent
occlus
therefor
could
use
appropri
patient
procedur
biliari
stent
placement
cholera
toxin
ct
escherichia
coh
heat
labil
lt
heat
stabl
st
toxin
mediat
intestin
secret
part
enter
reflex
arc
mayb
via
direct
effect
enter
nerv
shown
previous
ct
lt
st
induc
neurit
outgrowth
cell
enhanc
neuron
differenti
effect
nerv
growth
factor
ngf
method
cdna
microarray
technolog
use
identifi
earli
gene
express
cell
induc
ct
lt
st
affymetrix
growth
differenti
genechip
use
microarray
analysi
result
ct
lt
induc
fold
chang
respect
express
ngfinduc
protein
earli
growth
respons
gene
ngf
alon
induc
fold
chang
express
gene
ct
ngf
lt
ngf
induc
fold
chang
express
ngfinduc
protein
ct
lt
induc
fold
chang
respect
express
ngfinduc
factor
gene
ngf
induc
fold
chang
express
gene
ct
ngf
lt
ngf
induc
fold
chang
express
ngfinduc
factor
cebp
relat
transcript
factor
vgf
nerv
growth
factor
induc
gene
upregul
presenc
ct
ngf
lt
ngf
enterotoxin
ngf
alon
fold
chang
express
respect
signific
chang
gene
express
seen
st
discuss
ceil
ct
lt
induc
upregul
gene
involv
neuron
differenti
synergist
effect
ct
lt
ngf
occur
ngfinduc
gene
support
phenotyp
synergist
chang
previous
observ
new
gene
upregul
occur
cell
expos
ct
lt
ngf
find
suggest
ct
lt
ngf
separ
synergist
effect
gene
express
background
cytomegaloviru
cmv
infect
import
caus
morbid
mortal
solid
organ
transplant
recipi
tissu
invas
cmv
diseas
neg
antigenemia
screen
diagnost
dilemma
significantli
increas
patient
morbid
cmv
infect
defin
isol
cmv
viru
detect
cmv
viral
protein
nucleic
acid
bodi
fluid
tissu
specimen
cultur
immunohistochemistri
andor
detect
viral
inclus
bodi
tissu
gold
standard
diagnos
cmv
infect
serolog
use
detect
previou
infect
tissu
biopsi
time
consum
requir
invas
procedur
center
reli
rapid
serum
antigen
screen
guid
patient
manag
aim
studi
ascertain
accuraci
serum
antigen
screen
transplant
recipi
tissu
invas
cmv
diseas
method
retrospect
review
case
biopsyproven
tissu
invas
cmv
diseas
solid
organ
transplant
recipi
patient
record
rifalazil
prevent
relaps
clostridinm
difficileassoci
diarrhea
anton
paulin
efi
g
kokkot
david
rothstein
ciaran
p
kelli
charalabo
pothoulaki
background
object
clostridium
difficff
associ
diarrhea
coliti
cdad
current
treat
vancomycin
metronidazol
howev
patient
relaps
follow
discontinu
therapi
case
prolong
therapi
vancomycin
requir
recent
show
rifalazff
mgkgday
five
day
new
rifamycin
deriv
equal
effect
vancomycin
prevent
treat
cdad
syrian
hamster
howev
contrast
vancomycin
rifalazff
associ
relaps
use
syrian
hamster
model
cdad
establish
number
day
dose
rifalazff
need
achiev
full
therapeut
relapsefre
respons
b
compar
rifalazil
vancomycin
treatment
relaps
cdad
follow
vancomycin
treatment
method
golden
syrian
hamster
inject
sc
clindamycin
phosphat
mgkg
follow
hr
later
c
difficff
garag
cfu
hr
hamster
per
group
administ
gavag
either
vehicl
rifalazil
daffi
day
model
relaps
cdad
administeret
vancomycin
mgkg
rifalazil
mgkg
salin
garag
day
begin
one
week
initi
day
cours
vancomycin
challeng
hamster
result
vehicleadminist
anim
becam
moribund
cdad
day
c
difficff
gavag
none
rifalazil
mg
kgday
treat
anim
show
sign
cdad
day
discontinu
treatment
timecours
experi
indic
mgkgday
rifalazil
day
treatment
requir
obtain
full
therapeut
relapsefre
respons
doserespons
studi
use
mgkgday
indic
dose
rifalazil
low
mgkg
day
effect
treat
cdad
hamster
relaps
cdad
model
salinetr
control
hamster
euthan
sever
cdad
day
discontinu
vancomycin
treatment
contrast
none
anim
receiv
either
vancomycin
rifalazff
develop
fatal
cdad
howev
rifalaziltr
anim
gain
weight
significantli
higher
rate
vancomycintr
hamster
p
day
cours
studi
indic
greater
protect
mild
recurr
cdad
rifalazff
group
conclus
result
indic
low
dose
rifalazff
may
superior
vancomycin
prevent
treatment
relaps
cdad
support
grant
aetivbiot
inc
lexington
develop
vitro
model
infect
yet
mous
model
c
parvum
infect
differ
found
either
cours
sever
infect
wildtyp
tnfx
knockout
mice
though
tnfa
appear
essenti
recoveri
mani
question
remain
unansw
instanc
could
role
predominantli
proinflammatori
rather
link
parasit
dearanc
could
tnfa
redund
entiti
presenc
cytokin
crucial
cytokin
clearanc
parasit
vivo
method
small
intestin
histolog
section
taken
tnfx
ko
wildtyp
mice
infect
c
parvum
stain
h
e
compar
degre
inflamm
present
order
explor
relationship
tnfa
ifn
semiquantit
rtpcr
perform
intestin
sampl
obtain
peak
infect
group
differ
mucos
mrna
express
ifni
addit
ifn
ko
mice
develop
chronic
infect
c
parvum
treat
antitnf
antibodi
time
infect
level
oocyst
shed
measur
day
post
infect
result
histolog
level
inflamm
c
parvum
infect
tnf
ko
wildtyp
mice
appear
similar
suggest
presenc
tnfa
contribut
littl
inflammatori
process
mucos
express
similar
group
addit
antitnf
antibodi
ifn
ko
mice
infect
c
parvum
effect
degre
infect
thu
even
defici
environ
tnfc
seem
import
conclus
tnfcx
appear
minim
role
immun
respons
c
parvum
mous
model
infect
ulrich
r
bohr
michael
selgrad
christian
ochmann
andrea
fensk
doerth
kuester
albert
roessner
thoma
wex
peter
malferthein
background
enterohepat
helicobact
speci
capabl
colon
hepatobifiari
system
intestin
tract
laboratori
mice
bacteria
may
caus
variou
diseas
hepat
inflammatori
bowel
diseas
malign
preval
helicobact
infect
laboratori
mice
uncertain
investig
sampl
laboratori
mice
specificpathogen
free
tract
anim
facil
helicobacteracea
method
laboratori
mice
harbour
central
anim
laboratori
univers
fece
collect
analys
helicobacteracea
use
groupspecif
pcr
dnasequenc
subsequ
sequenc
analysi
perform
identifi
individu
helicobact
speci
doubl
infect
mice
speci
identif
complet
restrict
fragment
length
polymorph
result
test
laboratori
mice
pcr
assay
produc
strong
amplif
product
indic
helicobact
infect
nine
mice
pcrneg
remain
mice
pcr
assay
produc
margin
result
therefor
sampl
analyz
heficobacterposit
mice
rrna
sequenc
obtain
dnasequenc
amplif
product
could
clearli
assign
known
helicobact
speci
h
ganmani
n
h
sp
ulmiensi
h
hepatica
h
sp
hamster
b
mice
dnasequenc
indic
infect
anim
one
heficobact
speci
mice
coinfect
h
ganmani
h
hepaticu
diagnos
restrict
fragment
polymorph
analysi
conclus
although
mice
rear
spf
condit
mice
deliv
helicobact
free
investig
mice
helicobact
infect
frequent
detect
import
helicobact
infect
consid
undesir
incalcul
variabl
may
impact
reproduc
anim
experi
especi
field
hepatolog
gastroenterolog
commun
neurit
mast
cell
prototyp
exampl
neuroimmun
interact
previous
report
close
apposit
mucos
mast
cell
mmc
dens
network
calcitonin
gene
relat
peptid
cgrp
ir
extrins
primari
affer
nerv
fibr
lamina
propria
mansoniinfect
murin
ileum
cgrpir
fibr
origin
dorsal
root
ganglia
drg
use
optic
record
intracellular
calcium
examin
bidirect
interact
primari
cultur
mmc
drg
neuron
vitro
degranulatori
mast
cell
degranul
neuropeptid
cgrp
sp
determin
measur
extracellular
applic
mast
cell
degranul
gml
load
im
mmc
induc
transient
rise
mean
sd
cultur
cell
studi
lag
time
amplitud
rel
fluoresc
baselin
rf
smaller
percentag
mmc
activ
cgrp
cultur
cell
sp
cultur
cell
lag
time
respons
cgrp
sp
shorter
cgrp
respons
could
complet
block
control
cultur
pertussi
toxin
indic
involv
gprotein
applic
mmc
juic
obtain
degranul
load
drg
neuron
cultur
induc
rise
lag
time
amplitud
rf
also
show
degranul
mmc
cultur
dish
contain
drg
neuron
caus
compar
activ
rf
drg
neuron
much
longer
lag
time
p
cultur
conclus
result
demonstr
bidirect
crosstalk
cultur
mmc
drg
neuron
vitro
indic
function
relev
close
apposit
mmc
cgrpir
nerv
fibr
vivo
support
iuap
fwogrant
iwtgrant
fdj
de
jong
et
al
histochem
cell
biol
background
naamino
cotransport
nact
inhibit
chronic
intestin
inflamm
secondari
alter
affin
cotransport
amino
acid
whether
arachidon
acid
metabolit
eg
prostaglandin
leukotrien
known
elev
inflam
intestin
mucosa
may
affect
alter
unknown
aim
determin
whether
arachidon
acid
metabolit
metabolit
aam
mediat
inhibit
nact
chronic
enter
method
rabbit
model
inflammatori
bowel
diseas
produc
eimeria
magna
util
villu
cell
isol
rabbit
intestin
ca
chelat
techniqu
brush
border
membran
vesicl
bbmv
prepar
villu
cell
ca
precipit
differenti
centrifug
result
treatment
rabbit
chronic
enter
arachidonyl
trifluoromethyl
keton
atmk
inhibitor
arachidon
acid
metabol
result
revers
inhibit
nact
villu
cell
nadepend
alanin
uptak
minut
normal
inflam
inflam
atmk
n
p
atmk
effect
nact
normal
villu
cell
atmk
also
revers
inhibit
nakatpas
villu
cell
chronic
enter
nakatpas
activ
nmol
pimg
proteinminut
normal
inflam
inflam
atmk
p
howev
atmk
revers
inhibit
nact
villu
cell
bbmv
chronic
inflam
intestin
suggest
direct
effect
cotransport
nadepend
uptak
alanin
bbmv
pmolsmg
second
normal
inflam
inflam
atmk
p
kinet
studi
demonstr
atmk
revers
inhibit
nact
restor
affin
cotransport
amino
acid
without
effect
maxim
rate
uptak
amino
acid
vmax
western
blot
studi
also
demonstr
atmk
treatment
affect
imunoreact
level
nact
bbm
conclus
aam
product
abolish
chronic
inflam
intestin
inhibit
nact
allevi
mechan
revers
nact
inhibit
secondari
restor
affin
cotransport
amino
acid
thu
aam
like
mediat
inhibit
nact
chronic
inflam
intestin
pradip
k
bardhan
hamidur
rahman
david
sack
background
oral
rehydr
solut
or
success
rehydr
patient
dehydr
acut
diarrhea
howev
treatment
present
or
formul
reduc
volum
frequenc
durat
diarrhea
object
studi
whether
incorpor
or
compon
liposom
increas
small
intestin
absorpt
water
or
experiment
anim
model
method
vivo
perfus
entir
small
intestin
perform
total
adult
rat
divid
three
group
normal
rat
n
rat
expos
cholera
toxin
ct
n
rat
expos
peg
use
marker
net
movement
water
compar
tapiocabas
or
contain
liposom
aqui
kiposom
or
tapiocabas
or
without
liposom
tapiocaor
recent
whorecommend
hypoosmolar
or
waoor
result
three
or
solut
result
signific
absorpt
aqui
liposom
or
provid
significantli
statist
higher
level
absorpt
three
rat
group
compar
whoor
tapiocaor
result
treat
rat
indic
tapioca
appear
increas
absorpt
damag
mucosa
practic
improv
aqui
liposom
or
tast
less
salti
conclus
three
oral
rehydr
solut
well
absorb
aqui
kiposom
or
associ
highest
level
water
electrolyt
absorpt
compar
result
aqui
kiposom
or
tapiocaor
indic
liposom
respons
sigmfic
increas
absorpt
water
electrolyt
tapioca
inhibit
prolifer
host
tlymphocyt
induc
cell
cycl
arrest
studi
hypothes
vpr
induc
human
intestin
epitheli
cell
malfunct
method
cell
differenti
intestin
epitheli
cell
line
deriv
human
colon
adenocarcinoma
use
cell
infect
advpr
replicationdeficiem
adenoviru
carri
vpr
gene
determin
cell
cycl
profil
cell
stain
propidinm
iodid
cell
cycl
distribut
determin
facscan
examin
cytoskeleton
structur
cell
stain
fitcconjug
phalloidin
analyz
fluoresc
microscop
result
preliminari
data
indic
advprinfect
cell
exhibit
increas
ratio
compar
mock
infect
cell
effect
detect
within
hr
dose
depend
manner
observ
suggest
vpr
gene
express
intestin
epitheli
ceil
result
cell
cycl
arrest
util
phalloidin
stain
demonstr
factin
ring
advpr
cell
diminish
within
hr
infect
cytoskeleton
structur
infect
cell
disorgan
hr
infect
conclus
present
studi
indic
vpr
induc
cell
cycl
arrest
human
intestin
epitheli
cell
phase
disrupt
cytoskeleton
human
enterocyt
therefor
hypothes
vpr
may
play
role
pathogenesi
hiv
intestin
diseas
support
elois
warren
bott
young
investig
award
clostridium
difficil
primari
caus
nosocomi
antibioticassoci
diarrhoea
develop
countri
frequent
caus
pseudomembran
coliti
main
virul
factor
two
toxin
toxin
toxin
b
secret
bacteria
target
vaccin
studi
howev
surfac
layer
protein
slp
complet
cover
cell
also
target
immun
respons
diseas
studi
assess
abil
hightitr
rabbit
antic
difficil
slp
antibodi
protect
infect
lethal
hamster
challeng
model
slp
extract
type
c
difficil
strain
urea
purifi
monoq
anion
exchang
column
attach
fplc
system
new
zealand
white
rabbit
inject
subcutan
lag
purifi
slp
complet
freund
adjuv
boost
week
p
g
antigen
incomplet
freund
adjuv
specif
antibodi
confirm
western
blot
slp
slpspecif
antibodi
titr
harvest
serum
determin
elisa
two
group
hamster
n
challeng
orogastr
administr
mg
clindamycin
follow
c
difficil
cfu
c
difficil
preincub
rabbit
antislp
irrelev
serum
prior
administr
one
prechalleng
three
postchalleng
dose
rabbit
antislp
serum
also
given
c
difficileonli
group
n
also
includ
examin
permeabl
macromolecnl
hors
radish
peroxidas
hrp
kd
duoden
biopsi
eight
children
chronic
diarrhea
compar
control
valu
biopsi
five
patient
without
diarrhea
furthermor
addit
biopsi
diarrhea
patient
test
effect
mucos
addit
carboxyldextran
kd
gl
upon
permeabl
hrp
biopsi
mount
uss
chamber
seros
surfac
area
mm
c
hrp
ad
mucos
side
seros
appear
measur
enzymaticafli
minut
tissu
fix
electronmicruscopi
stain
hrpactiv
control
patient
hrpflux
minut
n
mucos
uptak
appear
detect
endocytosi
four
diarrhea
patient
three
microvilhi
inclus
diseas
hrp
uptak
detect
endocytosi
also
tight
junction
leak
paracellular
permeat
hrpflux
significantli
increas
n
p
presenc
carboxyldextran
hrpflux
patient
significantli
reduc
p
n
tight
junction
paracellular
stain
hrp
detect
anymor
four
diarrhea
patient
hrpflux
compar
control
n
detect
endocyt
uptak
latter
four
patient
carboxyldextran
effect
hrpflux
n
hrpstain
detect
endosom
moreov
rat
ileum
mount
uss
chamber
carbacholinduc
threefold
increment
hrp
permeabl
significantli
reduc
electroneg
carboxyldextran
neutral
dextran
conclud
mucos
addit
carboxyldextrau
may
prevent
loss
small
intestin
paracellular
macromolecular
barrier
function
electroneg
termin
carboxylgroup
import
aspect
find
may
possibl
lead
new
therapeut
approach
intestin
permeabl
disord
increas
intestin
barrier
permeabl
human
astroviru
infect
kindsey
moser
stacey
l
schuhzcherri
three
five
billion
case
diarrhea
report
throughout
world
everi
year
million
fatal
etiolog
agent
case
alway
identifi
role
virus
induc
diarrhea
becom
increasingli
recogn
astroviru
shown
second
lead
caus
viral
induc
diarrhea
children
spite
preval
popul
littl
research
conduct
mechan
astrovirn
pathogenesi
particularli
human
previou
find
avian
infect
model
demonstr
lack
either
cellular
damag
inflammatori
respons
tmed
hypothes
astroviru
infect
decreas
intestin
barrier
permeabilili
lead
diarrhea
absenc
cellular
damag
test
hypothesi
investig
effect
infect
intestin
barrier
permeabl
use
human
intestin
carcinoma
cell
briefli
cell
incub
day
use
bd
biocoat
intestin
differenti
environ
form
polar
cell
layer
cell
layer
infect
serotyp
human
astroviru
barrier
permeabl
measur
chang
transepitheli
electr
resist
ter
migrat
fiuorescentlylabel
dextran
across
cell
layer
observ
timedepend
decreas
ter
hffect
cell
absent
control
furthermor
hour
infect
see
increas
basolater
chamber
fluoresc
control
well
result
dicat
astrovirusinduc
increas
intestin
barrier
permeabl
celhdar
viral
mechan
effect
yet
identifi
howev
lurrent
pursu
possibl
relationship
astroviru
infect
cytoskelet
chang
effort
understand
decreas
barrier
integr
background
clostridium
difficil
c
difficil
major
caus
nosocomi
diarrhea
preval
rate
c
difficil
healthi
adult
believ
low
howev
current
studi
use
rtpcr
glass
powder
elimin
pcr
inhibitor
show
c
difficil
toxin
b
mrna
detect
approxim
fece
healthi
human
adult
studi
clarifi
valid
current
studi
attempt
show
whether
pcr
inhibitor
fece
actual
decreas
sensit
pcr
detect
c
difficil
glass
powder
elimin
pcr
inhibitor
increas
sensit
pcr
method
fecal
sampl
collect
inform
consent
healthi
human
adult
volunt
mean
age
sd
year
old
receiv
antibiot
past
month
admit
hospit
past
year
mrna
extract
fecal
sampl
acid
phenol
glass
powder
bio
ca
revers
transcript
extract
rna
convert
dna
amplifi
pcr
primer
toxin
b
gene
c
difficil
sinc
pcr
inhibitor
fece
carri
phenolchloroform
extract
procedur
also
extract
dna
fecal
sampl
use
phenolchloroform
subject
pcr
primer
revers
transcript
product
fecal
sampl
mix
phenolchloroform
extract
fecal
sampl
mixtur
subject
pcr
result
c
difficil
toxin
b
mrna
detect
fecal
sampl
rtpcr
contrast
fail
detect
toxin
b
gene
fecal
sampl
pcr
use
phenolchloruform
extract
procedur
amplif
toxin
b
mrna
inhibit
revers
transcript
product
fecal
sampl
mix
phenolchloroform
extract
conclus
result
suggest
pcr
inhibitor
fece
carri
phenol
chloroform
extract
procedur
decreas
sensit
pcr
glass
powder
effici
elimin
pcr
inhibitor
increas
sensit
pcr
toxigen
c
difficil
actual
might
present
gut
flora
healthi
human
adult
frequent
previous
suspect
genet
variat
ileal
bile
acid
bind
protein
gene
subject
diarrhea
robert
j
pell
natali
f
barley
umma
khair
julian
r
f
waiter
background
enterohepat
circul
bile
salt
involv
specif
bile
acid
transport
express
enterocyt
ileum
diseas
surgic
resect
termin
ileum
produc
bile
acid
malabsorpt
lead
diarrhea
idiopath
primari
bile
acid
malabsorpt
rel
common
caus
diarrheapredomin
irrit
bowel
syndrom
mutat
apic
sodiumlink
bile
transport
express
brushbord
membran
report
caus
diseas
found
patient
primari
bile
acid
malabsorpt
look
polymorph
anoth
transport
system
ileal
bile
acid
bind
protein
gena
ibabp
gene
symbol
express
cytoplasm
method
genom
dna
prepar
patient
chronic
diarrhea
includ
bile
salt
malabsorpt
confirm
sehcat
test
control
subject
without
diarrhea
approxim
lkb
promot
four
exon
includ
intronexon
junction
amplifi
sequenc
result
sever
differ
singl
nucleotid
polymorph
snp
identifi
promot
region
gene
subject
snp
promot
patient
one
polymorph
frequent
snp
found
subject
diarrhea
control
anoth
found
subject
diarrhea
control
snp
may
repres
consensu
transcript
factor
bind
site
number
snp
identifi
exon
region
includ
code
chang
exon
conclus
genet
variat
common
ibabp
gene
may
lead
function
abnorm
bile
acid
absorpt
studi
necessari
defin
contribut
polymorph
pathophysiolog
primari
bile
acid
malabsorpt
chronic
diarrhea
whole
intestin
permeabl
patient
chronic
diarrhea
noninvas
measur
organ
diseas
shane
devlin
jonathon
med
purpos
patient
present
complaint
chronic
diarrhea
often
irrit
bowel
syndrom
ib
distinguish
ib
patient
signific
organ
patholog
difficult
without
perform
invas
investig
noninvas
test
rule
organ
patholog
could
potenti
elimin
need
costli
investig
certain
patient
purpos
pilot
studi
determin
feasibl
use
assess
whole
intestin
permeabl
gastric
small
intestin
colon
predict
presenc
organ
patholog
patient
present
chronic
diarrhea
method
new
referr
tertiari
care
gastroenterolog
clinic
histori
three
stool
per
day
least
six
week
assess
enrol
patient
underw
investig
discret
treat
gastroenterologist
addit
appropri
investig
whole
intestin
permeabl
patient
assess
sucros
use
probe
gastric
permeabl
ratio
lactnlos
manuitol
use
probe
small
intestin
permeabl
sucralos
use
probe
colon
permeabl
patient
endomysi
antibodi
ema
screen
bloodwork
includ
complet
blood
count
result
date
complet
data
eight
patient
avail
invas
investig
done
patient
includ
esophagogastroduodenoscopi
egd
colonoscopi
small
bowel
follow
sbft
two
egd
colonoscopi
four
colonoscopi
alon
two
two
patient
final
diagnosi
lymphocyt
coliti
one
bad
postinfecti
ib
one
mycophenol
induc
coliti
two
mild
nonspecif
coliti
undetermin
etiolog
one
bad
diagnosi
assign
normal
investig
egd
colonoscopi
ema
neg
patient
gastric
small
intestin
colon
permeabl
normal
patient
conclus
preliminari
data
whole
intestin
permeabl
test
appear
valu
predict
presenc
organ
diseas
appear
abnorm
colon
small
intestin
permeabl
two
patient
report
lymphocyt
coliti
patient
studi
continu
effort
examin
util
permeabl
test
patient
popul
epecmedi
alter
nhe
activ
involv
transloc
intimin
epec
adhesin
intimin
allow
intim
attach
recruit
cytoskelet
protein
beneath
adher
microcoloni
abrog
increas
epecmedi
uptak
nmolmg
min
control
epec
atr
resp
triplic
p
epec
vs
atr
varieti
signal
molecul
includ
pkc
phospholipas
c
plc
activ
follow
epec
infect
therefor
inhibitor
pathway
test
effect
na
uptak
pkc
inhibit
bisindolylmaleimid
bim
lpm
decreas
epecinduc
uptak
vs
vs
vs
without
vs
inhibitor
p
implic
pkc
epecmedi
na
uptak
plc
inhibit
reduc
epecstimul
uptak
pka
inhibit
effect
vs
nmolmg
min
inhibitor
resp
conclus
studi
identifi
tir
import
effector
molecul
epecstimul
uptak
suggest
pkc
involv
alter
nhe
activ
pathogen
prevent
cytokineinduc
apoptosi
intestin
epitheli
cell
initi
specif
epitheli
cell
signal
transductinn
pathway
j
biol
chem
tight
junction
tj
form
barrier
movement
noxiou
substanc
intestin
lumen
intestin
tissu
previou
studi
show
oxid
stress
disrupt
tj
increas
paraceilular
permeabl
cell
monolay
present
studi
evalu
effect
lgg
supernat
lgg
protein
isol
lgg
disrupt
intestin
epitheli
tj
method
ceil
transwel
insert
incub
without
lgg
gml
ng
ml
paracellular
permeabl
evalu
measur
tranaepitheli
electr
resist
ter
fitcinuhn
flux
disrupt
tj
adherensjunct
assess
immunofluoresc
confoc
microscopi
use
specif
antibodi
effect
lgg
breakdown
evalu
incub
lgg
determin
level
micropl
spectrophotometr
assay
result
induc
timedepend
decreas
ter
inulin
flux
lgg
ad
one
hour
prior
continu
presenc
significantli
reduc
chang
ter
inulin
flux
dosedepend
manner
one
hour
n
decreas
ter
reduc
n
lgg
ltgml
inulin
flux
reduc
fiuxhrcm
n
lgg
incub
lgg
concentr
chang
level
pretreat
alon
lgg
aso
significantli
reduc
chang
ter
flux
confoc
microscop
immunofluoresc
imag
show
induc
reorgan
junction
intraceflular
compart
significantli
prevent
lgg
conclus
result
indic
lgg
may
secret
factor
regul
cellular
tight
junction
respons
help
protect
intestin
epitheli
barrier
function
oxid
stress
enteropathogen
e
call
epec
infect
inhibit
butyr
uptak
cell
alip
borthakur
kim
hodg
ravind
k
gill
krishnamurthi
ramaswami
gall
hecht
pradeep
k
dudeja
butyr
short
chain
fatti
acid
produc
enter
bacteri
ferment
undigest
carbohydr
key
sourc
metabol
energi
colonocyt
play
import
role
maintain
epitheli
integr
intestin
mucosa
decreas
avail
scfa
correl
chronic
inflamm
particularli
divers
coliti
date
virtual
inform
avail
modul
scfa
uptak
pathogen
microorgan
caus
secretori
inflammatori
diarrhea
human
intestin
regard
epec
major
caus
infantil
diarrhea
intestin
inflamm
effect
epec
infect
butyr
uptak
investig
use
human
intestin
epitheli
ceil
vitro
model
monolay
infect
epec
mutant
rain
butyr
transport
subsequ
determin
phdriven
butyr
uptak
result
demonstr
infect
cell
epec
result
substanti
decreas
butyr
uptak
decreas
earli
rain
p
nonpathogen
e
coil
effect
epec
hous
pathogen
island
encod
type
ill
secretori
system
ttss
transloc
bacteri
virul
protein
directli
host
cell
epec
exert
effect
host
cell
intim
attach
inject
effector
molecul
host
cell
cytoplasm
mutat
escn
encod
atpas
ffss
ablat
effect
epec
butyr
uptak
pmolmg
proteirdsmin
control
epec
escn
ttss
apparatu
complex
array
structur
epec
secret
protein
esp
termin
structur
apparatu
consist
espa
espb
espd
epec
secret
effector
protein
includ
espf
espg
esph
tir
map
infect
monolay
epec
mutant
harbor
mutat
either
espa
espb
espd
tr
transloc
intimin
receptor
ablat
effect
epec
butyr
uptak
cell
control
epec
tit
mutant
espg
esph
howev
effect
butyr
uptak
conclus
result
provid
evid
epec
inhibit
butyr
uptak
human
intestin
epitheli
cell
effect
depend
function
tfss
secret
epec
receptor
fir
specul
decreas
avail
butyr
intestin
epitheli
cell
induc
epec
infect
may
compromis
epitheli
integr
enhanc
inflamm
colon
epithelium
background
aim
previous
characteris
novel
bacteriocin
produc
human
commensalprobiot
broad
spectrum
antimicrobi
activ
also
report
commerci
avail
experiment
probiot
confer
host
protect
typhimurium
infect
aim
present
studi
examin
mechan
action
sever
level
includ
probioticpathogen
antagon
local
invas
transloc
host
cytokin
respons
method
balbc
mice
fed
b
infantt
l
salivariu
probiot
strain
n
per
strain
lxlogday
week
prior
challeng
typhimurium
feed
continu
day
invas
transloc
pathogen
confirm
recoveri
intestin
spleen
liver
product
cytokin
intestin
lymphoid
cell
assess
probioticpathogen
interact
vitro
studi
epitheli
cell
line
activ
buffer
nonbuff
probiot
supernat
without
bacteriocin
assess
probioticpathogen
cocultur
use
b
infanti
l
salivariu
result
vitro
cocultur
show
clearli
typhimurium
suscept
probioticderiv
bacteriocin
abp
test
howev
partial
direct
inhibit
pathogen
observ
could
account
chang
ph
due
lactic
acid
product
probiot
epitheli
bind
competit
inhibit
invas
demonstr
vitro
sever
lactobacilli
predict
vivo
probiot
perform
clinic
effect
probiot
strain
exhibit
reduc
local
invas
typhimurium
also
reduc
transloc
pathogen
liver
spleen
protect
effect
probiot
feed
associ
enhanc
product
ifni
intestin
peyer
patch
cell
stimul
vitro
salmonella
conclus
vitro
activ
put
probiot
typhimurium
predict
vivo
perform
subleth
infect
probiot
strain
exhibit
clinic
signific
protect
invas
pathogen
associ
enhanc
ifnproduct
intestin
lymphoid
cell
may
critic
mechan
action
background
previous
report
data
show
l
farcimini
improv
experiment
coliti
induc
tnb
rat
moreov
l
salivariu
exert
prophylact
effect
coliti
arthriti
mice
system
local
immunomodul
norrnalizatio
enter
flora
anoth
hand
n
brasiliensi
nb
infect
rat
associ
intestin
lung
inflamm
character
synchron
increas
mpo
activ
organ
peak
day
infect
therefor
aim
studi
determin
whether
oral
l
farciraini
treatment
exert
antiinflammatori
effect
two
differ
target
jejunum
lung
nbniduc
inflamm
rat
method
two
seri
experi
perform
group
male
wistar
rat
control
ral
salin
sc
nbinfect
rat
third
stage
infect
larva
ml
salin
sc
frora
day
day
inject
rat
receiv
daili
oral
treatment
cfu
l
farcimini
salin
first
seri
rat
exanguin
day
jejunum
lung
segment
collect
mpo
activ
assay
second
seri
number
leucocyt
individu
white
ceil
determin
bronchoalveolar
lavag
bal
result
compar
control
rat
nb
infect
significantli
increas
mpo
activ
jejunum
lung
u
g
protein
respect
l
farcimini
treatment
significantli
reduc
increas
mpo
jejunum
lung
segment
respect
likewis
number
macrophag
neutrophil
lymphocyt
eosinophil
significantli
increas
bal
nbinfect
rat
compar
control
treatment
l
farciraint
significantli
reduc
pulmonari
leucocyt
infiltr
bal
nbinfect
rat
similarli
white
cell
number
reduc
anim
treat
l
farcimini
conclus
work
show
oral
treatment
lfarcimini
antiinflammatori
effect
n
brasiliensi
infect
gut
lung
suggest
neuroimmun
link
two
organ
background
previou
data
show
l
farcimini
reduc
sever
experiment
coliti
releas
nitric
oxid
inhibit
stressinduc
increas
colon
paraceflular
permeabl
sensit
rat
aim
present
studi
determin
whether
benefici
effect
l
farcimini
stressinduc
colon
alter
may
result
intracolon
deliveri
probiot
method
ten
group
femal
wistar
rat
equip
nicr
wire
electrod
abdomin
striat
muscl
group
intracolon
ic
cathet
group
rat
receiv
oral
day
either
salin
group
cfuday
l
farcimini
group
submit
partial
restraint
stress
pr
group
sham
stress
group
stepwis
rectal
distens
rd
mm
fig
increment
mm
fig
perform
group
rain
pr
sham
stress
group
receiv
l
ci
ic
pr
sham
stress
colon
paraceflular
permeabl
assess
measur
radioact
recoveri
urin
h
hemoglobin
scaveng
infus
continu
colon
h
pr
sham
stress
rd
session
group
urin
recoveri
period
group
result
pr
increas
number
abdomin
contract
volum
rd
vs
rain
mm
hg
p
colon
permeabl
vs
p
compar
sham
stress
l
farcimini
treatment
prevent
increas
number
abdomin
contract
whatev
volum
rd
vs
rain
mm
hg
p
increas
permeabl
vs
p
hemoglobin
revers
protect
effect
l
farcimini
stressinduc
hyperalgesia
vs
mn
mm
hg
p
increas
colon
permeabl
vs
p
absenc
l
farcimini
treatment
hemoglobin
effect
per
se
conclus
work
indic
benefici
effect
two
week
treatment
l
farcimini
stressinduc
increas
colon
permeabl
sensit
link
intralumin
releas
probiot
p
fo
ileal
acid
mucinproduc
goblet
cell
number
higher
p
ith
fo
compar
diet
absenc
diarrhea
reduct
chlorid
secret
enhanc
mucos
barrier
function
increas
number
goblet
cell
produc
protect
acid
mucin
fo
indic
ferment
fiber
enhanc
exclus
properti
innat
mucos
immun
system
find
reveal
potenti
mechan
vberebi
consumpt
ferment
dietari
fiber
reduc
infectionassoci
symptom
follow
infect
salmonella
fund
illinoi
council
food
agricul
rural
research
lnlroduct
weftestablish
ingest
probiot
bacteria
reduc
gastrointestin
qection
inflamm
addit
aid
recoveri
effect
function
diarrhea
vce
hypothes
one
mechan
involv
last
therapeut
effect
may
relat
chang
intestin
motil
induc
probiot
method
vitro
experi
ment
perform
upon
isol
ileum
proxim
colon
segment
guinea
pig
whole
bacteria
cell
debri
fraction
cytoplasmat
crude
cell
extract
strain
within
probiot
prepar
vsl
bifidobacteria
lactobacilli
streptococcu
thermophiu
prepar
use
concentr
relev
found
human
intestin
backgroundam
fmlp
shown
enhanc
inflammatori
activ
anim
model
acut
coliti
etiolog
pathway
propos
would
involv
presenc
yet
unknown
initi
factor
antigen
gain
access
subepitheli
space
pathophysiolog
role
import
peptid
chronic
phase
coliti
still
unknown
hypothes
rout
administr
bacteri
peptid
fmlp
either
intraven
iv
intracolon
ic
thu
access
subepitheli
space
would
influenc
differ
inflammatori
respons
chronic
relaps
phase
coliti
method
six
week
initi
induct
acut
coliti
tnb
etoh
ic
chronic
relaps
inflamm
induc
administr
tnb
iv
hour
time
interv
three
day
five
group
rat
chronic
coliti
studi
reactiv
tnb
alon
reactiv
tnb
fmlp
dmso
iv
ic
administr
reactiv
tnb
dmso
iv
ic
administr
colon
remov
score
macroscop
microscop
damag
tissu
taken
myeloperoxidas
activ
section
musclefre
mucosa
mount
uss
chamber
epitheli
cell
basal
short
circuit
ctrrent
isc
resist
r
potenti
differ
pd
respons
acetylcholin
ach
use
indic
tissu
viabil
result
intraven
administr
fmlp
significantli
decreas
isc
tissu
viabil
distal
colon
compar
vehicl
treat
control
alsc
vs
pcm
p
ach
addit
intraven
administr
fmlp
aggrav
macroscop
microscop
damag
induc
tnb
contrast
intracolon
administr
fmlp
modifi
effect
tnb
macroscop
damag
viabil
paramet
reactiv
model
relaps
coliti
conclus
role
baqteri
peptid
chronic
inflamm
far
less
import
confin
lumen
colon
intact
epitheli
barrier
howev
peptid
abl
reach
system
circul
exacerb
ongo
inflamm
contribut
chang
tissu
viabil
damag
support
part
nrsa
niddk
nihmbr
introduct
unmethyl
cpg
motif
predominantli
present
bacteri
dnai
immunostimulatori
via
tolllik
receptor
tlr
commens
bacteria
play
role
maintain
immun
homeostasi
gut
dendrit
cell
dc
play
pivot
role
recogms
respond
microbi
product
includ
dna
shape
develop
cell
respons
therefor
determin
effect
dna
deriv
probiot
bifidobacteria
lactobacilli
streptococcu
salivatiu
subsp
thermophilu
present
probiot
combin
vsl
vsl
pharmaceut
ft
lauderdal
fl
usa
dc
method
dc
whole
blood
enrich
metrizamid
gradient
cultur
dna
deriv
probiot
bacteria
presenc
absenc
dc
identifi
muhicolour
flow
cytometri
hladr
lineag
neg
popul
within
popul
cdllc
myeloid
lc
plasmacytoid
dc
assess
express
activ
marker
analys
flow
cytometri
cytokin
product
ifna
assess
intracellular
stain
elisa
result
probiot
bacteri
dna
activ
myeloid
plasmacytoid
dc
indic
enhanc
express
dnatreat
cultur
dna
deriv
bacteri
strain
potent
induc
product
enrich
dc
popul
assess
elisa
whole
blood
cultur
bacteri
dna
select
induc
myeloid
dc
popul
low
level
transient
induc
bacteri
dna
earli
time
point
select
plasmacytoid
dc
block
led
lower
express
plasmacytoid
dc
decreas
product
myeloid
dc
conclus
bacteri
dna
probiot
strain
potent
ilio
induc
induc
low
level
ifna
dc
given
express
plasmacytoid
dc
may
hypothes
bacteri
dna
exert
primari
earli
effect
plasmacytoid
dc
effect
myeloid
dc
may
either
indirect
via
plasmacytoid
dc
direct
via
yet
unknown
mechan
year
us
million
case
salmonella
infect
infant
year
age
result
vari
degre
diarrhea
hypothesi
studi
fiber
differ
ferment
provid
benefici
effect
ileal
colon
intestin
function
structur
follow
salmonella
typhimurium
infect
piglet
old
n
random
control
c
sow
milk
replac
formula
control
formula
supplement
nonferment
methylcellulos
moder
ferment
soy
polysaccharid
complet
ferment
fructooligosaccharid
f
piglet
infect
coloni
form
unit
oral
gavag
ileal
colon
tissu
harvest
post
infect
electrophysiolog
histolog
analys
regardless
time
ileal
glucos
transport
group
elev
p
f
c
group
group
exhibit
moder
increas
compar
f
c
f
p
time
point
group
show
increas
p
ileal
glutamin
transport
compar
c
f
c
f
colon
glutamin
transport
elev
p
group
compar
treatment
c
f
colon
glutamin
transport
group
increas
compar
group
f
charg
basal
short
circuit
current
group
regardless
time
ileal
crypt
depth
decreas
group
compar
c
f
convers
colon
crypt
depth
group
increas
p
treatment
time
point
p
result
indic
fiber
posit
effect
enter
salmonella
typhimurium
infect
depend
degre
ferment
soy
polysaccharid
appear
elicit
greatest
improv
ileal
colon
function
structur
fund
illinoi
council
food
agricultur
research
baljit
walia
lixin
wang
florencia
castenada
rahul
bajaj
jess
roman
didier
merlin
andrew
gewirtz
shanthi
v
sitaraman
background
signific
host
factor
regul
bactenalepithefi
interact
mostli
unknown
yet
may
play
role
regul
intestin
inflamm
adenosin
potent
endogen
physiolog
regul
inflamm
whose
level
upregul
inflamm
studi
undertaken
investig
role
adenosin
modul
flbronectin
fn
synthesi
polar
fn
secret
effect
typhimurium
st
invas
induct
chemokin
secret
model
intestin
epithelia
method
primari
intestin
epitheli
cell
line
colon
epitheli
cell
line
use
strain
sl
use
invas
assay
measur
elisa
result
adenosin
ad
either
apic
basolater
aspect
cell
led
time
dose
depend
accumul
fn
cultur
supernat
polar
apic
compart
reach
maxim
level
h
apic
basolater
fold
increas
compar
control
addit
adenosin
confoc
microscopi
reveal
fn
local
apic
domain
model
intestin
epitheli
cell
stimul
apic
basolater
adenosin
induct
fn
significantli
downregul
respons
adenosin
receptor
antagonist
afloxazin
pka
inhibitor
complet
abolish
cycloheximid
adenosin
increas
fn
promot
activ
fold
compar
unstimul
control
indic
fn
induct
least
part
transcript
regul
final
pretreat
epithelia
exogen
fn
ugml
lumin
surfac
significantli
enhanc
adher
st
alon
x
fn
st
x
cfuinsert
invas
st
st
alon
x
fn
st
x
cfuinsert
upregul
basal
secret
control
st
fn
st
ngml
respect
intestin
epitheli
cell
infect
bacteria
conclus
use
physiolog
relev
epitheli
model
system
shown
first
time
fn
classic
extracellular
matrix
protein
secret
apic
compart
epitheli
cell
respons
adenosin
fn
may
critic
host
factor
modul
adher
invas
bacteria
st
regul
chemokin
secret
thu
play
key
role
mucosalimmun
respons
inflamm
character
murin
model
enteropathogen
e
coil
infect
suzana
savkov
jennile
villanueva
kristina
matkowskyj
gall
hecht
enteropathogen
e
coil
epec
import
caus
diarrhea
human
epec
infect
cultur
intestin
epitheli
cell
iec
induc
attach
effac
ae
lesion
increas
paracelhilar
permeabl
initi
inflamm
lack
small
anim
model
restrict
vivo
studi
examin
epechost
interact
demonstr
epec
attach
cultur
murin
iec
induc
ae
lesion
activ
inflammatori
molecul
colon
intestin
mice
aim
studi
character
mous
model
epec
infect
six
eight
week
old
mice
infect
epec
day
observ
water
consumpt
bodi
weight
time
sacrific
intestin
inspect
presenc
liquid
vs
form
stool
colon
assess
effac
microvifli
ae
lesion
overal
histolog
mice
infect
citrobact
rodentium
mous
pathogen
genet
similar
epec
use
comparison
day
infect
signific
differ
bodi
weight
water
intak
uninfect
mice
infect
epec
c
rodentium
entir
colon
uninfect
mice
fill
form
stool
pellet
proxim
colon
infect
mice
contain
fluid
form
stool
pellet
distal
colon
trend
toward
increas
colon
weight
infect
anim
mgcm
control
epec
p
c
rodentium
p
respect
hematoxylin
eosin
stain
reveal
crypt
abscess
increas
inflammatori
infiltr
lamina
propria
format
lymphoid
aggreg
loss
goblet
cell
epec
infect
mice
similar
chang
addit
colon
hyperplasia
seen
previous
describ
infect
c
rodentium
immunofluoresc
stain
intimin
epec
adhesin
suggest
adher
microcoloin
surfac
epithelium
costain
actin
reveal
intiminassoci
actin
aggreg
indic
ae
lesion
format
assess
colon
tissu
transmiss
electron
microscopi
confirm
intim
attach
bacteria
effac
microvilli
epec
c
rodentium
infect
mice
conclus
epec
infect
mice
result
ae
lesion
format
increas
colon
weight
liquid
stool
intestin
inflamm
data
demonstr
mous
may
provid
good
model
epec
infect
recent
studi
indic
tnfa
increas
intestin
tj
permeabl
may
import
mechan
lead
increas
antigen
penetr
intestin
inflamm
mechan
tnfa
modul
intestin
epitheli
tj
barrier
remain
unknown
purpos
studi
determin
intracellufar
mechan
involv
tnfc
modul
intestin
tj
barrier
use
filtergrown
intestin
monolay
specif
role
mlck
tj
barrier
regul
examin
method
tj
permeabl
determin
electr
epitheli
resist
epitheli
permeabl
paracelhilar
marker
result
tnfc
produc
concentr
depend
increas
tj
permeabl
alter
junction
local
tj
protein
occludin
tnfa
induc
increas
tj
permeabl
accompani
increas
mlck
express
mlck
inhibitor
prevent
tnfc
increas
tj
permeabl
alter
junction
local
tj
protein
tnfc
increas
mlck
protein
express
hr
preced
nfkb
activ
within
minut
tnfc
suggest
nfkb
activ
may
modul
mlck
express
nfkb
inhibitor
curcumin
prevent
tnfc
increas
mlck
protein
express
confirm
import
nfkb
activ
upregnl
mlck
protein
express
tnfa
also
caus
increas
mlck
mrna
express
indic
upregul
mlck
gene
transcript
process
curcumin
prevent
tnfu
increas
mlck
mrna
express
confirm
requir
nfkb
activ
mlck
gene
transcript
process
conclus
find
indic
tnfu
increas
intestin
tj
permeabl
mediat
increas
mlck
protein
express
data
also
suggest
tnf
x
increas
mlck
protein
express
depend
tnfa
induc
nfkb
activ
base
result
postul
tnf
x
activ
nfkb
lead
upregul
mlck
promot
activ
increas
mlck
gene
transcript
protein
express
subsequ
alter
tj
protein
local
increas
tj
permeabl
inhibit
zonulindepend
increas
intestin
permeabl
prevent
onset
type
diabet
bbwor
rat
anna
sapon
tammara
watt
debra
count
ronald
zielk
barbara
bizzarri
alessio
fasano
background
sever
studi
suggest
increas
intestin
permeabl
ip
due
alter
intestin
tight
junction
tj
involv
pathogenesi
mani
autoimmun
diseas
includ
type
diabet
recent
describ
novel
protein
zonufin
dictat
tj
compet
structurefunct
analysi
protein
allow
us
enguaeer
synthet
peptid
prevent
zonulin
bind
target
receptor
use
bbwor
diabeticpron
dp
rat
anim
model
demonstr
increas
intrafumin
zonufin
concentr
compar
diabeticresist
dr
rat
parallel
increas
ip
preced
onset
aim
establish
whether
fzio
prevent
onset
affect
ip
method
bbqqot
dp
rat
random
age
day
treatment
group
receiv
drink
water
plu
pgml
fzio
bicarbon
placebo
group
receiv
bicarbon
vivo
use
lactulosemannitol
assay
serum
zonulin
glucos
level
monitor
everi
day
rat
blood
glucos
consid
sacrif
within
hour
reach
diabet
statu
small
intest
mount
uss
chamber
measur
transepitheli
intestin
resist
teer
measur
intralumin
zonulin
determin
sandwich
elisa
bbwor
dr
rat
use
control
result
untreat
dp
rat
show
increas
zonulin
level
starti
age
day
parallel
increas
vivo
ip
rat
also
show
elev
zonulin
serum
level
howev
chang
ip
detect
eighti
percent
untreat
dp
rat
dp
rat
progress
diabet
state
averag
age
onset
diabet
significantli
delay
treat
rat
day
compar
untreat
anim
p
dp
rat
th
develop
show
signific
decrement
teer
ileum
compar
dr
rat
dp
rat
treat
show
teer
similar
detect
dr
rat
lntralumin
zonufin
significantli
elev
dp
rat
compar
dr
rat
irrespect
fzio
treatment
conclus
find
suggest
correla
tion
intralumin
zonulin
ip
daili
administr
zonulin
bindin
inhibitor
block
zonulin
permeat
effect
gut
prevent
onset
genet
suscept
bbwor
rat
transform
growth
factor
enhanc
enter
epitheli
barrier
via
activ
erkmapk
signal
upregnl
tight
junction
protein
kathryn
l
howe
colin
r
reardon
derek
mckay
background
mainten
epitheli
barrier
primari
import
balanct
health
diseas
transform
growth
factor
tgf
multifunct
cytokin
immunosuppress
wound
heal
properti
also
notabl
one
small
number
molecul
enhanc
epitheli
barrier
function
mechan
yet
defin
aim
determin
signal
pathway
cellular
chang
respons
tgf
barrier
function
gut
epithelia
method
filtergrown
colon
epitheli
cell
expos
tgf
longml
lh
pretreat
erkmapk
signahng
inhibitor
infect
adenoviru
encod
inhibitori
protein
transepitheli
electr
resist
ter
measur
index
permeabl
erkmapk
tight
junction
tj
protein
express
assess
immunoblot
tj
protein
distribut
visual
confoc
microscopi
result
tgf
elicit
signific
increas
ter
posttreat
p
n
monolay
enhanc
barrier
accompani
increas
express
occludin
determin
western
blot
whole
cell
protein
extract
n
corrobor
data
confoc
microscopi
reveal
thicker
band
perimet
tgf
ceil
compar
control
addit
western
blot
determin
increas
activ
ie
phosphoryl
erkmapk
tgf
exposur
respect
n
pharmacolog
inhibit
erk
activ
adenoviralinduc
inhibit
smad
signal
complet
prevent
tgf
increas
epitheli
barrier
function
monolay
conclus
tgf
epitheli
barrier
depend
erkmapk
smad
signal
like
result
increas
express
tight
junction
immunosuppress
barrierenhanc
role
target
deliveri
tgf
may
use
therapeut
strategi
enteropathi
associ
inflamm
alter
epitheli
permeabl
work
fund
canadian
institut
health
research
zeta
loss
gut
barrier
function
bf
oxid
stress
key
factor
pathogenesi
inflammatori
bowel
diseas
ibd
occludin
critic
bf
molecular
signal
underli
modul
remain
unclear
protein
kinas
c
pkc
key
barrier
permeabl
alter
sought
determin
whether
activ
atyp
pkc
novel
pkc
modul
occhidin
monolay
intestin
cell
method
use
uniqu
cell
clone
stabli
transfect
ectopicallyexpress
either
pkcor
isoform
inhibit
endogen
nativ
express
clone
preincub
egf
pkc
modul
oag
synthet
diacylglycerol
oxid
wild
type
wt
cell
treat
similarli
assess
bf
clearanc
occludin
subcellufar
distribut
phosphoryf
oxid
integr
dmmunoprecipit
page
laser
confocalq
pkc
distribut
activ
dmmunoblot
vitro
kinas
n
grp
result
rel
wt
cell
expos
oxid
clone
stabli
overexpress
pkc
fold
show
activ
protect
bf
occludin
indic
decreas
oxidationnitr
enhanc
particul
distribut
reduc
phosphoryl
increas
architectur
stabil
pkc
express
induc
occludin
stabil
oagindepend
egf
potenti
express
pkc
resid
particul
cytoskelet
fraction
along
occludin
less
cytosol
stabl
antisens
inhibit
pkc
activ
prevent
egf
protect
monolay
occludin
bf
bg
clone
induct
overexpress
fold
led
pkcactiv
instabl
bf
occludin
indic
increas
oxidationcytosohc
distribntionphosphoryf
decreas
architectur
integr
compar
wt
cell
expos
oxid
alon
measur
pkcb
induc
instabl
potenti
oxid
stabl
domin
inactiv
nativ
prevent
oxidantinduc
instabl
ocdudin
bf
conclus
activ
pkc
requir
occhidin
stabil
bf
intestin
monolay
activ
caus
din
instabl
monolay
barrier
disrupt
abil
alter
oxid
phoslat
stabil
occludin
cytoskeleton
novel
molecular
mechan
usli
attribut
pkc
isoform
cell
express
claudin
inflammatori
bowel
diseas
hyam
prasad
katri
kaukinen
roberto
mingrino
thoma
macdonald
jane
collin
k
rround
inflammatori
bowel
diseas
ibd
intestin
permeabl
increas
liev
result
inappropri
exposur
gut
immun
system
bacteri
flora
ight
junction
regul
epitheli
paracellular
permeabl
mechan
involv
llaudin
famili
adhes
transmembran
protein
hypothesis
alter
daudin
express
occur
ibd
inflammatori
cytokin
induc
chang
lethod
examin
express
clandin
inflam
noninflam
colon
q
intmunostain
western
blot
respons
gut
epitheli
cell
cytokin
studi
use
cell
monolay
cultur
monitor
transepitheli
electr
sistanc
ter
permeabl
fiuorescentlylabel
dextran
express
v
etaudin
immunofluoresc
western
blot
gult
normal
colon
claudin
could
detect
wherea
case
activ
id
case
inact
ulcer
coliti
observ
claudin
express
tight
junction
crypt
epitheli
cell
contrast
express
claudin
normal
colon
observ
tight
junction
later
cell
membran
itheli
cell
reduc
surfac
epithelium
case
activ
diseas
western
blot
confirm
find
cell
stain
simultan
antibodi
oboth
claudin
marker
cell
cycl
show
colocalis
two
antigen
hour
exposur
matur
monolay
ter
ifn
tnfa
lngml
led
mean
fall
ter
rel
control
monolay
lind
increas
dextran
permeabl
associ
fall
express
ilaudin
internalis
claudin
mclusion
claudin
propos
contribut
sodiumperm
pore
fight
junction
strand
epithelia
shown
express
increas
crypt
epithelium
ibd
appear
correl
cell
divis
alter
claudin
express
may
instead
respons
increas
level
certain
cytokin
lund
mucosa
ibd
may
underli
increas
permeabl
leakflux
garrhoea
note
diseas
intestin
flora
involv
physiolog
regul
colon
paracellular
permeabl
role
proteinaseactiv
receptor
par
nicola
cenac
rafael
garciavillar
christel
salvadorcarti
jean
fioramonti
lionel
background
role
colon
remain
unclear
previou
data
show
vivo
vitro
activ
colon
increas
paracellular
permeabl
anoth
hand
colon
resid
bacteria
shown
interact
colonocyt
intercellular
tight
junction
mechan
yet
defin
present
studi
aim
identifi
relationship
paraceflular
permeabl
resid
flora
mous
colon
method
ten
group
swiss
mice
use
group
receiv
simultan
week
two
antibiot
drink
water
ampicillin
gl
neomycin
gl
group
receiv
tap
water
mice
treat
tntracolon
infus
either
trypsin
umous
izl
group
twice
group
thrice
group
standard
colon
content
group
twice
group
end
antibiot
treatment
inil
permeabl
measur
group
control
colon
paracellular
permeabl
measur
infus
credta
colon
p
ci
mlh
hr
express
radioact
recov
outsid
colon
colon
collect
mice
immunochemistri
valu
express
mean
sem
group
result
group
untreat
antibiot
trypsin
increas
paracellular
permeabl
vs
p
one
two
infus
colon
content
effect
vs
respect
contrast
treatment
antibiot
decreas
paracellular
permeabl
vs
p
colonocyt
express
compar
control
antibiotictr
mice
singl
infus
trypsin
colon
content
effect
wherea
three
infus
trypsin
two
infus
colon
content
restor
paracellular
permeabl
increas
intestin
permeabl
endotoxemia
play
crucial
role
alcohol
liver
diseas
signific
bodi
evid
indic
acetaldehyd
metabol
product
ethanol
accumul
colon
lumen
alcohol
consumpt
previou
studi
show
acetaldehyd
disrupt
tight
junction
tj
increas
paracellular
permeabl
cell
monofay
present
studi
determin
role
eytoskelet
reorgan
phosphorylatinn
tjand
adheren
junction
aj
protein
evalu
protect
effect
epiderm
growth
factor
egf
acetaldehydeinduc
disrupt
tj
method
cell
transwefl
insert
expos
acetaldehyd
mm
absenc
presenc
egf
nm
hr
permeabl
evalu
measur
transepitheli
electr
resist
ter
unidirect
flux
fitcinulin
fitclipopolysaccharid
lf
reorgan
actin
cytoskeleton
redistribut
tj
aj
protein
determin
confoc
microscopi
actin
bind
tjand
ajprotein
analyz
immunoblot
analysi
isol
factin
fraction
phosphoryl
tjand
ajprotein
tyr
ser
thr
residu
analyz
immunoprecipit
immunoblot
analysi
result
egf
reduc
acetaldehydeinduc
reduct
ter
increas
permeabl
inulin
lp
timeand
dosedepend
manner
egfmedi
protect
effect
apic
basolater
surfac
attenu
ag
specif
inhibitor
egfreceptor
kinas
acetaldehyd
induc
reorgan
actin
cytoskeleton
result
redistribut
occludin
ecadherin
cellular
junction
reduc
level
occludin
ecadherin
associ
factin
egf
reduc
effect
acetaldehyd
actin
cytoskeleton
tjaj
protein
interact
acetaldehyd
increas
phosphoryl
occhidin
ecadherin
tyr
residu
decreas
phnsphoryl
serthr
residu
egf
prevent
effect
acetaldehyd
conclus
result
indic
egf
attenu
acetaldehydeinduc
disrupt
tj
aj
reduc
acetaldehydeinduc
effect
actin
cytoskeleton
phosphoryl
tjand
ajprotein
releas
tjand
ajprotein
actin
cytoskeleton
support
bindingcompetit
experi
cell
expos
excess
sligkvamid
ligand
show
signific
reduct
fzio
immunofluoresc
stain
particl
compar
monolay
expos
scrambl
peptid
suggest
fzio
bind
site
close
synonym
activ
cell
induc
signific
intracellular
cytoskeleton
reorganis
cell
prevent
pretreat
peptid
addit
sligkvamid
lumin
aspect
intestin
decreas
teer
compar
untreat
tissu
chang
complet
prevent
pretreat
conclus
find
suggest
close
relat
moieti
could
target
receptor
zot
zonulin
involv
regul
intercellular
tj
previous
shown
pgmediat
event
respons
initi
recoveri
barrier
function
vitro
porcin
model
intestin
ischemia
although
c
secretori
channel
involv
event
appear
nhe
isoform
involv
unknown
therefor
present
seri
experi
conduct
investig
contribut
select
nhe
isoform
recoveri
barrier
function
hypothes
pgmediat
blockad
respons
recoveri
barrier
function
ischemiainjur
ileum
porcin
ileal
mucosa
subject
ischemia
mount
uss
chamber
measur
transepitheh
electr
resist
ter
unidirect
flux
tissu
bath
indomethacin
block
endogen
pg
product
western
analys
nhe
isoform
perform
blockad
apic
applic
restor
ter
valu
control
level
recoveri
period
ischemiainjur
mucosa
base
improv
ter
compar
tissu
treat
indomethacin
alon
elev
ter
observ
blockad
correl
progress
signific
reduct
mucosaltoseros
flux
jna
histolog
evalu
ischemiainjur
tissu
reveal
epitheli
restitut
complet
within
rain
mount
uss
chamber
indic
sigulfic
increas
ter
presenc
attribut
chang
paracellular
rather
transceflular
resist
altern
blockad
rio
effect
ter
western
blot
identifi
protein
approxim
kda
molecular
mass
isoform
significantli
upregul
ischemia
furthermor
predominantli
express
villu
tip
ileal
porcin
mucosa
immuuoflouresc
label
collect
studi
demonstr
recoveri
barrier
function
presenc
pg
like
partial
attribut
blockad
crohn
patient
abnorm
increas
intestin
epitheli
permeabl
defect
intestin
tight
junction
tj
barrier
propos
etiolog
factor
crohn
diseas
cd
tnfa
produc
increas
intestin
tj
permeabl
sinc
level
markedli
increas
cd
tnfu
increas
intestin
tj
permeabl
could
contribut
factor
intestin
permeabl
defect
cd
purpos
studi
determin
intraceflular
mechan
involv
modul
intestin
epitheli
tj
permeabl
use
filtergrown
intestin
monolay
method
tj
permeabl
determin
electr
epitheli
resist
epitheli
permeabl
paracellular
marker
nfkb
activ
determin
cytoplasmictonuclear
transloc
nfkb
use
immunofluoresc
antibodi
label
nfkb
bind
dna
determin
electromobl
shift
assay
result
tnfa
produc
concentrationand
timedepend
increas
tj
permeabl
tnfa
increas
tj
permeabl
correl
increas
nfkb
activ
bind
activ
nfkb
nfkb
bind
site
dna
inhibit
tnfa
induc
nfkb
activ
select
nfkb
inhibitor
curcumin
triptolid
prevent
increas
tj
permeabl
indic
nfkb
activ
requir
tnfa
increas
tj
permeabl
tnfa
increas
tj
permeabl
accompani
downregul
protein
alter
junction
localiza
tion
protein
tnfa
modul
protein
express
junction
local
also
prevent
nfkb
inhibitor
tnfa
induc
apoptosi
cell
suggest
apoptosi
mechan
involv
tnfu
increas
tj
permeabl
background
zonukn
molecul
involv
regul
intestin
tight
junction
health
diseas
zonulin
mechan
action
partial
defin
biochem
characterist
still
larg
unknown
aim
purifi
stmcturafli
character
zonufin
protein
method
rat
small
intestin
tissu
analyz
combin
gel
filtrat
chromatographi
zonulin
sandwich
ell
rat
intestin
homogen
load
sephacryl
column
fraction
collect
assay
zonulin
content
fraction
also
resolv
sdspage
transfer
immunoblot
zonulinimmunoreact
antizot
antibodi
wild
type
mice
intestin
tissu
test
microsnapwel
assay
transepitheli
electr
resist
teer
zonufin
releas
stimul
tissu
determin
result
fraction
collect
test
zonukn
elisa
contain
highest
zonufin
concentr
western
analysi
reveal
two
major
band
migrat
approxim
appar
mr
zonulinpnsit
fraction
fs
zonufinneg
fraction
reveal
one
immunoreact
band
kda
therefor
kda
band
excis
comassi
bluestain
gel
subject
matrix
assist
laser
desorpt
ioniz
mass
spectrometri
search
use
profound
search
engin
protein
match
reveal
high
similar
protein
estim
z
score
rat
mast
cell
proteas
mcp
n
establish
whether
zonulin
mcpii
moieti
mierosnapwel
experi
conduct
mice
character
pleiotrop
defect
mucos
mast
cell
therefor
lack
mcpli
tissu
mount
microsnapwel
system
expos
increas
time
interv
h
zonufinreleas
stimuli
show
teer
decreas
teer
vs
untreat
tissu
p
parallel
increas
zonulin
releas
ngmg
protein
vs
untreat
tissu
p
similar
observ
stimul
wild
type
anim
respect
conclus
zonufin
structur
function
similar
ident
mcpii
may
repres
one
possibl
intestin
lumin
activ
involv
pathophysioogc
regul
intercellular
tight
junction
background
previou
data
show
acut
stress
increas
colon
paracellular
permeabl
mice
mast
cell
activ
ifn
secret
tcell
stress
impair
epitheli
gut
barrier
lead
excess
antigen
cross
immun
stimul
result
alter
epitheli
cell
intercellular
junction
aim
character
timerel
function
molecular
alter
tight
junction
tj
assess
chang
colonocyt
differenti
follow
acut
stress
method
ven
group
swiss
mice
use
investig
colon
express
mrna
eod
tj
protein
mean
real
time
rtpcr
group
submit
ute
stress
session
consist
content
plu
acoust
stimufi
hour
colon
llect
group
day
stress
session
respect
mice
group
unstress
control
mrna
encod
occludin
analyz
open
state
tj
assess
transmiss
electron
microscopi
tem
loreov
mimic
effect
stress
six
group
swiss
mice
treat
mast
activ
mgkg
ip
day
colon
collect
alkalin
osphatas
ap
activ
marker
colonocyt
differenti
assay
mucos
klmple
morpholog
alter
determin
colon
section
duboscqbrazil
ilv
ation
hemaluneosin
stain
result
three
day
stress
session
express
ina
encod
occludin
decreas
vs
itbitrari
unit
p
vs
p
respect
ompar
control
signific
decreas
zoi
observ
tem
show
tj
leaki
control
morpholog
examin
colon
show
loss
epitheli
integr
submucos
edema
three
day
final
activ
decreas
progress
day
dramat
increas
day
vs
mumg
protein
p
conclus
conclud
acut
stress
initi
postpon
day
deleteri
effect
intestin
barrier
function
alter
tj
thu
increas
paraceflular
permeabl
result
tj
modif
associ
impair
colonocyt
differenti
may
explain
longterm
effect
previou
studi
demonstr
stimul
recoveri
ischemicinjur
porcin
ileum
mechan
involv
reduct
paracellular
permeabl
rather
increas
restitut
furthermor
signal
mechan
respons
center
cisecret
interestingli
restor
secretori
event
appear
mediat
kleli
ci
channel
latter
find
base
uss
chamber
studi
select
blockad
cl
channel
ischemiainjur
porcin
ileum
prevent
barrier
function
wherea
blockad
cftr
outwardli
rectifi
cl
channel
effect
despit
exhibit
mark
reduct
secret
given
critic
role
restor
intestin
barrier
function
conduct
seri
experi
investig
express
local
pattern
cl
channel
ischemiainjur
porcin
ileum
porcin
ileal
mucosa
subject
ischemia
prepar
immunoblot
immunohistochemistri
techniqu
sdspage
perform
tissu
protein
extract
immunoprecipit
control
noniscbem
schemiainjur
porcin
ileal
tissu
co
immunoprecipit
experi
perform
immunoprecipit
extract
probe
occludin
antibodi
immunofloures
immunogold
label
experi
also
perform
express
singl
protein
band
approxim
kda
molecular
mass
signific
upregul
observ
ischemiainjur
ileal
tissu
compar
control
measur
quantit
densitometri
wherea
cftr
downregul
tissu
lmmunogold
electron
microscopi
reveal
local
tight
junction
intestin
epitheli
ceil
recov
ischemia
injuri
furthermor
immunofluoresc
indic
local
predominantli
apic
aspect
interepitheli
region
recov
mucos
villi
lesser
extent
mucos
crypt
coimmunoprecipit
experi
demonstr
occludin
protein
express
exclus
tight
junction
express
immunoprecipit
local
express
cl
channel
tight
junction
suggest
signal
event
initi
activ
transport
initi
recoveri
paracellular
resist
note
previou
studi
colon
permeabl
increas
rectal
auodynia
induc
lp
ecoli
raphael
moriez
helen
eutamen
christel
salvadorcarti
jean
fioramonti
lionel
bueno
background
septic
shock
associ
gut
immun
stimul
increas
paraceflular
permeabl
lead
bacteri
transloeat
viscer
pain
rat
ip
administr
lp
ecoli
caus
rectal
allodynia
studi
aim
evalu
whether
lpsiaduc
increas
colon
permeabl
link
epitheli
cell
cytoskeleton
contract
wether
rectal
lpsinduc
allodynia
result
alter
permeabl
method
first
group
male
wistar
rat
equip
vith
intracolon
cathet
receiv
respect
vehicl
control
lp
ecoli
l
lmgkg
mlck
inhibitor
prior
lp
inject
alon
colon
permeabl
measur
intracolon
inject
express
percent
radioact
collect
urin
secondli
abdomin
contract
criteria
viscer
pain
assess
rat
equip
intramuscular
nicr
wire
electrod
rectal
distens
perform
lp
administr
rat
pretreat
thirdli
treatment
western
blot
phosphoryl
mlc
tight
junction
electron
microscopi
examin
colon
epithelium
perform
result
lp
increas
colon
permeabl
control
p
significantli
attenu
effect
p
vs
control
lp
promot
delay
rectal
aflodynia
increas
number
abdomin
cramp
control
lowest
volum
distens
prevent
rectal
allodynia
p
electron
microscopi
show
lpsinduc
alter
tightjunct
integr
control
vs
p
associ
increas
phosphoryl
form
mlc
lp
treat
rat
effect
abolish
p
measur
paramet
effect
per
se
conclus
rat
lpsinduc
allodynia
distens
result
increas
paraceflular
permeabl
effect
link
lpsinduc
activ
mlck
phosphoryl
mlc
result
tightjunct
open
acut
stressinduc
colon
hypersensit
link
increas
paracellular
permeabl
rat
role
myosin
light
chain
kinas
afifa
aitbelgnaoin
sylvi
bradesi
vassilia
theodor
jean
finramonti
lionel
bueno
background
hypersensit
rectal
colon
distens
character
ib
patient
increas
gut
permeabl
describ
postdysenter
ib
patient
howev
link
estabhsh
two
pathophysiolog
event
aim
studi
determin
rat
whether
blockad
stressinduc
increas
colon
paraceflular
permeabl
reduc
concomit
hypersensit
colon
distens
ii
role
epitheli
cell
cytoskeleton
contract
effect
stress
permeabl
subsequ
hypersensit
method
eight
group
femal
wistar
rat
equip
intracolon
ic
cathet
hicr
wire
electrod
abdomin
striat
muscl
rat
submit
partial
restraint
stress
pr
group
sham
stress
group
tap
tight
junction
chemic
blocker
vehicl
infus
hour
mlh
pr
sham
stress
group
myosin
light
chain
kinas
inhibitor
mlck
mgkg
ip
inject
three
time
h
interv
pr
sham
stress
group
group
submit
progress
rectal
distens
rd
stepwis
volum
ml
rain
pr
session
sham
stress
group
receiv
slcredta
l
ilci
ic
pr
sham
colon
permeabl
assess
measur
radioact
poststress
urin
collect
result
pr
increas
colon
permeabl
vs
number
abdomin
contract
volum
rd
eg
ml
vs
min
compar
sham
tap
suppress
stressinduc
increas
colon
permeabl
vs
sensit
colon
distens
eg
ml
vs
rain
similarli
block
stressinduc
increas
colon
paracellular
permeabl
vs
sensit
eg
ml
vs
min
treatment
tap
effect
per
se
permeabl
sensit
absenc
stress
conclus
data
show
increas
colon
permeabl
induc
acut
stress
respons
stressinduc
rectal
hypersensit
result
epitheli
cell
cytoskeleton
contract
activ
mlck
consequ
mlck
inhibitor
may
repres
promis
treatment
postinfect
ib
potenti
mechan
underli
genisteinlnduc
chang
intestin
cell
dynam
neonat
piglet
intestin
anchian
chen
sharon
donovan
current
us
infant
fed
soy
formula
contain
mg
genisteinl
goal
investig
impact
oral
genistein
neonat
intestin
develop
piglet
fed
formula
con
alon
contain
lg
mgl
genistein
hg
cellular
prolifer
jejun
crypt
reduc
p
enterocyt
migrat
reduc
piglet
fed
hg
formula
estrogen
receptor
b
erb
express
small
intestin
high
affin
genistein
jejun
erb
mrna
express
lower
p
hg
group
compar
lg
group
neither
significantli
differ
con
genistein
signal
cell
prolifer
involv
protein
tyrosin
kinas
src
genistein
potent
specif
tyrosin
kinas
inhibitor
potentiafli
inhibit
src
activ
lead
observ
decreas
prohfer
jejun
crypt
cell
protein
abund
csrc
phosphosrc
determin
immunoblot
differ
abund
either
protein
observ
among
treatment
group
howev
lack
differ
may
impact
time
intestin
sampl
collect
rel
feed
geinstein
differ
csrc
phosphoryl
detect
within
minut
vitro
lastli
investig
whether
trend
suppress
enterocyt
migrat
hg
group
due
chang
trefoil
factor
express
protein
promot
cell
migrat
induc
estrogen
itf
express
jejunum
ileum
significantli
differ
among
group
express
stomach
lower
geinstein
group
compar
con
summari
genistein
concentr
present
soy
formula
detriment
impact
intestin
cell
dynam
downregul
jejun
erb
mrna
express
neonat
small
intestin
fund
state
illinoi
council
food
agricultur
research
express
intestin
amino
acid
peptid
transport
subject
regul
substrat
avail
includ
manipul
dietari
protein
intak
enterocyt
utilis
signific
proport
absorb
amino
acid
may
influenc
adapt
respons
determin
intestin
express
affect
remov
dietari
nutrient
studi
mrna
express
seri
nine
transport
amino
acid
peptid
nutrit
maintain
rat
oral
intak
transport
illustr
vari
pattern
express
along
longitudin
axi
intestin
vari
localis
lumin
basolater
plasma
membran
domain
role
specif
intestinotroph
hormon
respons
investig
group
rat
six
animalsgroup
maintain
total
parenter
nutrit
tpn
tpn
control
anim
orallyf
mrna
abund
transport
determin
proxim
distal
small
intestin
mucosa
use
semiqnantit
rtpcr
cell
grown
presenc
absenc
proxim
small
intestin
absenc
dietari
nutrient
specif
increas
express
mrna
nbat
mrna
abund
increas
distal
small
intestin
mrna
abund
unaffect
revers
effect
cell
decreas
express
absenc
lumin
amino
acid
suppli
enterocyt
adapt
maximis
amino
acid
uptak
meet
requir
three
subgroup
transport
identifi
differ
respons
tpn
may
reflect
differ
role
substrat
transport
locat
apic
basal
along
proximaldist
axi
intestin
reduc
transport
express
tpnfed
rat
cell
possibl
direct
effect
enterocyt
import
maintain
amino
acid
suppli
intestin
mucos
function
illustr
clone
express
three
member
human
gene
famili
use
saccharomyc
cerevisia
model
system
gene
express
aaron
turkish
mahajabeen
padamse
peter
oelker
annett
l
henneberri
stephen
l
sturley
investig
mechan
neutral
lipid
accumul
galvan
worldwid
epidem
obes
diabet
atherosclerosi
clarifi
physiolog
pathway
neutral
lipid
synthesi
role
enzym
involv
reaction
may
lead
therapeut
advanc
diseas
acylcoa
diacylglycerol
acyltransferas
dgat
activ
mediat
least
two
independ
enzym
human
turn
via
everexpand
human
genom
databas
shown
six
homologu
gene
famili
three
member
report
encod
acylcoa
monoacylglycerol
acyltransferas
mgat
function
three
gene
yet
describ
use
saccharomyc
cerevisia
model
system
explor
mechan
neutral
lipid
synthesi
demonstr
almost
complet
elimin
triglycerid
tg
synthesi
combin
delet
gene
acatrel
enzym
catalyz
phosphofipid
diacylglycerol
acyltransferas
reaction
yeast
ortholog
knockout
strain
transform
human
well
three
novel
gene
human
dgat
candid
gene
human
dgat
candid
gene
uudescrib
gene
name
background
short
chain
fatti
acid
scfa
absorb
enterocyt
small
intestin
littl
known
effect
small
intestin
motor
activ
scfa
absorpt
aim
studi
investig
relationship
spatiotempor
characterist
postprandi
duoden
motor
activ
absorpt
scfa
octano
acid
use
micromanometri
ncoctano
acid
breath
test
obt
materi
method
duoden
manometri
perform
healthi
volunt
women
men
median
age
yr
rang
use
cathet
incorpor
duoden
side
hole
space
interv
mix
nutrient
liquid
administ
intradnodenafli
kcal
total
follow
mg
octano
acid
label
nc
dissolv
ml
water
given
bolu
pressur
record
rain
infus
octano
acid
ncobt
perform
simultan
breath
sampl
taken
everi
minut
recoveri
nc
breath
sampl
measur
absorpt
octano
acid
manometr
analysi
period
analyz
data
duoden
side
hole
cluster
cluster
cover
cm
result
median
time
peak
excret
min
rang
median
absorpt
rate
micromolmin
rang
absorpt
rate
octano
acid
relat
mean
amplitud
duoden
pressur
wave
duoden
pw
second
cluster
r
p
first
rain
infus
octano
acid
recoveri
uc
relat
mean
amplitud
duoden
pw
cluster
relat
stronger
proxim
cluster
resp
r
p
r
p
distal
cluster
r
p
number
duoden
pw
relat
absorpt
scfa
either
time
place
conclus
mean
amplitud
duoden
pw
influenc
amount
absorpt
absorpt
rate
scfa
first
rain
avail
scfa
relat
observ
number
duoden
pw
scfa
absorpt
contribut
blood
clearanc
model
triglyceriderich
particl
target
specif
tissu
mimi
n
ton
nada
abumrad
richard
j
deckelbaum
fatti
acid
trartslocas
homolog
human
fatti
acid
transport
multifunct
adhes
receptor
scaveng
receptor
platelet
monocyt
whose
express
mainli
preferenti
tissu
high
fatti
acid
metabol
eg
adipos
tissu
intestin
oxid
red
muscl
fiber
question
role
blood
clearanc
tissuetarget
triglyceriderich
particl
tgrp
phospholipidstabil
emuls
commerci
avail
soy
oil
triglycerid
use
model
chylomicrons
tgrp
emuls
doubleradiolabel
nonhydrolyz
cholesteryl
oleoyl
ether
ce
triolein
follow
intraven
inject
nonsatur
dose
knockout
wildtyp
wt
litterm
fed
fast
state
order
determin
tgrp
tgrp
whole
particl
uptak
tg
hydrolysi
respect
show
clearanc
ce
tfiolein
comparison
wt
mean
fraction
catabol
rate
fcr
rate
movement
radioact
marker
blood
bodi
compart
wt
vs
fed
state
vs
poolshr
fast
state
fcr
wt
poolshr
respect
experi
triton
compound
obliter
tgrp
hydrolysi
perform
determin
whether
hydrolysi
affect
tgrp
uptak
inject
triton
result
signific
decreas
tg
hydrolysi
wt
decreas
tgrp
uptak
howev
proport
decreas
fcr
wt
experi
without
triton
support
hypothesi
uptak
tgrp
independ
tg
hydrolysi
data
show
higher
uptak
tgrp
heart
howev
occur
fed
state
collect
trend
greater
tgrp
uptak
wt
muscl
adipos
tissu
vs
count
per
minut
cpm
g
tissu
muscl
cpmg
tissu
adipos
tissu
respect
result
strongli
indic
novel
role
chylomicron
clearanc
tissuetarget
background
aim
iron
absorpt
attribut
activ
highli
regul
iron
uptak
pathway
localis
duodenum
howev
dietari
iron
absorb
duodenum
mean
reach
distal
small
intestin
colon
recent
work
led
identif
sever
gene
uptak
pathway
mice
human
main
dietari
iron
form
lumen
gut
must
reduc
form
duoden
ferric
reductas
dcytb
taken
enterocyt
transport
across
apic
membran
enterocyt
dival
metal
transport
lregl
respons
basolater
transport
iron
bodi
express
gene
mainli
localis
within
small
intestin
duodenum
proxim
jejunum
howev
local
function
gene
larg
intestin
fulli
understood
therefor
investig
cellular
localis
regul
express
gene
mous
caecum
colon
method
quantif
express
target
gene
ie
dcytb
iregl
rtpcr
carri
mean
lightcycl
roch
diagnost
gmbh
penzberg
germani
use
rna
extract
iron
defici
hypox
mous
larg
intestin
compar
control
protein
localis
regul
gene
measur
immunohistochemistri
use
frozen
section
larg
intestin
mice
result
dcytb
mrna
express
low
level
larg
intestin
compar
duodenum
contrast
iregl
mrna
express
signific
level
larg
intestin
increas
iron
defici
caecum
proxim
distal
colon
signific
increas
seen
distal
colon
hypoxia
increas
iregl
express
proxim
colon
immunohistochemistri
signific
level
iregl
detect
basolater
membran
colon
epitheli
cell
contrast
dcytb
virtual
undetect
apic
membran
colon
enterocyt
conclus
conclud
colon
epitheli
cell
express
basolater
lregl
capabl
regul
iron
transport
howev
dcytb
virtual
undetectahl
indic
uptak
pathway
iron
colon
may
differ
duodenum
iron
absorpt
colon
may
import
determin
whole
bodi
colon
epitheli
level
iron
compar
gene
chip
analysi
gene
mice
depriv
dietari
phosphat
jennif
k
uno
hua
xu
pawel
r
kiela
samantha
h
serey
jame
f
collin
fayez
k
ghishan
introduct
inorgan
phosphat
pi
necessari
mani
homeostat
mechan
mammal
thu
understand
intestin
absorpt
dietari
pi
great
import
date
napillh
cotransport
known
pi
transport
small
intestin
hypothes
unidentifi
gene
involv
small
intestin
pi
transport
homeostat
regul
pi
metabol
therefor
current
studi
design
identifi
novel
gene
involv
phosphat
homeostasi
intestin
transport
mice
method
mice
place
high
low
pi
contain
diet
week
mice
sacrif
per
group
intestin
mucosa
harvest
proxim
half
small
intestin
rna
purif
trizol
reagent
total
rna
sampl
process
accord
standard
protocol
produc
cdna
crna
crna
hybrid
mous
genom
express
array
affymetrix
array
wash
stain
scan
result
data
analyz
affymetrix
softwar
experi
repeat
two
time
differ
anim
group
result
data
analysi
reveal
gene
increas
express
dietari
pi
depriv
gene
exhibit
decreas
express
qualiti
control
paramet
establish
affymetrix
within
accept
rang
interestingli
gene
involv
ca
ion
transport
inositol
receptor
cholesterol
fatti
acid
transport
fatti
acid
bind
protein
metabol
udpglucoronosyhransferas
apoptosi
clusterln
among
signific
changer
treatment
addit
number
gene
implic
signal
transduct
pathway
also
show
chang
transcript
express
cholecystokinin
receptor
discuss
mous
array
allow
simultan
analysi
wellestablish
gene
studi
reveal
signific
number
differenti
express
gene
dietari
pi
depriv
particular
interest
gene
pertain
nutrient
transport
suggest
exist
novel
pathway
involv
regul
intestin
pi
homeostasi
transport
investig
support
nih
grant
introduct
mani
gene
express
human
small
intestin
genomewid
microarray
technolog
provid
sophist
tool
obtain
gener
inform
process
genet
control
data
avail
genomewid
gene
express
profil
human
small
intestin
abil
regul
biochem
process
transcriptom
level
nutrit
intervent
method
eight
volunt
test
two
separ
occas
overnight
fast
duoden
biopsi
taken
horizont
part
duodenum
cm
distal
pyloru
obtain
gastroduodenoscopi
subsequ
perfus
cathet
insert
proxim
small
intestin
inject
port
locat
proxim
descend
duodenum
posit
segment
proxim
small
intestin
perfus
salin
reach
steadi
state
either
mg
iron
ferrou
glucon
rain
final
salin
perfus
anoth
rain
second
duodenoscopi
perform
obtain
tissu
sampl
iron
challeng
gene
express
profil
tissu
sampl
measur
use
affyraetrix
microarray
chip
map
gene
inform
biolog
process
affect
iron
challeng
investig
use
genmapp
softwar
http
wwwgenmapporg
result
among
gene
express
baselin
tissu
sampl
gene
statist
increas
administr
lowand
high
iron
dose
respect
wherea
gene
significantli
downregul
respect
furthermor
gene
tend
mediat
iron
challeng
genmapp
analysi
reveal
iron
challeng
strongli
mediat
number
process
mainli
associ
signal
transduc
tion
conclus
microarray
technolog
profil
provid
use
tool
gener
research
hypothes
design
studi
larg
unknown
phenomena
respons
intestin
mucosa
nutrient
intervent
biolog
implic
microarrray
result
investig
addit
dedic
experi
changedmeasur
cell
cycl
gpcr
class
c
calcium
channel
tradit
japanes
diet
contain
high
level
offish
soy
associ
low
risk
colorect
cancer
good
epidemiolog
evid
support
protect
effect
fish
protect
effect
hrt
treatment
suggest
estrogen
like
compound
may
also
benefici
oestrogen
receptor
er
express
colon
er
predomin
form
phytooestrogen
preferenti
bind
aim
present
studi
investig
effect
fish
oil
soy
isoflavonoid
phytoestrogen
mitosi
apoptosi
express
er
ct
ib
colon
mucosa
method
femal
spragu
dawley
rat
expos
diet
contain
soy
extract
dri
wt
rich
isoflavonoid
dri
wt
extract
menhaden
oil
diet
period
two
week
apoptosi
mitosi
assess
microdissect
isol
crypt
describ
previous
express
oestrogen
receptor
housekeep
gene
gapdh
determin
rtpcr
use
taqman
result
fish
oil
soy
isotlavonoid
significantli
reduc
cypt
ceil
prolifer
fish
oil
increas
apoptosi
furthermor
diet
result
decreas
express
er
u
gene
fish
oil
soy
isoflavon
reduct
three
fold
increas
express
er
gene
compar
control
anim
conclus
upregul
er
gene
associ
antiprolif
effect
colorect
cancer
cell
thu
might
predict
protect
relat
develop
colorect
cancer
role
er
c
colon
uncertain
although
downregul
might
reduc
protect
effect
estradiol
colorect
carcinogenesi
howev
better
understand
rel
import
er
c
er
aetiolog
colorect
cancer
requir
extrapol
predict
effect
colorect
cancer
risk
increas
intestin
permeabl
endotoxemia
play
crucial
role
alcohol
liver
diseas
signific
bodi
evid
indic
acetaldehyd
metabol
product
ethanol
accumul
colon
lumen
alcohol
consumpt
previou
studi
showet
acetaldehyd
disrupt
yj
increas
paracelluiar
permeabl
cell
monolay
present
studi
evalu
protect
effect
lglutamin
acetaldehydeinduc
cytoskelet
reorgan
phosphoryl
tjand
adheren
junction
aj
protein
disrupt
tj
method
cell
transwel
insert
expos
acetaldehyd
txm
absenc
presenc
lglutamin
ram
hr
permeabl
evalu
measur
transepitheli
electr
resist
ter
unidirect
flux
inulin
lp
endotoxin
reorgan
actin
cytoskeleton
redistribut
tjand
ajpmtein
determin
confoc
microscopi
actin
bind
tjand
ajprutein
analyz
immunoblot
analysi
isol
factin
fraction
phosphoryl
tjand
ajprotein
tyr
ser
thr
residu
analyz
immunoprecipit
immunoblot
analysi
result
acetaldehyd
reduc
ter
increas
permeabl
inulin
lp
reduc
lglutamin
dglutamin
timeand
dosedepend
manner
protect
effect
glntamin
unaffect
glutaminas
inhibitor
laspargin
larginin
llysin
lalanin
show
signific
protect
acetaldehyd
lglutamin
prevent
acetaldehydeinduc
reorgan
actin
cytoskeleton
redistribut
occludin
ecadherin
cellular
junction
prevent
reduct
level
occludin
zoi
ecadherin
catenin
associ
factin
lglutamin
also
reduc
acetaldehydeinduc
increas
phosphoryl
occludin
ecadherin
catenin
tyr
residu
decreas
phosphoryl
serthr
residu
conclus
result
indic
lglntamln
attenu
acetaldehydeinduc
disrupt
tj
aj
reduc
acetaldehydeinduc
reorgan
actin
cytoskdeton
chang
phosphoryl
ecadherin
occludin
releas
tjand
ajprotein
factin
support
monitor
esophag
bodi
le
pressur
infus
cathet
system
dent
sleev
amdorf
inc
usa
monitor
esophag
ph
cm
le
microglass
ph
meter
microelectrod
inc
usa
serum
level
glucos
insulin
gastrin
measur
interv
hour
interv
hour
ingest
en
ml
label
mg
sodium
acet
cambridg
isotop
laboratori
inc
usa
breath
sampl
automat
continu
obtain
exclus
nasal
cannula
hour
ingest
test
meal
increas
en
viscos
g
low
methylest
pectin
ingest
entera
solut
studi
repeat
subject
anoth
day
result
ad
pectin
gastric
empti
coeffici
determin
breath
test
vs
mean
se
motil
index
gastric
antrum
measur
manometri
vs
significantli
p
higher
hour
ingest
without
pectin
studi
peak
gastrin
level
rain
ingest
decreas
rain
insulin
glucos
insulogen
index
differ
studi
conclus
gastric
amral
motil
lower
absenc
pectin
en
viscos
increas
ad
pectin
gastric
empti
enhanc
increas
antral
motil
increas
viscos
might
inhibit
rapid
flow
en
duodenum
ingest
inhibit
gastric
motil
via
duodenogastr
feedback
rather
chang
gastrin
level
recent
member
sglt
famili
bind
glucos
high
kd
transport
across
membran
identifi
put
glucos
sensor
intestin
diezsampedro
et
al
pna
specif
aim
studi
determin
rule
mediat
glucosedepend
releas
intestin
secret
method
human
bon
cell
line
model
ec
cell
use
determin
cellular
mechan
releas
chang
intracellular
calcium
measur
respons
glucos
mm
use
monolay
cell
mrna
measur
taqman
real
time
pcr
intestin
secret
measur
chang
weight
agams
cylind
insert
termin
ileum
anesthet
rat
secret
measur
respons
glucos
cmethylglucos
nonmetaboliz
glucos
analog
galactos
substrat
mannitol
mmole
min
pretreat
po
group
result
glucos
increas
intracellular
calcium
mm
chang
ratio
rim
mm
glucos
mrna
signal
detect
bon
cell
glucos
caus
signific
decreas
ileal
fluid
absorpt
compar
vehicl
treatment
vs
p
ameglucos
also
caus
signific
decreas
fluid
absorpt
vs
l
p
wherea
mannitol
galactos
signific
effect
ileal
secret
conclus
glucosemedi
releas
involv
candid
regul
releas
ec
cell
may
play
key
role
nutrient
sens
gut
diet
high
glucos
may
exacerb
diarrhea
andor
constip
associ
ib
ibd
may
result
chronic
mismatch
signal
abil
intestin
mucosa
mount
appropri
secretori
motil
respons
dietari
sugar
effect
fat
appetit
gastrointestin
gi
motil
secret
gi
hormon
includ
cholecystokinin
cck
glucagonlik
may
critic
depend
chain
length
fatti
acid
releas
lipolysi
postul
duoden
administr
lauric
acid
carbon
atom
would
suppress
appetit
modul
antmpylomduoden
apd
pressur
wave
pw
stimul
releas
cck
greater
extent
decano
acid
carbon
atom
healthi
men
year
studi
three
separ
day
doubleblind
randomis
fashion
appetit
percept
apd
pw
plasma
cck
concentr
measur
min
intraduoden
infus
ii
cio
iii
control
rate
mlmin
kcalmin
cio
total
amount
kcal
kj
energi
intak
quantifi
buffet
meal
offer
immedi
complet
infus
suppress
appetit
percept
p
energi
intak
p
figur
cio
induc
nausea
p
stimul
basal
pylor
pressur
peak
pressur
chang
baselin
mmhg
control
isol
pylor
pw
p
suppress
antral
duoden
pw
compar
control
p
transient
stimul
isol
pylor
pw
p
effect
antral
pw
markedli
stimul
duoden
pw
p
increas
plasma
cck
p
peak
conc
pmoll
cio
control
effect
substanti
greater
p
also
stimul
wherea
cio
p
peak
conc
pmoll
control
conclud
major
differ
effect
intraduoden
administ
appetit
energi
intak
apd
pw
gut
hormon
releas
human
observ
may
import
implic
use
appetit
suppress
background
disord
gastrointestin
function
includ
gastroparesi
occur
frequent
type
diabet
acut
chang
blood
glucos
concentr
major
effect
gastrointestin
motor
sensori
function
diabet
like
mani
motil
disturb
gastrointestin
symptom
associ
diabet
mediat
sensori
pathway
vagu
nerv
detect
glucos
proxim
small
intestin
circul
via
hepat
portal
vein
signal
brain
stem
anatom
molecular
compon
constitut
intestin
glucosensor
current
unknown
aim
determin
local
pattern
candid
molecul
involv
sens
glucos
duodenum
hepat
portal
vein
method
rat
duallabel
immunohstochemistri
perform
glucos
transport
suri
sulfonylurea
receptor
compon
pancreat
ka
potassium
channel
complex
duodenum
hepat
portal
vein
pancrea
tongu
site
known
suspect
detect
glucos
peripheri
anterograd
trace
dil
perform
nodos
ganglion
assess
vagal
innerv
rat
duodenum
hepat
portal
vein
result
rat
confirm
label
antibodi
specif
popul
pancreat
ceil
demonstr
presenc
apic
basolater
membran
duoden
epithelium
label
nerv
fiber
duoden
lamina
propria
shown
label
like
extrins
vagal
spinal
sensori
nerv
also
label
sensori
peptid
cgrp
anterograd
trace
show
vagal
end
close
proxim
duoden
lumen
within
endothelium
hepat
portal
vein
conclus
observ
suggest
glucos
may
activ
duoden
sensori
nerv
close
kate
potassium
channel
novel
mechanisn
consid
far
peripher
nerv
initi
point
glucos
sens
pathway
sensori
nerv
remain
characteris
anterograd
trace
result
strongli
suggest
hepat
sensori
fibr
sampl
venou
blood
directli
possibl
glucos
content
without
interven
cell
type
contrast
current
believ
background
ige
mediat
food
allergi
fa
result
driven
inflamm
caus
loss
gut
mucos
integr
elev
intestin
permeabl
aim
studi
investig
increas
permeabl
correl
allergen
potenc
differ
aliergen
sensit
challeng
anim
method
establish
model
fa
rat
brown
norway
male
week
old
system
sensit
peanut
p
spinach
ribulos
extract
sr
food
protein
oral
challeng
twice
correspond
protein
day
control
anim
treat
pb
one
hour
allergen
challeng
intestin
permeabl
measur
lactulos
mannitol
test
anim
receiv
sugar
probe
molecul
gavag
feed
urin
recoveri
quantifi
use
hplc
puls
electrochem
detect
assess
allergeninduc
immun
respons
total
allergen
specif
lge
level
serum
vitro
prolifer
respons
spleen
mnc
allergenmitogen
stimul
determin
result
despit
absenc
gastrointestin
clinic
symptom
intestin
permeabl
significantli
increas
two
fold
p
sensit
challeng
anim
compar
pb
control
lactulos
mannitol
ratio
pi
vs
sr
result
moder
also
signific
increas
pi
data
correspond
well
degre
aflergeinc
p
sr
observ
present
model
allergen
sensit
anim
result
enhanc
total
ige
serum
level
found
signific
increas
total
ige
level
peanut
sensit
anim
compar
pb
control
total
ige
versu
mgdl
small
differ
p
sr
group
total
ige
versu
furthermor
consider
level
specif
ige
induc
p
sensit
anim
luml
restimul
spleen
mnc
correspond
allergen
result
increas
prolif
respons
anim
sensit
peanut
sr
conclus
vivo
measur
intestin
permeabl
sensit
paramet
assess
earli
barrier
dysfunct
induct
lge
mediat
fa
help
estim
allergen
potenc
aliergen
background
unknown
whether
gastric
volum
respons
feed
influenc
meal
consist
aim
compar
gastric
volum
respons
isocalor
liquid
mix
solidliquid
meal
document
intraand
interindividu
reproduc
gastric
volum
measur
use
spect
imag
iv
method
eight
healthi
volunt
particip
studi
gastric
volum
measur
respons
ingest
liquid
nutrient
meal
occas
least
month
apart
within
week
second
liquid
meal
studi
particip
underw
third
studi
gastric
volum
respons
mix
meal
order
mix
second
liquid
meal
random
pair
test
compar
gastric
volum
mix
liquid
isocalor
meal
result
fast
postprandi
gastric
volum
associ
two
liquid
meal
significantli
differ
gastroparesi
frequent
limit
nutrit
critic
ill
underli
gastroduoden
motor
dysfunct
poorli
defin
assum
reflect
gastric
pump
failur
potenti
contribut
increas
small
intestin
si
feedback
unknown
aim
studi
determin
effect
gastric
submaxim
nutrient
infus
antropyloroduoden
apd
motil
gastric
empti
critic
ill
apd
pressur
record
mechan
ventil
patient
age
yr
apach
score
healthi
volunt
age
yr
use
channel
manometr
assembl
incorpor
sleev
sensor
measur
pylor
pressur
read
made
fast
si
infus
ensur
lkcalml
follow
gastric
bolu
ensur
gastric
empti
intragastr
ensur
measur
use
octano
breath
test
gastric
empti
coeffici
gec
calcul
studi
period
randomis
volunt
studi
separ
day
frequenc
antral
localis
pylor
duoden
pressur
wave
phase
activ
determin
analysi
mix
model
anova
result
summaris
tabl
volunt
neither
gastric
sl
nutrient
affect
apd
motil
compar
fast
valu
confirm
nutrient
dose
submaxim
antral
motil
decreas
condit
patient
compar
healthi
subject
si
nutrient
stimul
pylor
pressur
wave
patient
frequenc
greater
healthi
subject
phase
activ
decreas
si
nutrient
infus
volunt
critic
ill
gastric
empti
slower
patient
invers
relat
pylor
pressur
wave
frequenc
p
conclud
critic
ill
regul
fast
apd
motil
impair
increas
small
intestin
sensit
nutrient
may
contribut
delay
gastric
empti
background
recurr
abdomin
pain
rap
common
symptom
children
adolesc
rap
children
poorli
character
aim
measur
preval
rap
among
children
commun
describ
clinic
constel
natur
histori
rap
method
inform
consent
children
attend
two
middl
school
one
elementari
school
parent
complet
standard
questionnair
concern
socioeconom
paramet
abdomin
pain
intens
frequenc
durat
natur
rap
possibl
relationship
school
activ
eat
pattern
upper
gastrointestin
symptom
child
report
abdomin
pain
complet
muhidimension
measur
rap
consist
subscal
pain
intens
scale
item
nonpain
symptom
scale
item
satisfact
scale
item
result
children
invit
complet
questionnair
repos
rate
mean
age
year
children
classifi
rap
met
apley
criteria
overal
preval
rap
among
boy
vs
among
girl
ethnic
differ
rap
black
hispan
white
children
respect
pain
discomfort
occur
oncemonth
among
report
case
abdomin
pain
base
pain
intens
scale
report
moder
sever
pain
pain
minut
nausea
bloat
common
upper
symptom
associ
pain
eat
fresh
fruit
play
protect
role
rap
ci
children
serv
fruitsweek
compar
daili
serv
invers
correl
observ
rap
eat
fast
food
children
eat
daili
fastfood
restaur
frequent
episod
pain
eat
onceweek
ci
p
conclus
high
preval
abdomin
paindiscomfort
among
school
children
sever
enough
interfer
school
activ
healthi
eat
habit
appear
play
protect
effect
rap
children
effect
vip
agonist
agonist
experiment
acut
pancreat
tetsuhid
ito
mizuho
kojima
hisato
igarashi
takamasa
ohno
yoshiynki
arita
ken
kawab
david
h
coy
robert
jensen
hajim
nawata
background
aim
date
clarifi
vip
receptor
exist
immun
ceil
lymphocyt
monocyt
macrophag
indic
vip
may
involv
immun
inflammatori
respons
effect
vip
cours
acut
pancreat
unclear
address
investig
effect
select
agonist
two
subtyp
vip
receptor
vpac
agonist
acut
pancreat
method
acut
pancreat
induc
mice
four
intraperiton
inject
caemlein
cn
gkg
singl
inject
lp
mgkg
hour
first
cn
inject
agonist
agonist
secretin
nmolfoodi
administ
minut
administr
lp
serum
amylas
tnfc
level
determin
histolog
chang
pancrea
evalu
vitro
isol
monocyt
origin
spleen
determin
product
hour
stimul
lp
ngml
vip
agonist
agoinst
also
investig
express
mrna
monocyt
result
agonist
significantli
decreas
serum
amylas
tnfcx
wherea
agonist
produc
mark
increas
amylas
level
histolog
vip
agonist
attenu
sever
pancreat
wherea
agonist
secretin
show
signific
effect
pancrea
vitro
mrna
obvious
express
monocyt
stimul
lp
vip
present
biphas
pattern
decreas
product
monocyt
concentr
enhanc
high
concentr
agonist
reduc
level
wherea
agonist
increas
dosedepend
agonist
reduc
tnfc
level
dose
depend
manner
conclus
result
indic
vip
attenu
sever
experiment
acut
pancreat
enzymat
morpholog
consid
effect
vip
result
inhibit
proinflammatori
cytokin
product
monocyt
mainli
ceruleininduc
acut
pancreat
rat
thoma
griesbach
purina
schuligoi
bernhard
peskar
shown
previous
edema
format
acut
ceruleininduc
pancreat
due
releas
bradykinin
within
pancrea
mani
tissu
bradykinin
releas
prostaglandin
pg
especi
turn
contribut
bradykininmedi
increas
vascular
permeabl
studi
releas
acut
pancreat
respect
time
cours
depend
bradykinin
action
contribut
oedema
format
acut
pancreat
induc
iv
infus
cemlein
nmolkgh
h
anesthet
spraguedawley
rat
control
anim
receiv
phosphatebuff
salin
prostaglandin
synthesi
quantifi
releas
per
min
supernat
tissu
sampl
incub
use
radioimmunoassay
pge
inflammatori
edema
reach
peak
valu
within
h
resolv
h
induct
pancreat
bradykiinn
receptor
antagonist
icatib
nmolkg
sc
potent
attenu
edema
format
b
receptor
antagonist
dalkd
nmolkg
sc
effect
product
significantli
elev
h
show
continu
increas
h
h
format
alter
icatib
dalkd
contrast
cyclooxygenas
cox
inhibitor
indomethacin
mgkg
ip
abolish
prostanoid
releas
time
point
select
inhibitor
mgkg
ip
also
inhibit
synthesi
inhibitor
dfu
mgkg
ip
effect
none
cox
inhibitor
inhibitori
effect
edema
format
ceruleininduc
pancreat
edema
format
releas
pgez
differ
time
cours
pgez
releas
via
receptor
contribut
increas
vascular
permeabl
prostanoid
releas
kininmedi
oedema
format
thu
independ
model
furthermor
seem
contribut
even
later
stage
inflammatgri
injuri
model
background
aim
mucos
addressin
cell
adhes
known
play
import
role
etiolog
ibd
whether
express
within
inflam
pancrea
whether
may
possibl
play
role
form
pancreat
inflamm
previous
investig
purpos
studi
measur
express
regul
function
recent
establish
murin
pancreat
endotheli
cell
line
vitro
method
deriv
mous
pancreat
endotheli
cell
system
use
cell
origin
obtain
mice
express
temperaturesensit
larg
antigen
mice
immortomic
express
examin
western
immunoblot
cell
lysat
stimul
tnfa
also
studi
signal
pathway
regul
pancreat
express
respons
use
sever
pharmacolog
signal
blocker
proteasom
inhibitor
parp
inhibit
tyrosin
kinas
genistein
mapk
mapk
pkc
pkg
lymphocyt
adhes
mediat
integrin
studi
use
integrin
express
lymphocyt
cell
line
tki
presenc
absenc
satur
dose
mab
result
tnfc
induc
doseand
timedepend
manner
pkc
tyrosin
kinas
mitogenactiv
protein
kinas
nfcbparp
depend
ifn
induc
express
cell
tnfa
significantli
induc
lymphocyt
endotheli
adhes
block
tnfcinduc
adhes
found
depend
conclus
induc
pancreat
endotheli
cell
tnfa
cytokin
may
therefor
contribut
form
acut
chronic
pancreat
novel
pancreat
endotheli
cell
line
might
provid
use
model
studi
cytokin
mediat
inflamm
reproduc
aspect
pancreat
vitro
although
pain
cardin
featur
pancreat
etiolog
poorli
understood
treatment
remain
difficult
vanilloid
receptor
play
fundament
role
transduct
pain
due
peripher
tissu
injuryinflamm
part
trpvi
current
increas
inflamm
role
pain
pancreat
unknown
aim
determin
whether
current
enhanc
pancreat
method
current
measur
acut
dissoci
pancreat
affer
neuron
identifi
pancreat
affer
retrograd
label
cholera
toxin
b
alexa
dye
inject
pancrea
pancreat
induc
two
ip
inject
larginin
mg
kg
control
anim
receiv
salin
sensori
neuron
isol
thorac
dorsal
root
ganglia
drg
experi
perform
within
hour
current
induc
either
bath
spritzer
applic
capsaicin
cap
measur
voltag
clamp
mode
hold
potenti
mv
level
mrna
drg
measur
northern
blot
result
experi
use
bath
applic
cap
microm
proport
neuron
sensit
cap
significantli
greater
pancreat
rat
compar
control
p
among
neuron
respond
cap
current
normal
neuron
capacit
significantli
greater
pancreat
compar
control
papf
p
experi
use
spritzer
applic
cap
microm
proport
neuron
sensit
cap
significantli
greater
pancreat
rat
compar
control
p
among
neuron
respond
cap
normal
current
significantli
greater
pancreat
compar
control
papf
p
mrna
drg
tgtll
elev
fold
rat
pancreat
n
p
conclus
current
proport
pancreat
affer
respons
capsaicin
increas
pancreat
part
increas
may
due
upregul
data
support
hypothesi
play
critic
role
pain
transmiss
pancreat
purpos
activ
tether
peptid
ligand
sligrl
proteolyt
liber
allow
bind
intramolecularli
receptor
activ
site
follow
activ
phnsphoryl
intern
degrad
thu
disappear
use
experiment
monitor
receptor
activ
physiolog
proteolyt
activ
trypsin
also
activ
nonproteolyt
expos
solubl
prepar
activ
peptid
recent
singh
et
al
gastroenterolog
report
sever
caemleinindue
pancreat
increas
genet
delet
suggest
normal
express
exert
protect
effect
pancreat
current
report
studi
examin
mechan
respons
protect
method
mice
given
hourli
intraperiton
inject
caerulein
tgkg
induc
pancreat
invitro
studi
freshli
isol
mous
acini
expos
supramaxi
mauy
stimul
concentr
nm
caerulein
activ
peptid
sligrl
level
monitor
immunoblot
analysi
use
antibodi
result
first
hour
caeruleininduc
pancreat
decreas
pancreat
level
increas
reach
steadyst
lower
level
observ
prior
induct
pancreat
exposur
acini
supramaxim
stimul
caerulein
nm
invitro
also
result
timedepend
decreas
acinar
cell
level
conclus
receptor
activ
intern
degrad
caerulein
induc
pancreat
follow
exposur
acini
supramaximafli
stimul
concentr
caerulein
invitro
hypothes
activ
reflect
proteolyt
cleavag
tether
receptor
intracellularli
activ
trypsin
leak
extraceflular
space
support
nih
grant
introduct
necrosi
sever
acut
pancreat
ap
associ
high
morbid
mortal
compromis
pancreat
microcircul
role
galanin
play
regul
pancreat
perfus
unclear
howev
known
vasoact
effect
organ
may
import
develop
necrosi
ap
aim
method
determin
presenc
locat
galanin
pancrea
tissu
harvest
australian
possum
n
fix
polyethylen
glycol
section
prepar
lmmunohistochem
label
galainn
qualit
assess
undertaken
examin
function
role
galanin
possum
anim
anaesthetis
pancrea
expos
blood
pressur
bp
pancreat
vascular
perfus
pvp
use
laser
doppler
flowmetri
head
bodi
tail
pancrea
continu
measur
galainn
n
galanin
antagonist
galantid
n
given
increas
intraven
iv
bolu
dose
nmol
nmol
respect
iv
infus
drug
evalu
concentr
nmol
nmol
respect
result
galanin
found
promin
fibr
surround
blood
vessel
pancrea
galanin
caus
maximum
rise
bp
baselin
minut
durat
nmol
dose
maximum
pressor
respons
durat
effect
dose
depend
galantid
caus
opposit
effect
maxim
decreas
blood
pressur
baselin
recoveri
minut
nmol
dose
fall
follow
recoveri
contrast
rise
bp
pvp
fell
galanin
administr
maximum
baselin
galantid
caus
biphas
effect
initi
maxim
increas
follow
maxim
fall
highest
dose
conclus
fall
pvp
associ
galanin
administr
initi
increas
pvp
achiev
block
endogen
galarlin
suggest
galanin
may
import
regul
pvp
thu
galanin
may
role
develop
necrosi
ap
breakdown
integr
intestin
wall
believ
implic
bacteri
transloc
recent
found
apoptosi
acceler
intestin
epitheli
cell
bacteri
transloc
induc
rat
sever
acut
pancreat
hand
believ
cascad
caspas
activ
involv
signal
pathway
apoptosi
caspas
initi
mitochondri
pathway
caspas
initi
death
receptor
pathway
caspas
effector
pathway
studi
clarifi
molecular
mechan
apoptosi
intestin
epitheli
cell
involv
caspas
investig
materiaiss
method
male
wistar
rat
weigh
use
pancreat
induc
retrograd
inject
sodium
deoxychol
biliopancreat
duct
ileum
remov
immunohistochemistri
activ
caspas
caspas
caspas
measur
villou
height
perform
apoptosi
evalu
tunel
stain
ileum
dna
fragment
elisa
ileal
mucosa
moreov
effect
caspas
inhibitor
zvadfmk
investig
result
immunoreact
activ
caspas
caspas
caspas
increas
top
villi
h
induct
pancreat
number
tunel
posit
cell
fragment
dna
ileal
epithelium
significantli
increas
h
induct
pancreat
immunoreact
activ
caspas
diminish
breakdown
intestin
mucosa
h
induct
pancreat
administr
caspas
inhibitor
reduc
apoptosi
induct
rate
maintain
integr
intestin
mucosa
conclus
sever
acut
pancreat
caspas
caspas
caspas
activ
ileal
mucosa
earli
phase
thereaft
apoptosi
induc
result
suggest
apoptot
chang
ileal
epithelium
induc
via
mitochondri
pathway
death
receptor
pathway
male
lewi
rat
random
group
group
ischemia
sir
group
ischemia
vehicl
group
sham
surgeri
sir
group
sham
surgeri
vehicl
shamoper
rat
underwem
surgic
procedur
without
occlus
sir
ragkgd
vehicl
given
intraperitoneafli
daili
day
surgeri
day
sacrif
anim
group
examin
intravit
microscopi
ivm
group
rat
kill
day
obtain
tissu
sampl
blood
sampl
analyz
plasma
serum
amylas
lipas
level
semiquantitv
score
use
assess
histolog
injuri
standard
h
e
stain
prolifer
apoptesi
index
measur
day
ischemia
result
sir
effect
microcireul
morpholog
shamoper
anim
group
vs
group
anim
subject
ischemia
treatment
sir
significantli
reduc
amylas
level
h
group
vs
selenium
essenti
cofactor
antioxid
glntathion
peroxidas
pathway
one
mechan
propag
acinar
cell
injuri
acut
pancreat
ap
serum
selenium
level
deplet
clinic
acut
pancreat
degre
deplet
correspond
sever
clinic
trial
suggest
oral
selenium
supplement
improv
outcom
clinic
ap
find
remain
unsubstanti
studi
test
hypothesi
intraven
selenium
supplement
given
diseas
induct
modul
cours
experiment
ap
studi
compli
american
physiolog
associ
guidelin
anim
care
male
spragnedawley
rat
randomli
alloc
one
group
n
follow
group
control
intervent
group
acut
pancreat
ap
induc
intraperiton
hydrochlorid
mg
per
bodi
weight
day
group
ap
selenium
ixgkg
h
induct
ap
anim
given
buprenorphin
analgesia
previous
demonstr
effect
outcom
model
sacrif
sampl
pancreat
lung
histolog
snap
frozen
liquid
nitrogen
examin
haematoxylin
eosin
stain
histopathologist
blind
group
alloc
biochem
endpoint
serum
amylas
serum
antioxid
level
bronchoalveolar
lavag
protein
bal
lung
mydoperoxidas
activ
mpo
statist
comparison
nonparametr
test
p
result
karginin
induc
ap
characteris
oedema
neutrophfl
infiltr
acinar
cell
degranul
elev
serum
amylas
selenium
supplement
effect
serum
selenium
level
howev
selenium
supplement
associ
reduct
bal
protein
compar
ap
p
mannwhitney
utest
addit
acinar
cell
degranul
pancreat
inflammatori
cell
infiltr
absent
selenium
treat
anim
conclus
rel
prolong
studi
model
intervent
selenium
start
induct
ap
amelior
histolog
stigmata
acinar
cell
injuri
reduc
pancreat
inflammatori
infiltr
protect
effect
lung
injuri
find
suggest
postinduct
selenium
modul
pancreat
lung
injuri
experiment
ap
differenti
express
rat
caeruleinlnduc
panereat
naoki
matsumura
yoshifumi
takeyama
takashi
ueda
makoto
shinzeki
hidehiro
sawa
goshikazu
kuroda
background
aim
acut
pancreat
inflammatori
process
variabl
sever
possibl
mortal
morbid
due
infect
known
tolllik
receptor
tlra
play
import
role
bacteri
sepsi
system
inflamm
tlr
bind
specif
pathogenassoci
molecular
pattern
pamp
induc
product
reactiv
oxygen
nitrogen
intermedi
proinflammatori
cytokin
upregul
express
costimulatori
molecul
recogn
fipoteico
acid
lta
gramposit
bacteria
recogn
lipopolysaccharid
lp
gramneg
bacilli
howev
report
concern
role
tir
acut
pancreat
studi
aim
investig
express
tlp
pampsmedi
cytokin
product
macrophag
rat
caeruleminduc
pancreat
materi
method
male
wistar
rat
g
use
studi
caernleininduc
pancreat
made
administr
intraven
inject
caerulein
ia
gkgh
hour
steril
normal
salin
mlhr
h
caemlein
group
control
model
made
administr
intraven
inject
steril
normal
salin
mlh
h
control
group
macrophag
isol
bronchoalveolar
lavag
bad
fluid
mrna
express
assay
rtpcr
protein
express
assay
western
blot
moreov
estim
product
tnfc
elisa
lta
lp
result
express
mrna
protein
level
caemlein
group
depress
comparison
control
group
caemlein
group
ltamedi
tnfa
releas
bal
macrophag
also
decreas
compar
control
group
hand
express
mrna
protein
level
caemlein
group
significantli
enhanc
lpsmediat
tnfreleas
bal
macrophag
caemlein
group
also
increas
comparison
control
group
conclus
result
suggest
impair
respons
lta
bal
macrophag
caerulein
group
deriv
lower
express
higher
express
caus
hyperreact
lp
model
biliari
pancreaf
l
paul
paul
van
minnen
niel
g
venneman
jaap
e
van
dijk
hein
g
gooszen
loui
akkerman
karel
j
van
erpecum
biliari
reflux
pancreat
duct
essenti
pathogenesi
biliari
pancreat
hypothes
hydrophob
bile
salt
cholesterol
crystal
may
enhanc
phospholipid
may
decreas
sever
pancreat
method
model
system
pb
compos
hydrophob
taurodeoxychol
tdc
physiolog
mixtur
bile
salt
mb
hydrophil
tauroursodeoxychol
tudc
without
cholesterol
crystal
phosphatidylcholin
pc
infus
bile
duct
male
spraguedawley
rat
complet
retrograd
spread
pancrea
confirm
methylen
blue
twentyfour
hour
later
anim
sacrif
histopatholog
score
peri
pancreat
inflamm
result
sever
acut
pancreat
depend
bile
salt
hydrophobi
tdc
mb
tudc
pb
histopatholog
score
respect
p
phosphatidylcholin
protect
detriment
effect
tdc
high
low
concentr
score
vs
case
pc
tdc
pc
ratio
vs
cholesterol
crystal
increas
sever
pancreat
model
system
contain
tdc
mb
tudc
pb
respect
p
conclus
rat
model
hydrophob
bile
salt
cholesterol
crystal
aggrav
bfliari
pancreat
wherea
phospholipid
protect
effect
aim
acut
pancmat
often
associ
gastrointestin
motil
disturb
howev
underli
mechan
remain
larg
unknown
therefor
studi
effect
acut
necrotis
pancreat
contractil
isol
musd
strip
gastric
fundn
jejunum
method
acut
necrotis
pancreaini
induc
feed
young
femal
mice
cholinedefici
cd
ethionin
supplement
diet
cde
hour
longitudin
muscl
strip
prepar
gastric
fundn
jejunum
mount
organ
bath
isometr
tension
record
enter
nervemedi
contract
electr
field
stimul
ef
hz
contract
carbachol
cch
substanc
p
sp
serotonin
prostaglandin
kci
mm
studi
control
cd
cde
mice
sever
acut
pancreat
assess
histolog
examin
mice
histolog
sever
score
cde
diet
includ
cde
group
result
ef
cch
sp
induc
contract
jejun
gastric
fundu
muscl
strip
control
cd
cde
mice
howev
jejun
contract
significantli
decreas
cde
mice
acut
pancreat
tabl
wherea
jejun
contractil
cd
mice
compar
control
mice
tabl
hand
acut
pancreat
affect
contractil
gastric
fundu
muscl
strip
sinc
contract
ef
cch
sp
pgf
c
gastric
fundn
similar
control
cd
cde
mice
conclus
result
show
acut
necrotis
pancreat
lead
decreas
contractil
jejunum
contractil
gastric
fundu
remain
normal
pancreat
result
suggest
acut
necrotis
pancreat
lead
disturb
contractil
activ
specif
region
gut
background
acut
pancreat
ap
character
disturb
pancreat
microcircul
lead
ischemia
consequ
necrosi
pancreat
tissu
leukocyteendotheliuminteract
erythrocyt
flow
pattern
well
investig
pathophysiolog
process
contrast
remain
unclear
platelet
contribut
perfus
disturb
aim
studi
investig
platelet
activ
function
experiment
model
ap
method
ap
grade
sever
induc
rat
control
anim
n
ringer
solut
iv
mild
ap
n
cerulein
iv
sever
ap
n
glycodeoxychol
acid
intraduct
cemlein
iv
induct
ap
intravit
microscopi
perform
anim
group
separ
stain
platelet
lml
blood
rhodamin
platelet
veloc
well
temporari
firm
platelet
adhes
endothelium
investig
capillari
field
postcapiflari
venul
addit
serum
thromboxan
level
measur
remain
anim
per
gruop
histolog
damag
evalu
h
induct
ap
result
histolog
h
show
mild
ap
anim
receiv
cerulein
contrast
anim
gdoc
applic
inflamm
necrosi
signifikantli
evid
inflamm
vs
necrosi
lntravit
microscopi
show
significantli
plateletendothelium
interact
anim
ap
compar
control
anim
addit
tbxlevel
significantli
higher
ap
anim
conclus
platelet
activ
play
import
role
pathophysiolog
acut
especi
necrot
pancreat
mild
ap
mainli
temporari
plateletendothelium
interact
observ
sever
ap
character
firm
platelet
adhes
consecut
coagulatori
activ
perfus
failur
background
aim
pancreat
known
induc
chang
inilammatori
cell
howev
littl
known
regard
relationship
lymphocyt
migrat
pattern
differ
tissu
subject
affect
pancreat
present
work
pancreat
induc
rat
sodium
taurochol
ceil
surfac
express
profil
helper
cytotox
ceil
selectin
integrin
cdila
cell
receptor
g
determin
lymphocyt
deriv
either
whole
blood
spleen
rat
hour
method
acut
pancreat
induc
wistar
rat
retrograd
infus
sodium
taurochol
pancreat
duct
whole
blood
spleen
collect
hour
peripher
blood
mononuclear
cell
pbmc
separ
organ
ficollpaqu
pbmc
incub
conjug
antibodi
express
cell
surfac
antigen
analyz
flow
microfluorimetri
result
minim
express
observ
lymphocyt
deriv
either
blood
spleen
fold
increas
express
observ
blood
lymphocyt
compar
splenic
lymphocyt
vs
integrin
express
similar
lymphocyt
organ
cdlla
express
selectin
show
fold
increas
blood
compar
splenic
lymphocyt
vs
lymphocyt
group
predominantli
conclus
inflammatori
chang
pancreat
tissu
specif
may
provid
insight
migrat
lymphocyt
differ
organ
understand
cell
surfac
express
integrinselectin
profil
may
provid
novel
approach
immunotherapi
pancreat
effect
tumor
necrosi
factor
pathogenesi
sever
acut
pancreat
qi
zhu
weiyan
yao
yaozong
yuan
background
aim
although
recent
data
provid
evid
tumor
necrosi
factor
tnf
play
import
role
sever
acut
pancreat
sap
exact
mechan
remain
unclear
aim
studi
clarifi
effect
tumor
necrosi
factor
pathogenesi
sap
method
thirtysix
male
spraguedawley
rat
randomli
alloc
group
sap
group
control
group
sap
induc
inject
steril
sodium
taurochol
biliopancreat
duct
control
group
given
sham
oper
rat
sacrif
hour
onset
oper
blood
sampl
pancreat
tissu
harvest
sever
pancreat
assess
accord
level
serum
amylas
histolog
score
serum
level
tumor
necrosi
factor
alpha
tnfalpha
examin
elasa
express
pancreat
tissu
peripher
blood
mononuclear
cell
pbmc
determin
semiqnantit
rtpcr
result
level
serum
amylas
tnfalpha
sap
group
significantli
higher
control
group
time
point
p
seper
express
pbmc
p
pancreat
tissu
p
p
sap
group
significantli
upregnl
time
point
express
reach
maximum
hour
onset
experi
pbmc
declin
sap
tissu
sampl
sever
edema
congest
demonstr
hour
bleed
necrosi
illustr
hour
among
parenchyma
pancreata
conclus
tnfalpha
pivot
factor
pathogenesi
pancreat
bind
may
intensifi
patholog
deterior
pancreat
tissu
result
bleed
necrosi
present
studi
indic
pathog
netic
role
cytotox
tnf
pathway
clinic
featur
sap
enhanc
leucocyt
activ
upregul
pbmc
pancreat
tissu
hepatocyt
growth
factor
attenu
pancreat
damag
sever
acut
pancreat
rat
jinhang
ni
yaozong
yuan
weiyan
yao
background
research
indic
exogen
hgf
may
reduc
pancreat
damag
mild
acut
pancreat
howev
whether
hgf
could
attenu
sever
acut
panceat
remain
unknown
present
studi
aim
observ
effect
hgf
administr
inflamm
sever
acut
pancreat
rat
method
male
spragnedawley
rat
randomli
divid
group
sham
oper
control
hgf
hgf
plu
antibodi
separ
rat
made
biliopancreat
duct
cannuat
duodenum
sever
acut
pancreat
control
hgf
hgf
plu
antibodi
group
induc
retrograd
infus
sodium
taurochol
mlkg
bodi
wt
biliopancreat
duct
speed
mlhour
rat
sham
oper
group
infus
physic
salin
instead
thirti
minut
induct
pancreat
rat
hgf
group
given
microgramkg
bodi
wt
hgf
rat
hgf
plu
antibodi
group
given
mgkg
bodi
wt
antihgf
monoclon
antibodi
well
hgf
hgf
group
three
hour
biliopancreat
infus
blood
pancrea
rat
harvest
sera
amylas
lipas
determin
pancreat
histolog
score
pancreat
assess
independ
two
pathologist
result
rat
given
microgramkg
bodi
wt
hgf
show
lower
level
sera
amylas
lipas
histolog
score
vs
control
group
p
phenomenon
observ
rat
given
microgramkg
bodi
wt
hgf
rat
given
microgram
kg
bodi
wt
hgf
plu
antihgf
antibodi
similar
level
sera
amylas
lipas
histolog
score
vs
control
group
p
conclus
conclud
administr
enough
exogen
hgf
induct
sever
acut
pancreat
could
attenu
follow
pancreat
damag
rat
subtot
colectomi
prior
experiment
acut
pancreat
ap
rat
shown
reduc
mortal
howev
effect
subtot
colectomi
proxim
small
bowel
bacteri
overgrowth
infect
pancreat
necrosi
unknown
aim
experi
investig
effect
subtot
colectomi
rat
acut
pancreat
method
male
spragnedawley
rat
alloc
four
studi
group
underw
two
laparotomi
interv
group
sham
laparotomi
salin
biliari
duct
infus
group
subtot
colectomi
salin
infus
group
lil
sham
laparotomi
induct
ap
ductal
infus
mm
glycodeoxychol
acid
follow
intraven
cerulein
group
iv
subtot
colectomi
ap
seventytwo
hour
second
laparotomi
blood
periton
fluid
mesenter
lymph
node
liver
spleen
pancrea
duodenum
ileum
collect
microbiolog
analysi
result
total
rat
includ
seven
rat
exclud
hyperbilirubinaemia
four
rat
die
surgeri
mortal
due
ap
subtot
colectomi
caus
duoden
ileal
bacteri
overgrowth
aerob
group
vs
li
duodenum
cfu
coloni
form
unit
g
vs
ileum
cfug
vs
total
bacteri
count
pancrea
duodenum
ileum
rat
ap
previou
colectomi
significantli
higher
rat
ap
group
iil
vs
iv
pancrea
cfug
vs
duodenum
cfug
vs
ileum
cfug
vs
duoden
bacteri
overgrowth
pancreat
infect
gramposit
aerob
correl
significantli
r
p
conclus
duoden
bacteri
overgrowth
play
import
role
infect
pancreat
necrosi
subtot
colectomi
induc
small
bowel
bacteri
overgrowth
increas
pancreat
infect
acut
pancreat
therapeut
effect
oxpapc
anim
model
sever
acut
pancreat
xingpeng
wang
lei
li
aim
studi
therapeut
effect
oxid
oxpapc
anim
model
sever
acut
pancreat
sap
investig
mechan
method
fortyeight
mice
randomli
divid
sap
group
oxpapc
group
sap
induc
administr
seven
intraperiton
inject
cerulein
rnicrogkg
hourli
interv
lp
inject
hour
first
cerulein
inject
oxpapc
obtain
air
oxid
dri
papc
extent
oxid
monitor
positit
ion
flow
inject
electrospray
mass
spectrometri
treatment
oxpapc
start
minut
lp
inject
hour
first
cerulein
inject
blood
specimen
pancrea
harvest
serum
level
amylas
lactat
dehydrogenas
ldh
measur
sever
pancreat
evalu
histolog
score
use
semiqnantit
analysi
hematoxylin
eosinstain
section
pancrea
semiquantit
revers
transcriptionpolymeras
chain
reaction
rtpcr
perform
quantifi
intrapancreat
tnfalpha
beta
eselectin
mrna
level
express
phosphat
jnk
nfkappa
b
investig
method
western
blot
activ
pmn
yeloperoxidas
mpo
determin
zymohistochemistri
result
seven
time
cerulein
inject
induc
edemat
pancreat
necrotis
pancreat
develop
soon
lp
challeng
serum
amylas
level
progress
increas
maximum
reach
hour
treatment
oxpapc
significantli
decreas
amylas
level
hour
reduc
ldh
histolog
treatment
oxpapc
allevi
sever
pancreat
injuri
includ
inflammatori
cell
infiltr
necrosi
hour
intrapancreat
tnfalpha
beta
eselectin
mrna
level
reduc
oxpapctr
group
hour
western
blot
show
downregul
phosphat
jnk
nfkappa
b
signific
decreas
mpo
activ
oxpapc
group
hour
conclus
oxpapc
decreas
sever
ofexperimetu
pancreat
inhibit
intrapancreat
inflammatori
mediat
express
vivo
protect
effect
oxpapc
mediat
least
part
block
endotoxin
signal
pathway
protect
effect
melatonin
largininelnduc
experiment
acut
pancreat
rat
annamaria
szabolc
iv
peter
hegyi
ilona
varga
jozsef
raszaki
gabor
papal
tama
letoha
reka
sari
zoltan
rakonczay
jr
jano
lonov
russel
reiter
tama
takac
free
radic
lipid
peroxid
import
role
pathogenesi
local
system
inflamm
acut
pancreat
aim
studi
determin
effect
freerad
scaveng
melatonin
earli
phase
experiment
acut
uecrot
pancreat
method
male
wistar
rat
divid
five
group
rat
group
receiv
gkg
bodi
weight
larginin
larg
ip
twice
interv
h
induc
acut
pancreat
group
rat
treat
mgkg
bodi
weight
melatonin
ip
rain
prior
larg
administr
group
rat
receiv
dose
melatonin
h
induct
pancreat
larg
group
singl
dose
melatonin
administ
describ
previous
rat
group
c
serv
control
reciv
physiolog
salin
inject
ip
rat
exsanguin
h
last
larg
inject
result
group
larg
caus
sever
necrot
pancreat
confirm
signific
elev
serum
amylas
level
pancreat
weightbodi
weight
ratio
pwbw
pancreat
myeloperoxidas
activ
vs
group
c
elev
serum
amylas
level
significantli
reduc
group
vs
group
activ
pancreat
antioxidatu
enzym
cuznsuperoxid
dismutas
sod
mnsod
catalas
cat
significantli
increas
h
induct
pancreat
group
pancreat
cat
activ
significantli
reduc
compar
group
group
vs
group
c
lipid
peroxid
level
glutathion
peroxidas
cuznsod
activ
significantli
increas
liver
wherea
melatonin
pretreatmem
abolish
chang
decreas
activ
liver
cat
vs
group
c
conclus
sever
acut
pancreat
moder
protect
effect
melatonin
observ
h
follow
pancreat
induct
demonstr
decreas
serum
amylas
activ
lipid
peroxid
work
support
hungarian
scientif
research
fund
tumor
cell
known
form
dorsal
ruffl
respons
certain
growth
factor
previous
demonstr
stimul
varieti
receptor
tyrosin
kinas
rtk
includ
egfr
pdgfr
induc
rapid
transient
assembl
cortactin
actin
complex
concentr
structur
near
lead
edg
highli
metastat
human
pancreat
ductular
tumor
cell
complex
move
along
dorsal
membran
wave
like
fashion
constrict
disappear
concomit
format
disappear
dorsal
wave
mark
reorgan
actin
stress
fiber
local
lamellipodia
extens
mbc
goal
current
studi
test
egfinduc
dorsal
wave
endocyt
structur
sequest
intemaf
egf
receptorfigand
complex
cell
surfac
ductular
tumor
cell
express
egfrgfp
stimul
ngml
egf
observ
fluoresc
microscopi
within
minut
mark
sequestr
tag
receptor
wave
occur
subsequ
gener
numer
receptor
posit
tubularvesicular
structur
electron
microscopi
confirm
wave
structur
form
along
dorsal
membran
surfac
emend
numer
tubul
cytoplasm
observ
increas
label
dorsal
wave
structur
cholera
toxin
compar
surround
plasma
membran
importantli
dorsal
wave
select
sequest
stimul
egfr
away
nonstimul
receptor
neither
pdgf
transferrin
receptor
enrich
wave
despit
activ
intern
egfr
ligand
dorsal
wave
stain
multipl
antibodi
clathnn
caveolin
incorpor
gfptag
clathrin
summari
find
describ
format
novel
dorsal
tubularvesicular
structur
requir
particip
actin
cytoskeleton
sequest
egfr
specif
gm
rich
plasma
membran
invagin
subsequ
intern
independ
tradit
endocyt
structur
clathrin
pit
caveola
find
provid
new
inform
pancreat
tumor
cell
intern
tyrosin
receptor
kinas
like
facilit
motil
invas
pancreat
acinar
cell
known
regul
exocytosi
protein
synthesi
secretori
protein
transport
respons
secretori
stimulu
whether
secretori
vesicl
format
also
regul
acinar
cell
unclear
previous
demonstr
larg
ubiquit
express
gtpase
essenti
scission
nascent
secretori
viral
proteincontaiinng
vesicl
carrier
transgolgi
network
tgn
cultur
epitheli
cell
goal
studi
determin
whether
agonist
stimul
induc
morpholog
alter
acinar
cell
golgi
apparatu
defin
role
golgi
structur
zymogen
granul
zg
format
chang
golgi
structur
integr
assess
util
golgi
tgn
lipid
protein
marker
live
fix
cell
upon
stimul
cholecystokinin
cck
subsequ
zg
size
number
quantifi
cell
express
domin
neg
gtpasedefect
protein
result
regul
secret
acinar
cell
induc
mark
fragment
tgn
pretgn
compart
golgi
well
region
tgn
involv
gener
constitut
traffick
vesicl
unaffect
coincid
fragment
tgn
regul
secret
signific
recruit
acinar
cell
golgi
compart
rest
state
inhibit
function
cultur
acinar
cell
express
gtpase
defici
domin
neg
protein
induc
format
larg
perinnclear
membran
aggreg
interestingli
membran
disrupt
observ
nonacinar
epitheli
cell
type
clone
cell
hepatocyt
nrk
kidney
suggest
perturb
specif
zg
format
importantli
reduct
zg
number
within
mutant
acinar
cell
occur
although
observ
substanti
increas
size
zg
express
domin
neg
protein
result
increas
averag
zymogen
granul
size
conclus
find
suggest
acinar
cell
tgn
dynam
organdi
respons
agonist
stimul
becom
fragment
via
recruit
action
furthermor
play
import
role
de
novo
biogenesi
zg
acinar
cell
possibl
role
vesicul
select
cargo
condens
matur
zg
background
glucagonlik
intestin
incretin
hormon
deriv
process
proglucagon
exert
insulmotrop
action
insulinproduc
pancreat
betacel
establish
multipotetui
progenitor
cell
pancrea
term
ygic
cell
line
transdifferenti
adult
pancreat
acinar
cell
ductal
progenitor
cell
aim
analyz
effect
transdifferenti
establish
normal
rat
pancreat
ductal
cell
investig
potenti
role
futur
cell
therapi
use
normal
pancreat
duct
cell
pancreat
precursor
cell
method
treatment
recombin
came
absenc
serum
ygic
cell
transfect
make
induc
transfect
produc
identifi
express
scf
ckit
neurod
insulin
glucagon
cftr
westem
blot
rtpcr
elisa
method
result
notchl
neurod
shh
key
player
embryon
pancrea
develop
modul
treatment
downregul
stem
cell
marker
scf
ckit
induc
treatment
wherea
cftr
ductal
marker
downregul
furthermor
treatment
induc
insulin
glucagon
ygic
cell
howev
fail
modul
glucokinas
impli
factor
affect
earli
event
endocrin
differenti
termin
differenti
cell
conclus
stimul
differenti
ductal
progenitor
ceil
insulinproduc
cell
find
suggest
model
islet
develop
pancreat
progenitor
cell
differenti
pancreat
endocrin
cell
express
receptor
glucagon
insulin
background
aim
cytokin
tumor
necrosi
factorix
tnfix
play
key
role
develop
acut
pancreat
howev
mechan
involv
poorli
understood
chang
actin
cytoskeleton
pancreat
acinar
cell
earli
event
pancreat
prolinerich
tyrosin
kinas
one
import
regul
cytoskeleton
present
studi
sought
determin
involv
tnfix
signal
pancreat
acinar
cell
protein
kinas
c
pkc
implic
upstream
mediat
activ
stimuli
pancreat
acinar
cell
also
examin
whether
pkc
isoform
involv
tnfix
induc
activ
method
dispers
rat
pancreat
acini
stimul
tnfix
ngml
western
blot
analysi
examin
tyrosin
phosphoryl
site
essenti
proteinprotein
interact
full
catalyt
activ
respect
activ
convent
og
novel
e
atyp
pkc
isoform
measur
kinas
assay
use
isoformspecif
immunoprecipit
isoformoptim
peptid
substrat
role
individu
pkc
isoform
phosphoryl
assess
isoformspecif
pkc
inhibitor
result
tnfix
rapidli
stimul
tyrosin
phosphoryl
phosphoryl
reach
maximum
rain
plateau
rain
tnfix
stimul
wherea
phosphoryl
peak
rain
phosphoryl
site
prevent
inhibitor
na
salicyl
tyrphostin
broadspectrum
pkc
inhibitor
gf
also
inhibit
phosphoryl
site
induc
suggest
involv
pkc
mechan
tnfu
activ
novel
pkc
isoform
e
atyp
pkc
isoform
convent
pkc
isoform
isoformspecif
peptid
inhibitor
pkc
e
markedli
inhibit
phosphoryl
site
induc
tnfa
contrast
pkc
inhibitor
affect
phosphoryl
conclus
tnfc
induc
phosphoryl
pancreat
acinar
cell
pathway
mediat
novel
pkc
isoform
b
e
signal
mechan
may
play
import
role
pancreat
novel
protein
kinas
c
soform
mediat
cholecystokinininduc
activ
nfkb
pancreat
acinar
cell
diverg
pathway
akihiko
satoh
anna
gukovskaya
melissa
daghighian
joseph
r
reev
jr
stephen
j
pandol
background
aim
prolinerich
tyrosin
kinas
import
regul
cytoskeleton
recent
link
nfkb
activ
induc
gprotein
activ
nfkb
activ
chang
actin
cytoskeleton
pancreat
acinar
cell
import
earli
event
pancreat
cck
induc
nfcb
activ
phosphorylatinn
pancreat
acini
protein
kinas
c
pkc
mediat
process
howev
relationship
two
signal
pathway
well
involv
individu
pkc
isoform
known
present
studi
sought
determin
whether
involv
cckinduc
nfkb
activ
pancreat
acinar
cell
method
dispers
rat
pancreat
acini
stimul
cck
min
nfkb
bind
activ
measur
electrophoret
mobil
shift
assay
degrad
inhibitori
ikba
protein
western
blot
tyrosin
phosphoryl
site
essenti
proteinprotein
interact
full
catalyt
activ
respect
examin
western
blot
use
isoformspecif
pkc
inhibitor
assess
pkc
isoform
involv
nfkb
activ
phosphoryl
specif
pharmacolog
inhibitor
examin
role
src
kinas
process
result
cck
supraphysiolog
concentr
nm
caus
nfkb
activ
phosphoryl
site
wherea
physiolog
concentr
nm
induc
phosphoryl
isoformspeciflc
peptid
inhibitor
pkc
e
inhibit
nfkb
activ
phosphoryl
induc
cck
hand
specif
inhibitor
atyp
pkc
isoform
affect
neither
nfkb
activ
phosphoryl
data
show
pkc
b
mediat
nfkb
activ
phosphoryl
induc
cck
src
kinas
inhibitor
prevent
phosphoryl
affect
nfkb
activ
indic
distinct
downstream
mechan
involv
conclus
result
show
key
role
pkc
downstream
patholog
effect
cck
phosphoryl
mediat
nfkb
activ
induc
cck
pancreat
acinar
cell
acut
pancreat
frequent
diseas
pancrea
acut
phase
pancreat
harm
pancreat
enzym
express
reduc
howev
gene
strongli
activ
phcnotyp
chang
might
enabl
pancrea
protect
acut
attack
pancreat
convers
particip
pathophysiolog
mechan
diseas
aim
research
character
molecular
level
pancreat
emerg
program
set
respons
pancreat
use
quantit
fluoresc
cdna
microarray
hybrid
approach
identifi
pancreat
gene
induc
pancreat
cell
acut
pancreatin
mous
describ
clone
sequenc
express
analysi
gene
name
ipi
whose
activ
relat
acut
phase
experiment
pancreat
analysi
structur
indic
gene
interferoninduc
encod
put
transsmembran
protein
amino
acid
long
theoret
pl
predict
molecular
weight
da
vivo
studi
swiss
mice
show
strongli
activ
pancrea
earli
caerulein
treatment
northern
blot
analysi
pancrea
tissu
cdna
probe
show
maxim
express
hour
cerulein
administr
situ
hybrid
mrna
digoxigenin
label
crna
probe
pancreat
tissu
mous
acut
pancreat
show
express
restrict
acinar
cell
interestingli
mrna
also
express
intestin
earli
stage
salmonella
typhimurinm
infect
vitro
studi
use
nih
cell
show
express
induc
nfalpha
activ
stress
treatment
like
heat
shock
cell
express
less
capac
develop
coloni
appropri
antibiot
select
hela
ceil
transfect
yield
surviv
coloni
compar
empti
transfect
cell
cell
line
follow
growth
arid
death
rate
day
period
cell
show
significantli
lower
p
prolifer
rate
control
cell
conclus
identifi
new
interferoninduc
gene
activ
pancrea
acut
phase
pancreat
whose
express
inhibit
cell
prolifer
cystein
string
protein
csp
cochaperon
heat
shock
protein
known
prevent
onset
acut
pancreat
rodent
previous
report
csp
express
outer
leaflet
zymogen
granul
zg
membran
propos
role
csp
activ
zg
traffick
interact
csp
known
zg
membran
regulatori
protein
investig
direct
associ
csp
snare
protein
shown
coimmunoprecipit
colp
immunofluo
rescenc
microscopi
convers
csp
interact
previou
studi
report
regul
zg
exocytosi
howev
investig
role
acinar
cell
secret
demonstr
use
permeabd
acinar
cell
prepar
acinar
cell
permeabilz
perfringolysino
incub
cytoplasm
domain
recombin
exposur
cell
vamp
protein
known
inhibit
snare
protein
complex
format
exocytosi
acinar
cell
found
dose
depend
inhibit
amylas
secret
approxim
establish
snare
protein
involv
exocytosi
investig
csp
interact
protein
reveal
csp
high
affin
complex
csp
quantit
coip
isol
zg
membran
find
confirm
gstpufl
assay
immunofluoresc
microscopi
subcellular
fraction
show
strong
coloc
molecul
zg
cell
apex
data
indic
csp
molecular
complex
acinar
cell
snare
protein
zg
membran
propos
cochaperon
activ
csp
may
facilit
dynam
interact
snare
protein
machineri
physiolog
pathophysiolog
state
clusterin
overexpress
acut
pancrcat
protect
acinar
cell
line
apoptot
stimuli
han
bodek
vuk
savkov
sebastian
gaiser
joachim
mossner
volker
keim
introduct
clusterin
overexpress
acut
pancreat
exocrin
pancrea
studi
intend
clarifi
role
chisterin
express
use
acinar
cell
line
model
materi
method
cdna
clnsterin
subclon
sens
pclusens
antisens
pcluanti
direct
express
vector
cell
stabli
transfect
protein
express
determin
westernblot
cell
line
expos
differ
concentr
cerulein
cer
staurosporin
st
lysophosphatitylcholin
lpc
cell
viabil
assay
wsttest
hour
caspas
activ
stress
monitor
use
cotransfect
either
express
plasmid
vector
code
fusion
protein
eyfp
contain
nuclear
export
signal
ne
fuse
cleavag
side
silent
cell
ne
locat
eyfp
cytoplasm
activ
apoptosi
ne
cut
eyfp
transloc
nucleu
apoptot
cell
quantifi
fluoresc
microscop
result
j
cell
exhibit
basal
express
ckisterin
exposur
cell
stressor
cer
st
lpc
induc
clusterin
express
stabl
transfect
pclusens
pchianti
led
cell
overor
underexpress
chisterin
compar
control
stressor
decreas
cell
viabil
dosedepend
ceil
overexpress
clusterin
show
higher
cell
viabihti
cellular
stress
cell
line
transfect
pchianti
show
diminish
clnsterin
express
respons
stress
agent
well
reduc
viabil
compar
control
cotransfect
experi
pclusens
sensor
vector
cellular
stress
show
diminish
apoptosi
cell
compar
control
contrast
cell
transfect
pcluanti
reveal
enhanc
activ
condit
effect
block
specif
inhibitor
cell
viabil
stress
could
amelior
ad
specif
inhibitor
conclus
clusterin
protect
cell
agent
mimick
cellular
stress
acut
pancreat
block
endogen
clusterin
express
led
higher
activ
stress
ceil
contrast
overexpress
clusterin
hinder
apoptot
event
clusterin
seem
part
defens
program
exocrin
pancrea
organ
injuri
helicobact
pylori
infect
induc
intestin
metaplasia
relat
gene
gastric
epitheli
cell
via
pathway
naoki
asano
akira
imatani
atsushi
masamun
motoki
ohyauchi
makoto
yonechi
shuichi
ohara
tooru
shimosegawa
background
aim
intestin
metaplasia
im
known
precursori
lesion
gastric
cancer
helicobact
pylori
hp
infect
human
stomach
one
major
caus
im
littl
known
molecular
biolog
pathway
recent
homeobox
gene
report
induc
im
report
relationship
hp
infect
attempt
reveal
molecular
biolog
pathway
hp
infect
im
term
induct
method
use
human
gastric
cancer
cell
gciy
express
vitro
model
gastric
epitheli
cell
infect
hp
examin
express
rtpcr
western
blot
next
tri
reveal
signal
transduct
hp
infect
express
assess
import
two
nfkb
bind
site
gene
promot
electrophoreticmobl
shift
assay
emsa
nfkb
oligonucleotid
western
blot
ikba
luciferas
report
assay
also
peform
luciferas
report
assay
use
cilostazol
formerli
report
suppressor
phosphoryl
phosphatas
tensin
homologu
delet
chromosom
pten
inhibitor
wortmannin
find
whether
pten
particip
pathway
express
result
express
detect
lhour
hp
infect
rtpcr
western
blot
emsa
use
nfkb
oligonudeotid
detect
shift
band
nuclear
protein
extract
ffp
infect
gciy
western
blot
show
decreas
ikba
hp
infect
cell
infect
hp
show
rel
luciferas
aciv
compar
cell
wortmaninn
activ
luciferas
activ
suggest
inhibit
induc
background
helicobact
pylori
hp
adher
gastric
epitheli
ceil
activ
sever
signal
transduct
pathway
preliminari
data
found
hp
adher
gastric
cell
increas
intracellular
ca
level
j
physiol
increas
activ
nonreceptor
prolinench
tyrosin
cell
type
phosphatas
contain
protein
tyrosin
involv
regul
cell
morpholog
prolifer
apoptosi
therefor
want
examin
present
studi
relationship
cell
morpholog
normal
human
gastric
mucou
epitheli
cell
method
normal
human
gastric
mucou
epitheli
cell
surgic
specimen
cultur
dmem
serum
media
hp
vcddtype
strain
grown
agar
plate
immunoprecipit
western
blot
use
detect
phosphoryl
paxillin
immunofluoresc
microscopi
use
examin
signal
molecul
cell
morpholog
resuh
hp
treat
cell
rapid
fold
increas
phosphoryl
detect
within
rain
parafl
increas
paxillin
phnsphoryl
hptreat
cell
becam
dephospholyl
rain
parallel
increas
phosphoryl
hp
treat
cell
immunoprecipit
detect
phosphoryl
form
paxillin
pretreat
cell
intracellular
ca
chelat
bapta
pkc
inhibitor
sum
reduc
paxiflin
phosphoryl
phosphoryl
observ
beatkil
bacteria
long
term
hptreatment
cell
produc
cell
round
detach
pretreat
cell
inhibitor
calpeptin
prolong
hpinduc
phosphorylatinn
attenu
morpholog
respons
lmmunofluoresc
hptreat
cell
detect
primarili
focal
adhes
paxillin
conclus
h
pylori
treatment
normal
human
gastric
mucou
epitheli
cell
induc
phosphoryl
paxillin
bind
phosphatas
may
regul
dephosphoryl
hpylori
activ
may
part
signal
mechan
control
focal
adhes
paxillin
regul
normal
gastric
epitheli
cell
morpholog
prolifer
apoptosi
background
aim
cyclooxygenas
cox
ratelimit
enzym
prostaglandin
play
import
role
inflamm
carcinogenesi
induc
varieti
factor
includ
cytokin
growth
factor
tumor
promot
aim
studi
determin
effect
h
pyloninduc
gastric
inflamm
apoptosi
cell
prolifer
method
h
pylori
strain
inocul
stomach
strain
wildtyp
wt
defici
mice
mice
sacrif
week
later
wt
defici
mice
without
h
pylori
inocul
use
control
densiti
h
pylori
colon
cultur
gastric
protein
express
western
blot
gastric
prostaglandin
level
elisa
sever
chronic
gastric
inflamm
apoptosi
tune
prolifer
assay
gastric
epitheli
cell
determin
result
signific
differ
densiti
h
pylori
colomz
defici
wt
mice
protein
express
increas
h
pyloriinfect
wt
mice
protein
express
defici
mice
gastric
level
gastriti
score
increas
wt
defici
mice
h
pyloriinfect
compar
uninfect
mice
without
h
pyloriinfect
defici
mice
higher
apoptosi
index
wt
mice
h
pylori
infect
induc
stronger
gastriti
apoptosi
less
cell
prolifer
defici
mice
wt
mice
tabl
conclus
week
h
pylori
colon
studi
model
defici
enhanc
gastriti
potenti
aipi
ratio
induc
h
pylori
infect
aim
helicobact
speci
establish
persist
infect
gastric
mucosa
surfact
protein
spd
coflectin
innat
immun
system
express
gastric
mucosa
vivo
upregul
helicobact
refect
vitro
spd
bind
h
pylori
h
feli
caus
aggreg
bacteria
aim
studi
determin
role
spd
host
defenc
gastric
colonis
helicobact
gastric
inflamm
immun
spd
defici
mous
model
method
specif
pathogenfre
spd
mice
n
background
wild
type
mice
infect
garag
hfeli
week
determin
abil
clear
infect
low
infect
dose
h
fell
week
investig
inflammatori
respons
gastric
colonis
h
feli
assess
use
histolog
realtim
pcr
cell
prolif
respons
h
fell
specif
antigen
examin
incorpor
assay
inflammatori
score
determin
neutrophil
count
four
area
stomach
cardia
bodi
transit
zone
antrum
result
spd
mice
effect
colonis
h
fell
week
postchalleng
infect
dose
spd
show
significantli
higher
colonis
rate
control
p
cell
prolif
respons
also
significantli
reduc
absenc
spd
p
nentrophil
respons
significantli
differ
spdand
wild
type
mice
conclus
absenc
spd
associ
increas
suscept
low
dose
infect
failur
bacteri
clearanc
reduc
level
cell
respons
helicobact
suggest
spd
role
protect
infect
small
innocula
pathogen
involv
activ
increas
antigen
present
antigen
present
cell
helicobaet
pylori
gastriti
jan
ott
heik
neumann
rainer
lebert
andrea
bastian
hen
schrader
wolfgang
e
schmidt
frank
schmitz
introduct
aim
antimicrohi
peptid
effector
molecul
innat
immun
system
crucial
gastrointestin
barrier
function
toulik
receptor
pattern
recognit
receptor
initi
immun
respons
aim
studi
systemat
character
express
variou
antimicrobi
peptid
infecti
noninfect
gastriti
clarifi
put
role
tolllik
receptor
tlr
well
involv
signal
mechan
method
gastric
biopsi
obtain
patient
inform
consent
n
heficobact
pylori
hp
posit
gastriti
cgastriti
unspecif
gastriti
patient
ppitherapi
control
without
inflamm
treatment
gastric
ag
cell
incub
caga
vaca
posit
neg
h
pylori
strain
proinflammatori
stimuli
express
antimicrobi
peptid
quantifi
realtim
pcr
intracellular
signal
determin
western
blot
analysi
specif
blockag
distinct
sgnale
molecul
clarifi
put
role
tlr
basal
express
pattern
determin
transient
transfect
tlr
perfrom
result
gastric
mucosa
constitut
express
defensin
express
induc
infecti
noninfecti
gastriti
express
significantli
correl
infect
h
pylori
express
antimicrobi
peptid
rnase
detect
sampl
healthi
control
well
variou
form
gastriti
obviou
correl
infect
hp
express
adefensin
detect
ag
cell
constitut
express
wherea
stimul
live
caga
vaca
posit
hp
hp
lysat
hp
condit
media
differenti
induc
express
express
antimicrobi
peptid
induc
follow
activ
tlr
mediat
map
kinas
conclus
antimicrobi
peptid
differenti
express
infecti
noninfecti
gastriti
human
induct
peptid
express
h
pylori
requir
direct
contact
microorgan
addit
mediat
recognit
hpylori
initi
f
specif
effector
molecul
seem
mediat
tlr
result
suggest
differenti
innat
immun
respons
contribut
protect
gastral
mucosa
pattern
recognit
receptor
key
eficinng
inflammatori
respons
bacteri
lipopolysaccharid
lp
recent
shown
function
missens
mutat
fourth
exon
gene
caus
aberr
lp
handl
increas
risk
hypochlorhydria
premalign
chang
stomach
aim
examin
whether
poiymorph
influenc
risk
gastric
cancer
gc
caucasian
subject
method
use
pcrrflp
nucleas
assay
genotyp
polymorph
polish
populatinnbas
casecontrol
studi
compris
gastric
cancer
case
control
odd
ratio
confid
interv
ci
calcul
logist
regress
use
adjust
confound
variabl
result
frequenc
mutat
control
popul
similar
caucasian
popul
alld
hardyweinberg
equilibrium
signific
associ
carnag
mutat
increas
risk
gc
adjust
ci
increas
risk
appli
equal
diffus
intestin
type
gc
stronger
noncardia
subsit
risk
higher
h
pylori
posit
case
conclus
result
indic
carriag
mutat
increas
risk
gc
caucasian
popul
specul
aberr
handl
lp
origin
due
mutat
lead
exagger
inflammatori
respons
characteris
sever
gastriti
gastric
atrophi
hypochlorhydria
ultim
increas
risk
gc
find
expand
strengthen
role
host
genet
factor
pathogenesi
h
pyloriinduc
gc
presenc
gastric
epitheli
cell
potenti
role
regul
cell
helicobact
pylori
infect
soumita
da
giovanni
snarez
ellen
beswick
david
bland
victor
rey
background
aim
gastric
epitheli
ceil
gec
express
class
mhc
costimulatori
molecul
may
permit
act
antigen
present
cell
apc
sinc
strateg
locat
lumin
antigen
resid
intraepitheli
lamina
propria
cell
gec
could
play
major
role
immunopathogenesi
associ
h
pylon
infect
howev
h
pylon
infect
cell
hyporespons
afford
protect
ligand
apc
bind
cell
receptor
neg
regul
ceil
thu
hypothesi
address
studi
gec
express
allow
inhibit
local
cell
contribut
chroinciti
h
pylori
infect
method
presenc
new
member
detect
rtpcr
chang
express
gec
follow
h
pylori
infect
determin
real
time
quantit
rtpcr
flow
cytometr
analysi
function
role
crosstalk
gec
cell
assess
cocultnr
presenc
block
agent
antibodi
pdifc
result
addit
costimul
ligand
icosl
rtpcr
reveal
express
gec
also
detect
flow
cytometri
gec
kato
iii
cell
line
also
nontransform
ceil
express
gec
increas
follow
h
pylori
infect
detect
real
time
rtpcr
interestingli
ifn
gamma
produc
h
pylori
infect
increas
express
gec
tnfalpha
also
increas
express
wherea
lp
littl
effect
express
cocultnr
gec
cell
reveal
function
role
promot
cell
apoptosi
regul
cytokin
express
limit
cell
prolifer
conclus
induct
h
pylori
treat
gec
indic
possibl
role
immunosuppress
function
studi
indic
involv
receptor
member
gec
background
ghrelin
recent
describ
growth
hormon
releas
peptid
synthesis
mainli
oxynt
mucosa
stomach
power
effect
secret
growth
hormon
directli
signal
hypothalam
regulatori
nuclei
control
energi
haemostasi
h
pylori
gastriti
invari
associ
local
immun
respons
though
organ
gener
persist
lead
chronic
gastric
inflamm
influenc
h
pylon
associ
gastriti
regul
gastric
ghrelin
studi
specul
inflamm
oxynt
mucosa
may
impair
ghrelin
synthesi
may
account
associ
h
pylon
infect
growth
delay
childhood
method
total
rna
extract
pair
fundic
biopsi
revers
transcrib
cdna
subject
quantit
real
time
pcr
result
normalis
housekeep
gene
hhprt
h
pylori
statu
determin
separ
antral
biopsi
ghrelin
sequenc
use
statist
analysi
done
use
mann
whitney
test
result
twenti
six
patient
recruit
studi
five
patient
h
pylori
gastriti
rest
normal
histolog
signific
differ
demograph
anthropometr
two
group
h
pylori
gastriti
v
control
mean
sd
age
v
p
sex
f
v
v
p
bioimped
v
p
ghrelinhhprt
mrna
ratio
mean
sd
sampl
h
pylori
gastriti
compar
control
p
conclus
h
pylon
infect
associ
regul
gastric
fundic
gene
express
reduc
gastric
product
ghrelin
patient
h
pylori
associ
gastriti
may
contribut
extra
intestin
manifest
infect
via
reduc
gh
releas
andor
via
disturb
regul
appetit
energi
homeostasi
mechan
local
inflamm
inhibit
gastric
ghrelin
express
still
remain
investig
hi
h
pylori
llp
strain
infect
anim
n
plu
control
n
sacrif
week
postinfect
pi
infect
confirm
cultur
andor
histolog
serum
gastrin
measur
radioimmunoassay
haematoxylin
eosin
antichromogranin
stain
section
use
grade
gastric
patholog
enterochromaffinlik
ecl
cell
respect
result
hf
hp
inocul
gerbil
infect
gastric
patholog
hf
week
pi
greater
corpu
antrum
consist
mark
atrophi
parietalchief
cell
cystic
chang
mucou
metaplasia
antrum
week
hp
associ
significantli
greater
chronic
inflamm
p
polymorph
activ
p
atrophi
p
hr
corpu
signific
differ
chronic
inflamm
atrophi
observ
hf
associ
significantli
greater
activ
p
ecl
cell
hyperplasia
p
hp
week
pi
serum
gastrin
significantli
increas
hf
pm
p
hp
infect
p
compar
uninfect
control
gastric
carcinoid
present
hfinfect
gerbil
absent
hp
strain
infect
gerbil
conclus
gastric
patholog
induc
hp
strain
hf
gerbil
differ
longterm
hf
infect
result
corpu
predomin
gastriti
elev
gastrin
ecl
cell
hyperplasia
gastric
carcinoid
hpinfect
mongolian
gerbil
establish
experiment
model
gastric
carcinogenesi
result
longterm
infect
gastric
mucosa
germ
role
gastrin
prolong
hipergastrinemia
induc
omeprazol
treatment
anim
remian
establish
studi
effect
intragastr
inocul
mongolian
gerbil
hp
strain
caga
vaca
cfuml
isol
gastric
ulcer
patient
hp
infect
noninfect
gerbil
receiv
daili
treatment
week
vehicl
salin
nmolfag
ip
pentagastrin
nmolkg
sc
omeprazol
mgkg
sc
wk
upon
hp
inocul
morpholog
chang
glandular
mucosa
assess
histolog
viabl
hp
analyz
rapid
ureas
test
densiti
hpcolon
evalu
count
number
coloni
per
plate
addit
gastric
blood
flow
gbf
measur
hga
clearanc
techniqu
plasma
gastrin
determin
ria
express
protein
assess
western
blot
hp
infect
detect
anim
histolog
hp
cultur
rapid
ureas
test
earli
lesion
seen
wk
upon
hpinocul
consist
chronic
gastriti
increas
mucos
fold
elong
interfuveolar
ridg
format
multipl
lymphoid
follicl
gastric
mucosa
end
studi
typic
adenomat
hyperplasia
cellular
atypia
observ
togeth
atroph
gastriti
intestin
metaplasia
dysplasia
intraepitheli
neoplasia
especi
gerbil
treat
gastrin
omeprazol
hpinfect
gerbil
plasma
gastriu
level
increas
fold
sigmfic
rise
mucos
protein
express
observ
effect
markedli
enhanc
gerbil
treat
pentagastrin
omeprazol
gbf
hpinfect
gerbil
treat
pentagastnn
omeprazol
significantli
lower
hpinfect
treat
vehicl
decreas
gbf
remain
constant
end
observ
period
conclud
gastrin
prolong
hypergastrinemia
caus
long
omeprazol
treatment
subsequ
induct
play
major
role
develop
typic
function
chang
impair
gastric
mucos
microcircul
promot
patholog
chang
lead
gastric
carcinogenesi
helicobact
pylori
infect
human
antral
cell
line
alter
express
level
cell
matrix
protein
dystroglycan
paxiuin
result
increas
rate
migrat
jian
kang
victoria
conlin
susan
curti
ying
zhao
edwin
moor
steven
pelech
alison
buchan
aim
woundclosur
requir
epitheli
cell
migrat
sheet
oppos
singl
cell
predict
achiev
alter
express
cell
matrix
protein
whilst
cefl
cell
adhes
protein
express
remain
constant
dystroglycan
one
protein
involv
maintain
attach
epitheli
cell
basement
membran
experi
address
question
whether
heflcobact
pylon
infect
alter
express
attach
protein
dystroglycan
paxiflin
cell
migrat
rate
method
cell
starv
prior
infect
wild
type
cag
avac
h
pylon
incub
migrat
assay
wound
made
across
centr
well
rate
wound
closur
monitor
interv
period
cell
lyse
presenc
proteas
inhihitor
immunoprecipit
experi
fix
paraformaldebyd
immunocytochem
analysi
usmg
deconvolut
microscopi
result
western
blot
analysi
h
pylori
infect
ceil
reveal
decreas
dystroglycan
protein
express
conjunct
increas
paxiuin
protein
express
tyrosin
phosphoryl
control
n
parallel
immunocytochem
analysi
show
transloc
dystroglycan
paxilin
away
basal
membran
correl
increas
cell
migrat
control
n
conclus
h
pylori
infect
increas
migratori
rate
epitheli
cell
part
decreas
dystroglycan
level
alter
distribut
paxiflin
focal
adhes
background
betadefensin
famili
endogen
antimicrobi
peptid
engag
host
defenc
promin
mucos
epithelia
skin
other
previous
shown
human
beradefensin
hbd
potent
bactericid
agent
h
pylori
present
ident
signal
pathway
involv
hostbacteri
cross
talk
lead
modul
defensin
express
remain
larg
unknown
present
studi
investig
role
nfkb
map
kinas
signal
event
central
player
inflammatori
immun
respons
regul
method
ag
gastric
epitheli
cell
infect
cytotox
h
pyloristrain
defensin
gene
express
quantifi
activ
mapk
pathway
follow
detect
phosphospeciflc
antibodi
erk
andjnk
enzym
nfkb
activ
determin
lkba
degrad
phosphoryl
result
conclus
three
map
kinas
pathway
activ
wild
type
bacteri
strain
potent
rapid
induct
erk
follow
slower
induct
jnk
pathway
ikba
degrad
maxim
rate
similar
observ
illb
stimul
map
kinas
inhibitor
studi
suggest
critic
role
erk
pathway
bacterialinduc
illb
stimul
defensin
gene
express
current
delin
upstream
signal
event
like
respons
differenti
defensin
gene
express
observ
infect
inflamm
polymorph
evalu
nucleas
pcr
assay
taqman
vntr
result
cc
found
control
stomach
cancer
bgu
du
patient
respect
ct
found
control
stomach
cancer
bgu
du
patient
respect
tt
suggest
high
express
found
control
stomach
cancer
bgu
du
patient
respect
odd
ratio
ill
tff
diseas
stomach
cancer
bgu
du
compar
control
ci
ci
ci
respect
ilirn
ul
found
control
stomach
cancer
bgu
du
patient
respect
ilirn
found
control
stomach
cancer
bgu
du
patient
respect
found
control
stomach
cancer
bgu
du
patient
respect
differ
depend
diseas
partli
origin
low
proport
express
korea
result
similar
analysi
hpposit
subject
diseas
control
conclus
slightli
increas
proport
tt
genotyp
group
stomach
cancer
bgu
control
without
statist
signific
howev
tlgenotyp
significantli
protect
du
occurr
hp
infect
korea
impact
longterm
acid
suppress
develop
gastric
glandular
atrophi
helicohact
pylon
hp
infect
patient
debat
vigor
also
suggest
mark
acid
inhibit
might
induc
gastriti
colonis
bacteria
hp
patient
method
report
seven
year
follow
analysi
biopsi
gastric
corpu
mucosa
patient
reflux
esophag
randomis
omeprazol
therapi
ome
antireflux
surgeri
ar
patient
randomis
ar
subsequ
oper
randomis
omeprazol
treat
seven
year
patient
ome
group
patient
ar
group
remain
studi
biopsi
taken
corpu
mucosa
score
accord
sydney
classif
system
ar
patient
remain
hpneg
throughout
studi
period
initi
hpneg
turn
hppo
initi
hppo
turn
neg
final
persist
hppo
correspond
number
ome
group
patient
result
biopsi
patient
remain
hpneg
throughout
studi
develop
atrophi
sign
chronic
inflamm
rare
phenomenon
decreas
group
none
sign
activ
gastriti
hpinfect
patient
atrophi
score
improv
one
deterior
five
omeprazol
treat
patient
correspond
figur
ar
treat
patient
one
three
progress
inflamm
score
note
omeprazol
group
chang
seen
ar
group
conclus
longterm
acid
inhibit
alter
oxynt
mucos
morpholog
hpneg
gerdpati
indic
major
influenc
longterm
acid
inhibit
develop
glandular
atrophi
gastric
mucosa
hpposit
patient
helicobact
pylori
hpylori
infect
probabl
acquir
childhood
caus
vigor
immun
respons
unclear
subgroup
infect
children
develop
peptic
ulcer
report
trend
strain
caus
sever
diseas
children
journal
pediatr
gastroenterolog
nutrit
howev
pathogenesi
depend
sole
ulcerogen
strain
hpylori
also
variabl
host
respons
aim
aim
studi
assess
signific
tnfu
promot
polymorph
relat
infect
hpylori
strain
children
method
antral
biopsi
hpylori
posit
children
age
year
analyz
children
duoden
diseas
includ
eros
duoden
andor
duoden
ulcer
gastriti
hpylori
infect
diagnos
bacteri
cultur
histolog
genom
dna
extract
antral
biopsi
use
character
genet
polymorph
tnfr
promot
nucleotid
posit
pcrbase
restrict
fragment
length
polymorph
hpylon
strain
examin
cag
vac
result
children
duoden
diseas
infect
posit
strain
g
polymorpfi
tnf
c
promot
vs
children
gastriti
alon
p
fisher
exact
test
conclus
combin
bacteri
tnfc
g
polymorph
may
risk
factor
peptic
ulcer
diseas
children
infect
hpylori
larger
studi
need
confirm
associ
heficobact
pylori
hp
infect
link
gastric
mucos
hyperprofifer
carcinogenesi
howev
mechan
involv
relat
fulli
elucid
yet
modul
cell
prolifer
differenti
regul
transcript
sever
gene
product
tyrosin
kinas
involv
regul
cell
prolifer
differenti
transform
tumor
progress
alm
method
aim
studi
evalu
correl
gastric
mucos
inflamm
grade
total
tyrosin
kmase
wk
activ
prolif
activ
label
index
estim
express
patient
h
pylori
infect
patient
h
pylori
infect
h
pylori
neg
control
includ
studi
biopsi
specimen
gastric
mucosa
subject
assess
inflamm
degre
accord
updat
sydney
classif
immunohistochemistri
monoclon
antibodi
well
total
tyrosin
kinas
activ
elisa
assay
kit
result
total
tyrk
activ
label
index
li
sigmficantli
higher
hp
hp
group
vs
pmolpmgmin
p
vs
p
respect
signific
correl
r
observ
li
total
tyrk
activ
examin
subject
immunoreact
detect
patient
intestin
metaplasia
addit
accumul
commonli
detect
other
patient
sever
grade
chronic
gastriti
p
mean
gastric
mucos
total
tyrk
activ
patient
immunoreact
yield
pmolpmgmin
significantli
higher
p
neg
subject
pmolpmgmin
signific
correl
li
immunoreact
examin
patient
conclus
result
suggest
tyrosin
kinas
may
play
import
role
develop
gastric
mucos
hyperprofifer
h
pyloninduc
chronic
gastriti
possibl
earli
gastric
carcinogenesi
result
lend
support
hypothesi
mutat
may
earli
event
stomach
carcinogenesi
cours
hpylori
infect
studi
support
polish
committe
scientif
research
grant
young
seok
cho
ok
ran
shin
sung
soo
kim
jong
hyun
park
hnin
suk
chae
myung
gyu
choi
sok
han
chang
lee
sik
chung
background
peroxisom
profiferatoractiv
receptor
ppari
nuclear
transcript
factor
play
critic
role
regul
express
gene
associ
inflamm
ppari
express
human
gastric
cancer
well
colon
cancer
activ
ppari
figand
produc
proapoptut
effect
amelior
grow
cancer
cell
h
pylori
main
etiolog
agent
gastric
inflamm
rais
cell
turnov
gastric
epithelium
longstand
infect
organ
relat
develop
noncardia
gastric
cancer
aim
studi
investig
effect
h
pylori
express
ppar
mrna
protein
chronic
gastriti
method
gastric
biopsi
sampl
taken
h
pylori
infect
n
noninfect
n
patient
endoscop
examin
ppari
mrna
quantifi
real
time
pcr
normal
data
express
rel
copi
number
ppari
protein
express
evalu
imag
analysi
immunohistochem
stain
stain
intens
grade
stain
intens
stain
result
ppari
local
nuclei
foveolar
epitheli
cell
infect
unifect
mucosa
ppar
protein
express
higher
h
pylori
infect
patient
noninfect
patient
vs
hp
infect
noninfect
respect
p
howev
ppari
mrna
level
significantli
differ
vs
hp
infect
noninfect
respect
p
also
could
deduc
appar
relat
express
ppari
mrna
ppar
protein
immunohistochemistri
conclus
ppar
express
increas
h
pylon
infect
chronic
gastriti
hui
liu
cfistina
seminomora
cara
olsen
steven
mog
richard
peek
andr
duboi
gastric
cancer
caus
environment
mitogen
eg
helicobact
pylon
nitros
compound
addit
suppress
dna
repair
gene
methyhransferas
mgmt
express
increas
gastric
cancer
risk
human
monkey
examin
effect
h
pylori
infect
nitrosatnig
carcinogen
ethylnitronitrosognanidin
enng
express
illb
mgmt
also
current
investig
whether
cancer
emerg
report
monkey
year
enng
j
natl
cancer
inst
gastruscopi
perform
monkey
natur
infect
h
pylori
biopsi
fix
histolog
cultur
flash
frozen
molecular
analys
mrna
express
ii
pylori
rrna
mgmt
determin
use
absolut
quantit
rtpcr
taqman
method
standard
curv
clone
rna
fragment
normal
bactin
ng
rna
statist
signific
calcul
use
kruskalwalh
test
anova
infect
cure
quadrupl
therapi
anim
divid
four
group
control
c
n
inocul
virul
h
pylon
strain
isol
patient
gastric
cancer
h
n
enng
e
mgday
h
pylori
inocul
enng
start
month
postinocul
n
followup
gastroseopi
biopsi
perform
regular
interv
follow
antibiot
cultur
neg
express
rrna
nlb
suppress
p
mgmt
express
chang
significantli
month
post
inocul
h
h
e
group
antral
gastriti
h
pylori
present
gastric
lumen
attach
epitheli
cell
lamina
propria
recov
isol
ident
input
strain
rapd
fingerprint
therefor
studi
microarray
dna
analysi
express
increas
h
pylori
infect
monkey
mgmt
express
increas
h
e
compar
c
tabl
lllb
mgmt
mrna
express
significantli
correl
rrna
express
h
h
e
p
thu
express
dna
repair
gene
initi
increas
exposur
h
pylon
andor
enng
similar
earlier
report
cancer
appear
month
enng
repeat
endoscopi
continu
perform
interv
background
aim
notch
signal
system
play
import
role
process
tissu
develop
cell
differenti
mediat
inhibitori
effect
hairi
enhanc
split
homologu
he
protein
basic
helixloophelix
bhlh
type
transcript
factor
id
inhibitor
differenti
dna
bind
protein
also
act
neg
regul
bihlh
protein
molecul
known
particip
intestin
cell
differenti
littl
known
contribut
gastric
mucos
develop
present
studi
investig
express
notch
receptor
id
protein
human
gastric
mucosa
without
hpylori
infect
materi
method
endoscop
biopsi
specimen
obtain
hpylorineg
volunt
hpyloriposit
chronic
gastriti
case
consent
immunohistochemistri
notchl
receptor
ldi
protein
perform
stmptoavidinbiotin
peroxidas
method
use
formalinfix
paraffinembed
section
result
normal
gastric
mucnsa
notch
receptor
protein
express
cell
locat
around
glandular
isthmu
pariet
cell
surfac
epitheli
cell
express
rel
weak
comparison
hpyloriinfect
gastric
mucosa
accompani
variou
level
inflamm
intestin
metaplasia
differ
hpylorineg
case
express
notch
receptor
id
protein
hpylorposit
case
extend
upper
part
surfac
epitheli
cell
correspond
degre
ofinflarnmatori
cell
infiltr
addit
columnar
cell
intestin
metaplasia
extens
express
notch
receptor
ld
protein
basal
part
surfac
pit
goblet
cell
express
conclus
present
studi
suggest
notch
receptor
ld
protein
may
play
import
role
gastric
mucos
cell
differenti
chang
express
pattern
may
contribut
deviat
gastric
type
cell
lineag
commit
relat
develop
intestin
metaplasia
gastric
mucosa
hpylori
infect
masahiko
nakamura
hidenori
matsui
kaori
nishikawa
shinichi
takahashi
kanji
tsuchimoto
previou
investig
mous
gastric
mucosa
infect
helicohact
heflmanniihk
organ
hhhlo
bacilli
found
local
deeper
fundic
antral
gland
compar
hehcohact
pylon
addit
administr
blocker
hhloinfeet
mice
brought
increas
apoptot
pariet
cell
thu
present
studi
undertaken
clarifi
precis
alter
pariet
cell
differenti
hhloinfect
acidsuppressantadminist
mous
gastric
mucosa
materi
method
mice
infect
hhlo
month
use
follow
experi
treatment
cimetidin
lansoprazol
mgkg
bw
everi
hour
day
orogastr
intuh
cell
immunoreact
one
rnabind
protein
specif
local
cytoplasm
stem
cell
digest
tract
detect
indirect
immunohistochem
method
addit
number
brdureact
pariet
cell
investig
doubl
stain
antibrdu
h
katpas
monoclon
antibodi
number
pariet
cell
nucleu
calcul
electron
microscopi
clarifi
convers
mucou
neck
cell
pariet
cell
doubl
stain
monoclon
antibodi
one
antibodi
glandular
mucou
cell
h
katpas
also
perform
local
hhlo
fundic
gland
shown
use
antibodi
hp
type
iv
secretori
apparatu
result
multinucl
brduimmunoreact
pariet
cell
increas
hhlohabit
apoptot
pariet
cell
base
fundic
gland
cimetidinetr
group
control
fansoprazoletr
group
posit
cell
immunoreact
suggest
pariet
ceil
dedifferenti
matur
pariet
cell
deriv
mucou
neck
cell
conclus
blocker
administr
hhloinfect
mous
shown
bring
dedifferenti
pariet
cell
locat
base
fundic
gland
transcript
factor
foxll
express
mesodermderiv
tissu
like
kidney
mesenchym
digest
tract
express
endodermderiv
epitheli
ceil
gener
foxll
knock
ko
mice
analyz
phenotyp
ko
mice
loss
foxll
gene
led
sever
reduct
acid
secret
could
stimul
histamin
gastrin
bethanechol
camp
investig
mechan
impair
acid
secret
foxll
ko
mice
assess
express
h
katpas
alphaand
betasubunit
western
blot
found
express
alphaand
betasubunit
reduc
foxll
ko
mice
compar
wildtyp
wt
mice
possibl
reduc
express
h
katpas
result
decreas
number
pariet
cell
foxll
ko
mice
test
possibihti
perform
histochem
analysi
pariet
cell
use
pariet
cellspecif
lectin
dba
signific
differ
number
pariet
cell
wt
foxll
ko
mice
also
perform
flow
cytometri
examin
express
level
h
kalpha
found
foxll
ko
pariet
cell
express
smaller
amount
h
kaipha
wt
pariet
cell
electron
microscop
observ
reveal
appar
differ
ultrastmctur
pariet
cell
nonstimul
state
wt
foxll
ko
mice
howev
treat
histamin
secretori
canaliculi
foxll
ko
pariet
cell
expand
fulli
connect
apic
membran
like
wt
cell
find
indic
foxll
ko
mice
fusion
tubulovesicl
secretori
canaliculi
might
obstruct
prompt
us
studi
express
thought
regul
membran
fusion
event
tubulovesid
secretori
canaliculi
pariet
cell
express
level
rabl
protein
almost
equival
wt
foxll
ko
mice
wherea
protein
decreas
foxll
ko
mice
compar
wt
mice
result
indic
express
well
h
katpas
alphaand
betasubunit
perturb
absenc
foxll
defect
acid
secret
foxll
ko
pariet
cell
seem
result
combin
effect
impair
membran
fusion
tubulovesicl
secretori
canalicuh
due
reduc
decreas
express
h
katpas
alphaand
betasubunit
proton
excret
background
aim
duoden
mucos
bicarbon
secret
dmb
provid
import
first
line
duoden
mucos
defens
gastric
acid
ca
depend
secretagogu
carbachol
induc
increas
intracellular
ca
stimul
dmb
howev
underli
mechan
still
unclear
duoden
mucosa
aim
present
studi
determin
sourc
clearanc
intracellular
ca
util
dmb
mice
method
duoden
mucosa
nih
swiss
mice
strip
seromnscular
fater
mount
uss
chamber
shortcircuit
current
isc
measur
express
sodiumcalcium
exchang
ncx
transient
receptor
potentiallik
channel
trp
duoden
mucosa
analyz
western
blot
result
carbachol
pm
induc
increas
isc
biphas
manner
initi
peak
vs
izeqcmh
n
p
second
plateau
vs
peq
n
p
carbacholinduc
increas
dmb
isc
mediat
mnscarin
receptor
extracellular
ca
sinc
atropin
solut
total
abolish
effect
carbachol
n
p
preatreat
cyclopiazon
acid
gm
caffein
alon
increas
basal
isc
prevent
carhacholinduc
increas
lsc
p
howev
combin
cyclopiazon
acid
caffein
abolish
initi
lac
peak
increas
carbachol
nifedipin
p
voltageg
calcium
channel
blocker
gm
receptoroper
calcium
channel
blocker
effect
respons
carbachol
n
p
nickel
lmm
trp
blocker
affect
initi
peak
vs
peqcm
p
prevent
second
plateau
vs
peqcm
h
n
p
induc
carbachol
moreov
pm
inhibitor
ncx
potenti
second
plateau
vs
n
p
induc
carhachol
western
blot
analysi
show
express
protein
duoden
mucosa
conclus
result
underscor
import
intracellufar
ca
regul
duoden
mucosa
ion
transport
possibl
dmb
stimul
muscarin
receptor
may
caus
ca
releas
caffeinesensit
intracellular
store
also
extracellular
ca
entri
via
trp
ncx
may
involv
ca
clearanc
cytosol
resolv
effect
mnscarin
stimul
gene
express
regul
gastric
pariet
cell
lidong
wang
john
del
vall
background
cytokin
interleukin
il
potent
interferongamma
ifn
induc
factor
play
essenti
role
host
defens
inflamm
sever
studi
demonstr
kip
stimul
product
cytokin
human
gastric
mucosa
cultur
primari
gastric
epitheli
cell
despit
observ
cellular
constitu
il
origin
stomach
establish
object
perform
follow
studi
examin
gene
express
regul
primari
gastric
mucos
ceil
method
canin
gastric
mucos
cell
isol
collagenas
digest
sever
popul
chief
mucou
pariet
cell
enrich
counter
flow
dutriationpercol
densiti
centrifug
cultur
matrigelco
plate
express
examin
rtpcr
use
canin
primer
rtpcr
product
bp
analyz
electropboresi
agaros
gel
contain
ethidium
bromid
band
examin
uv
light
presenc
amplifi
dna
result
mrna
express
constitut
detect
gastric
pariet
cell
tnfalpha
ngml
significantli
stimul
gene
express
time
depend
fashion
maxim
respons
basal
n
p
hour
return
baselin
within
hour
examin
signal
pathway
tnfalpha
induc
gene
express
gastric
pariet
cell
pretreat
nfkappa
b
inhibitor
pdtc
pkc
inhibitor
kinaseakt
inhibitor
erk
inhibitor
em
min
pdtc
abolish
tnfalpha
induc
gene
express
furthermor
partial
inhibit
stimulatori
effect
tnfalpha
gene
express
basal
inhibit
n
p
alter
effect
tnfalpha
conclus
demonstr
gastric
pariet
cell
express
addit
tnfalpha
stimul
gene
express
via
nfkappa
b
kinas
akt
pathway
result
suggest
noninflammatori
cell
express
import
cytokin
gastric
pariet
cell
may
play
role
mediat
action
gastric
mucosa
physiolog
genom
gastric
pariet
cell
nil
lambrecht
iskandar
yakubov
georg
sach
background
pariet
cell
respons
secret
acid
stomach
sever
uniqu
characterist
eg
high
mitochondri
content
h
k
atpas
specif
receptor
howev
mani
protein
express
cell
unknown
like
physiolog
relev
aim
determin
specif
express
gene
rat
pariet
cell
use
subtract
comparison
approach
digonudeotid
express
microarray
method
microarray
technolog
appli
use
subtracr
comparison
rat
gastric
mucos
pronas
digest
fraction
centrifug
nycodenz
gradient
elutri
mlmin
rpm
purifi
nycodenz
gradient
pariet
cell
primari
digest
purifi
homogen
measur
either
immunostain
auto
fluoresc
x
enrich
rna
purifi
cell
mucos
digest
separ
label
cohybrid
agil
oligonucleotid
express
array
n
rna
gene
specif
express
pariet
cell
increas
least
fold
rna
fold
decreas
like
absent
pariet
cell
result
gene
array
enrich
fold
includ
heat
shock
protein
cell
cycl
prolifer
gene
perhap
due
cell
prepar
addit
gene
found
fold
enrich
marker
gene
pariet
cell
enrich
receptor
mitochondri
protein
etc
specif
gene
present
pariet
cell
includ
potassium
channel
na
facilit
glucos
transport
prostaglandin
receptor
prostaglandin
transport
endocytor
apic
membran
associ
glycoprotein
cytoskelet
protein
ezrin
kcnqi
express
confirm
real
time
pcr
gapdh
control
agil
rat
microarray
contain
valid
oligonucleotid
hkatpas
subunit
real
time
pcr
show
increas
ofa
subunit
express
gene
found
decreas
includ
pepsinogen
mucin
somatostatin
ghrelin
conclus
combin
cell
purif
subtract
comparison
microarray
technolog
lead
snapshot
overal
physiolog
gene
express
pattern
pariet
cell
method
use
identifi
novel
gene
express
pariet
cell
gammaaminonbutyr
acid
gaba
modul
gastric
acid
secret
ga
central
arid
peripher
mechan
probabl
activ
gabaa
gab
receptor
eur
j
pharmacol
re
comraun
mol
pathol
pharmacol
gaba
effect
ga
character
mice
aim
determin
effect
gaba
ga
secret
mice
involv
gabaa
gabab
gab
receptor
method
urethaneanesthet
mice
ga
monitor
interv
continu
intragastr
perfus
salin
backtitr
ph
effect
iv
gaba
select
gabaa
muscimol
gabab
rbaclofen
gabac
imidazol
acid
hydrochlorid
agonist
ga
investig
result
basal
ga
low
urethaneanesthet
mice
mu
toolh
gaba
mgkg
iv
modifi
basal
ga
gab
agonist
rbaclofen
mgkg
iv
stimul
ga
doserel
manner
mu
molh
respect
n
similarli
potent
gabab
agonist
mgkg
iv
also
stimul
ga
doserel
manner
muj
molh
respect
gab
agonist
muscimol
mgkg
iv
affect
basal
ga
gabac
agonist
imidazol
mgkg
iv
tendenc
inhibit
basal
ga
mgkg
mu
toolh
vs
basal
mu
toolh
significantli
reduc
basal
ga
mgkg
mu
toolh
vs
basal
stimulatori
respons
mgkg
similar
elicit
vagal
stimul
prevent
pretreat
select
gaba
antagonist
mgkg
iv
molh
conclus
mice
activ
gabab
receptor
stimul
ga
colinerg
vagallymedi
mechan
lack
effect
gaba
might
relat
inabl
cross
bloodbrain
barrier
charl
l
watson
katalin
f
medzihradszki
john
g
fort
benzimidazol
famili
proton
pump
inhibitor
ppi
includ
omeprazol
lansoprazol
pantoprazol
commonli
recogn
effect
treatment
hyperacid
gastroesophag
reflux
diseas
compound
thought
neutral
inact
introduc
acid
environ
undergo
chemic
rearrang
leav
reactiv
form
disulfid
bond
atpas
pump
near
target
membran
recent
evid
suggest
pantoprazol
may
react
differ
ilk
form
nonreduc
bond
gastment
gastment
reduc
agent
effici
remov
ppi
hkassoci
bind
restor
acid
secret
except
pantoprazol
examin
molecular
basi
find
studi
reactiv
ppi
defin
synthet
peptid
use
mass
spectrometri
nmr
also
present
method
determin
site
action
vivo
consist
earlier
find
convers
drug
activ
form
highli
depend
ph
moder
ph
drug
rapidli
degrad
non
reactiv
product
activ
lower
ph
model
primari
acid
secret
activ
form
stabil
though
less
reactiv
toward
synthet
peptid
result
also
demonstr
activ
ppi
select
suflhydryl
bind
variabl
reaction
origin
thought
irreduc
natur
pantoprazol
bind
simpl
steric
hindranc
due
previous
undocu
reaction
presenc
primari
amin
nelia
tobey
chri
argot
taylan
kay
barlow
roy
c
orlando
aimbackground
epithelium
human
tract
studi
effect
mount
endoscop
biopsi
miniuss
chamber
j
lab
clin
med
therefor
use
technolog
compar
basic
electr
data
sodium
transport
capac
esophag
stratifi
squamou
epithelium
ess
barrett
special
columnar
epithelium
bsce
method
endoscop
jumbo
biopsi
obtain
subject
normal
ess
subject
bsce
mount
miniuss
chamber
lucit
ring
apertur
diamet
ram
measur
potenti
differ
pd
shortcircint
current
lsc
calcul
total
electr
resist
rt
bath
normal
ringer
solut
ph
gass
co
result
mean
sem
ess
n
vs
bsce
n
basal
pd
vs
mv
isc
vs
uampscm
r
vs
ohmcm
notabl
basal
isc
rt
significantli
differ
ess
vs
bsce
p
consist
differ
report
vivo
esophag
pd
ess
bsce
remov
sodium
lumin
seros
bath
solut
reduc
isc
ess
bsce
vs
respect
p
sodium
restor
restor
isc
basal
level
seros
addit
ouabain
ram
reduc
isc
tissu
conclus
data
document
ess
bsce
distinct
electr
properti
assess
vitro
endoscop
jumbo
biopsi
mount
miniuss
chamber
bsce
higher
net
ion
transport
capabl
lower
transepithefi
rt
ess
unlik
ess
net
ion
transport
bsce
independ
net
sodium
movement
base
direct
current
could
reflect
either
chlorid
andor
bicarbon
secret
bsce
support
tomoo
fujisawa
kyoichi
adachi
yoshinori
komazawa
takafumi
mihara
tomoko
katsub
takan
azumi
kenji
fumta
mohammad
ak
rumi
syunji
ishihara
yuji
amano
yoshikazu
kinnshita
introduct
acid
suppress
effect
receptor
antagonist
report
reduc
continu
administr
kiowev
clarifi
whether
helicohact
pylori
h
pylori
infect
affect
declin
acid
suppress
effect
addit
examin
whether
toler
phenomenon
occur
administr
lafutidin
new
acid
suppress
activ
via
receptor
also
increment
calcitonin
gene
relat
peptid
cgrp
aim
clarifi
whether
h
pylori
infect
affect
toler
toler
phenomenon
occur
continu
administr
lafutidin
subject
method
subject
healthi
male
volunt
mean
age
yr
subject
examin
ambulatori
intragastr
ph
monitor
without
medic
day
administr
famotidin
bid
lafutidin
bid
crossov
fashion
h
pylori
infect
examin
urea
breath
test
data
percentag
time
intragastr
ph
analyz
nighttim
daytim
period
result
subject
divid
seven
h
pylori
posit
thirteen
h
pylori
neg
case
data
mean
percentag
time
intragastr
ph
shown
tabl
percentag
time
intragastr
ph
significantli
higher
h
pylori
neg
case
h
pylori
posit
case
toler
phenomenon
observ
administr
drug
h
pylori
neg
case
report
previous
hand
toler
phenomenon
observ
h
pylori
posit
case
continu
administr
famotidin
la
utidin
iconclns
toler
phenomenon
treatment
occur
administr
lafutidin
well
famotidin
studi
also
clearli
demonstr
toler
phenomenon
observ
case
helicobact
pylori
infect
background
gastric
carcinoma
strongli
associ
h
pylori
infect
also
high
dietari
salt
intak
carcinogen
factor
associ
reduct
gastric
acid
secret
howev
direct
effect
high
salt
intak
acid
product
poorli
document
gerbil
shown
model
investig
pathogenesi
gastric
cancer
addit
gerbil
desert
anim
toler
high
dietari
salt
intak
toler
creat
uniqu
opportun
investig
effect
high
salt
intak
gastric
acid
secret
method
gerbil
divid
group
anim
first
acut
treatment
group
oral
fed
either
ml
nacl
solut
min
ligat
stomach
second
chronic
treatment
group
fed
high
salt
nacl
rodent
diet
gerbil
test
acid
secretori
capac
week
studi
method
pyloru
ligat
employ
group
determin
vivo
gastric
acid
secret
stomach
excis
three
hour
ligat
volum
gastric
juic
measur
acid
total
acid
output
determin
titrat
gastric
juic
naoh
ph
result
acut
treatment
group
signific
reduct
total
acid
output
gerbil
oral
fed
solut
compar
untreat
normal
salin
fed
nacl
control
vs
vs
p
respect
contrast
volum
gastric
juic
significantli
higher
fed
gerbil
untreat
normal
salin
fed
control
vs
p
respect
chronic
treatment
group
reduct
tota
acid
output
gerbil
high
salt
diet
week
compar
normal
diet
control
vs
respect
furthermor
contrast
effect
acut
salt
intak
reduct
volum
gastric
juic
compar
controi
vs
respect
conclus
first
report
demonstr
reduct
gastric
acid
secret
acut
chronic
high
salt
intak
gerbil
data
confirm
assumpt
high
salt
intak
may
compromis
secretori
function
oxynt
mucosa
addit
may
explain
part
synergist
associ
h
pylori
infect
high
salt
diet
develop
gastric
cancer
object
explor
polymorph
relat
metabol
acidsuppress
efficaci
rabeprazol
omeprazol
method
random
open
crossov
compar
studi
thirtysix
healthi
subject
whose
genotyp
statu
previous
determin
allelespecif
polymeras
chain
reaction
amplif
twentyfour
extens
metabolis
homo
hetero
em
twelv
poor
metabolis
pm
singl
oral
dose
mg
rabeprazol
omeprazol
cross
manner
blood
sampl
collect
variou
timepoint
hour
administr
intragastr
ph
record
preadminstr
hour
result
differ
two
group
c
auc
mean
ti
thioetberrabeprazol
pm
significantli
longer
p
em
omeprazol
except
omeprazol
signific
differ
prarmacokinet
paramet
pm
em
p
total
time
percent
time
intragastr
ph
pm
significantli
longer
higher
em
ome
group
p
light
acidsuppress
efficaci
median
ph
pm
significantli
higher
em
ome
group
p
light
night
acidsuppress
efficaci
conclus
rabeprazol
predominantli
transform
thioether
metabolit
nonenzymat
manner
pharmacokinet
rabeprazol
less
depend
polymorph
metabol
omeprazoi
highli
depend
genet
polymorph
may
less
influenc
genet
polymorph
rabeprazol
omeprazol
acidinhibitori
efficaci
character
gastric
acid
secret
isol
stomach
flinder
line
rat
robert
p
bonin
ireneusz
padol
gervai
touga
richard
h
hunt
premis
flinder
sensit
line
fsl
rat
select
bred
increas
respons
compar
counterpart
flinder
resist
line
frl
rat
success
use
model
depress
howev
potenti
fsl
rat
act
model
disord
larg
unexplor
cholinerg
pathway
heavili
involv
gastric
acid
secret
possibl
fsl
rat
exhibit
uniqu
gastric
physiolog
util
model
gastric
disord
method
physiolog
acid
secret
character
fsl
frl
spraguedawley
sd
rat
use
isol
lumenperfns
stomach
model
acid
secret
perfus
measur
ph
electrod
model
allow
test
acid
secret
without
involv
central
nervou
system
respons
carbachol
bethanechol
epibatidin
histamin
pentagastrin
prostaglandin
compar
signific
indic
pvalu
result
signific
differ
carbacho
bethanechol
potenc
maxim
effect
found
frl
fsl
sd
rat
respons
complet
inhibit
atropin
epibatidin
highli
select
nicotin
agonist
effect
strain
histamin
significantli
potent
frl
fsl
sd
purpos
posthoc
analysi
assess
abil
escal
dose
esomeprazol
lansoprazol
produc
gastric
ph
steadi
state
wake
hour
method
continu
intragastr
ph
record
day
follow
repeat
oral
dose
either
esomeprazol
lansoprazol
open
singlecent
random
sixway
crossov
studi
healthi
helicobact
pylorineg
volunt
femal
receiv
esomeprazol
rag
lansoprazol
mg
daili
breakfast
day
washout
period
day
treatment
percentag
time
intragastr
ph
first
hour
follow
dose
day
calcul
endpoint
chosen
reflect
time
heartbum
like
occur
result
see
tabl
greater
proport
esomeprazoletr
patient
intragastr
ph
least
first
first
hour
follow
dose
day
equival
dose
lansoprazol
conclus
standarddos
esomeprazol
provid
greater
proport
subject
intragastr
ph
significantli
longer
period
first
hour
dose
dose
lansoprazol
includ
twice
standard
dose
also
true
whole
period
therefor
doubl
standard
dose
lansoprazol
provid
level
acid
control
esomeprazol
mg
daili
time
acid
product
peak
reflux
symptom
commonli
affect
patient
purpos
studi
evalu
possibl
associ
abnorm
hypopharyng
esophag
acid
exposur
laryng
sign
symptom
suspect
reflux
laryng
method
patient
sign
symptom
suspect
reflux
laryng
enrol
clinic
trial
esomeprazol
mg
bid
vs
placebo
week
patient
elig
criteria
includ
symptom
reflux
laryng
throat
clear
cough
globu
sore
throat
hoars
consecut
month
sign
reflux
laryng
base
laryngoscop
examin
use
video
stroboscopi
end
runin
period
prior
random
studi
medic
sandhil
scientif
ambulatori
ph
test
perform
probe
place
hypopharynx
cm
proxim
upper
esophag
sphincter
ue
proxim
esophagu
cm
distal
ue
distal
esophagu
cm
proxim
le
use
blind
ph
trace
independ
expert
central
laboratori
evalu
hypopharyng
trace
pharyngealassoci
reflux
par
event
ph
test
evalu
valid
distal
proxim
esophag
acid
exposur
valu
calcul
total
time
ph
exclud
meal
time
acid
exposur
time
compar
publish
normal
valu
patient
classifi
normal
abnorm
acid
exposur
hypopharyng
trace
presenc
pharyng
reflux
episod
consid
abnorm
result
see
tabl
regardless
symptom
abnorm
ph
test
uncommon
patient
clear
associ
baselin
suspect
reflux
laryng
sign
symptom
sever
abnorm
acid
exposur
abnorm
acid
exposur
appear
predict
treatment
respons
conclus
symptom
sign
suspect
lpr
popul
patient
defin
laryngoscop
examin
use
video
stroboscopi
associ
abnorm
hypopharyng
esophag
acid
exposur
util
ph
test
establish
diagnosi
reflux
laryng
respons
therapi
popul
reevalu
yasushi
funaki
toshihiro
konagaya
hiroshi
kaneko
toshihiko
hayakawa
akihito
kasahara
akihito
lida
hiroshi
imamura
shinichi
kakumu
background
aim
remark
increas
intragastr
ph
night
time
noctum
intragastr
ph
elev
sometim
observ
h
pyloriposit
gastric
ulcer
patient
examin
ambulatori
h
ph
monitor
attempt
investig
factor
affect
gastric
ph
elev
night
gastric
ulcer
patient
method
twenti
patient
male
yo
h
pyloriposit
gastric
ulcer
gave
inform
consent
includ
histolog
assess
biopsi
specimen
perform
accord
sydney
system
ambulatori
h
intragastr
ph
monitor
sampl
gastric
juic
corpu
nasogasr
tube
blood
forearm
vein
simultan
hospit
h
stop
drug
affect
gastric
acid
intragastr
ph
acid
determin
titrat
ammonia
level
bile
acid
level
sampl
gastric
juic
serum
gastrin
level
measur
result
twenti
patient
divid
follow
three
group
accord
time
ratio
intragastr
ph
night
time
group
case
group
b
case
group
c
case
neither
endoscop
atrophi
score
histolog
atrophi
score
show
signific
differ
among
group
howev
histolog
inflamm
score
corpu
higher
mroup
group
c
serum
gastrin
concentr
bile
acid
level
gastric
juic
higher
group
signific
differ
observ
ammonia
concentr
gastric
juic
analyz
correl
among
paramet
evalu
time
gastric
juic
blood
posit
correl
observ
ph
collect
gastric
juic
bile
acid
level
correl
determin
among
ph
ammonia
serum
gastrin
level
evalu
time
cours
ph
collect
gastric
juic
group
b
nipe
observ
sampl
collect
show
highest
ph
lowest
acid
valu
analyz
result
intragastr
ph
monitor
everi
hour
mean
ph
show
highest
valu
conculus
patient
low
gastric
acid
output
accompani
sever
corpu
gastriti
induc
h
pylori
infect
decreas
acid
secret
natur
accord
circadian
rhythm
might
main
etiolog
explain
minimum
acid
secret
observ
dawn
result
nipe
chunyan
nin
jinyan
luo
object
assess
genotyp
pattern
cytochrom
chines
uigur
han
popul
compar
popul
method
ninetysix
uigur
hart
unrel
chines
healthi
subject
male
femal
age
uigur
male
femal
age
han
genotyp
polymeras
chain
reaction
restrict
fragment
length
polymorph
pcrrflp
identifi
wildtyp
wt
gene
two
mutat
result
uigur
incid
poor
metabol
mlml
phenotyp
subject
extens
metabol
consist
homozygon
wtwt
heterozyg
heterozyg
wtml
homozyg
heterozyg
detect
uigur
uigur
popul
allel
frequenc
deduc
hart
frequenc
allel
major
mutat
uignr
consist
hart
popul
frequenc
allel
popul
sixti
time
mutant
allel
conclus
frequenc
distribut
poor
metabol
extens
metabol
uigur
popul
significantli
lower
p
higher
p
hart
popul
respect
consist
causasian
signific
differ
uigur
han
respect
allel
frequenc
jaladanki
n
rao
dessi
boneva
xin
guo
lan
liu
tongtong
zou
huifang
zhang
jiani
wang
earli
mucos
restitut
occur
consequ
epitheli
cell
migrat
reseal
superfici
wound
injuri
increas
cytosol
ca
concentr
crucial
initi
cellular
respons
consist
initi
phase
reflect
ca
releas
intracellular
store
second
phase
result
ca
influx
ca
permeabl
ion
channel
capacit
ca
entri
cce
activ
ca
store
deplet
repres
major
ca
influx
mechan
nonexcit
cell
molecular
compon
constitut
process
remain
elus
permeabl
ca
highli
express
differenti
intestin
epitheli
ceil
studi
determin
trpc
involv
cce
intestin
epitheli
cell
play
role
cell
migrat
restitut
method
studi
conduct
cell
deriv
rat
small
intestin
crypt
ectop
express
induc
stabl
transfect
express
vector
encod
cdna
control
pcmv
promot
express
measur
rtpcr
western
blot
analysi
cce
elicit
passiv
store
deplet
use
cyclopiazon
acid
cpa
cell
migrat
measur
model
mimic
earli
cell
divisionindepend
stage
epitheli
restitut
result
five
select
clone
stabl
trpcltransfect
cell
highli
express
level
mrna
protein
stabl
transfect
cell
increas
time
parent
cell
respect
increas
express
stabl
cell
associ
increas
rest
nm
cpainduc
cce
nm
stabl
cell
also
exhibit
increas
cell
migrat
wound
cellamm
inhibit
express
use
antisens
nucleotid
reduc
cce
also
inhibit
cell
migrat
wound
cce
decreas
sirnatr
cell
cell
migrat
inhibit
wound
consist
treatment
specif
cce
blocker
also
inhibit
cce
cell
migrat
conclus
find
strongli
suggest
candid
protein
ca
channel
mediat
cce
intestin
epitheli
cell
play
critic
role
restitut
regul
influx
background
ethanol
well
establish
barrier
breaker
gastric
mucosa
effect
cellular
level
remain
detail
previous
shown
intracellular
free
calcium
concentr
increas
gap
junction
close
cell
volum
decreas
exposur
volvol
ethanol
primarili
cultur
rabbit
gastric
epitheli
cell
method
rat
gastric
mucos
rgm
cell
grown
confluenc
coverslip
filter
membran
gap
junction
diffus
measur
load
cell
bleach
small
area
laser
measur
recoveri
confoc
microscop
intracelhilar
calcium
measur
spectrofluorometricafli
load
cell
cell
volum
measur
cell
monolay
load
calcein
imag
along
za
confoc
microscop
chang
fluoresc
intens
intercept
measur
cell
volum
chang
use
inhibit
intracellular
calcium
releas
lanthaninm
block
cell
membran
calcium
select
ion
channel
babta
serv
mtracelhilar
calcium
chelat
agent
result
ethanol
vv
exposur
increas
intracelfular
calcium
nm
n
p
decreas
cell
volum
n
p
induc
gap
junction
closur
fluoresc
recoveri
n
p
seros
potassium
channel
blocker
quinin
almost
complet
prevent
ethanol
induc
cell
volum
decreas
suggest
open
basolater
potassium
channel
underli
cell
shrinkag
babta
complet
nm
n
p
lanthanium
partial
nm
n
p
inhibit
ethanol
induc
intracelhilar
calcium
increas
babta
also
abolish
ethanol
induc
volum
decreas
p
fanthanium
smaller
effect
p
also
abolish
closur
gap
junction
induc
ethanol
fluoresc
recoveri
babta
lanthainum
conclus
lumin
ethanol
open
hasolater
calcium
depend
potassium
select
channel
result
shrinkag
cell
block
intercellular
gap
junction
action
mediat
intracelhilar
calcium
signal
gene
therapi
serum
respons
factor
acceler
heal
experiment
esophag
ulcer
mechanist
implic
jianyuan
chai
dolgor
baatar
andrzej
tarnawski
serum
respons
factor
srf
transcript
factor
regul
gene
involv
cellular
respons
injuri
stress
mitogen
stimuli
role
tissu
injuri
ulcer
heal
explor
aim
studi
examin
effect
esophag
ulcer
srf
express
whether
gene
therapi
srf
cdna
acceler
esophag
ulcer
heal
method
esophag
ulcer
induc
rat
topic
applic
acet
acid
onto
seros
surfac
lower
esophagu
rat
esophag
ulcer
treat
singl
local
inject
hismyctag
plasmid
express
either
sre
antisens
sre
vehicl
plasmid
control
esophag
tissu
obtain
day
treatment
studi
ulcer
size
quantit
histolog
gene
express
rtpcr
westem
blot
immunohistochemistri
elucid
cellular
target
mechan
rat
gastric
epitheli
cell
smooth
muscl
cell
microvascular
endotheli
cell
rgmec
transfect
plasmid
result
esophag
ulcer
sigmficanfli
activ
srf
mrna
express
fold
p
sre
protein
express
fold
p
six
day
treatment
rat
inject
srf
express
plasmid
reduc
ulcer
size
p
acceler
reepitheli
improv
restor
muscular
compon
increas
anglogenesi
granul
tissu
p
local
express
antisens
srf
rat
result
larger
ulcer
p
reduc
angmgenesi
p
srftransfect
cell
demonstr
increas
cell
migrat
increas
cell
prolifer
p
similar
result
obtain
srftransfect
rgmec
cell
conclus
esophag
ulcer
trigger
sre
express
mucosa
border
necrosi
srf
gene
therapi
acceler
reepitheli
muscl
restor
angiogenesi
knockdown
srf
delay
ulcer
heal
srf
promot
migrat
prolifer
rat
epitheli
endotheli
smooth
muscl
cell
studi
demonstr
first
time
import
role
srf
esophag
ulcer
heal
feasibl
gene
therapi
effect
specif
jnk
inhibitor
rat
experiment
gastric
injuri
kazunori
harada
yutaka
matsui
keiichi
mitsuyama
asuka
suzuki
nobuo
tomiyasu
kosuk
takaki
yoshitaka
satoh
brydon
l
bennett
atsnshi
toyonaga
michio
sata
background
junntermin
kinas
jnk
particip
intracelhilar
signal
cascad
result
inflammatori
respons
therefor
inhibit
jnk
pathway
may
form
basi
new
strategi
treatment
acut
gastric
injuri
howev
jnk
activ
gastric
injuri
human
well
anim
model
yet
shown
function
signific
vivo
remain
unclear
effect
inhibit
synthesi
inflammatori
cytokin
inhibit
phosphoryl
jnk
aim
studi
determin
whether
jnk
particip
experiment
gastric
injuri
method
acut
gastric
injuri
induc
spraguedawley
rat
intragastr
administr
ethanol
phosphoryl
jnk
exam
rat
stomach
nsmg
immunohistochemistri
western
blot
analysi
phosphoryl
kinas
also
examin
stomach
human
acut
gastric
injuri
immunohistochemistri
rat
receiv
twice
daili
inject
mgkg
subcutan
vehicl
induct
experiment
injuri
anim
kill
hour
later
serum
stomach
harvest
determin
degre
gastric
injuri
product
cytokin
result
western
blot
analysi
reveal
timedepend
increas
tissu
level
phosphorylatedjnk
erk
cours
experiment
injuri
presenc
phosphojnk
demonstr
epitheli
cell
mononuclear
cell
rat
human
diseas
stomach
prophylact
treatment
significantli
reduc
patholog
score
treat
anim
diminish
express
tnfalpha
level
downregul
jnk
activ
site
injuri
conclus
data
identifi
jnk
signal
involv
pathophysiolog
experiment
gastric
injuri
furthermor
antiinflammatori
potenti
inhibitor
anim
vivo
suggest
jnk
inhibitor
may
provid
new
therapeut
option
treatment
acut
gastric
injuri
human
cgrpimmunoreact
nerv
regener
partial
depend
bone
morphogenet
well
bfgf
effect
lafutidin
masahiko
nakamura
hiroshi
serizawa
kanji
tsuchimoto
regener
enter
nerv
gener
thought
weak
recent
immunohistochemi
studi
use
rat
heatsear
gastric
ulcer
regener
cgrpimmunoreact
nerv
stimul
acid
stabl
takeda
pharmaceut
industri
endogen
bfgf
acidlabil
effect
blocker
proton
pump
inhibitor
enter
nerv
regener
depend
potenc
acid
suppress
suggest
exist
mediat
thu
present
studi
undertaken
clarifi
signific
sever
growth
factor
bfgf
gastric
ulcer
heal
materi
method
wistar
strain
male
mr
weigh
g
use
follow
experi
heat
sear
ulcer
provok
direct
applic
heat
sear
apparatu
seros
surfac
glandular
stomach
three
day
one
two
week
experi
bw
lafutidin
mgkg
bw
famotidin
mgkg
bw
given
orogastr
mtubat
everi
twelv
hour
format
ulcer
local
bone
morphogenet
bmp
receptor
plateletderiv
growth
factorbb
pdgfbb
observ
local
enter
nerv
detect
monoclon
antibodi
gruwthassoci
protein
cholin
acetyltransferas
cgre
result
vehicletr
group
reger
cgrp
immunoreact
nerv
weak
lafutidin
treatment
brought
signific
increas
regener
cgrp
immunoreact
nerv
receptor
surround
regener
nerv
mark
accumul
immunoreact
mesenchym
cell
recogn
granul
tissu
reveal
myofibrublast
pr
immunoreact
bmp
receptor
mostyl
seen
mesenchym
cell
includ
fibroblast
myofibrobfast
enter
nerv
hand
mesenchym
cell
shown
vehicletr
group
pretreat
antibodi
one
week
fomat
ulcer
decreas
regener
cgrpimmunoreact
nerv
conclus
regener
cgrp
immunoreact
nerv
depend
exist
mostli
recogn
myofibroblast
granul
tissu
feng
un
wang
yingmin
wang
jerrold
r
turner
inflammatori
bowel
diseas
character
immun
cell
activ
compromis
epitheli
barrier
function
one
potenti
regul
barrier
function
mlck
increas
myosin
light
chain
mlc
phosphoryf
decreas
epitheli
barrier
function
recent
shown
treatment
epitheli
monolay
increas
mlc
phosphoryl
paracelfular
permeabl
mlck
inhibit
revers
event
aim
studi
determin
mechan
ifn
tnfa
regul
mlc
phosphoryl
disrupt
intestin
epitheli
barrier
function
method
cell
treat
basolater
ifn
ngml
hr
follow
remov
basolater
tnfa
ngml
addit
barrier
function
measur
transepitheli
resist
ter
mlck
express
mlc
phosphoryl
determin
immunoblot
result
follow
tnfa
addit
ter
monolay
prime
ifn
began
fall
hr
tnfa
addit
pfateau
drop
hr
tnfa
affect
ter
absenc
ifn
pretreat
ter
decreas
associ
increas
mlc
phosphoryl
increas
mlck
protein
express
hr
determin
whether
chang
ter
mlck
express
mediat
nfkb
activ
monolay
treat
sulfasalazin
ssa
inhibitor
ikk
cox
mm
ssa
complet
prevent
ter
loss
mlck
upregul
mlc
phosphoryl
tnfa
howev
mm
ssa
prevent
nfcb
nuclear
transloc
induc
tnfu
treatment
min
contrast
mm
ssa
block
nfkb
nuclear
transloc
increas
tnfcxinduc
ter
loss
similarli
proteasom
inhibitor
peptid
block
nfkb
transloc
exacerb
tnfainduc
ter
loss
respect
effect
sulfasalazin
due
cox
inhibit
gener
salicylatedepend
effect
relat
compound
sulfapyridin
acetylsalicyl
prevent
ter
decreas
conclus
ifnand
tnfcx
act
synergist
decreas
intestin
epitheli
barrier
function
upregul
mlck
express
induc
mlc
phosphoryl
ssa
prevent
barrier
dysfunct
block
increas
mlck
express
protect
effect
independ
tnfcxmediat
nfkb
cox
activ
superfici
gastric
mucos
injuri
primarili
heal
rapid
gastric
restitut
wherebi
exfoli
surfac
epithelium
replac
flatten
neoepithelinm
form
migrat
surviv
epitheli
cell
around
lesion
protein
novel
adapterscaffold
protein
regul
dynam
actin
assembl
migrat
kidney
cell
ajp
studi
explor
action
migratori
cell
cultur
model
simul
gastric
restitut
method
local
ecadherin
factin
analys
immunocytochem
confoeal
microscopi
cultur
rat
gastric
mucos
rgm
cell
migrat
analysi
rgm
cell
spars
grown
coverslip
microgrid
separ
group
cell
inject
either
rabbit
affin
purifi
concentr
antibodi
rabbit
igg
migrat
cell
microgrid
follow
wnth
microscop
averag
migrat
speed
calcul
differ
seri
rgm
cell
grown
spars
cell
cultur
dish
migrat
stimul
ngml
hgf
hour
membran
cytosol
fraction
perform
ultracemrifng
analys
western
blot
detect
cytosol
membran
fraction
result
stationari
rgm
cell
local
perirmclearli
ecadherin
pactin
stain
normal
epitheli
cell
migrat
cell
appear
threadlik
accumul
lead
edg
lamellipodia
coloc
ecadherin
factin
stationari
cell
present
cytosol
fraction
migrant
cell
appear
also
membran
fraction
indic
membran
transloc
migrat
speed
uninject
cell
mh
rabbit
igg
inject
cell
intracellular
inject
retard
migrat
speed
ganh
p
conclus
complex
factin
ecadherin
migrat
gastric
epitheli
cell
possibl
act
scaffold
protein
cytoskeleton
membran
protein
intracellular
blockad
antibodi
almost
complet
stop
cell
migrat
suggest
crucial
role
process
background
infect
helicobact
priori
associ
induct
gastric
mucos
injuri
like
prostaglandin
pg
capsaicmsensit
affer
neuron
play
crucial
role
regul
gastric
mucos
integr
addit
capsaicin
proton
noxiou
heat
stimul
affer
neuron
via
activ
vanilloid
receptor
result
releas
neuropeptid
calcitoinn
generel
peptid
cgrp
aim
investig
role
gastric
mucos
defens
mice
infect
h
pylori
method
mice
inocul
h
pylon
four
month
inocul
cimetidm
mgkg
antagonist
capsazepin
mgkg
cgrp
antagonist
nmol
kg
administ
one
week
four
hour
flnai
administr
drug
n
hc
ethanol
oral
administ
induc
gastric
lesion
product
mydoperoxidas
mpo
activ
marker
neutrophil
infiltr
measur
gastric
tissu
gastric
epitheli
cell
apoptosi
assess
byimmunohistochem
stain
singlestrand
dna
mrna
cyclooxygenas
cox
determin
quantit
realtim
rtpcr
result
mpo
activ
number
apoptot
cell
gastric
mucosa
significantli
increas
h
pyloriinfect
mice
uninfect
mice
tf
pylari
infect
elev
product
gastric
tissu
prevent
gastric
damag
induc
prevent
effect
h
pylori
infect
abolish
treatment
indomethacin
pge
revers
inhibitori
effect
indomethacin
prevent
damag
h
priori
infect
although
cimetidin
affect
neither
lesion
format
product
h
pyloriuninfect
mice
counteract
cytopmtect
effect
h
priori
infect
reduc
product
treatment
capsazepin
also
inhibit
product
aggrav
hcletohinducd
gastric
damag
h
pyloriinfect
mice
h
pylori
infect
increas
level
mrna
respect
none
treatment
affect
level
mrna
either
conclus
increas
gastric
acid
backdiffus
due
impair
mucos
barrier
function
h
pyloriinfect
mice
may
stimul
product
via
activ
may
contribut
mainten
gastric
mucos
integr
lafutidin
acceler
rat
gastric
ulcer
heal
vegf
gene
activ
capsaicinsensit
affer
neuron
yasuhiro
fujiwara
kamahid
higuchi
reiko
suto
harunon
fujita
takashi
takashima
masaki
hamaguchi
tetsuya
ianigawa
eiji
sasaki
gazunari
tominaga
roshio
watanab
nobuhid
oshitain
takayuki
matsumoto
tetsuo
arakawa
lafutidin
novel
histamin
antagonist
exhibit
potent
gastroprotect
activ
mediat
capsaicinsensit
affer
neuron
addit
gastric
acid
antisecretori
effect
present
studi
design
examin
effect
lafutidin
express
cytokin
growth
factor
growth
factor
receptor
gene
express
rat
gastric
ulcer
method
lafutidin
mgkg
cimetidin
mgkg
given
rat
acet
acidinduc
gastric
ulcer
week
express
cytokin
tnfa
miplcq
rant
growth
factor
tgfx
hgf
bfgf
vegf
receptor
egfr
mrna
measur
realtim
rtpcr
immunohistochem
stain
perform
determin
local
target
protein
result
express
cytokin
growth
factor
growth
factor
receptor
mrna
gastric
ulcer
significantli
increas
compar
normal
gastric
mucosa
lafutidin
significantli
acceler
gastric
ulcer
heal
stimul
vegf
mrna
express
compar
control
cimetidinetr
rat
effect
lafutidin
complet
abolish
chemic
ablat
capsaicinsensit
sensori
neuron
chemic
deafferent
induc
reduct
mrna
express
respect
rat
treat
lafutidin
vegf
local
mesenchym
cell
ulcer
bed
vegfr
found
endotheli
cell
conclus
lafutidin
acceler
rat
gastric
ulcer
vegf
gene
activ
capsaicinsensit
affer
neuron
rebamipid
activ
gene
import
regul
metabol
signal
golgi
cytoskelet
function
nitric
oxid
gastric
mucos
cell
novel
mechan
mucos
protect
ulcer
heal
action
andrzej
tamawski
jianynan
chai
rama
pal
clinic
experiment
data
indic
rebamipid
rb
new
drug
develop
japan
protect
gastric
mucosa
alcohol
bile
acid
ammonia
h
pylori
toxin
free
radic
ischemiareperfus
injuri
acceler
heal
gastric
colon
oral
aphtou
ulcer
mechan
action
fulli
explain
activ
gene
regul
gastric
cell
metabol
deactiv
toxic
metabolit
cell
signal
nitric
oxid
gener
explor
rb
antiulc
drug
method
normal
rat
gastric
epitheli
cell
treat
vehicl
rb
mgml
hr
studi
gene
express
affymetx
rat
genom
gene
array
chip
contain
gene
data
analysi
use
genespr
program
activ
gene
confirm
rtipcr
western
blot
also
examin
whether
rbinduc
express
cell
mediat
via
mapl
signal
pathway
result
gene
significantli
upregul
rb
includ
aldehyd
dehydrogenas
aldh
class
oxid
larg
spectrum
endogen
exogen
aldehyd
eg
ethanol
metabolit
toxic
low
level
serin
threonin
protein
kinas
activ
stress
map
kinas
induc
synthas
ino
gene
involv
golgi
transport
eg
gapdh
membran
ca
atpas
cytoskelet
gene
eg
attropomyosin
myosin
heavi
chain
c
actininlim
essenti
cell
metabol
transport
mainten
cell
integr
respect
upregul
mechanist
studi
show
rb
activ
erk
cell
rbinduc
gene
activ
critic
depend
signal
conclus
rebamipid
activ
gastric
epitheli
cell
gene
encod
enzym
metabol
toxic
aldehyd
aldh
enhanc
blood
flow
mucos
protect
no
activ
mapk
kinas
regul
cell
metabol
transport
cytoskelet
function
cell
rebamipid
activ
via
pathway
find
reveal
new
molecular
target
provid
new
insight
mechan
wide
spectrum
mucos
protect
ulcer
heal
action
rebamipid
well
indic
new
applic
drug
gene
express
analysi
rat
gastric
mucosa
ischemiareperfus
use
tissu
microdissect
highdens
oligonucleotid
array
effect
ppargamma
ligand
tomohisa
takagi
fuji
naito
hiroshi
lchikawa
naoya
tomatsuri
kazuhiro
katada
yutaka
isozaki
masaaki
kuroda
hisato
tsuboi
toshimitsu
okuda
satoshi
kokura
norimasa
yoshida
toshikazu
yoshikawa
background
peroxisom
proliferatoractiv
receptorg
pparg
member
nuclear
hormon
receptor
superfamili
recent
implic
regul
inflammatori
respons
recent
report
protect
ischemiareperfus
ir
induc
gastric
mucos
injuri
pparg
ligand
piogbtazon
aim
present
studi
analyz
gene
express
rat
gastric
epitheli
cell
induc
ir
injuri
use
highdens
oligonucleotid
array
investig
effect
pparg
ligand
express
gene
method
gastric
mucos
damag
induc
male
wistar
rat
clamp
celiac
arteri
mni
follow
reperfns
specif
pparg
ligand
pioglitazon
given
rat
intraperiton
lh
vascular
clamp
express
pparg
determin
rtpcr
western
blot
immunohistochemistri
total
rna
gastric
epitheli
cell
extract
microdissect
method
gastric
frozen
tissu
ir
treat
withwithout
pparg
ligand
gastric
epitheli
cdna
form
rna
amplif
labelingassay
kit
gene
express
anlysi
perform
use
cdna
genechip
affymetrgx
confirm
realtim
pcr
northen
blot
result
gastric
express
pparg
confirm
rtpcr
western
blot
local
gastric
epitheli
cell
inflammatori
cell
express
enhanc
pioglitazon
trteatment
ir
upregul
oxid
stressrel
gene
catalas
peroxiredoxin
etc
cytokinerel
gene
etc
express
upregul
gene
revers
treatment
ligand
conclus
pparg
ligand
inhibit
ir
induc
gastric
mucos
injuri
suppress
oxid
stressrel
gene
cytokinerel
gene
conclus
activ
pparg
may
repres
novel
approach
treatment
gastric
inflamm
induc
ir
background
mechan
develop
reflux
esophag
fulli
clarifi
tight
junction
bear
paracellular
seal
esophag
epithelium
may
role
develop
mucos
injuri
yet
literatur
describ
express
tight
junction
protein
esophagu
without
reflux
esophag
materi
method
chronic
acid
reflux
esophag
model
prepar
male
wister
rat
method
omura
et
al
scand
j
gastmenterol
sham
oper
implement
control
one
two
week
oper
rat
sacrif
follow
studi
perform
fuluoroimmunostain
anticlaudin
antibodi
observ
alter
distribut
pauem
tight
junction
use
confoc
laser
microscopi
scan
imag
analysi
system
western
blot
analysi
quantit
investig
alter
claudin
protein
rat
esophag
mucosa
without
esophag
result
evid
macroscop
eros
occur
two
week
oper
small
eros
note
week
surgeri
control
rat
claudin
local
cellular
membran
esophag
epitheli
ceil
mainli
granular
layer
esophag
rat
one
two
week
surgeri
express
clausin
cm
apart
eros
local
mainli
spnion
layer
express
individu
ceil
shift
cytoplasm
cell
membran
western
blot
analysi
reveal
express
protein
significantli
decreas
esophag
rat
intens
band
densitomet
independ
three
experi
compar
control
p
conclus
esophag
mucosa
rat
esophag
local
claudin
one
tight
junction
protein
shift
cell
membran
cytoplasm
granular
layer
spinou
layer
decreas
express
even
normal
appear
mucosa
result
suggest
paraceilular
seal
esophag
epithelium
may
role
develop
esophag
eros
less
lrrit
action
wine
japanes
sake
rat
stomach
compar
studi
whiski
ethanol
akari
nakagiri
akiko
tanaka
shinichi
kato
koji
takeuchi
backgroundaim
ingest
alcohol
especi
excess
caus
acut
gastric
lesion
gastriti
human
yet
mncosal
irrit
action
alcohol
beverag
remain
larg
unknown
sinc
alcohol
beverag
wine
japanes
sake
contain
number
nonalcohol
compon
might
afford
protect
mucos
irrit
action
ethanol
present
studi
examin
mucos
imt
action
whiski
wine
japanes
sake
rat
stomach
ex
vivo
vitro
comparison
ethanol
sinc
wine
japanes
sake
contain
glucos
nonalcohol
compon
abund
also
investig
effect
glucos
supplement
mucnsal
irrit
action
ethanol
method
urethan
anesthesia
rat
stomach
mount
ex
vivo
chamber
perfus
salin
transmucos
potenti
differ
pd
measur
basal
pd
stabil
mucosa
expos
rain
ml
ethanol
whiski
white
wine
japanes
sake
sinc
wine
sake
contain
alcohol
concentr
whiski
ethanol
dilut
distil
water
contain
alcohol
concentr
invitro
studi
cell
cultur
dmem
confluenc
cell
treat
alcohol
beverag
rain
cell
viabil
determin
crystal
violet
result
ethanol
whiski
appli
chamber
caus
decreas
pd
wine
japanes
sake
decreas
slightli
increas
transmucos
pd
histolog
appar
damag
surfac
epitheli
cell
observ
exposur
whiski
ethanol
yet
damag
induc
wine
japanes
sake
likewis
ethanol
whiski
markedli
reduc
cell
viabil
cell
rain
incub
neither
wine
japanes
sake
effect
addit
supplement
glucos
significantli
prevent
reduct
pd
cell
viabil
caus
ethanol
effect
antagon
cotreat
given
infus
mgkgh
conclus
result
suggest
mucosai
irrit
action
japanes
sake
wine
much
less
ethanol
whiski
glucos
one
nonalcohol
compon
protect
gastric
mucosa
irrit
action
ethanol
thu
lessdamag
action
japanes
sake
wine
may
least
partli
account
glucos
contain
alcohol
beverag
rat
role
coxl
akiko
tanaka
yoshiaki
kubo
masaki
taniguchi
koji
takeuchi
backgroundaim
precondit
stress
known
prevent
stressinduc
gastric
lesion
yet
role
pg
cox
isozym
play
respons
remain
unknown
present
studi
examin
effect
preconditiong
stress
mild
stress
stressinduc
gastric
lesion
investig
role
pgcox
isozym
protect
effect
mild
stress
method
male
sd
rat
use
h
fast
anim
expos
mild
stress
coldrestraint
stress
degre
c
rain
sever
stress
coldrestraint
stress
degre
c
h
mild
stress
follow
sever
stress
h
later
gastric
mucosa
examin
dissect
microscop
indomethacin
mgkg
sc
select
inhibitor
mgkg
po
rofeeoxib
select
inhibitor
mgkg
po
quinacrin
inhibitor
phospholipas
mgkg
sc
given
rain
mild
sever
stress
test
period
bodi
temperatur
monitor
rectal
thermomet
express
examin
rtpcr
result
sever
mild
stress
caus
hemorrhag
lesion
stomach
ulcerogen
respons
significantli
worsen
indomethacin
rofecoxib
mild
stress
significantli
suppress
gastric
ulcerogen
respons
induc
sever
stress
respons
attenu
nidomethacin
also
rofecoxib
bodi
temperatur
lower
sever
stress
yet
mild
stress
prevent
decreas
bodi
temperatur
respons
sever
stress
effect
attenu
indomethacin
rofecoxib
express
mrna
upregul
stomach
h
sever
stress
without
mild
stress
express
potent
observ
hypothalamn
sever
stress
without
mild
stress
addit
quinacrin
also
total
abolish
protect
action
mild
stress
gastric
lesion
decreas
bodi
temperatur
caus
sever
stress
conclus
result
suggest
stressinduc
gastric
lesion
worsen
inhibit
mild
stress
protect
sever
stressinduc
gastric
lesion
mediat
pg
produc
central
peripher
effect
function
associ
prevent
lower
bodi
temperatur
activ
play
role
protect
action
mild
stress
probabl
trigger
central
pg
product
overexpress
survvin
vegf
egf
receptor
regener
epithelium
human
gastric
ulcer
new
insight
mechan
heal
andrzej
tarnawski
shiunkwei
chiou
woo
sung
moon
jayashri
kidao
egf
receptor
egfr
overexpress
heal
experiment
gastric
ulcer
relev
find
human
gastric
ulcer
uncertain
express
role
survivin
antiapoptot
mitosisfacilit
protein
vegf
egf
egfr
spatial
relationship
normal
ulcer
human
gastric
mucnsa
remain
unexplor
form
basi
studi
method
human
biopsi
specimen
norrad
gastric
mucosa
gastric
ulcer
obtain
endoscopi
patient
fortynin
surgic
specimen
gastric
ulcer
retriev
surgic
patholog
archiv
studi
f
express
egf
egfr
mrna
rtpcr
sitt
hybrid
express
survivin
egfr
vegf
protein
immunohist
chemistri
andor
b
western
blot
quantif
signal
intens
use
videoimag
system
result
normal
human
gastric
mucosa
survivin
express
nuclei
surfac
epitheli
foveoiar
cell
egfr
express
foveolar
cell
express
vegf
epitheli
cell
epithelium
fine
ulcer
margin
regener
gland
demonstr
signific
overexpress
egf
egfr
mrna
protein
increas
p
arid
signific
overexpress
survivin
p
vegf
strongli
induc
epitheli
endotheli
ceil
exhibit
coloc
conclus
regener
epithelium
human
gastric
ulcer
repres
new
celllineag
strongli
overexpress
survivin
vegf
egf
egfr
overexpress
survivin
prevent
apoptosi
promot
cell
prolifer
thu
give
regener
cell
surviv
advantag
sinc
vegf
receptor
predomin
local
endotheli
cell
vegf
secret
regenerat
ing
epitheli
cell
like
activ
angiogenesi
underli
granul
tissu
coloc
vegf
regener
epitheli
cell
endotheli
suggest
ther
interact
autocrin
regul
sinc
prostaglandin
transactiv
egfr
natur
ivi
overexpress
egfr
regener
epithelium
activ
mitogen
motogen
pathway
essenti
reepithefi
alendron
caus
seriou
gastrointestin
advers
effect
aim
investig
montelukast
leukotrien
receptor
antagonist
protect
damag
rat
administ
mgkg
alendmn
gavag
day
either
alon
follow
treatment
montelukast
mgkg
last
day
follow
drug
administr
pylor
ligat
perform
later
rat
kill
stomach
tissu
remov
gastric
acid
gastric
ulcer
index
valu
malondialdehyd
mda
end
product
lipid
peroxid
ghitathion
gsh
key
antioxid
myeloperoxidas
mpo
activ
indirect
evid
tissu
neutrophil
infiltr
well
histolog
appear
stomach
tissu
determin
chronic
oral
administr
alendron
induc
signific
gastric
damag
increas
myeloperoxidas
activ
lipid
peroxid
tissu
glutathion
level
decreas
treatment
montelukast
prevent
damag
well
chang
biochem
paramet
light
microscopi
alendron
group
reveal
desquam
surfac
epithelium
glandular
degener
epithelium
sfightli
damag
montelukasttr
alendron
group
find
present
studi
suggest
alendron
induc
oxid
gastric
damag
local
irrit
effect
caus
neutrophil
infiltr
tissu
wherea
montelukast
protect
damag
antiinflammatori
action
cyclopamin
sonic
hedgehog
signal
inhibitor
promot
intestin
metaplasti
chang
gatric
ulcer
heal
mice
yasutada
akiba
manabu
nakashita
kenichi
katsub
masahiko
nakamura
hiroshi
nagata
soichiro
miura
jonathan
kaunitz
hiromasa
lshii
sonic
hedgehog
shh
key
molecul
epitheli
develop
includ
gastric
gland
disrupt
shh
induc
intestin
mucosa
glandular
stomach
mous
embryogenesi
sbh
express
adult
human
mous
stomach
clinic
gastric
metaplasia
intestin
hypothes
shh
signal
may
relat
process
gastric
gland
regener
present
studi
undertaken
examin
effect
shh
gastric
ulcer
heal
use
shh
signal
inhibitor
cyclopamin
cyp
male
mice
g
bw
use
experiment
gastric
ulcer
induc
acet
acid
treatment
semsal
surfac
anterior
wall
glandular
stomach
cyp
daili
administ
mgkg
sc
normal
mice
half
acet
acidtr
mice
day
ulcer
induct
day
gastric
mucos
tissu
includ
ulcer
lesion
day
examin
routin
histolog
immunohistochemistri
mucin
core
protein
prolifer
marker
shh
receptor
patch
result
cyp
treatment
alon
effect
control
gastric
mucosa
cyptreat
ulcer
group
cyp
treatment
effect
ulcer
area
heal
rate
although
heal
mucosa
day
becam
grossli
rough
thick
compar
untreat
ulcer
group
histolog
reveal
mixedtyp
intestin
metaplasia
alcian
blueposit
pseudopylor
gland
frequent
wide
form
cyptreat
ulcer
group
wherea
pseudopylor
gland
format
schiffand
untreat
ulcer
group
cell
frequent
strongli
observ
base
heal
mucosa
neighbor
epithelium
cyptreat
ulcer
group
wherea
observ
control
gastric
mucosa
infrequ
weakli
observ
heal
mucosa
untreat
ulcer
group
cell
patchedposit
cell
also
increas
cyptreat
ulcer
group
summari
cyp
enhanc
intestin
metaplast
chang
accompani
increas
cell
prolifer
gastric
ulcer
heal
conclus
shh
essenti
gastric
gland
regener
stem
cell
inhibit
upregnl
specif
intestin
mucin
gene
find
suggest
modul
shh
pathway
may
involv
pathogenesi
h
pylorirel
intestin
metaplasia
novel
gastric
pentadecapeptid
bpc
recent
demonstr
exhibit
cytoprotecr
antiinflammatori
angiogen
activ
variou
model
gastric
injuri
oesophag
remain
unknown
whether
peptid
could
affect
gastric
acid
secret
interact
prostaglandin
pg
system
heal
chronic
gastric
ulcer
studi
effect
bpc
gastric
acid
secret
rat
chronic
gastric
fistula
without
gastric
ulcer
induc
seros
applic
acet
acid
ulcer
area
anoth
group
rat
effect
cotreat
bpc
indomethacin
mgkgday
ig
ulcer
heal
determin
rat
acet
acid
ulcer
kill
day
upon
ulcer
induct
area
gastric
ulcer
measur
planimetr
gastric
blood
flow
gbf
ulcer
margin
assess
clearanc
techniqu
gastric
mucos
gener
pge
determin
use
ria
gastric
acid
output
reduc
ulcer
induct
effect
persist
time
interv
test
bpc
appli
grade
concentr
rang
gkg
xgkg
fail
influenc
significantli
gastric
acid
output
rat
without
gastric
ulcer
area
ulcer
control
rat
decreas
significantli
day
heal
ulcer
complet
day
gbf
vehiclecontrol
rat
show
gradual
rise
decreas
ulcer
size
significantli
higher
ulcer
margin
ulcer
crater
final
reach
day
valu
significantli
differ
record
intact
gastric
mucosa
contrast
ulcer
present
till
day
rat
treat
indomethacin
accompani
signific
fall
gbf
ulcer
margin
treatment
bpc
gkgd
ip
reduc
significantli
ulcer
area
day
rais
significantli
gbf
ulcer
margin
compar
vehicletr
anim
concurr
treatment
indomethacin
suppress
gener
revers
almost
complet
acceler
ulcer
heal
induc
bpc
gkgd
ip
accompani
increas
gbf
ulcer
margin
evok
peptid
conclud
bpc
acceler
heal
chronic
gastric
ulcer
without
influenc
gastric
secret
via
mechan
involv
increas
gastric
microcircul
ulcer
margin
endogen
pg
system
background
ecadherin
mediat
depend
homophil
adhes
apic
membran
polaris
epitheli
cell
regul
motil
differenti
cell
shape
integrin
cellmatrix
adhes
molecul
also
localis
basolater
surfac
function
cellcel
adhes
poorli
understood
aim
elucid
molecular
interact
ecadberin
integrin
may
contribut
function
crosstalk
method
two
oesophag
carcinoma
cell
line
one
colon
carcinoma
cell
line
use
express
cellular
localis
eeadherirdcatenin
integrin
assess
immunofluoresc
confoc
microscopi
proteinprotein
interact
cell
identifi
use
sequenti
coimmunoprecipit
ip
western
blot
use
solubl
cell
lysat
transient
transfect
integrin
construct
conduct
use
reagent
result
confoc
microscopi
confirm
integrin
well
ecadherin
iocalis
ceilcel
border
plate
collagen
show
ecadherin
target
apic
membran
wherea
integrin
apicobas
surfac
molecul
show
apicobas
localis
cell
plate
glass
ip
western
blot
show
coimmunprecipit
ecadherin
integrin
keep
structur
interact
two
molecul
integrintransfect
cell
appear
form
less
cohes
coloni
result
suggest
structur
possibl
function
interact
ecadherin
integrin
occur
transient
integrin
overexpress
may
impair
ecadherin
cellcel
adhes
abil
introduct
argon
beam
plasma
coagul
abpc
use
abl
treatment
highgrad
dysplasia
barrett
esophagu
hgd
experiment
potenti
method
reduc
neoplast
potenti
barrett
esophagu
neosquamon
mucosa
replac
ablat
tissu
may
still
contain
buri
glandular
epithelium
beneath
surfac
believ
buri
glandu
ar
tissu
neosquam
mucosa
may
reduc
neoplast
potenti
test
hypothesi
examin
cellular
characterist
neosquam
mucosa
ablat
barrett
esophagu
ablat
hgd
compar
normal
esophag
mucosa
preablat
sampl
barrett
hgd
method
sampl
select
prospect
collect
databas
util
strict
inclus
criteria
follow
second
pathologist
review
identifi
archiv
esophag
mucos
biopsi
patient
normal
histolog
appear
patient
barrett
esophagu
hgd
patient
neosquam
mncosa
ablat
barrett
ablat
hgd
neosquam
mucosa
buri
glandular
tissu
biopsi
sampl
use
monoclon
antibodi
immunohistochem
stain
two
independ
blind
observ
measur
quantit
scale
express
enzym
suggest
increas
neoplast
potenti
indic
pathway
oncogen
resist
apoptosi
repres
cellular
prolifer
mean
valu
observ
calcul
group
compar
result
enzym
express
abnorm
mucosa
post
ablat
level
significantli
reduc
barrett
hgd
conclus
ablat
patholog
mucosa
barrett
esophagu
hgd
reduc
express
cellular
indic
potenti
neoplast
behaviour
neosqnam
mucosa
develop
howev
normal
esophag
epithelium
implic
followup
patient
larger
studi
need
confirm
find
loss
gut
barrier
function
bf
oxid
damag
key
pathogenesi
inflammatori
bowel
diseas
ibd
use
monolay
intestin
cell
report
oxid
depolymer
factin
cytoskeleton
disrupt
bf
atyp
pkc
isoform
h
abund
cell
hypothes
pkcx
activ
key
oxidantinduc
disrupt
actin
cytoskelet
subunit
assembl
architectur
monolay
bf
method
use
first
multipl
set
gi
cell
clone
transfectcd
stabli
overexpress
induct
pkcr
inhibit
activ
nativ
pkck
clone
expos
oxid
eg
pkc
modul
wild
type
wt
cell
treat
manner
measur
bf
clearanc
fluorometri
actin
cytoskelet
stabil
confoc
microscopi
pkck
subcellular
distribut
immunoblot
pkcx
activ
vitro
kinas
molecular
dynam
polymer
f
monomer
g
actin
kda
protein
actin
filament
page
result
w
cell
oxid
exposur
caus
transloc
pkcr
membran
cytoskelet
particul
fraction
activ
nativ
pkc
reduct
actin
assembl
increas
g
decreas
f
instabl
factin
architectur
bamer
dysfunct
b
transfect
ceil
induct
pkc
overexpress
fold
caus
oxidantlik
injuri
effect
includ
chang
molecular
dynam
actin
cytoskeleton
overexpress
induc
disrupt
potentiatedsyperg
oxid
express
pkcx
mostli
found
cytoskelet
particul
fraction
indic
activ
c
stabl
domin
neg
inactiv
nativ
pkck
substanti
protect
oxid
injuri
monolay
actin
dynam
bf
show
first
time
l
oxid
induc
instabl
epitheli
actin
cytoskeleton
larg
part
activ
pkcx
signal
intestin
monolay
hyperactiv
pkck
isolorm
requir
condit
disrupt
molecular
dynam
fand
gactin
cytoskeleton
thu
identifi
novel
biolog
mechan
destabil
cytoskelet
dynam
cellular
integr
oxid
proinflammatori
like
condit
among
atyp
subfamili
pkc
isoform
cell
pkcx
activ
may
therefor
play
crucial
role
gut
injuri
oxidantinduc
disord
ibd
backgroundaim
previous
report
acidinduc
hco
secret
duodenum
mediat
activ
receptor
yet
inform
relationship
ep
receptor
subtyp
acidinduc
gastric
secret
sinc
gastric
secret
distinct
mechan
concern
messeng
compar
duoden
secret
possibl
differ
ep
receptor
subtyp
involv
acidinduc
secret
present
studi
investig
ep
receptor
involv
acidinduc
secret
stomach
method
male
sd
rat
mice
includ
wildtyp
owe
use
h
fast
urethan
anesthesia
chamber
stomach
proxim
duoden
loop
perfns
salin
secret
measur
ph
use
phstat
method
ad
mm
mucos
acidif
perform
expos
stomach
duodenum
mm
mm
respect
min
ep
agoinst
given
iv
ep
antagonist
given
sc
min
administr
ep
agonist
mucos
acidif
result
mucos
acidif
markedli
increas
gastroduoden
hco
secret
rat
wt
mice
indomethacinsensit
manner
acidinduc
secret
stomach
significantli
inhibit
prior
administr
antagonist
antagonist
disappear
mice
contrast
acidinduc
duodenum
secret
significantli
inhibit
disappear
mice
mgkg
also
increas
gastroduoden
secret
rat
wt
mice
stimulatori
action
stomach
inhibit
disappear
ep
mice
duodenum
attenu
larg
suppress
mice
furthermor
gastric
hco
secret
stimul
agonist
butaprost
agonist
duoden
secret
increas
agonist
agonist
conclus
result
suggest
acidinduc
hco
secret
mediat
endogen
pg
via
differ
ep
receptor
subtyp
stomach
duodenum
receptor
former
receptor
latter
involv
prostaglandin
e
receptor
subtyp
prostacyclin
ip
receptor
decreas
acid
secret
stomach
damag
masato
nakashima
eitaro
aihara
masamun
hayashi
koji
takeuchi
backgroundaim
applic
mild
irrit
stomach
caus
lumin
alkal
mainli
inhibit
acid
secret
previous
report
decreas
acid
respons
mucos
exposur
taurochol
na
tc
mediat
endogen
prostaglandin
pg
produc
howev
remain
unknown
type
pg
receptor
involv
phenomenon
present
studi
invesug
role
pge
receptor
subtyp
prostacyclin
ip
receptor
decreas
acid
respons
stomach
exposur
tc
use
knockout
mice
lack
receptor
method
male
mice
includ
wildtyp
wt
ip
use
h
fast
urethan
anesthesia
stomach
mount
exvivo
chamber
perfus
salin
acid
secret
lumin
ph
well
transmucos
potenti
differ
measur
exposur
mm
tc
rain
mucos
pgflcl
content
measur
eia
indomethacin
mgkg
select
inhibitor
mgkg
rofecoxib
select
inhibitor
mgkg
given
intraduoden
rain
tc
result
mucos
exposur
tc
wt
mice
caus
mark
pd
reduct
stomach
pd
respons
similarli
observ
anim
lack
either
ip
receptor
wt
mice
indomethacin
affect
pd
lumin
ph
basal
acid
secret
significantli
attenu
decreas
acid
secret
increas
lumin
ph
exposur
tc
effect
indomethacin
mimick
rofecoxib
yet
neither
drug
effect
pd
respons
although
decreas
acid
respons
exposur
tc
similarli
observ
anim
lack
receptor
respons
partial
mitig
mice
especi
later
period
exposur
markedli
attenu
ip
mice
mucos
level
pgfla
significantli
increas
stomach
exposur
tc
similarli
group
mice
cicaprost
ip
agunist
pgkg
well
sulproston
agonist
rag
kg
given
slgnificantli
decreas
histaminestimul
acid
secret
conclus
result
suggest
reduc
acid
respons
stomach
damag
mediat
endogen
pg
deriv
mainli
receptor
partial
receptor
background
gastric
mucosa
infect
helicobact
pylori
h
pylori
resist
noxiou
agent
although
bacterium
caus
neutrophil
infiltr
overexpress
inflammatori
cytokin
tumor
necrosi
factora
tnfa
gastric
mucosa
recent
studi
demonstr
prostagiandin
pgea
deriv
play
import
role
protect
effect
h
pylon
infect
exert
biolog
action
bind
pge
receptor
ep
pharmacolog
subdivid
four
subtyp
aim
assess
role
ep
gastric
mucos
defens
h
pyloriinfect
mice
method
mice
infect
h
pylori
month
use
gastric
lesion
induc
oral
administr
n
ethanol
macroscop
evalu
rain
later
mice
subcutan
administ
select
inhibitor
mgkg
concomit
without
oral
administr
ep
select
agonist
dose
pgkg
hour
challeng
mice
h
pylori
infect
intraperiton
administ
recombin
mous
tnfa
etoh
express
tnfa
mrna
determin
quantit
realtim
rtpcr
local
tnfc
examin
immunohistochem
result
h
pylori
infect
increas
mrna
significantli
prevent
gastric
damag
induc
hcietoh
abolish
protect
effect
h
pylori
infect
select
agonist
agonist
revers
inhibitori
effect
prevent
damag
h
pylori
infect
level
mrna
tnfc
markedli
elev
h
pylori
infect
increas
administr
exogen
tnfa
aggrav
hcl
etohinduc
gastric
damag
among
ep
agoinst
select
agonist
inhibit
increas
tnfa
express
tnfa
express
inflammatori
cell
gastric
mucosa
conclus
deriv
may
play
import
role
resist
hcietoh
h
pyloninfect
mice
activ
among
ep
exert
antiinflammatori
effect
contribut
protect
gastric
mucosa
antiapoptosi
protein
survivin
key
mediat
adapt
cytoprotect
ethanolinduc
gastric
mucos
injuri
michael
k
jone
tomohiko
akahoshi
shninkwei
chiou
andrzej
tamawski
tetsuya
tanigawa
backgroundaim
antiapoptosi
protein
survivin
promot
cell
surviv
mitosi
although
survivin
express
differenti
adult
tissu
recent
studi
demonstr
survivin
express
normal
gastric
mucosa
studi
aim
determin
whether
survivin
play
role
adapt
cytoprotect
produc
gastric
mucosa
mild
irrit
ethanol
etoh
concentr
necrot
effect
subsequ
concentr
etoh
exposur
method
fast
rat
receiv
nil
water
control
etoh
intragastr
rain
prior
administr
tal
water
control
etoh
gastric
tissu
obtain
hr
later
vitro
rat
gastric
epitheli
cell
treat
survivin
antisens
sirna
knockdown
survivin
protein
level
control
sirna
affect
express
preincub
serumfre
medinta
alon
control
serumfre
medium
contain
etoh
incub
medium
contain
etoh
studi
extent
macroscop
injuri
survivin
express
western
blot
immunohistochemistri
cytotoxicitycel
necrosi
vitro
lactas
dehydrogenas
releas
apoptosi
tunel
stain
result
preadministr
etoh
reduc
macroscop
injuri
follow
subsequ
exposur
etoh
p
vs
control
preadministr
etoh
also
result
increas
survivin
express
p
vitro
preincub
rgmi
cell
medium
contain
etoh
reduc
cell
death
respons
subsequ
incub
presenc
etoh
p
vs
control
preincub
medium
contain
etoh
also
increas
survivin
express
level
p
resist
cell
death
result
etoh
pretreat
significantli
decreas
p
sirna
treatment
conclus
protect
concentr
etohinduc
gastric
mucos
injuri
prior
administr
mild
irrit
etoh
associ
upregul
survivin
express
level
vitro
survivin
defici
significantli
suppress
resist
etohinduc
cell
death
provid
lowdos
etoh
pretreat
survivin
like
key
mediat
adapt
cytoprotect
etohinduc
gastric
mucos
injuri
geranylgeranylaceton
enhanc
express
nfkb
activ
rat
gastric
mucos
cell
yuki
yabe
hal
ying
fu
yuko
tsukahara
hiroaki
murata
shingo
tsuji
sunao
kawano
background
geranygeranylaceton
gga
introduc
clinic
field
antiulc
drug
addit
cytoprotecr
action
gga
also
acceler
heal
peptic
ulcer
even
helicobact
pylori
infect
hand
prostaglandin
protect
effect
gastric
mucosa
increas
mucos
blood
flow
mucin
bicarbon
ion
secret
aim
explor
molecular
mechan
gga
action
focus
use
rat
gastric
mucos
cell
cell
method
cell
x
incub
hour
medium
supplement
heatinactiv
fc
starvat
incub
hour
differ
dose
gga
express
nfkb
phosphoryl
evalu
western
blot
product
measur
eia
activ
nfkb
assess
electrophoret
mobil
shift
assay
emsa
report
assay
perform
transfect
plasmid
contain
transcript
factor
tf
bind
sequenc
nfkb
cre
mutat
sequenc
result
gga
increas
express
product
dosedepend
manner
ram
gga
ram
activ
nfkb
ikb
emsa
clearli
show
nfkb
transloc
nucleu
furthermor
report
assay
demonstr
gga
treatment
significantli
enhanc
luciferas
activ
plasmid
contain
three
tfbind
sequenc
transfect
activ
attenu
mutat
nfkb
cre
conclus
gga
enhanc
express
product
activ
nfkb
lmmunoloc
na
n
cotransport
esophag
submucos
gland
hani
n
nakhoul
solang
abdulnournakhoul
hendrik
dejong
nazih
k
nakhoul
roy
c
orlando
introduct
esophag
submucos
gland
smg
human
secret
bicarbon
rich
fluid
contribut
esophag
defens
reflux
gastric
acid
smgbear
pig
esophagu
like
human
esophagu
recent
demonstr
show
could
block
remov
treatment
did
nonselect
anion
transport
inhibitor
indic
one
like
present
cell
smg
sinc
na
n
cotransport
nbc
major
contributor
epitheli
cell
investig
presenc
locat
nbc
within
smg
molecular
techniqu
immunofluor
cenc
method
use
smg
isol
pig
esophagu
total
rna
extract
rna
resin
purif
system
total
rna
use
gener
first
strand
cdna
revers
transcript
pcr
studi
immunofluoresc
studi
carri
pig
esophagu
frozen
liquid
nitrogen
cut
mount
gelarinco
slide
section
fix
rehydr
block
serum
doublelabel
antibodi
rknbc
rat
kidney
nbc
cc
na
katpas
section
incub
specif
fluoresc
secondari
antibodi
counterstain
nuclear
stain
mount
photo
graph
use
epifluoresc
microscop
result
use
genespecif
primer
compat
publish
nbc
clone
rknbc
human
pancrea
nbc
human
heart
nbc
identifi
pcr
product
homolog
segment
human
pancrea
nbc
addit
use
race
anoth
bp
pcr
product
includ
end
open
read
frame
obtain
immunofluoresc
studi
show
na
katpas
antibodi
stain
basolater
membran
mucin
weak
stain
duct
cell
strong
stain
intens
stain
without
polar
distribut
serou
demilun
cell
contrast
na
koatpas
rknbc
antibodi
stain
lumin
membran
duct
cell
intens
weak
stain
basolater
membran
wherea
stain
evid
mucin
cell
rknbc
like
na
katpas
intens
stain
serou
cell
membran
without
polar
distribut
conclus
nbc
present
duct
serou
cell
esophag
smg
intens
stain
coloc
na
katpas
serou
cell
suggest
activ
ion
transport
process
cell
locat
nbc
lumin
membran
duct
cell
may
indic
locu
gland
support
nih
aga
student
research
fellowship
award
h
n
nakhoul
inhibit
glucosylceramid
synthas
attenu
format
aceticacid
induc
gastric
ulcer
rat
manabu
nakashita
soichiro
miura
keita
uehara
yasutada
akiba
tetsu
takeuchi
hidekazu
suzuki
hiroshi
nagata
hiromasa
ishii
background
sphingolipid
involv
divers
cell
process
includ
cell
apoptosi
previous
report
inject
phorbol
ester
result
format
gastric
ulcer
rat
gastric
mucosa
signific
increas
ceramid
content
j
pharm
exp
howev
remain
unknown
whether
ceramid
directli
evok
gastric
mucos
damag
studi
investig
effect
glucosylceramid
synthas
inhibitor
acet
acidinduc
gastric
ulcer
see
ceramid
metabolit
involv
pathogenesi
ulcer
format
method
gastric
ulcer
produc
inject
acet
acid
aa
submucos
layer
rat
glandular
stomach
accord
okab
carl
examin
role
complex
sphingolipid
fumonisin
inhibit
ceramid
synthas
inject
gastric
wall
togeth
aa
glucosylceramid
synthas
inhibitor
ppmp
nbutyldeoxynojirimycin
nbdnj
also
administ
aa
gastric
ulcer
format
evalu
hour
later
time
cours
ceramid
content
stomach
quantifi
extract
major
lipid
resolv
thinlay
chromatographi
use
petroleum
ether
diethyl
ether
first
solvent
chloroform
methanol
second
solvent
number
apoptot
ceil
gastric
mucosa
determin
immunohistochemistri
use
polyclon
antibodi
ssdna
result
aa
induc
signific
lesion
gastric
mucosa
hour
aa
inject
accompani
increas
ceramid
content
increas
apoptot
cell
number
fumonisin
inhibit
ceramid
format
attenu
aainduc
gastric
ulcer
decreas
number
apoptosi
suggest
import
de
novo
ceramid
synthesi
hand
administr
ppmp
nbdnj
inhibit
metabol
ceramid
glycosylceramid
also
significantli
attenu
aainduc
gastric
mucos
apoptosi
mucos
damag
spite
increas
ceramid
content
mucosa
result
suggest
ceramid
metabolit
may
ulcerogen
conclus
conclus
ceramid
pathway
especi
ceramid
metabolit
significantli
contribut
aainduc
gastric
damag
possibl
via
increas
apoptosi
backgroundaim
coxi
constitut
express
isoform
cox
respons
gastric
housekeep
function
shown
induc
variou
gastric
diseas
involv
either
mucos
fenc
mechan
repair
process
present
studi
examin
possibl
import
gastric
mucos
protect
ischemiareperfus
ir
injuri
characterist
increas
free
radic
product
deriv
activ
neutrophil
method
ischemia
induc
mice
clamp
celiac
arteri
follow
remov
clamp
po
select
inhibitor
ip
select
inhibitor
rebamipid
ip
mucoprotect
agent
could
induc
gastric
mucosa
administ
mice
ischemia
gastric
damag
evalu
histolog
use
myeloperoxidas
mpo
activ
cox
protein
express
evalu
western
blot
analysi
immunohistochemistri
intercellular
adhes
gastric
mucosa
evalu
elisa
immunohistochemistri
effect
drug
thiobarbitur
acid
reactiv
substanc
tbar
paramet
free
radic
product
gastric
tissu
gastric
blood
flow
also
evalu
result
express
induc
mucosa
reperfns
express
alter
local
coxl
ir
injuri
mucosa
mainli
observ
endotheli
cell
pretreat
reduc
gastric
blood
flow
reperfus
point
tbar
level
express
furthermor
significantli
decreas
gastric
mucos
injuri
mpo
activ
ir
mice
contrast
pretreatmerit
increas
tbar
level
mpo
activ
ir
mice
albeit
insignificantli
furthermor
inhibit
significantli
increas
icami
express
gastric
tissu
aggrav
gastric
damag
ir
mice
rebamipid
pretreat
reduc
express
ir
injuri
suggest
rebamipid
reduc
gastric
ir
injuri
via
mechan
independ
express
mice
conclus
ir
mice
involv
upregul
reperfus
flow
therebi
aggrav
gastric
mucosa
increas
free
radic
product
protect
gastric
mucosa
downregul
express
gastric
mucosa
backgroundaim
known
acid
inhibitori
mechan
damag
stomach
involv
endogen
nitric
oxid
acid
secret
stomach
turn
stimul
presenc
synthas
inhibitor
ngnitrolargiinn
methyl
ester
lname
process
mediat
histamin
releas
mucosa
partli
depend
capsaicinsensit
sensori
neuron
howev
role
vagal
nerv
acid
respons
damag
stomach
remain
unexplor
present
studi
investig
role
vagal
sensori
nerv
acid
respons
stomach
damag
absenc
presenc
lname
method
urethan
anesthesia
rat
stomach
mount
exvivo
chamber
perfus
salin
acid
secret
measur
applic
mm
taurochol
tc
rain
vagotomi
perform
subdiaphragmat
portion
vagal
sensori
denerv
done
applic
capsaicin
cervic
portion
result
mucos
exposur
tc
caus
decreas
acid
secret
increas
lumin
pretreat
lname
complet
attenu
decreas
acid
secret
follow
tc
suppress
hminal
releas
result
enhanc
secret
basal
valu
effect
lname
significantli
revers
coadministr
larginin
bilater
vagotomi
reduc
basal
acid
secret
vagal
sensori
denerv
effect
vagotom
rat
stomach
acid
secret
decreas
follow
tc
treatment
remain
decreas
even
presenc
lname
likewis
vagal
sensori
denerv
also
total
attenu
increas
acid
secret
respons
lname
damag
stomach
follow
tc
treatment
addit
exposur
stomach
tc
increas
histamin
output
lumen
respons
significantli
prevent
either
bilater
vagotomi
vagal
sensori
denerv
conclus
result
suggest
damag
stomach
activ
acid
stimulatori
pathway
addit
nodepend
inhibitori
mechan
acid
stimul
damag
stomach
mediat
histamin
releas
mucosa
process
associ
capsaicinsensit
affer
neuron
vagu
lname
increas
acid
secret
unmask
acid
stimulatori
respons
suppress
nodepend
inhibitori
mechan
live
anim
ratiometr
intracellular
ph
measur
rat
duoden
epithelium
use
tetsu
takeuchi
leinng
zhang
jonathan
kaunitz
background
laboratori
measur
ph
duoden
epithelium
live
rodent
vivo
fluoresc
ratio
imag
microscopi
frim
use
carboxyfluorescein
bcecf
fluomphor
sinc
bcecf
dual
excitationsingl
emiss
fluorescein
deriv
ratio
pair
acquir
simultan
allow
time
movement
live
anim
subject
imag
acquisit
prevent
precis
imag
registr
method
address
problem
sought
use
singl
excitationdu
emiss
phsensit
fluoresc
dye
microlmag
split
fluoresc
emiss
ident
field
differ
wavelength
enabl
simultan
acquisit
ratio
pair
imag
fashion
movement
anim
affect
imag
registr
enabl
pixeltopixel
concord
analyz
ratio
pair
found
produc
brightest
longest
last
imag
snarf
deriv
initi
load
mucos
cell
fluoresc
usabl
rain
use
vitro
calibr
curv
abl
measur
intracellular
ph
ph
duoden
mucos
cell
live
rat
result
exposur
physiolog
acid
puls
ph
min
prompdi
lower
ph
recoveri
baselin
follow
acid
challeng
conclus
techniqu
greatli
decreas
effort
taken
measur
ph
vivo
enabl
measur
ph
frequent
time
point
bcecfbas
method
sinc
duoden
epithelium
lumin
ph
chang
quickli
coordin
chang
ph
frequent
measur
ph
mark
advantag
exist
method
respect
consid
use
altern
bcecf
measur
ph
vivo
grapefruitse
extract
gse
contain
flavonoid
possess
antibacteri
antioxid
properti
whether
exert
gastroprotect
activ
mueosal
damag
remain
unknown
studi
compar
effect
gse
appli
intragastricauy
ig
gastric
mucos
lesion
induc
rat
topic
applic
ethanol
h
water
immers
restraint
stress
wr
without
inhibit
cyclooxygenas
cox
activ
indomethacin
rofecoxib
respect
b
suppress
nosynthas
lnna
mgkg
ip
c
inactiv
sensori
nerv
capsaicin
mgkg
sc
gse
administ
rain
prior
ethanol
wr
one
hour
ethanol
h
end
wr
number
area
gastric
lesion
measur
planimetri
gastric
blood
flow
gbf
assess
clearanc
techniqu
blood
collect
plasma
gastrin
level
ria
gastric
mucos
biopsi
taken
determin
mucos
gener
malonylodialdehyd
mda
content
index
lipid
peroxid
ethanol
wr
caus
gastric
lesion
accompani
signific
fall
gbf
signific
rise
mucos
mda
content
pretreat
gse
mgkg
ig
dosedepend
attenu
gastric
lesion
induc
ethanol
wr
dose
reduc
lesion
mgkg
respect
protect
effect
gse
similar
obtain
rat
pretreat
exogen
wgkg
ig
protect
effect
gse
accompani
signific
rise
gbf
gener
plasma
gastrin
level
fold
mark
inhibit
gastric
mda
contem
effect
significantli
reduc
pretret
indomethacin
rofecoxib
pretreatmem
lnna
capsaicin
denerv
aggrav
ethanol
wrsinduc
gastric
damag
significantli
attenu
gastroprotect
hyperem
effect
gse
addit
exogen
cgrp
vgkg
sc
restor
gseinduc
protect
accompani
hyperemia
rat
capsaicin
denerv
conclud
gse
exert
potent
gastroprotect
activ
ethanol
wrsinduc
gastric
lesion
protect
involv
endogen
pg
suppress
lipid
peroxid
hyperemia
probabl
mediat
neuropeptid
cgrp
releas
sensori
nerv
aim
reactiv
oxygennitrogen
speci
accumul
inflam
stomach
level
high
hypothes
exposur
gastric
gland
lead
patholog
alter
intracellular
level
nonca
metal
ion
potenti
zn
method
rabbit
gastric
gland
load
fluoresc
dye
bind
intraceuular
dival
cation
ca
ka
zn
gland
load
second
fluoresc
dye
high
bind
affin
zn
lid
affect
ca
lum
fluoresc
measur
ratiometr
result
ringer
contain
egta
exposur
result
dose
depend
n
loomm
n
n
irrevers
increas
determin
whether
respons
due
ca
alon
gland
e
ringer
expos
n
dose
presenc
tpen
highaffin
chelat
zn
z
tq
x
presenc
tpen
respons
delay
attenu
compar
gland
expos
absenc
tpen
addit
gland
perfus
ringer
expos
thapsigargin
deplet
major
intracellular
ca
store
endoplasm
reticulum
previou
experi
use
model
acet
acid
induc
chronic
gastric
ulcer
show
inhibit
angiotensin
convert
enzym
ace
lisinopril
blockad
angiotensin
receptor
losartan
acceler
heal
process
experiment
gastric
ulcer
howev
precis
mechan
ace
inhibit
experiment
model
investig
yet
test
hypothesi
angiotensin
potent
vasodilatatori
member
angiotensin
famili
peptid
respons
protect
action
ace
inhibit
heal
experimem
gastric
ulcer
use
angiotensin
receptor
antagonist
placebo
lisinopril
losartan
pretreat
rat
experi
perform
wistar
rat
weigh
upon
laparotomi
gastric
ulcer
initi
area
induc
use
acet
acid
pentobarbit
anesthesia
seven
day
ulcer
induct
gastric
ulcer
area
ua
microcirculatori
gastric
blood
flow
gbf
ulcer
crater
margin
use
laserdoppl
flowmetri
measur
gastric
ulcer
heal
investig
control
placebo
pretreat
lisinopril
rag
kg
losartan
mg
g
lisinopril
losartan
pretreat
anim
control
anim
day
ulcer
induct
ua
decreas
gbf
increas
gastric
ulcer
margin
vs
intact
mucosa
p
lisinoprdand
losartan
pretreat
anim
mark
acceler
heal
gastric
ulcer
observ
lisinopril
pretreat
group
ua
decreas
gbf
increas
ulcer
margin
administr
significantli
chang
heal
rate
acet
ulcer
howev
given
lisinoplil
pretreat
anim
angiotensin
receptor
antagonist
almost
complet
revers
action
lisinopril
acet
acidinduc
model
gastric
ulcer
lisinopril
pretreat
anim
ua
reduc
ns
differ
vs
control
group
gastric
ulcer
group
gbf
valu
increas
ulcer
margin
vs
intact
mucosa
result
indic
renin
angiotensin
system
respons
delay
heal
process
experiment
gastric
ulcer
rat
inhibit
ace
increas
gastric
microcirculatori
blood
flow
revers
neg
effect
renin
angiotensin
system
activ
upon
gastric
ulcer
heal
process
stimul
angiotensin
releas
background
recent
investig
demonstr
pioglitazon
specif
peroxisom
proliferatoractiv
receptor
ppar
ligand
markedli
inhibit
ischemiareperfusioninduc
gastric
mucos
injuri
via
block
neutrophil
accumul
gastric
mucosa
rat
aim
present
studi
perform
gene
express
analysi
rat
gastric
mucos
cellular
respons
hypoxiareoxygen
use
highdens
oligonucleotid
array
investig
effect
ppar
ligand
express
gene
method
experi
perform
use
rat
cell
line
deriv
normal
gastric
mucosa
cell
subject
hypoxia
plexigla
chamber
nitrogen
carbon
dioxid
min
reoxygen
initi
put
environ
normoxia
oxygen
carbon
dioxid
nitrogen
cytokineindnc
neutrophtl
cxcchemokin
product
sampl
assay
ell
mrna
express
protein
examin
rtpcr
western
blot
analysi
treatment
pioglitazon
mrna
express
protein
measur
ppar
express
cell
determin
rtpcr
western
blot
analysi
immunohistochemistri
total
rna
extract
hypoxiareoxygen
differ
gene
express
profil
investig
use
genechip
rat
array
affymetrix
result
pparreceptor
express
cell
mrna
protein
induc
hypoxia
follow
reoxygen
pioglitazon
significantli
inhibit
increas
express
mrna
protein
concentr
oim
hypoxiareoxygen
upregnr
oxid
stressrel
gene
catalas
peroxiredoxin
cytokinerel
gene
cinc
secret
phosphoprotein
express
upregul
gene
revers
treatment
ligand
conclus
hypoxiareoxygen
directli
induc
product
modifi
gene
express
ppar
ligand
suppress
gene
express
protein
cell
hypoxiareoxygen
result
suggest
ppar
ligand
use
treat
ischemicinduc
inflammatori
process
gastric
injuri
tnfalpha
downregul
tff
express
gastric
epitheli
cell
tadahito
shimada
yoichiro
fujii
ayako
koitabashi
kumi
hosaka
kyoko
tabei
takashi
namatam
masashi
yoneda
hideyuki
hiraishi
akira
terano
background
aim
trefoil
factor
famili
tff
peptid
play
critic
role
defens
repair
gastrointestin
mucosa
among
three
tff
member
express
high
level
gastric
epitheli
cell
howev
regulatori
mechan
gastric
tff
express
fulli
understood
known
whether
inflammatori
stimuli
affect
tff
express
studi
examin
effect
tnfalpha
express
gastric
epitheli
cell
method
cell
line
deriv
human
gastric
cancer
use
model
gastric
epitheli
cell
endogen
tff
mrna
express
analyz
realtim
quantit
rtpcr
report
gene
assay
promot
sequenc
gene
gene
insert
luciferas
report
vector
nfkappab
activ
monitor
use
report
vector
contain
multipl
copi
nfkappab
respons
element
upstream
luciferas
gene
nfkappabluc
domin
neg
ikappabalpha
overexpress
effect
nfkappab
suppress
test
mutanttyp
lack
probabl
nfkappab
respons
element
within
promot
also
made
report
gene
assay
psvbetagalactosidas
vector
alway
cotransfect
standard
result
tnfalpha
ngml
caus
inhibit
express
endogen
tff
mrna
report
gene
assay
use
tff
confirm
suppress
transcript
tnfalpha
effect
tnfalpba
dosedepend
maximum
effect
observ
ngml
tnfalpha
stimul
nfkappab
activ
dosedepend
manner
maximum
effect
also
observ
ngml
overexpress
domin
neg
ikappabalpha
prevent
nfkappab
activ
tnfalpha
block
inhibitori
effect
tnfalpha
transcript
tnfalpha
similarli
suppress
transcript
wildtyp
mutanttyp
nfkappab
respons
element
delet
conclus
tnfalpha
downregul
tff
express
gastric
epitheli
cell
suggest
gastric
tff
express
dysregul
inflammatori
condit
action
tnfalpha
appear
mediat
nfkappab
direct
involv
nfkappab
respons
element
tff
promot
like
hsp
known
involv
cytoprotect
environment
stress
mediat
function
molecular
chaperon
report
heat
shock
protein
stressinduc
play
essenti
role
gastric
colon
mucosa
vivo
also
recent
report
could
play
role
wound
restor
present
studi
studi
biolog
charact
genetransfect
gastric
mucos
cell
materi
method
rat
gastric
mucos
cell
line
cultur
incub
cdna
human
gene
transfect
cell
highli
express
cell
select
clone
singl
clone
express
compar
use
studi
cytoprotect
abil
ethanol
analyz
ldhreleas
wound
restor
artifici
creat
wound
monitor
compar
cell
result
success
clone
express
gastric
mucos
cell
express
protein
level
compar
cell
overexpress
clearli
enhanc
cytoprotect
abil
ethanolinduc
cell
damag
p
wound
restor
enhanc
cell
compar
cell
p
conclus
result
suggest
might
play
import
role
cytoprotect
also
wound
restor
gastric
mucos
cell
mediat
function
molecular
chaperon
appl
extract
prevent
oxid
injuri
human
gastric
epitheli
cell
vitro
marco
romano
giulia
graziani
concetta
tuccillo
vincenzo
foghano
background
gener
reactiv
oxygen
speci
harm
gastric
mucosa
fresh
fruit
vegetabi
exert
multipl
biolog
effect
mucosa
gastrointestin
tract
due
antioxid
content
whether
appl
polyphenol
extract
ape
prevent
reactiv
oxygen
speciesrel
damag
gastric
cell
uukown
aim
studi
design
assess
whether
ape
counteract
oxid
damag
gastric
epitheli
cell
vitro
evalu
mechan
effect
method
use
mkn
gastric
epitheli
cell
deriv
human
well
differenti
gastric
adenocarcinoma
ape
obtain
freez
dri
appl
flesh
annurca
varieti
follow
extract
methanol
oxid
stress
induc
incub
cell
xanthin
oxidas
xo
muml
presenc
xanthin
x
cell
damag
assess
ldh
releas
mtt
intracellular
antioxid
activ
determin
use
abt
azinobi
ethylbenzothiazolin
sulfon
method
malondialdheyd
intraceflular
concentr
index
lipid
peroxid
determin
hplc
fluorometr
detect
result
xxo
dosedepend
significantli
damag
gastric
cell
preincub
ape
significantli
prevent
xxoinduc
injuri
decreas
cell
damag
p
pure
catechin
chlorogen
acid
main
polyphenol
compon
ape
effect
ape
prevent
oxid
injuri
gastric
cell
pretreatmem
ape
increas
intracellular
concentr
catechin
chlorogen
acid
epicatechin
pretreat
ape
caus
increas
intraceflular
antioxid
activ
significantli
prevent
drop
induc
xxo
pretreat
ape
counteract
xxoinduc
increas
malondialdhyd
format
conclus
ape
significantli
protect
gastric
epitheli
cell
vitro
damag
brought
reactiv
oxygen
speci
catechin
chlorogen
acid
seem
greatli
contribut
aperel
protect
effect
ape
increas
intraceflular
antioxid
activ
prevent
lipid
peroxid
induc
reactiv
oxygen
speci
mkn
cell
suitabl
vitro
system
screen
veget
compound
antioxid
properti
elucid
mechan
action
postul
diet
enrich
appl
polyphenol
might
exert
benefici
effect
gastric
patholog
condit
relat
gener
reactiv
oxygen
speci
backgroundaim
endogen
prostaglandin
pg
involv
adapt
gastric
protect
acut
injuri
cyclooxygenas
cox
respons
product
pg
phenomenon
nitric
oxid
also
play
role
mucos
defens
mechan
howev
role
pg
play
mucos
defens
inflam
stomach
remain
unclear
present
studi
examin
effect
variou
cox
synthas
no
inhibitor
gastric
ulcerogen
respons
induc
repeat
administr
iodoacetamid
ia
investig
role
pg
mncosal
defens
inflam
stomach
method
male
sd
rat
use
gastric
inflamm
induc
drink
ia
tap
water
day
indomethacin
nonselect
cox
inhibitor
mgkg
po
select
coxi
inhibitor
rag
kg
po
rofecoxib
select
inhibitor
mgkg
po
lname
nonselect
no
inhibitor
mgkg
sc
aminognanidin
select
ino
inhibitor
mgkg
sc
given
twice
h
h
termin
ia
treatment
result
give
ia
drink
water
day
produc
minim
damag
stomach
increas
myeloperoxidas
mpo
activ
damag
significantli
worsen
indomethacin
lname
increas
mpo
activ
worsen
effect
indomethacin
reproduc
either
ro
fecoxib
although
effect
less
pronounc
mucos
content
markedli
increas
ia
treatment
express
mrna
stomach
increas
product
significantli
suppress
rofecoxib
well
indomethacin
addit
upregul
ino
express
product
also
observ
lainduc
inflam
stomach
lname
aminoguanidin
significantli
reduc
increas
product
aggrav
gastric
lesion
induc
ia
hand
gastric
acid
secret
pyloronslig
stomach
decreas
follow
ia
treatment
reduc
acid
respons
significantli
revert
inhibitor
test
conclus
result
suggest
endogen
pg
deriv
also
produc
cno
ino
involv
mucos
defens
inflam
stomach
partli
decreas
acid
secret
nentrophil
migrat
inhibit
trailinduc
mitochondri
apoptosi
human
colon
cancer
cell
revers
robert
penington
frank
sinicrop
background
trail
tnfrelat
apoptosi
induc
ligand
promis
anticanc
agent
induc
apoptosi
multipl
tumor
cell
type
engag
death
receptormedi
apoptot
pathway
determin
whether
trail
also
trigger
regul
mitochondri
apoptot
pathway
whether
small
molecul
inhibitor
revers
antiapoptot
effect
method
cell
stabli
transfect
plasmid
vector
alon
cell
incub
recombin
human
trail
apoptosi
analyz
annexin
vfitc
label
inhibitor
zlehdfmk
clonigeinc
cell
surviv
determin
treatment
trail
day
diluent
effect
trail
upon
bid
truncat
cleavag
cytochrom
c
smac
releas
determin
cell
fraction
immunoblot
cell
effect
trailinduc
apoptot
signal
determin
result
overexpress
cell
partial
protect
reduct
dosagedepend
induct
apoptosi
trail
cell
demonstr
increas
clonigen
surviv
compar
cell
trail
treatment
vs
remain
clone
block
trailmedi
cleavag
bad
effect
upon
cleavag
bid
truncat
inhibitor
reduc
trailinduc
apoptosi
cell
overexpress
attenu
bax
transloc
mitochondria
cytosol
releas
cytochrom
c
smac
addit
ceil
treat
trail
revers
protect
increas
apoptosi
rel
trail
alon
alon
induc
apoptosi
cell
cotreat
trail
show
increas
bax
transloc
cytoehrom
c
releas
rel
trail
treatment
alon
conclus
trail
engag
mitochondri
apoptot
pathway
ceil
inhibit
overexpress
suppress
bax
transloeat
releas
proapoptot
mitochondri
protein
effector
cleavag
cotreat
revers
effect
data
indic
import
modul
therapeut
efficaci
trail
colon
carcinoma
cell
etoposid
induc
gene
express
gi
tract
analysi
candid
gene
andrea
davi
penelop
ottewel
ann
mcnamara
john
r
jenkin
alastair
j
watson
background
establish
normal
mous
small
intestin
epithelium
crypt
villi
undergo
apoptnsi
follow
treatment
dna
damag
agent
includ
etoposid
cancer
patient
receiv
vepesid
treatment
suffer
bloodi
diarrhoea
indic
normal
intestin
epithelium
also
sensit
chemotherapeut
agent
hypothesis
differenti
apoptot
respons
along
cryptvillu
axi
mous
small
intestin
may
serv
invivo
model
studi
normal
resist
intestin
epithelium
cell
chemotherapi
aim
studi
identifi
novel
gene
involv
stress
respons
method
total
mrna
extract
treat
hour
human
colon
adenoma
isogen
pair
cell
line
use
probe
human
unigen
cdna
chip
array
vanderbilt
express
data
interpret
use
cluster
analysi
programm
candid
mrna
express
chang
confirm
real
time
pcr
qpcr
use
abi
prism
seri
appli
biosystem
protein
express
investig
western
blot
wb
immunocytofluoresc
icd
mous
invivo
studi
identifi
candid
gene
perform
treat
bw
hour
small
intestin
epithelium
wildtyp
null
total
epithelium
isol
use
modifi
weiser
chelat
buffer
gentl
agit
result
one
gene
identifi
array
analysi
confirm
qpcr
baculovir
iap
repeat
member
inhibitor
apoptosi
iap
famili
exhibit
increas
express
increas
p
stress
human
cell
wb
demonstr
protein
express
upregul
icf
indic
perinuclearmitochondri
localis
invivo
mous
model
found
opposit
result
downregul
mrna
qpcr
n
decreas
p
protein
wb
n
p
follow
treatment
conclus
respons
gene
human
invitro
mous
invivo
model
normal
invivo
mous
intestin
epithelium
treatment
reduc
express
consist
increas
incid
apoptosi
observ
histolog
analysi
contrast
transform
cell
express
induc
could
contribut
toward
apoptot
resist
cell
lack
guanylyl
cyclas
c
gcc
affect
polyp
number
apoptosi
apcm
v
mice
elizabeth
mann
carmen
r
stroup
ralph
giannella
background
gcc
transmembran
receptor
bacteri
heatstabl
enterotoxin
st
mammalian
peptid
guanylin
uroguanylin
mediat
ion
secret
via
cgmp
signal
addit
effect
enterocyt
apoptosi
andor
cell
cycl
progress
document
previous
use
mice
heterozyg
apc
allel
min
mice
model
intestin
cancer
shown
reduct
median
number
polyp
min
mice
also
carri
knock
gcc
gene
object
studi
probe
mechan
wherebi
polyp
number
reduc
method
use
microarray
technolog
affymetrix
determin
differ
gene
express
intestin
wild
type
min
min
mice
northern
blot
assay
use
valid
microarray
result
examin
apoptosi
cytosol
homogen
intestin
mucosa
elisa
detect
presenc
nucleosom
cell
death
assay
roch
result
analysi
microarray
result
use
genespr
silicon
genet
show
rel
small
number
gene
differ
fold
greater
p
among
genotyp
gener
gene
whose
express
level
differ
wild
type
min
intestin
exhibit
level
similar
wild
type
min
intestin
includ
gene
transcript
factor
receptor
tyrosin
kinas
mer
apoptosi
effector
proteas
caspas
easpas
final
examin
level
cytosoi
nucleosom
indic
apoptot
cell
death
demonstr
decreas
apoptosi
min
intestin
rel
wild
type
occurr
apoptosi
min
intestin
similar
wild
type
conclus
reduc
number
adenoma
mice
carri
apc
allel
gcc
null
background
indic
gcc
act
modifi
tumor
format
andor
progress
use
microarray
profil
demonstr
loss
gcc
mini
mice
lead
modul
express
number
gene
differ
wild
type
min
increas
similar
wild
type
profil
one
possibl
consequ
although
mechan
clear
program
cell
death
affect
increas
min
intestin
may
contribut
decreas
polyp
number
suppress
effect
death
signal
provid
select
growth
advantag
transform
tumor
cell
phospholipas
pla
famili
member
releas
arachidon
acid
aa
synthes
prostaglandin
pg
respons
immun
stimul
wherea
pg
promot
cell
prolifer
aa
one
major
determin
apoptosi
coordin
express
maintain
effect
balanc
avail
aa
gener
pg
howev
present
studi
use
immunohistochemistri
found
cpla
express
absent
human
colon
adenocarcinoma
overexpress
analysi
carri
colonocyt
evalu
function
sigmfic
observ
use
antisens
ofigo
found
reduc
level
led
doserel
attenu
tnfe
induc
apoptosi
base
vitro
analysi
evalu
apoptot
statu
human
colon
tumor
found
significantli
lower
tunel
stain
tumor
addit
studi
reveal
loss
presenc
elev
occur
preneoplast
aberr
crypt
foci
obtain
close
focu
colonoseopi
patient
screen
increas
risk
colon
cancer
conclus
propos
dispar
cpla
statu
disrupt
balanc
aa
pg
may
lead
resist
cell
death
signal
colon
tumorigenesi
may
provid
subset
colon
crypt
select
growth
advantag
oesophagu
express
distinct
set
heat
shock
protein
respons
stress
rang
substanc
reflux
ingest
studi
aim
determin
function
regul
one
protein
squamou
epitheli
heat
shock
protein
relat
diseas
process
oesophag
biopsi
analys
presenc
sampl
patient
patholog
symptom
noneros
reflux
diseas
detect
reduc
patient
eros
reflux
diseas
detect
one
sampl
barrett
metaplasia
squamou
tissu
barrett
patient
howev
express
protein
overproduc
cell
expos
rang
toxin
test
viabil
trypan
blue
exclus
compar
isogen
control
cell
show
higher
degre
resist
bile
acid
low
ph
ethanol
alon
effect
combin
bile
acid
deoxychof
acid
effect
amplifi
cell
treat
hour
stain
propidium
iodid
analys
flow
cytometri
presenc
bile
acid
increas
cell
phase
cell
cycl
reduct
phase
increas
less
overproduc
cell
conclus
express
constitut
normal
squamou
oesophag
tissu
nerd
reduc
erd
absent
mani
barrett
case
presenc
increas
viabil
stabl
cell
line
presenc
varieti
substanc
oesophagu
commonli
expos
growth
arrest
respons
bile
acid
occur
earlier
cell
cycl
produc
mutat
analysi
perform
pcr
sequenc
defici
cell
line
transient
transfect
express
vector
tgf
respons
reassess
result
hetia
chtrt
gihtrt
exhibit
inhibit
prolifer
induct
pal
respons
increas
dose
tgf
oesophag
cell
gohtrt
segi
growth
inhibit
riot
exhibit
induct
respons
tgf
apart
unrespons
cell
line
display
tgf
induc
increas
pal
express
cell
express
mrna
protein
result
base
pair
substitut
exon
gene
background
growth
condit
low
oxygen
hallmark
growth
pancreat
cancer
may
induc
specif
epigenet
gene
express
profil
known
angiogen
cytokin
upregul
conditiol
littl
known
prometastat
gene
aim
present
stndi
aim
clone
new
hypoxia
induc
gene
character
possibl
new
gene
growth
pancreat
cancer
method
clone
new
hypoma
induc
gene
achiev
rda
repres
differenti
analysi
method
cell
line
cultur
h
hypox
condit
hypox
induct
identifi
gene
confirm
northern
blot
analysi
clone
sequenc
express
studi
human
pancreat
cancer
specimen
cell
line
done
real
time
quantit
pcr
western
blot
tissu
specimen
analyz
immunohistoehemistri
situ
hybrid
tumor
cell
invas
studi
matrigel
invas
assay
cell
viabil
mtt
assay
bone
marrow
recent
demonstr
serv
site
cell
prime
memori
gener
blood
born
tumor
associ
antigen
murin
model
similarli
major
breast
cancer
patient
bone
marrow
pancreat
cancer
patient
harbour
high
level
tumor
reactiv
memori
cell
cell
activ
subsequ
memori
format
believ
requir
antigen
present
activ
antigen
present
ceil
activ
base
danger
signal
provid
mfectiou
agent
autolog
tumor
contrast
known
elicit
effect
mechan
counteract
cell
respons
therefor
remain
unclear
taaspecif
memori
cell
sustain
tumor
patient
pancreat
cancer
demonstr
prevent
cytolyt
cell
respons
secret
antiinflammatori
cytokin
nevertheless
describ
first
time
high
frequenc
taa
specif
memori
ceil
bone
marrow
test
pancreat
cancer
patient
cell
capabl
ifni
secret
upon
stimul
exert
cytotox
autologn
tumor
cell
vitro
contrast
memori
cell
patient
chronic
pancreat
react
antigen
deriv
autolog
inflammatori
pancreat
tissu
thu
gener
autoantigen
reactiv
memori
cell
restrict
tumor
patient
report
first
time
taa
dependend
cognat
interact
blood
born
monocyt
tumor
reactiv
memori
cell
pancreat
cancer
patient
lead
monocyt
activ
characteris
induct
th
polar
cytokin
activ
requir
mhc
restrict
cytolysi
autolog
tumor
cell
cytolyt
memori
cell
essenti
uptak
process
tumor
antigen
monocyt
subsequ
induct
driven
cognat
interact
tumor
specif
mhc
lesser
extend
mhc
ii
restrict
memori
cell
thu
mhc
restrict
cytolyt
cell
may
play
crucial
role
sustain
respons
allow
tumor
antigen
uptak
present
monocyt
activ
secret
polar
cytokin
data
suggest
initi
trigger
mhc
restrict
cytolyt
ceil
might
capabl
sustain
high
number
function
memori
cell
even
absenc
inflammatori
danger
signal
background
pancreat
cancer
major
oncolog
challeng
due
aggress
growth
metastasi
molecular
mechan
underli
deadli
behavior
well
understood
shown
adrenomedullin
adm
highli
express
pancreat
cancer
compar
normal
pancrea
chronic
pancreat
cancer
re
studi
investig
effect
adm
pancreat
cancer
cell
growth
metastasi
invas
method
rtpcr
immunohistochemistri
use
assess
adm
express
elisa
kit
use
detect
secret
adm
human
pancreat
cancer
cell
line
growth
assess
use
mt
assay
migrat
examin
use
transwel
cell
migrat
assay
invas
use
biocoat
matngel
lnvasion
assay
purifi
human
adm
purchas
sigma
result
microarray
data
shown
adm
express
fold
higher
pancreat
cancer
compar
normal
pancrea
pancreat
elev
express
pancreat
cancer
cell
line
rtpcr
confirm
microarray
data
immunohistochemistri
reveal
express
adm
specif
pancreat
neoplast
epithelium
evalu
pancreat
cancer
tissu
array
demonstr
pancreat
adenocarcinoma
overexpress
adm
compar
control
pancrea
adm
secret
pancreat
cancer
cell
line
medium
eg
level
adm
protein
secret
correl
well
microarmi
data
addit
adm
nm
pancl
cell
stimul
cell
prolifer
control
p
adm
nm
concentr
depend
stimulatori
effect
pancl
cell
migrat
invas
concentr
nm
adm
increas
migrat
control
p
invas
control
p
conclus
adm
highli
express
pancreat
cancer
ceil
may
act
autocrin
factor
stimul
pancreat
cancer
cell
growth
migrat
invas
vitro
studi
need
defin
role
adm
pancreat
tumorigenesi
cycl
regul
apoptosi
jorg
kleeff
ahm
guweidhi
nathalia
gies
knnt
ketter
markn
w
buchler
murray
korc
helmut
friess
background
belong
famili
protein
involv
modul
divers
signal
transduct
pathway
loss
express
observ
number
human
cancer
suggest
may
role
tumor
suppressor
gene
aim
investig
express
function
role
pancreat
ductal
adenocarcinoma
method
express
analyz
use
laser
captur
microdissect
realtim
quantit
pcr
immunohistochemistri
western
blot
analysi
role
apoptosi
cell
cycl
regul
evalu
western
blot
immunoprecipit
eac
analysi
result
mrna
level
increas
pancreat
adenocarcinoma
comparison
normal
pancreat
sampl
local
pancreat
cancer
ceil
pancreat
cancer
ceil
degre
express
decis
mainten
cell
cycl
checkpoint
induct
apoptosi
respons
radiat
apoptosisinduc
agent
neither
accompani
signific
accumul
chang
associ
bad
bax
conclus
mark
overexpress
pdac
togeth
multipl
known
alter
potenti
interact
partner
suggest
import
role
aberr
downstream
signal
pancreat
cancer
background
aim
report
extracelhilar
matrix
ecm
protein
growth
factor
key
environment
factor
protect
pancreat
cancer
cell
death
hypothes
antiapoptot
effect
factor
mediat
reactiv
oxygen
speci
ro
studi
determin
effect
ecm
protein
growth
factor
ro
pancreat
cancer
cell
sourc
ro
product
role
ro
prosurviv
effect
ecm
growth
factor
method
human
pancreat
carcinoma
ceil
cultur
h
fibronectin
faminm
polyhema
nonadher
substrat
prevent
cell
attach
without
serum
insulinhk
growth
factor
igei
measur
intracellular
ro
fac
analysi
cell
label
rossensit
probe
dcf
nad
p
h
oxidas
activ
cell
homogen
lucigeninderiv
chemiluminesc
apoptosi
character
dna
fragment
phosphatidylserin
extern
activ
cytochrom
c
releas
mitochondri
depolar
mitochondri
dnadeplet
cell
gener
long
term
cultur
mia
cell
ethidinm
bromid
result
ecm
protein
fibronectin
laminin
growth
factor
fb
increas
intracellular
ro
stimul
nad
p
h
oxidas
activ
nad
p
h
oxidas
inhibitor
diphenylen
iodoinum
dpi
neither
xanthin
oxidas
inhibitor
allopurinnl
synthas
inhibitor
lname
block
ro
product
stimulatori
effect
ecm
protein
growth
factor
cellular
ro
nad
p
h
oxidas
activ
cell
deplet
mitochondri
nadh
dehydrogenas
parent
mia
data
indic
nonmitochondri
nad
p
h
oxidas
sourc
ro
induc
ecm
protein
growth
factor
inhibit
ro
pharmacolog
agent
dpi
superoxid
scaveng
tiron
antioxid
nacetylcystein
overexpress
mnsod
stimul
apoptosi
mia
cell
apoptosi
associ
mitochondri
dysfunct
effector
caspas
activ
dna
fragment
phosphatidylserin
extern
conclnsion
ecm
protein
growth
factor
stimul
ro
product
pancreat
cancer
cell
nonmitochondri
membran
nad
p
h
oxidas
inhibit
enzym
potenti
therapeut
strategi
induc
apoptosi
pancreat
cancer
christoph
muefler
stephan
emmrich
gisela
sparmann
diana
avram
robert
jaster
stehn
lieb
joerg
emmrich
background
aim
grow
evid
extracellular
matrix
ecm
influenc
tumor
growth
inhibit
synthesi
tumorderiv
stroma
may
potenti
therapeut
target
cancer
progress
prolin
analogu
cishydroxyprolin
chp
inhibitor
collagen
deposit
examin
effect
rat
pancreat
carcinoma
cell
line
well
rat
pancreat
stellat
cell
psc
method
primari
psc
isol
pancrea
rat
use
collagenas
digest
densiti
gradient
centrifug
addit
two
immort
psc
line
ltc
also
use
cell
prolifer
measur
brdu
incorpor
celltit
kit
promega
monitor
apoptosi
use
cell
death
detect
elisa
roch
involv
focal
adhes
kinas
fak
chp
induc
signal
transduct
analyz
western
blot
result
chp
caus
growth
inhibit
use
cell
popul
dose
depend
manner
furthermor
chp
affect
spread
investig
cell
line
adher
grow
cell
round
detach
surfac
cultur
flask
lead
apoptosi
cell
detach
could
revert
chp
remov
chp
shown
induc
cleavag
fak
indic
integrinmedi
signal
transduct
effect
chp
could
prevent
addit
lprulin
cultur
medium
conclus
result
show
chp
abl
inhibit
growth
pancreat
carcinoma
cell
well
pancreat
stellat
cell
cleavag
inactiv
fak
involv
mediat
chp
effect
studi
anim
model
necessari
investig
potenti
therapeut
effici
chp
pancreat
cancer
introduct
overexpress
tyrosin
kinas
receptor
famili
member
epiderm
growth
factor
receptor
respect
ligand
frequent
observ
pancreat
cancer
well
chronic
pancreat
materialsmethod
three
independ
transgen
mous
line
overepxress
control
proxim
rat
elastas
promot
gener
pronucelar
inject
pancrea
isol
acini
transgen
mice
analys
standard
procedur
rna
protein
level
detect
real
time
pcr
immunohistochemistri
western
blot
ra
activ
detect
immunopecipit
assay
kinas
activ
detect
use
specif
antibodi
result
overexpress
exocinr
pancrea
result
increas
ra
activ
least
two
three
mous
line
downstream
activ
ra
effector
includ
transgen
mice
display
increas
prolifer
rate
acinar
duct
cell
sign
acinar
cell
damag
accumul
extracellular
matrlx
type
cyclin
induc
acinar
ceil
result
increas
ra
activ
unexpectedli
cyclm
found
downreguf
cell
moreov
observ
area
focal
infiltr
interspers
exocrin
pancrea
nfkb
bind
activ
induc
transgen
acinar
cell
compar
control
contribut
high
level
chemokin
cytokin
gene
express
conclus
data
suggest
overexpress
acinar
cell
lead
increas
gtpbound
ra
level
without
cell
cycl
progress
due
downregul
cyclin
mediat
inflammatori
respons
via
nfkb
activ
acinar
cell
data
show
biolog
respons
tyrosin
kinas
receptorp
signal
depend
highli
cellular
context
releas
apoptot
pancreat
tumor
cell
induc
toler
bind
immatur
dendrit
cell
jan
schmidt
markn
w
buchler
angela
marten
background
aim
chemoa
well
immunotherapeut
approach
induc
apoptosi
tumor
cell
apoptot
cell
known
activ
homolog
complement
opson
sinc
matur
dendrit
cell
dc
inhibit
bind
complement
receptor
immatur
dc
induc
toler
investig
induct
toler
puls
dc
apoptot
ceil
presenc
absenc
nativ
serum
method
apoptosi
pancreat
carcinoma
cell
induc
either
heatstress
chemotherapi
antibodi
monocytederiv
dc
puls
apoptot
cell
without
nativ
serum
dc
analyz
matur
state
flow
cytometri
cytotox
activ
determin
toler
prevent
addit
substanc
anti
cdllb
nacetyldghicosamin
nadg
block
bind
result
former
strategi
apoptosi
induct
result
releas
puls
dc
apoptot
cell
presenc
serum
prevent
matur
dc
induc
final
toler
toler
could
prevent
almost
complet
block
interact
cpo
receptor
conclus
chemoa
well
immunotherapeut
approach
induc
apoptosi
tumor
ceil
releas
apoptot
tumor
cell
prevent
fulli
matur
dc
immatur
dc
induc
antigenspecif
silenc
toler
block
could
mostli
prevent
effect
seem
attent
drawn
frequent
neglect
innat
immun
system
background
neuropeptid
correspond
g
proteincoupl
receptor
gpcr
autoctineparacrin
stimul
growth
multipl
human
cancer
cell
function
neurotensin
nt
receptor
significantli
upregul
pancreat
cancer
paca
seem
relat
kra
mutat
present
aggress
tumor
paca
cell
also
overexpress
egf
receptor
egfr
implic
autocrineparacrin
loop
onsetmaintenana
malign
howev
interact
nt
egf
pancreat
cancer
less
well
studi
aim
examin
signal
pathway
mediat
nt
egf
activ
extracelhifarregul
kinas
erk
stimul
dna
synthesi
anchorageindepend
growth
paca
cell
line
mia
method
result
nt
egf
potent
activ
erk
dosedepend
manner
nt
induc
erk
activ
abolish
pkc
inhibitur
egf
stimul
erk
activ
abrog
egfr
tyrosin
kinas
inhibitor
ag
pkc
inhibitor
combin
nt
egf
howev
significantli
potenti
prolong
erk
stimul
even
hour
prevent
synergist
effect
result
stimul
level
induc
egf
alon
biolog
respons
prolong
erk
activ
nt
egf
synergist
stimul
dna
synthesi
measur
hthymidin
incorpor
abrog
mek
inhibitor
pkc
inhibitor
diminish
synergist
effect
result
stimul
level
egf
treatment
alon
final
nt
egf
synergist
stimul
coloni
format
hallmark
neoplast
progress
mia
cell
neuropeptid
includ
bradykinin
vasopressin
stimul
synergist
dna
synthesi
combin
egf
paca
cell
conclus
result
indic
potent
stimulatori
effect
nt
egf
erk
activ
dna
synthesi
coloni
format
mediat
distinct
signal
pathway
combin
nt
egf
led
potenti
prolong
erk
seem
critic
synergist
effect
dna
synthesi
anchorageindepend
growth
paca
cell
thu
knowledg
signal
pathway
neuropeptid
ha
human
pancreat
cancer
could
form
basi
novel
approach
combinatori
treatment
regiment
deadli
diseas
futur
proteom
analysi
tgf
signal
pathway
pancreat
carcinoma
cell
use
rna
interfer
silenc
express
takaaki
imamura
bumihiko
kanai
takaynki
kawakami
jazag
amarsanaa
hideaki
ijichi
yujin
hoshida
yasuo
tanaka
tsuneo
ikenou
keisuk
tateishi
takao
kawab
makoto
miyagishi
kazunari
taira
fumio
imazeki
osamu
yokosuka
masao
omata
background
tumorsuppressor
gene
commonli
lost
mutat
colorect
pancreat
cancer
also
intracellular
transmitt
transform
growth
factor
tgf
signal
tumorsuppressor
function
presum
resid
capac
mediat
growth
inhibit
howev
certain
tgf
transcript
respons
retain
cell
although
mitogenactiv
protein
kinas
mapk
activ
independ
appear
unidentifi
signal
pathway
aim
establish
pancreat
carcinoma
cell
whose
protein
express
stabli
knock
down
identifi
novel
target
molecul
tgf
signal
use
twodimension
gel
electrophoresi
mass
spectrometri
method
establish
pancreat
carcinoma
cell
whose
express
knock
stabl
transfect
plasmid
express
short
interf
rna
sirna
cell
treat
ngml
tgf
control
buffer
hour
solubl
protein
extract
subject
statist
analysi
silver
stain
spot
use
pdquest
softwar
identifi
spot
increas
fold
decreas
fold
use
malditoftof
quantit
chang
identifi
spot
confirm
westem
blot
antibodi
avail
chang
mrna
also
examin
investig
whether
identifi
molecul
stimul
mapk
tgf
stimul
perform
without
pretreat
select
erk
inhibitor
result
protein
express
signal
impair
knock
cell
spot
investig
show
fold
increas
show
fold
decreas
tgf
stimul
identifi
protein
upregul
protein
downregnl
ten
novel
target
protein
function
cytoskelet
regul
cell
cycl
oxid
stress
apoptosi
quantit
chang
confirm
western
blot
almost
ident
shown
gel
although
mrna
protein
identifi
vimentin
appear
regul
via
neither
mapk
pathway
conclus
introduc
sirnamedi
gene
silenc
proteom
reveal
novel
tgf
signal
pathway
involv
rna
local
establish
cellular
polar
gastric
epithelium
jason
c
mill
nikla
andersson
christoph
c
chen
thaddeu
stappenbeck
jeffrey
gordon
gastric
epithelium
mice
human
compos
thousand
invagin
known
gastric
unit
gu
gastric
epitheli
progenitor
cell
gep
resid
middl
isthmu
gu
continu
repopul
entir
epithelium
spawn
five
distinct
cell
lineag
differ
markedli
lifespan
pattern
migrat
biolog
function
elucid
molecular
genet
underpin
gastric
epitheli
renew
undertaken
dna
microarraybas
express
profil
gep
well
acidsecret
pariet
cell
pepsinogensecret
zymogen
chiet
cell
zc
largescal
est
sequenc
project
lasercaptur
microdissect
gep
part
stem
cell
genom
anatomi
project
scgap
wwwscgaporg
consortium
furthermor
develop
new
bioinformat
tool
allow
comparison
gene
express
profil
dispar
function
genom
experi
microarray
est
sequenc
etc
analyz
molecular
aspect
renew
stomach
compar
tissu
one
entic
observ
gep
like
hematopoiet
stern
ceil
express
higher
level
progeni
gene
eg
mago
regul
splice
transport
local
mrna
drosophila
homolog
gene
requir
establish
cell
polar
fate
determin
oogenesi
neurogenesi
propos
differenti
mammalian
epitheli
cell
may
also
involv
process
local
transcript
translat
cell
differenti
accordingli
lcm
follow
quantit
rtpcr
coupl
light
em
immunohistochemistri
show
despit
extens
rough
er
elabor
secretori
apparatu
matur
zc
express
transcript
mediat
mrna
local
eg
staufenl
lower
level
differenti
progenitor
also
find
transcript
involv
establish
cell
polar
preferenti
express
progenitor
eg
protein
kinas
c
rel
differenti
cell
rac
homolog
tcio
suggest
stomach
serv
fertil
vivo
system
studi
asymmetr
cell
divis
establish
cell
polar
intestin
stem
cell
locat
deep
crypt
leiberkuhn
demonstr
multipot
precursor
princip
lineag
within
epithelium
date
understand
properti
cell
greatli
hamper
lack
method
isol
identifi
character
thu
aim
studi
develop
method
isol
viabl
intestin
stem
cell
assess
put
stem
cell
fraction
express
known
marker
intestin
hematopoet
stem
cell
hypothes
mani
adult
tissu
intestin
epitheli
stem
cell
may
identifi
side
popul
sp
flow
cytometri
follow
stain
dnabind
dye
hoechst
method
gener
singl
cell
suspens
mous
jejunum
digest
collagenas
subject
serial
sediment
filtrat
cell
suspens
stain
hoechst
either
fitc
pe
label
antibodi
subject
dual
wavelength
flow
cytometri
describ
goodel
et
al
q
exp
med
experi
sp
fraction
collect
rna
analysi
via
realtim
quantit
rtpcr
result
stain
hoechst
cell
found
viabl
dual
wavelength
flow
cytometri
show
distinct
sp
compris
viabl
cell
hematopoet
cell
exclud
basi
immunoreact
sp
reduc
number
consist
expect
number
intestin
epitheli
stem
cell
neg
sp
show
minim
express
surfac
marker
hematopoet
stem
cell
specif
thi
ckit
contrast
rtpcr
analysi
rna
sp
fraction
show
presenc
mrna
known
marker
intestin
epitheli
stem
cell
conclus
appear
success
isol
viabl
stem
cell
mous
small
intestin
avail
cell
contribut
significantli
basic
understand
epitheli
biolog
well
new
therapi
intestin
damag
support
nih
grant
recent
succeed
develop
pancreat
islet
liver
stz
mice
helperdepend
adenoviru
hdad
mediat
transfer
neuroddoetacelfufin
neurodbetacellulin
treatment
complet
correct
diabet
month
one
shot
inject
vector
hand
treatment
revers
hyperglycemia
one
week
produc
fatal
hepat
caus
express
trypsin
neurodbetacelfulintr
mice
detect
liver
insulin
isletspecif
transcript
includ
proinsulinprocess
enzym
beta
cellspecif
glucokinas
sulfonyfurea
receptor
immunohistochemistri
reveal
presenc
insulin
glucagon
pancreat
polypeptid
pp
somatostatinproduc
cell
organ
islet
cluster
immunoelectron
microscop
studi
show
insulinspecif
secretori
granul
pack
cytoplasm
immunogold
reaction
insulin
locat
granular
core
pdxltreat
mice
hand
singl
insulin
posit
cell
scatter
liver
form
isletlik
cluster
cell
produc
four
islet
hormon
well
trypsin
uftrastructur
level
immatur
secretori
granul
observ
cytoplasm
data
suggest
neurodbetacelfulin
promis
gene
therapi
treatment
insulindepend
diabet
howev
gene
therapi
seem
harm
exocrinedifferenti
activ
background
signal
regul
crypt
stem
cell
homeostasi
develop
role
postnat
intestin
epitheli
regener
unclear
studi
test
hypothesi
bcatenintcf
signal
molecul
differenti
express
regener
recapitul
express
pattern
intestin
develop
method
rat
model
intestin
epitheli
regener
involv
isol
subcutan
graft
postnat
crypt
cell
aggreg
use
graft
retriev
day
regener
pool
time
point
express
bcatenin
assay
western
blot
b
actin
control
quantifi
densitometri
effect
bcatenin
induc
mnu
mgkg
bcateinn
downstream
gene
express
assess
bcatenin
high
express
cell
line
rama
cell
respect
posit
control
postnat
intestin
colon
development
control
result
bcatenin
express
increas
declin
progress
regener
graft
highli
express
posit
development
control
undetect
regener
graft
mnu
treatment
increas
bcatenin
development
control
tissu
bcatenin
unregul
graft
undetect
conclus
bcatenin
signal
preserv
bcatenin
appear
perturb
crypt
morphogenesi
postnat
intestin
regener
enhanc
neuron
surviv
stem
cell
transplant
gut
effect
immunosuppress
caspas
inhibit
mariaadelaid
micci
matthew
pattillo
pankaj
j
pasricha
introduct
although
neural
stem
cell
nsc
transplant
promis
tool
restor
enter
nervou
system
varieti
motihti
disord
posttranspl
surviv
appear
critic
limit
factor
success
anatom
function
repopul
may
determin
immunolog
well
nonimmun
mediat
mechan
includ
intrins
program
toward
apoptnsi
studi
investig
role
mechan
surviv
transplant
nsc
method
mous
cnsderiv
nsc
cnsnsc
isol
subventricular
zone
svz
embryon
mice
trarlsgen
engin
express
gfp
cnsnsc
transplant
densiti
use
consist
site
depth
inject
pyloru
wild
type
wt
mice
without
administr
cyclosporin
cya
rag
ml
scid
mice
separ
experi
nsc
transplant
wt
without
addit
caspas
inhibitor
inject
media
acyvadcmk
ixm
one
week
posttransplant
anim
sacrif
implant
cell
visual
count
use
laser
scanmng
confoc
microscop
counterstain
nucleic
acid
stain
topro
result
cya
treatment
result
greater
number
graft
cell
wherea
dramat
increas
number
seen
scid
mice
compar
control
addit
caspas
inhibitor
also
result
greatli
enhanc
surviv
fold
increas
control
conclus
result
indic
immun
mechan
caspas
activ
modul
cell
surviv
neural
cell
transplant
cyclosporin
probabl
inadequ
immunosuppress
regimen
improv
cell
surviv
nsc
gut
howev
pretreat
caspas
inhibitor
may
practic
method
enhanc
abil
transplant
nsc
surviv
new
environ
cellular
distribut
fxr
rxr
express
develop
rat
ileal
mucosa
sandi
hwang
keina
r
tompkin
susan
j
heninng
ileal
bile
acid
bind
protein
ibabp
cytosol
protein
express
primarili
ileal
enterocyt
believ
involv
intestin
absorpt
bile
acid
development
express
characteihz
dramat
increas
mrna
protein
level
third
postnat
week
rat
wellrecogn
target
gene
bile
acid
receptor
fxr
heterodim
partner
rxru
develop
rat
ileum
fxrrxra
dnabind
activ
detect
end
third
postnat
week
earlier
suckl
period
fxr
rxrx
protein
detect
suckl
rat
whole
ileal
homogen
nuclear
versu
cytosol
local
determin
hypothes
chang
nuclear
tmnslocat
either
fxr
rxrx
may
account
development
pattern
fxrrxrc
dnabind
activ
method
mucnsal
scrape
ileum
untreat
rat
collect
posmat
day
crude
nuclear
cytosof
whole
cell
extract
prepar
use
western
blot
separ
experi
day
pup
administ
fxr
agonist
dose
mgkg
receiv
vehicl
oral
gavag
whole
ileal
tissu
collect
hour
ater
northern
blot
analysi
ibabp
mrna
result
rxrc
found
abund
nuclear
fraction
ileal
mucosa
age
contrast
fxr
bare
detect
nuclei
suckl
ileum
abund
cytosol
fraction
day
fxr
readili
detect
ileal
nuclei
although
still
abund
cytosol
suckl
anim
receiv
ibabp
mrna
induc
adult
level
wherea
minim
amount
detect
vehicl
control
conclus
fxr
rxrt
differ
cellular
distribut
nuclei
suckl
rat
ileal
mucosa
rxra
highli
express
wherea
much
reduc
level
fxr
induct
ibabp
mrna
adult
level
ileum
anim
treat
fxr
agonist
suggest
lack
fxr
activ
thu
ibabp
express
suckl
ileum
may
primarili
due
insuffici
amount
intralumin
bile
acid
act
fxr
ligand
bile
acid
may
act
directli
activ
fxrrxrc
alreadi
present
nucleu
may
drive
nuclear
transloc
fxr
work
support
nih
grant
identif
map
kinas
phosphoryl
site
involv
transcript
activ
sebastien
mongrain
gerald
beruatchez
nathali
rivard
claud
asselin
introduct
intestin
one
major
transcript
factor
involv
epitheli
cell
differenti
homeodomaincontain
transcript
factor
caudal
famili
one
intestin
target
sucraseisomaltas
enzym
express
brush
border
enterocyt
littl
known
signal
transduct
pathway
involv
regul
activ
howev
previous
demonstr
substrat
mapk
transcript
activ
modul
mapk
therefor
want
defin
mechan
regul
mapk
method
overlap
extens
mutagenesi
construct
delet
mutant
well
specif
mutant
put
mapk
phosphoryl
site
dnabind
capac
verifi
electrophoret
mobil
shift
assay
emsa
gst
pulldown
assay
perform
determin
mapk
dock
site
vitro
phosphoryl
assay
without
perform
identifi
mapk
phosphoryl
site
transactiv
potenti
sucraseisomahas
promot
assess
transient
transfect
human
colon
carcinoma
cell
result
mutat
affect
dnabind
capac
specif
element
mapk
dock
site
locat
amino
acid
consensu
mapk
phosphoryl
site
serin
serin
phosphoryf
mapk
mapk
phosphoryl
site
locat
amino
acid
mutat
serin
alanin
significantli
decreas
transactiv
potenti
sucras
isomaltas
promot
delet
amino
acid
decreas
conclus
inde
novel
substrat
mapk
mapk
may
well
import
regul
transcript
activ
research
financ
cihr
ccfc
nserc
enzym
catalyz
limit
step
prostaglandin
format
constitut
overexpress
play
import
role
carcinogenesi
chronic
inflammatori
syndrom
understand
mechan
control
express
colorect
cancer
examin
regul
occur
posttranscript
level
aspect
gene
regul
primarili
mediat
conserv
aurich
element
within
mrna
region
rna
bind
studi
identifi
translat
repressor
regulatori
factor
capabl
bind
signific
tialmedi
regul
express
observ
null
fibroblast
produc
increas
protein
level
prostaglandin
synthesi
wildtyp
fibroblast
treatment
growth
factor
tgf
promot
enhanc
mrna
express
wild
type
null
fibroblast
increas
protein
express
observ
defici
cell
defici
alter
gene
transcript
steadyst
mrna
level
rapid
mrna
turnov
result
implic
novel
role
arebind
protein
suppressor
express
translat
level
furthermor
colon
cancer
cell
constitut
transcrib
mrna
display
defect
bind
rna
also
increas
translat
mrna
enhanc
protein
synthesi
find
implic
function
translat
silenc
express
support
hypothesi
dysregul
rnabind
promot
express
neoplasm
ribosom
protein
regul
tnf
gene
express
mark
worthington
jare
w
pelo
mari
g
harp
tnf
protein
express
regul
transcript
translat
mrna
instabl
interest
tnf
gene
regul
prompt
us
perform
yeast
twohybrid
screen
use
tristetraprolin
ttp
bait
ttp
requir
proper
posttranscript
regul
tnf
gmcsf
cytokin
mrna
caus
rapid
deadenyl
destruct
bind
aurich
element
also
express
inflammatori
region
crohn
diseas
sgand
ribosom
protein
isol
screen
origin
describ
tnfinduc
protein
known
rna
bind
near
mrna
cap
complex
ribosom
protein
protein
known
function
interact
mrna
tnf
mrna
translat
inhibit
protein
compon
stress
granul
sg
includ
tiai
initi
factor
protein
interact
confirm
use
nhplcuesi
ms
sequenc
epitopetag
ttp
complex
process
identifi
nativ
sg
protein
import
tnf
regul
found
bind
ttp
ttp
bound
tnf
rna
emsa
coupl
regul
directli
address
use
hiciferas
report
gene
fuse
tnf
express
endotoxininserlsit
promot
report
plasmid
transfect
macrophag
cell
line
without
express
plasmid
e
coil
endotoxin
translat
derepress
tnf
report
approxim
background
without
addit
plasrnid
increas
activ
background
cell
current
select
understand
repertoir
cytokin
stimul
macrophag
modul
overexpress
conclus
tnfstimuf
protein
compon
stress
granul
bind
aurich
regul
ttp
protein
abl
ttp
bound
tnf
aurich
element
express
increas
endotoxininduc
protein
express
regul
tnf
whether
macrophageproduc
cytokin
enhanc
protein
level
subject
ongo
investig
put
intestin
specif
enhanc
locat
sequenc
cdxi
gene
regul
express
intestin
wei
xu
enrm
b
rankin
debra
g
silberg
eunran
suh
introduct
cdxl
homeobox
transcript
factor
play
critic
role
intestin
epitheli
cell
growth
differenti
cdxl
gene
express
complex
pattern
two
stage
mous
develop
first
stage
cdxi
express
primit
ectoderm
mesoderm
detect
express
endoderm
second
stage
cdxl
express
limit
develop
intestin
express
remain
strong
intestin
epithelium
throughout
life
date
littl
known
molecular
mechan
regul
development
spatial
pattern
express
normal
intestin
induc
downregul
colon
adenoma
cancer
present
studi
focu
upon
initi
mainten
human
cdxi
gene
transcript
intestin
analyz
cisact
regulatori
element
comprehens
transgen
mice
studi
method
elucid
mechan
gene
regul
employ
seri
transgen
mous
studi
use
flank
sequenc
human
gene
dnase
l
hypersensit
assay
perform
local
enhanc
element
result
transgen
mice
contain
nucleotid
rel
transcript
start
site
cdxi
gene
demonstr
transgen
express
depend
upon
site
insert
express
transgen
insert
site
depend
contain
intestinespecif
regul
demonstr
ectop
express
transgen
brain
gastric
smooth
muscl
howev
nucleotid
gene
direct
transgen
express
specif
intestin
epithelium
abl
switch
transgen
express
mesoderm
ectoderm
earli
develop
endoderm
specif
later
develop
similar
pattern
endogen
cdxl
gene
express
furthermor
dnase
hypersensit
assay
reveal
two
activ
chromatin
region
gene
locat
kb
kb
upstream
cdxi
gene
respect
may
function
put
intestinespecif
enhanc
conclus
upstream
sequenc
contain
put
intestin
specif
enhanc
regul
development
spatial
pattern
gene
express
identif
basal
promot
region
human
intestin
napiilb
gene
hna
xu
jennif
uno
michael
lnouy
jame
collin
fayez
ghishan
introduct
human
intestin
sodiumphosph
cotransport
hnapiiib
play
import
role
intestin
pi
absorpt
previou
studi
shown
human
napiiib
gene
promot
contain
bp
upstream
gene
transcnption
initi
site
activ
cell
howev
minim
dna
sequenc
transcript
factor
involv
activ
known
identif
focu
studi
method
delet
promot
construct
made
pcr
restrict
enzym
digest
subclon
basic
vector
contain
luciferas
report
gene
truncat
promot
construct
transfect
cell
lipofectamin
nuclear
protein
extract
ceil
standard
method
electrophoret
mobil
shift
assay
emsa
perform
character
nuclear
proteindna
interact
result
seri
delet
construct
bp
made
bp
hnapiqib
gene
promot
construct
end
base
report
gene
assay
show
delet
promot
construct
bp
function
cell
bp
construct
emsa
dna
oligonucleotid
show
nuclear
protein
bind
dna
oligo
span
bp
bp
region
bind
could
compet
unlabel
otigo
emsa
oligo
cover
bp
confirm
bp
requir
nuclear
protein
bind
protein
bound
region
identifi
nuclear
protein
supershift
assay
mutat
region
abolish
dnaprotein
interact
also
abolish
promot
activ
cell
conclus
bp
upstream
region
human
intestin
napilib
gene
requir
activ
gene
express
one
transcnption
factor
involv
activ
like
belong
famili
work
focu
identifi
addit
transcript
factor
bind
bp
bp
region
hnapiiib
gene
promot
defin
possibl
proteinprotein
interact
necessari
full
transcript
activ
human
napillb
gene
express
investig
support
nih
grant
generegulatori
activ
genom
region
surround
polymorph
associ
adulttyp
hypolactasia
jesper
troelsen
tine
g
k
jensen
jorgen
olsen
purpos
aim
investig
generegulatori
effect
region
express
lactasephlorizin
hydrolas
lph
thu
function
connect
cisel
low
lactas
express
seen
aduhtyp
hypolactasia
method
recent
studi
shown
tc
nucleotid
polymorph
posit
upstream
factas
gene
associ
aduhtyp
hypolactasia
lactas
nonpersist
variant
analys
generegnlatori
activ
gener
seri
human
lph
promot
report
gene
construct
contain
bp
fragment
variant
construct
transfect
intestin
cell
line
analyz
report
gene
express
transcript
factor
hnflee
known
involv
lph
express
overexpress
order
analyz
import
geueregnlatori
activ
region
bind
nuclear
factor
region
analyz
electropboret
mobil
shift
assay
emsa
super
shift
assay
use
nuclear
extract
sequenc
bind
intestin
nuclear
factor
region
surround
posit
identifi
dnase
footprint
result
transfect
experi
reveal
region
strong
transcript
enhanc
variant
lactas
persist
four
time
activ
variant
lactas
nonpersist
shown
transcript
factor
hnflot
stimul
enhanc
activ
nuclear
factor
extract
bind
strongli
variant
wherea
bind
variant
much
weaker
four
footprint
identifi
region
surround
posit
one
ootprint
cover
posit
also
footprint
put
site
detect
emsa
supershift
assay
verifi
footptint
region
abl
bind
intestin
transcript
factor
conclus
bind
nuclear
factor
c
variant
correl
differ
generegulatori
activ
support
notion
tc
polymorph
causal
adulttyp
hypolactasia
region
surround
posit
furthermor
contain
bind
site
intestin
transcript
factor
indic
sever
transcript
factor
bind
region
necessari
observ
enhanc
activ
vivo
character
tempor
control
region
lactas
gene
promot
eric
sibley
xiaoyong
cai
charalambo
maravelia
yanhong
li
background
aim
lactas
gene
transcript
maxim
prewean
mammal
declin
markedli
upon
matur
previou
studi
transgen
mice
indic
fragment
factas
promot
direct
appropri
matur
declin
report
express
small
intestin
aim
character
region
lactas
promot
involv
mediat
tempor
express
lactas
gene
method
transgen
mice
harbor
fragment
flank
region
rat
actas
gene
clone
upstream
firefli
fuciferas
report
screen
transgen
express
vivo
photon
detect
intensifi
chargecoupl
devic
iccd
camera
transgen
express
quantifi
luciferas
assay
tissu
homogen
rtpcr
total
rna
isol
distinct
midjejun
segment
harvest
preand
postwean
transgen
mice
result
postwean
offspr
factas
promoterreport
transgeinc
line
undergo
declin
luciferas
report
gene
express
compar
express
level
prewean
offspr
matur
declin
express
promot
transgen
compar
endogen
lactas
gene
contrast
postwean
offspr
lactas
promoterreport
transgen
line
undergo
lofold
induct
luciferas
express
compar
level
prewean
offspr
induct
express
lactas
promot
transgeu
compar
endogen
sucraseisomahas
trehalas
digest
hydrolas
gene
proxim
bp
promot
sequenc
lactas
sucraseisomaltas
gene
contain
similar
dna
bind
site
intestinespecif
transcript
factor
conclus
fragment
lactas
promot
direct
similar
spatial
express
pattern
small
intestin
transgen
mice
howev
tempor
pattern
express
mediat
promot
fragment
contrast
fragment
endogen
factas
promot
result
suggest
key
tempor
control
element
involv
mediat
postwean
matur
declin
lactas
express
resid
bp
region
kb
kb
upstream
lactas
transcript
startsit
delet
matur
declin
control
region
lactas
gene
yield
proxim
promot
induc
upon
wean
similar
promot
intestinespecif
digest
hydrolas
gene
mutant
defect
bind
transcript
cooper
hnfla
theodor
simon
joyc
k
divin
lora
j
staloch
christoph
w
rowley
hnfla
transcript
factor
critic
express
gene
involv
hepat
lipid
metabol
includ
rat
liver
fatti
acid
bind
protein
gene
fabpl
determin
fabpl
contain
adjac
bind
site
factor
proxim
promot
haploinsuffici
result
disord
hepat
lipid
metabol
well
matur
onset
diabet
young
type
singl
amino
acid
chang
also
result
found
two
point
mutant
retain
near
wildtyp
abil
transactiv
fabpl
transgen
cultur
cell
open
question
mutant
result
diseas
hnfllx
exhibit
mark
function
cooper
fabpl
tmnsgene
activ
similar
cooper
observ
two
factor
activ
hepat
gene
howev
two
mutant
complet
lack
function
cooper
hnfla
furthermor
hnf
la
bound
solut
two
hnf
mutant
exhibit
decreas
absent
bind
hnf
lcc
result
suggest
one
mechan
mutat
result
defect
hepat
lipid
metabol
loss
cooper
hnf
lcx
identif
novel
gene
aberr
methyl
hepatoma
cell
tetsuhiro
chiba
osamu
yokosuka
kenichi
fukai
motohisa
tada
yuichi
hirasawa
fumio
imazeki
hiromitsu
saisho
transcript
silenc
f
tumor
suppressor
mismatch
repair
gene
due
hypermethyl
island
play
import
role
carcinogenesi
previous
demonstr
gene
includ
hepatocyt
growth
factor
activ
inhibitor
bikunin
show
particularli
high
substanti
induct
chang
treatment
multipl
hepatoma
cell
use
cdna
microarray
fukai
et
al
cancer
re
press
studi
examin
methyl
statu
island
gene
except
estim
associ
aberr
methyl
level
acetyl
histon
among
gene
name
ecadhefin
collagen
type
insulinlik
growth
factor
bind
protein
connect
tissu
growth
factor
ctgf
fibronectin
exhibit
methyl
island
multipl
hepatoma
cell
line
base
bisulfit
genom
sequenc
also
analyz
methyl
statu
primari
hepatoma
tissu
sever
gene
show
aberr
methyl
island
hepatoma
cell
line
chromatin
immunoprecipit
chip
assay
use
antiacetyl
histon
antibodi
show
dna
methyl
histon
deacetyl
cooper
gene
silenc
gene
except
fn
studi
primari
hepatoma
tissu
use
methylationspecif
pcr
mspcr
methyl
signal
ctgf
detect
patient
respect
although
methyl
signal
observ
normal
liver
tissu
sampl
aberr
methyl
gene
gener
tend
observ
frequent
advanc
stage
chronic
liver
damag
conclus
show
linkag
dna
methyf
histon
deacetyl
regul
gene
express
identifi
novel
methyl
gene
hepatoma
cell
line
ie
ctgf
microarray
base
strategi
result
mspcr
suggest
might
involv
hepatocarcinogenesi
also
suggest
gene
would
target
dna
methyltransferas
inhibitor
suggest
might
natur
occur
domin
neg
regul
sensori
combin
treatment
hdac
inhibitor
neuron
code
noxiou
stimuli
class
hdac
result
transactiv
lap
gene
seen
tr
presenc
al
fold
fold
hdac
alon
effect
basal
lap
gene
activ
howev
presenc
hdac
inhibit
lap
gene
activ
vari
degre
depend
upon
specif
hdac
tr
studi
potent
inhibitor
inhibit
lap
activ
induc
either
trod
tri
caus
approxim
inhibit
lap
activ
induc
either
tr
contrast
hdac
famili
member
minim
effect
lap
gene
activ
inhibit
furthermor
absenc
ligandindepend
repress
mediat
trcd
tr
larg
block
hdac
famili
member
conclus
among
variou
mammalian
hdac
appear
play
major
role
context
thyroid
hormon
activ
lap
gene
hongzhen
hu
chunbo
wang
craig
k
colton
michael
zhu
jacki
wood
transient
receptor
potenti
vandloid
also
known
vanilloid
receptor
found
member
vainfloid
type
trp
superfamili
nonselect
cation
channel
noxiou
heat
acid
alkaloid
irrit
sever
endogen
ligand
activ
channel
asid
role
sensori
code
noxiou
stimuli
sensit
inflammatori
mediat
underli
signal
brain
inflammatori
patholog
bodili
organ
properti
rat
human
cdna
known
wherea
cdna
mous
character
report
molecular
clone
two
cdna
variant
dorsal
root
ganglia
mice
deduc
protein
design
trpvla
contain
amino
acid
respect
aris
altern
intron
recognit
signal
within
exon
gene
use
rtpcr
coupl
southern
hybrid
show
predomin
express
trpvla
sever
tissu
signific
express
trpvllb
dorsal
root
ganglia
skin
stomach
tongu
express
cell
xenopu
oocyt
trpvla
form
calcium
permeabl
channel
activ
ligand
known
stimul
trpvi
function
nevertheless
coexpressinn
inhibit
function
trpvla
found
concatem
least
two
subuint
requir
domin
neg
effect
subunit
channel
data
transcript
profil
erika
whitney
vincent
w
yang
iv
background
krppeldik
factor
also
known
gutenrich
kruppelfik
factor
gklf
shown
exert
checkpoint
function
phase
cell
cycl
mechan
exert
effect
incomplet
understood
aim
identifi
mechan
regul
cell
cycl
use
microarraybas
transcript
profil
method
cell
system
establish
human
colon
cell
line
rko
express
control
induc
promot
respond
insect
hormon
analogu
ponasteron
pa
chen
et
al
j
mol
bioi
total
rna
extract
cell
treat
pa
vehicl
ethanol
hr
hybrid
affymetrix
chip
data
normal
hr
untreat
control
analyz
use
genespr
analysi
softwar
express
profil
time
period
use
identifi
gene
either
posit
neg
correl
studi
examin
gene
known
function
cell
cycl
control
use
gene
tree
cluster
result
level
began
increas
hr
follow
addit
pa
continu
increas
hr
foldchang
rel
control
hr
respect
select
gene
involv
cell
cycl
regul
analysi
group
posit
correl
neg
correl
express
profil
exampl
upregnl
gene
includ
transcript
factor
tumor
suppressor
plag
cell
cycl
inhibitor
cull
exampl
downregul
gene
includ
function
cell
cycl
progress
mcm
promot
mani
gene
group
contain
gcrich
bind
site
resembl
bind
sequenc
conclus
posit
regul
express
mani
gene
function
inhibitor
cell
cycl
neg
regul
express
anoth
group
promot
cell
cycl
result
studi
valid
checkpoint
function
recent
shown
tumor
suppressor
colorect
cancer
zhao
et
al
oncogen
studi
also
indic
potenti
direct
transcript
regul
mani
target
gene
due
presenc
gcrich
sequenc
element
promot
gene
purpos
purpos
identifi
promot
element
common
gene
express
small
intestin
crypt
villi
respect
method
pure
ileal
villi
crypt
prepar
obtain
eleven
week
old
mice
use
publish
procedur
rna
extract
use
prepar
biotin
label
crna
follow
hybrid
affymetrix
mous
genechip
promot
gene
refseq
databas
extract
mous
genom
sequenc
form
background
set
promot
subset
promot
control
gene
display
four
fold
differ
express
level
crypt
villi
also
defin
cisel
overrepres
crypt
villu
subset
promot
compar
background
promot
set
identifi
use
newli
develop
algorithm
http
wwwcstauacilrshamirprimaprimahtm
result
comparison
crypt
villu
express
pattern
predict
dnaarray
analysi
conform
well
result
situ
hybrid
previous
present
literatur
analysi
promot
structur
gene
specif
crypt
villu
express
respect
reveal
overrepresent
p
cell
cycl
relat
cisel
nfi
mycmax
cryptspeinf
promot
wherea
villusspecif
promot
overrepresentarion
cisel
cell
factor
tcflef
p
interferon
regulatori
factor
p
hepatoeyt
nuclear
factor
p
activ
protein
lapl
p
p
conclus
result
demonstr
clear
relationship
intestin
cellular
function
promot
structur
activ
gene
activ
promot
profil
crypt
compart
character
presenc
cisel
known
control
cellcycl
regul
gene
promot
activ
villu
compart
overrepres
eisel
reflect
signal
wncoetacatenin
map
kinas
lapl
tgfbeta
signal
patwhay
addit
cellular
specialis
apolipoprotein
hydrolas
product
reflect
overrepresent
cisel
prior
studi
demonstr
ghicocorticoid
hormon
elicit
function
matur
small
intestin
evidenc
abil
elicit
dramat
increas
express
variou
digest
hydrolas
sucraseisomaltas
trehalas
howev
mrna
gene
display
slow
increas
follow
ghicocorticoid
administr
first
detect
hr
thu
hypothes
function
matur
secondari
effect
result
one
immedi
earli
gene
glucocorticoid
action
develop
intestin
method
identifi
primari
respons
gene
perform
microarray
analysi
pool
rna
jejunum
untreat
postnat
day
mous
pup
litterm
receiv
dexamethason
hr
ahead
fluoresc
dyefabel
sampl
hybrid
quadrupl
glass
spot
cdna
micmarray
contain
cdna
clone
nation
institut
age
dna
clone
set
manufactur
baylor
microarray
core
facil
result
data
analysi
ils
rel
stringent
criteria
identifi
total
mrna
significantli
upregnl
significantli
downregul
hr
glucocorticoid
treatment
amongst
upregul
mrna
magnitud
increas
detect
microarray
rang
select
mrna
throughout
rang
subsequ
analyz
northern
blot
mrna
chosen
detect
northern
blot
confirm
upregnl
dexamethason
gener
strong
correl
magnitud
increas
observ
microarray
analysi
northern
blot
addit
time
point
show
although
mrna
increas
detect
hr
peak
hr
return
baselin
hr
gene
ontolog
analysi
show
preponder
gene
known
involv
prolifer
apoptosi
differenti
conclus
gene
differentiadon
categori
like
candid
mediat
glucocorticoidinduc
matur
intestin
function
work
support
grant
nih
analysi
gene
express
pattern
duodenum
iron
defici
rat
jame
f
collin
christina
cum
monica
kiela
eric
r
hine
fayez
k
ghishan
express
mani
recent
identifi
gene
involv
intestin
iron
transport
known
induc
irondefici
thu
identifi
novel
gene
involv
import
physiolog
process
perform
compar
gene
chip
studi
irondefici
rat
day
day
week
irondefici
anemia
induc
rat
dietari
iron
restrict
proxim
duoden
mucosa
harvest
rna
purif
biotinyl
crna
produc
hybrid
rat
genom
gene
chip
affymetrix
chip
wash
scan
standard
protocol
experi
repeat
three
time
age
differ
group
rat
result
data
analyz
dmt
softwar
affymetrix
nine
comparison
perform
data
age
wherebi
three
high
iron
data
set
compar
three
low
iron
data
set
sybr
green
realtim
pcr
use
confirm
chang
gene
express
seen
chip
sever
gene
interest
result
demonstr
gene
known
involv
transepitheli
iron
transport
show
increas
express
age
studi
eg
dival
metal
ion
transport
duoden
cytochrom
transferrin
receptor
howev
iron
transport
gene
show
chang
express
anemia
age
eg
hephaestin
old
mice
note
upregul
arnphiregulin
downregul
trefoil
factor
doldrat
observ
upregulatinn
mhc
class
la
gene
downregul
disabl
homolog
lgg
receptor
fcrn
sucraseisomahas
novel
observ
includ
strong
upregul
aquaporin
wk
wk
prolifer
cell
nuclear
antigen
also
note
age
signific
downregul
type
lib
sodiumphosph
cotransport
napiiib
perhap
interest
upregnl
enterocytespecif
basolater
copper
atpas
wk
wk
hypothes
absenc
dietari
iron
transport
copper
cell
lead
upregnl
atpta
thu
comprehens
seri
experi
describ
novel
chang
gene
express
proxim
duodenum
irondefici
rat
identifi
potenti
novel
gene
involv
intestin
iron
absorpt
microarraybas
express
profil
embryon
intestin
mathl
null
mice
noah
f
shroyer
huda
zoghbi
background
mous
aton
homolog
bhlh
transcript
factor
requir
develop
secretori
lineag
intestin
addit
neuron
defect
null
mice
lack
enteroendocrin
goblet
paneth
cell
aim
studi
identifi
gene
express
intestin
secretori
ceil
import
develop
intestin
epithelium
method
rna
embryon
day
intestin
purifi
heterozyg
embryo
triplic
pool
rna
embryo
use
interrog
affymetrix
genechip
mg
genespr
dchip
softwar
program
use
identifi
gene
fold
chang
rna
pool
statist
analysi
result
compar
express
profil
previous
gener
cdna
array
northern
blot
realrim
rtpcr
individu
gene
use
valid
differ
identifi
express
profil
result
genechip
comparison
intestin
identifi
gene
show
fold
chang
gene
total
gene
includ
group
secretori
cell
specif
gene
secretin
cryptdin
gene
chang
least
fold
either
intestin
comparison
group
identifi
gene
appear
development
regul
misexpress
mathl
intestin
subset
gene
gobletspecif
gene
analyz
northern
blot
andor
realtim
rtpcr
comparison
cenechip
profil
nia
cdna
array
identifi
addit
gene
signific
chang
use
confirm
genechipderiv
profil
conclus
express
profil
mathl
intestin
identifi
aberr
express
mathl
mutant
intestin
secretori
cell
specif
gene
gene
express
differenti
cell
crypt
comparison
two
embryon
stage
identifi
rnani
genet
differ
intestin
use
defin
genet
program
intestin
develop
assess
express
statu
gene
known
import
intestin
epitheli
differenti
show
gene
minim
chang
eg
mark
chang
eg
pdxl
analysi
allow
tent
placement
mathl
genet
hierarchi
intestin
ontogeni
gene
express
profil
provid
uniqu
opportun
gain
insight
develop
differ
type
gastric
cancer
tumor
sampl
heterogen
thought
decreas
sensit
tumor
specif
microarray
analysi
thu
microdissect
preamplif
rna
frequent
perform
howev
techniqu
may
also
induc
consider
chang
express
profil
object
measur
variat
gene
express
within
gastric
cancer
sampl
perform
gene
chip
analysi
two
rna
prepar
extract
tumor
specimen
method
five
gastric
cancer
origin
either
gastroesophag
junction
distal
stomach
match
nodular
involv
n
patholog
grade
tumor
classifi
intestin
patholog
tumor
sampl
dissect
liquid
nitrogen
rna
prepar
two
separ
tumor
fragment
extract
individu
process
hybrid
affymetrix
gene
chip
contain
probe
set
approx
human
gene
transcript
express
profil
analyz
use
microarray
suit
mfymetrix
genespr
silicon
genet
result
gastric
cancer
show
littl
varianc
express
profil
differ
region
tumor
sampl
case
gene
chip
display
mean
pairwis
correl
coeffici
compar
valu
differ
tumor
sampl
express
varianc
two
express
profil
percentag
total
chang
affymetrix
reveal
remark
low
averag
valu
compar
fragment
tumor
sampl
result
agreement
data
obtain
microarray
experi
use
rna
prepar
ident
cell
cultur
conclus
found
surprisingli
low
degre
express
profil
variabl
within
gastric
tumor
sampl
data
suggest
tissu
heterogen
domin
sourc
error
microarray
analysi
larger
tumor
sampl
make
total
rna
extract
appropri
strategi
perform
gene
chip
express
profil
gastric
cancer
ongo
studi
compar
qualiti
gene
express
profil
deriv
total
rna
extract
gener
laser
microdissect
preampfif
gastric
cancer
tissu
investig
error
induc
detail
express
profil
gastric
cancer
sampl
oligonucleotid
microarray
analysi
reveal
low
neurotensni
nt
gastrointestin
gi
hormon
bind
receptor
ntr
regul
prolifer
normal
neoplast
intestin
cell
molecular
mechan
remain
larg
undefin
matrix
metalloproteinas
mmp
report
play
critic
role
endotheli
cell
migrat
matrix
remodel
angiogen
process
among
mmp
membranetyp
import
molecul
trigger
invas
tumor
cell
purpos
studi
identifi
whether
express
regul
nt
use
human
colon
cancer
cefi
line
human
pancreat
cancer
cell
line
mia
possess
highaffin
ntr
method
mia
cell
incub
serumfre
medium
treatment
cell
treat
nt
h
total
rna
extract
assess
express
use
rnase
protect
assay
determin
signal
pathway
involv
nt
mediat
effect
cell
pretreat
rain
mek
inhibitor
ii
inhibitor
wortmannin
iii
inhibitor
iv
variou
pkc
inhibitor
protein
extract
analyz
western
express
result
nt
promot
timedepend
induct
mrna
express
without
affect
express
mmp
cell
ntmediat
protein
induct
block
inhibit
convent
novel
pkc
partial
inhibit
inhibitor
wortmannin
inhibit
convent
pkc
suggest
predomin
role
certain
pkc
isoform
map
kinas
induct
nt
conclus
importantli
result
demonstr
first
time
induct
gut
hormon
nt
signal
pathway
involv
activ
pkc
map
kinas
delin
signal
transduct
mechan
regul
cellular
effect
nt
provid
import
insight
molecular
pathway
respons
ntmediat
effect
normal
neoplast
cell
associ
hpylori
age
sex
site
duke
stage
grade
turnout
elev
plasma
progastrin
level
plasma
progastrin
marker
turnout
recurr
low
sensit
ci
high
specif
ci
liver
metastas
also
elev
patient
high
plasma
progastrin
remov
primari
tumour
associ
decreas
postop
plasma
progastrin
level
chang
plasma
pmgastrin
level
follow
resect
liver
metastas
colorect
cancer
conclus
risk
recurr
time
greater
elev
plasma
progastrin
level
plasma
progastrin
marker
tumour
recurr
low
sensit
high
specif
role
plasma
progastrin
level
patient
undergo
resect
primari
metastat
liver
diseas
need
investig
assay
increas
sensit
larger
group
patient
biopsi
sampl
phosphoryl
pkbakt
shown
higher
p
pair
conclus
exogen
gastrin
via
upregul
pkbakt
phosphoryl
oesophag
cell
endogen
gastrin
may
contribut
basal
pkbakt
phosphoryl
degrad
downstream
target
ikbcc
level
gastrn
express
increas
develop
potenti
explain
increas
activ
pkb
akt
find
suggest
role
gastrni
progress
oesophag
adenocarcinoma
pkbakt
activ
ikba
degrad
subsequ
inhibit
apoptosi
michael
blaeker
michael
schmitz
sylvia
burghardt
heiner
greten
andrea
de
weerth
background
somatostaim
sm
analogu
inhibit
cell
prolifer
stimul
distinct
somatostatin
receptor
sstr
date
five
receptor
subtyp
known
sm
analogu
current
clinic
use
exhibit
high
affin
moder
affin
low
affin
recent
year
compound
introduc
therapi
advanc
inoper
hepatocellular
carcinoma
hcc
efficaci
treatment
debat
due
controversi
result
clinic
trial
compar
consider
number
patient
treat
sm
analogu
littl
known
express
sstr
subtyp
hcc
aim
studi
therefor
systemat
analyz
incid
sstr
tumor
method
hcc
investig
immunohistochemistri
use
sstr
subtyp
specif
antibodi
pancreat
islet
shown
express
five
sstr
use
posit
control
specif
neg
control
primari
antibodi
preabsorb
use
antigen
result
expresson
sstr
subtyp
visual
pancreat
islet
contrast
hcc
display
high
variabl
express
pattern
well
express
level
sstr
nine
differ
express
pattern
identifi
commonli
express
receptor
subtyp
investig
hcc
follow
none
tumor
express
receptor
express
correl
histopatholog
paramet
tumor
stage
underli
liver
diseas
discuss
differ
receptor
express
might
influenc
clinic
respons
treatment
sm
analogu
might
least
part
explain
controversi
find
clinic
trial
patient
hcc
low
incid
hcc
impli
patient
adequ
respond
therapi
current
sm
analogu
hand
commonli
express
might
serv
target
novel
ligand
preferenti
affin
receptor
subtyp
cell
growth
activ
phosphatidylinositol
pathway
jingbo
qiao
junghe
kang
b
mark
ever
dai
h
chang
previous
shown
neuroblastoma
nb
express
gastrinreleas
peptid
grp
advancedstag
tumor
express
increas
level
receptor
grpr
also
shown
grp
stimul
nb
cell
growth
howev
exact
role
grpr
regul
nb
cell
growth
unknown
therefor
purpos
studi
determin
whether
upregul
grpr
alon
stimul
nb
cell
growth
discern
molecular
mechan
involv
process
method
neuroblastoma
cell
line
sknsh
c
use
experi
establish
grpr
stabl
express
neuroblastoma
cell
line
transfect
human
grpr
cdna
insert
ntermini
gfp
pegfp
express
vector
observ
immunofiuoresc
microscopi
western
blot
receptor
bind
assay
cell
plate
plate
rpmi
eb
count
day
cell
growth
presenc
variou
kinas
inhibitor
lmmunoblot
also
perform
use
specif
phosakt
phosrb
antibodi
grp
peptid
secret
media
measur
ria
result
nb
cell
grpr
transfect
confirm
immunofluoresc
western
blot
nearli
increas
grpr
bind
capac
note
grpr
overexpressnig
cell
compar
gfp
vector
alon
cell
overexpress
grpr
without
exogen
grp
treatment
demonstr
signific
constitut
increas
ceil
growth
day
treatment
inhibitor
attenu
growth
grpr
transfect
cell
howev
inhibitori
effect
seen
inhibitor
mek
grpr
transfect
ceil
show
constitut
higher
express
pakt
prb
grp
secret
media
significantli
differ
grpr
transfect
control
ceil
ngml
vs
ng
ml
hr
conclus
data
demonstr
increas
grpr
bind
capac
result
promot
nb
cell
growth
without
alter
grp
secret
suggest
import
role
grpr
regul
nb
cell
growth
addit
crucial
pathway
involv
grpmediat
stimul
nb
cell
growth
vitro
model
provid
valuabl
tool
identifi
molecular
mechan
involv
grpiuduc
tumor
progress
neuroblastoma
develop
potenti
novel
therapi
backgroundaim
amid
gastrin
releas
peptid
grp
identifi
autoctin
growth
factor
small
cell
lung
cancer
role
develop
progress
colorect
carcinoma
less
clear
addit
biolog
activ
nonamid
grp
investig
therefor
aim
determin
whether
bombesin
mammalian
homologn
grp
amid
nonamid
grp
stimul
prolifer
migrat
human
colorect
carcinoma
cell
line
whether
gastrinreleas
peptid
receptor
grpr
antagonist
inhibit
effect
method
cell
prolifer
measur
mtt
colorimett
assay
assay
cell
migrat
use
woundheal
model
express
grp
receptor
grpr
rtpcr
activ
mitogenactiv
protein
kinas
mapk
focal
adhes
kinas
fak
measur
westernblot
product
inositol
phosphat
measur
use
phosphoryl
result
treatment
either
bombesin
amid
nonamid
grp
result
signific
increas
prolifer
migrat
woundheal
assay
mitogen
migratori
effect
amid
nonamid
form
inhibit
grp
receptor
antagonist
desmet
presenc
grp
receptor
mrna
four
colorect
carcinoma
cell
line
demonstr
transfect
cell
domin
neg
phosphatidylinositol
affect
bombesnistimul
cell
prolifer
inhibit
bombesinstimul
cell
migrat
bombesin
grpgiy
activ
phospholipas
c
caus
earli
transient
phosphoryl
mapk
fak
conclus
conclud
amid
nonamid
form
grp
acceler
prolifer
migrat
dldi
human
colorect
cancer
ceil
via
grpr
phosphatidylinositol
involv
ceil
migrat
signal
pathway
result
suggest
potenti
role
grpr
antagonist
manag
colorect
cancer
receptor
splice
variant
retain
lntron
mediat
gastrinlnduc
background
enhanc
express
gene
report
colorect
cancer
pharmacolog
inhibit
cox
enzym
associ
decreas
risk
colon
cancer
polyp
format
recent
splice
variant
receptor
frame
insert
unspfic
intron
clone
human
colon
cancer
postul
exhibit
enhanc
growthpromot
effect
howev
role
role
mediat
carcinogen
eftect
matureamid
gastrin
colorect
cancer
fulli
explor
aim
aim
present
studi
determin
whether
mediat
overexpress
gene
human
colon
cancer
cell
upon
stimul
gastrin
method
ceil
transfect
human
wild
type
stimul
gastrin
transactiv
promot
determin
luciferas
report
gene
assay
promot
transfect
co
wt
cell
narrow
gastrinrespons
regulatori
element
induct
express
explor
mrna
protein
level
use
real
time
rtpcr
western
blot
prostagfandin
secret
measur
elisa
result
gastrin
stimul
secret
well
mrna
express
cell
express
wild
type
gastrirl
also
potent
transactiv
bp
promotor
uciferas
report
gene
timeand
concentrationdepend
manner
maxim
gastrin
respons
observ
upon
stimul
nm
gastrin
h
incub
analysi
promot
reveal
proxim
promotor
sequenc
span
bp
essenti
gastrininduc
transcript
inhibit
jnk
pathway
reveal
three
signal
pathway
requir
full
transactiv
gene
gastrin
conclus
effect
gastrin
gene
mediat
activ
observ
provid
model
mutant
gastrin
receptor
influenc
pathogenesi
colorect
cancer
cecil
perrault
sarah
glover
ethan
sherman
roger
transontay
richard
v
benya
background
grp
receptor
grpr
normal
express
epitheli
cell
line
adult
colon
aberrantli
upregul
colon
cancer
protein
act
morphogen
promot
assumpt
better
differenti
phenotyp
retard
metastasi
abil
activ
fak
metastas
liver
tumor
cell
must
elud
immunolog
surveil
around
hepat
sinnsoid
yet
noth
known
kinet
tumor
ceil
transit
particular
vascular
space
serumand
proteinfre
condit
thu
aim
studi
employ
comput
chip
design
ie
microfabr
technolog
order
creat
transluc
synthet
sinnsoid
allow
cell
transit
evalu
function
grpinduc
fak
activ
method
photomask
templat
channel
possess
endothdi
surfac
pattern
transfer
silicon
wafer
photolithographi
microchannel
diamet
long
connect
inletoutlet
reservoir
mm
apart
sinusoid
shear
stress
dyne
crn
gener
use
doubl
syring
pump
ceil
record
realtim
use
soni
hire
video
camera
allow
transit
number
transit
time
calcul
evalu
studi
grpinduc
fak
activ
cell
behavior
studi
ceil
nativ
express
grpr
cell
manipul
induc
express
frnk
domin
neg
regul
fak
control
teton
promot
j
cell
physiol
press
result
cell
expos
grp
activ
fak
abl
transit
micwchannel
constant
shear
stress
transit
took
ms
travers
ltrn
distanc
contrast
frnk
upregul
permit
cell
transit
micmchannel
less
ms
conclus
grp
bind
receptor
caus
fak
becom
activ
result
cell
becom
less
abl
transit
nticrochannel
design
mimic
hepat
sinnsoid
cell
would
suscept
target
destruct
immunolog
cell
known
resid
space
would
decreas
propens
success
metastas
liver
find
suggest
grpigrpr
inactiv
colon
cancer
may
predispos
tumor
cell
metastas
huip
zhou
kamam
murthi
smooth
muscl
gut
express
mainli
vpacz
receptor
coupl
via
g
stimul
camp
activ
campdepend
protein
kinas
pka
previous
shown
receptor
phosphoryl
mediat
g
protein
coupl
receptor
arid
activ
enhanc
via
select
phosphoryl
pka
aim
character
effect
pkainduc
phosphoryl
desensit
intern
recycl
receptor
smooth
muscl
cell
method
studi
done
cultur
gastric
muscl
cell
express
wildtyp
kinaseinact
arid
pka
pbosphorylationsit
defici
receptor
intern
recycl
measur
radioligand
bind
receptor
biotinyl
receptor
desensit
measur
decreas
camp
format
respons
vip
receptor
phosphoryl
measur
immunoprecipit
specif
vpac
antibodi
cell
label
result
receptor
phosphoryl
intern
follow
similar
time
cours
maxim
within
rain
receptor
phosphoryl
intern
absent
muscl
cell
express
kinasedefici
impli
receptor
phosphoryl
intern
exclus
mediat
receptor
partli
phosphoryl
cell
express
pka
phosphoryfationsit
defici
impli
phosphoryl
pka
augment
activ
receptor
phosphoryl
receptor
intern
determin
residu
bind
receptor
biotinyf
exposur
vip
greatli
diminish
ceil
express
pkasit
defici
similarli
receptor
recycl
determin
recoveri
mivip
bind
receptor
biotinyl
treatment
vip
diminish
cell
express
pkasit
defici
final
function
receptor
desensit
determin
decreas
camp
respons
exposur
vip
also
significantli
diminish
cell
express
pleasit
defici
conclus
receptor
phnsphoryl
mediat
phosphoryl
pka
greatli
enhanc
activ
abil
induc
receptor
phosphoryl
intern
desensit
interact
extracellular
matrix
ecm
molecul
adhes
receptor
muscl
contribut
tensil
strength
arid
contractil
prior
work
suggest
ligand
type
receptor
cluster
insideout
signal
might
regul
adhes
postul
adhes
forc
might
also
determin
mechan
membran
receptor
anchor
method
assay
forc
associ
singl
adhes
bond
involv
ecm
molecul
faminin
laminin
receptor
dystrnglycan
dg
surfac
live
myoblast
use
highresolut
forc
spectroscopi
dg
receptor
express
assay
immunofluoresc
electron
microscopi
cell
adhes
collagen
fibronectin
laminin
assay
mn
attach
assay
result
adhes
greater
laminin
compar
collagen
fibronectin
wherea
immunofluoresc
electron
microscopi
demonstr
dg
cluster
configur
cell
surfac
respons
laminin
evalu
laminindg
bond
forc
spectroscopi
forc
distanc
curv
separ
experi
reveal
two
mechan
domain
membran
bond
detach
rim
membran
deform
smaller
magnitud
pn
bond
detach
nm
membran
deform
significantli
greater
pn
p
sinc
receptor
express
cluster
relat
cytoskeleta
attach
elect
modifi
membran
mechan
variat
dg
receptor
express
stabli
transfect
wild
type
myoblast
antisens
dg
express
construct
yield
clone
l
reduct
dg
surfac
express
compar
wild
type
ceil
lle
ceil
demonstr
significantli
less
whole
cell
adhes
laminin
less
frequent
smaller
dg
cluster
respons
faminin
increas
stretch
cantilev
retract
forc
spectroscopi
determin
reduc
adhes
lie
cell
laminin
due
select
elimin
bond
occur
low
deform
membran
domain
conclus
dg
laminin
receptor
express
surfac
myoblast
forc
associ
singl
faminindg
bond
vari
bond
rate
mechan
load
factor
predict
degre
membran
deform
propos
tether
receptor
cluster
cytoskeleton
dynam
regul
ecmreceptor
adhes
forc
muscl
aga
abstract
mechan
downregul
neurokinin
receptor
signal
graem
cottrel
eileen
f
gradi
nigel
w
bunnett
shortterm
exposur
cell
substanc
p
sp
induc
desensit
neurokinini
receptor
follow
receptor
endocytosi
recycl
welldefin
mechan
howev
mechan
downregul
longterm
exposur
sp
subsequ
recoveri
respons
investig
aim
investig
effect
hingterm
exposur
cell
sp
signal
traffick
method
studi
nkirtransfect
knrk
cell
examin
effect
chronic
exposur
sp
ca
signal
measur
local
determin
immunofluoresc
confoc
microscopi
nkir
ubiquitin
determin
immunoprecipit
western
blot
result
incub
cell
sp
nm
hour
abolish
sp
induc
ca
mobil
remov
agonist
recov
within
hour
recoveri
signal
prevent
cycloheximid
p
epoxomicin
thu
depend
new
protein
synthesi
proteolyt
activ
proteasom
respect
chronic
exposur
sp
induc
redistribut
plasma
membran
intracelhilar
locat
found
earli
endosom
coloc
ysosom
marker
immunoprecipit
immunoblot
ubiqintin
observ
continu
exposur
sp
hour
induc
format
ubiquitinnkir
contain
complex
determin
whether
chronic
sp
exposur
induc
ubiquitln
associ
protein
mutat
five
lysin
residu
ctermin
taft
arginin
mutant
receptor
express
cellsurfac
signal
normal
mobil
caz
internahz
sp
chronic
exposur
sf
still
result
format
ubiquitinnkir
contain
complex
similar
manner
wildtyp
receptor
howev
sp
exposur
ceil
express
mutant
receptor
observ
recov
signal
recoveri
period
hour
addit
mutant
ten
intracellular
lysin
residu
mutat
recov
signal
hour
conclus
chronic
exposur
cell
sp
downregnl
signal
nkir
associ
receptor
ubiquitin
recoveri
downregul
depend
ubiquitin
state
receptor
support
background
aim
ghrefin
gastrointestin
peptid
report
augment
neuropeptidey
npi
gene
express
hypothalamu
increas
food
intak
report
enhanc
plasma
ghrelin
level
rat
streptozotocininduc
diabet
exhibit
low
bodi
weight
hyperphagia
feb
lett
hand
nitric
oxid
synthas
inhibit
nnitrolarginin
methyl
ester
lname
decreas
daili
food
intak
bodi
weight
mice
life
sci
recent
report
nosynthes
neuron
express
npi
receptor
present
hypothalamu
j
neuroendocrinol
present
studi
design
investig
effect
suppress
ghrelin
dynam
method
lname
mgkgbodi
administ
subcutan
weekold
male
wistar
rat
seven
day
later
rat
examin
food
depriv
plasma
gastric
ghrelin
level
measur
radioimmunoassay
preproghrefin
mrna
express
measur
quantit
rtfcr
ghrelinimmunoreact
cell
stomach
evalu
immunohistochemistri
serum
leptin
level
measur
elisa
separ
experi
also
investig
effect
rat
administ
dname
treatment
result
lname
treat
rat
gastric
total
activ
ghrefin
level
gastric
preproghrelin
mrna
express
level
number
ghrelinimmunoreact
cell
stomach
show
signific
chang
compar
control
rat
daili
food
intak
bodi
weight
lname
treat
rat
decreas
significantli
compar
control
rat
plasma
total
fmolml
activ
ghrelin
level
rat
increas
significantli
compar
control
rat
fmolml
p
suggest
compensatori
increas
plasma
ghrefin
serum
leptin
level
lname
treat
rat
pgml
decreas
significantli
compar
control
rat
pgml
p
hand
dname
treatment
sigmficantli
chang
plasma
ghrelin
level
conclus
attenu
synthesi
daili
food
intak
decreas
significantli
gastric
ghrelin
secret
increas
significantli
thu
ghrelin
secret
might
show
compensatori
increas
offset
decreas
appetitestimulatori
signal
supernat
whole
cell
lysat
separ
reversephas
hplc
supemat
determin
elisa
bind
label
demonstr
use
histag
pparoverexpress
construct
result
stimul
primari
cec
homogen
without
caionophor
follow
format
high
amount
linoieic
acid
metabolit
ngml
decreas
secret
readout
cell
activ
pronounc
preincub
tnfa
stimul
control
compar
ppar
agonist
troglitazon
tnfa
stimul
comrol
pm
higher
known
pparligand
bind
assay
cell
lysat
overexpress
histag
ppar
clearli
demonstr
direct
interact
conclus
high
amount
induc
cec
stimul
linol
acid
metabol
bind
ppar
antiinflammatori
effect
therefor
dehydrogenas
might
cecspecif
therapeut
target
ulcer
coliti
extrapancreat
trypsin
iv
cleav
activ
proteaseactiv
receptor
par
graem
cottrel
silvia
amadesi
eileen
f
gradi
nigel
w
bunnett
certain
serin
proteas
signal
cell
cleav
activ
par
sinc
par
regul
hemostasi
inflamm
pain
heal
import
determin
agonist
receptor
howev
mani
tissu
proteas
activ
par
unknown
although
pancreat
trypsin
may
cleav
activ
par
small
intestin
pancrea
receptor
express
cell
normal
expos
pancreat
trypsin
aim
determin
whether
extrapancreat
form
trypsin
par
agonist
method
assess
express
par
trypsinogen
extrapancreat
cell
line
tissu
rtpcr
immunofluoresc
function
assay
clone
express
trypsinogen
determin
activ
par
express
knrk
cell
measur
ca
transient
result
epitheli
cell
line
prostat
colon
airway
human
colon
mucosa
express
mrna
encod
par
trypsinogen
iv
enteropeptidas
natur
activ
trypsinogen
immunoreact
trypsinogen
iv
detect
vesicl
cell
trypsinogen
iv
clone
cell
express
cho
cell
also
local
cytoplasm
vesicl
engan
trypsinogen
iv
ntermin
lgk
signal
peptid
direct
constitut
secret
allow
enzymat
character
enteropeptidas
treatment
condit
medium
reduc
appar
molecular
mass
trypsinogen
iv
kda
gener
enzymat
activ
consist
format
trypsin
iv
contrast
pancreat
trypsin
trypsin
iv
activ
unaffect
addit
polypeptid
inhibitor
soybean
trypsin
inhibitor
aprotinin
exposur
cell
line
express
fai
trypsin
iv
increas
ca
strongli
desensit
cell
subsequ
challeng
par
agonist
respons
cell
lack
receptor
conclus
trypsin
iv
potenti
agonist
extrapancreat
epitheli
tissu
resist
endogen
trypsin
inhibitor
may
permit
prolong
signal
support
biolog
activ
fragment
glycineextend
gastrin
hong
phil
shehau
kevin
bamham
raymond
norton
arthur
shulk
graham
baldwin
background
nonamid
gastnn
progastrin
glycineextend
gastrin
induc
prolifer
migrat
variou
cell
line
vitro
prolifer
colon
mucosa
vivo
earlier
nuclear
magnet
reson
nmr
studi
defin
tertiari
structur
zgpwlesaygwmdfg
show
ferric
ion
essenti
biolog
activ
first
bind
second
panneqinn
et
al
j
biol
chem
aim
studi
defin
minimum
biolog
activ
fragment
determin
whether
ferric
ion
requir
biolog
activ
method
fragment
g
contain
five
glutam
residu
lesayg
leay
esay
lesa
le
ea
es
investig
activ
measur
prolifer
wound
heal
assay
nontransform
gastric
epitheli
cell
line
requir
ferric
ion
activ
test
inclus
iron
chelat
desferrioxamin
assay
stoichiometri
affin
ferric
ion
bind
fragment
determin
absorpt
fluoresc
spectroscopi
respect
residu
involv
bind
defin
nmr
spectroscopi
result
cell
migrat
prolifer
studi
show
nonapeptid
lesayg
fulli
activ
activ
shorter
peptid
reduc
less
depend
presenc
ferric
ion
fluoresc
quench
experi
indic
peptid
bind
ferric
ion
affin
approxim
weaker
ggli
kd
nmr
result
show
truncat
peptid
defin
structur
prefer
iron
bind
site
differ
ggli
conclus
conclud
ntermin
tetrapeptid
ctermin
pentapeptid
requir
biolog
activ
homeobox
contain
gene
also
express
small
intestin
mucosa
shown
play
critic
role
pancreat
develop
express
pancreaticspecif
gene
includ
insulin
purpos
determin
role
regul
gip
express
intestin
kcell
method
immunohistochemistri
employ
evalu
express
gip
wild
type
wt
null
mutant
ko
mice
northern
blot
analysi
western
blot
analysi
immunocytochemistri
use
evalu
rna
protein
express
neuroendocrin
cell
line
electromobl
shift
assay
emsa
chromatin
immunoprecipit
assay
chip
specif
antibodi
employ
analyz
specif
dnaprotein
interact
gip
promot
result
coloc
gip
demonstr
mous
intestin
kcell
immunohistochem
comparison
wt
ko
day
dpc
mous
embryo
show
reduct
number
duoden
gipexpress
cell
absenc
express
addit
transcript
protein
found
cell
emsa
show
specif
bind
protein
cisregnlatori
region
btween
base
promot
final
use
chip
analysi
demonstr
vivo
bind
region
gip
promot
conclus
result
studi
indic
transcript
factor
pdxd
play
critic
role
cellspecif
express
gene
also
suggest
possibl
ontogen
link
gip
insulin
abdomin
surgeri
caus
periton
adhes
patient
peptid
substanc
p
sp
proinfiammatori
mediat
may
particip
local
inflammatori
respons
associ
adhes
format
previous
show
rat
model
sp
receptor
antagonist
spra
decreas
adhes
format
periton
tissu
contigu
adhes
spra
increas
mrna
level
tissu
plasminogen
activ
tpa
matrix
metafioproteinas
mmp
hr
postsurgeri
fibrinolyt
effect
tpa
prevent
adhes
evid
implic
mmp
regul
fibrinolyt
acttviti
aim
studi
determin
spra
administr
affect
periton
fibrinolyt
activ
vivo
sp
alter
express
tpa
mesotheli
cell
line
peritoneum
play
import
role
adhes
format
method
use
rat
model
adhes
format
surgeri
perform
rat
receiv
daili
ip
inject
ragkg
bid
spra
pfizer
receiv
salin
hr
postsurgeri
periton
fluid
collect
oper
anim
nonoper
control
assess
fibrinolyt
activ
fibrin
zymographi
addit
experi
perform
human
mesotheh
cell
line
evalu
role
sp
peritoneum
sp
nm
administ
cell
hr
media
collect
assess
activ
casein
zymographi
tpa
paid
tpa
inhibitor
mrna
level
analyz
semiquantit
rtpcr
result
zymographi
periton
fluid
show
band
lysi
determin
repres
free
tpa
tpa
bound
paid
clesteras
inhibitor
total
tpa
activ
periton
fluid
significantli
increas
surgeri
compar
nonoper
control
increas
p
spra
administr
cell
expos
sp
hr
tpa
mrna
express
decreas
p
effect
mrna
level
consist
previou
data
show
sp
decreas
mrna
level
cell
activ
decreas
p
media
hr
conclus
vivo
spra
data
support
hypothesi
sf
promot
adhes
format
inhibit
fibrinolyt
activ
periton
caviti
vitro
studi
suggest
effect
may
mediat
part
sp
reduct
tpa
periton
mesotheli
ceil
spl
regul
insulin
depend
neuron
no
express
nada
buhi
christoph
ferri
alter
nno
express
enter
nervou
system
link
human
gastrointestin
disord
diabet
gastropathi
previous
report
profound
reduct
pylor
nno
mrna
protein
express
function
diabet
mice
revers
insulin
treatment
jcl
regulatori
domain
mnrnie
nno
consist
multipl
altern
splice
tirst
exon
la
lb
lc
part
exon
upstream
translat
initi
site
previous
report
includ
major
promot
respons
calcium
pna
insulinrespons
mous
neuroblastoma
cell
transient
transfect
report
construct
consist
exon
la
lb
lc
without
downstream
exon
sequenc
well
exon
promot
alon
fuse
gal
report
gene
follow
treatment
nm
insulin
hour
report
activ
significantli
induc
exon
transfect
vs
rlumg
protein
similar
report
induct
observ
transfect
treat
insulin
mimet
bpv
truncat
analysi
exon
promot
sequenc
reveal
presenc
insulin
respons
element
ire
rel
translat
initi
site
site
fragment
recent
describ
insulin
respons
j
molend
two
major
specif
complex
identifi
nuclear
extract
isol
cell
treat
insulin
hour
use
radiolabel
oligonucleotid
one
disrupt
competit
excess
spl
consensu
oligonucleotid
antibodi
addit
consensu
ofigonucleotid
antibodi
transcript
factor
test
compet
cell
cotransfect
report
construct
spi
express
vector
basal
insuhn
stimul
report
activ
sigmficantli
increas
doubl
transfect
basal
vs
insulin
stimul
vs
furthermor
pretreat
mithramycin
potent
inhibitor
spl
bind
gc
rich
dna
motif
total
abolish
stimulatori
effect
insulin
conclud
spl
activ
nno
transcript
bind
exon
promot
respons
insulin
possibl
interact
bombesin
regul
cyclin
express
activ
earli
growth
respons
protein
dongmei
xiao
christoph
albanes
richard
pestel
horst
c
weber
object
amphibian
peptid
bombesin
bn
mammalian
homologu
gastrinreleas
peptid
grp
bind
select
grp
receptor
grpr
high
affin
grpr
critic
function
normal
digest
system
human
grpr
hgrpr
found
aberrantli
overexpress
cancer
gastrointestin
tract
lung
prostat
therebi
mediat
potent
signal
cell
prolifer
via
ligandspecif
receptor
activ
previous
show
map
kinas
pathway
subsequ
activ
immedi
earli
gene
involv
bninduc
cell
prolifer
cyclin
regulatori
subunit
sever
cyclindepend
kinas
altern
downstream
target
map
kinas
pathway
requir
progress
phase
therefor
critic
target
prolifer
signal
phase
object
studi
elucid
whether
human
involv
bninduc
mitogen
signal
method
northern
blot
western
blot
use
detect
hgrpr
depend
express
transcript
activ
measur
prostat
cancer
cell
function
hgrpr
transient
transfect
assay
usmg
serial
human
promoterhiciferas
report
plasmid
result
found
studi
bn
rim
induc
express
mrna
protein
level
time
cours
experi
mrna
increas
hour
bn
treatment
similarli
protein
induc
bn
bn
treatment
mammum
respons
occur
mutat
promot
activ
analys
show
bnenhanc
transcript
requir
bind
nuclear
protein
bp
region
cdi
promot
contain
bind
site
transcript
factor
express
also
induc
bn
requir
bnenhanc
transcript
inhibit
map
kinas
pathway
either
inhibitor
domin
neg
ra
mutant
rasn
partial
abolish
bninduc
cd
promot
activ
conclus
bninduc
express
cell
mediat
activ
interact
bp
region
human
promot
partial
map
kinasedepend
pathway
find
repres
novel
altern
mechan
bndepend
stimul
cell
prolifer
regul
directli
cell
cycl
human
epitheli
cancer
cell
goal
studi
identifi
mous
cck
gene
region
contain
sequenc
respons
express
intestin
endocrin
ceil
method
lacz
express
constmct
contain
kb
mous
cck
gene
sequenc
test
transgen
mice
mous
enteroendocrin
cell
line
express
fetal
adult
transgen
mice
determin
measur
activ
tissu
homogen
histochemi
stain
frozen
tissu
section
immunostani
cck
neuron
marker
peripherin
use
identifi
cell
type
express
tmnsgene
express
cell
assess
transient
transfect
measur
activ
compar
express
rat
intestin
cell
line
nonintestin
cell
line
cho
hela
result
transgen
mice
express
intestin
brain
spleen
liver
follow
tissu
distribut
endogen
gene
line
j
transgen
express
activ
normal
time
develop
local
cckexpress
cell
howev
analysi
transgen
founder
demonstr
express
intestin
epithelium
occur
low
effici
founder
exhibit
proper
mucos
stain
pattern
analysi
express
cultur
cell
also
demonstr
enteroendocrin
cell
express
enhanc
express
cell
comparison
nonendocrin
cell
line
conclus
kb
mous
cck
gene
region
contain
suffici
regulatori
inform
direct
gene
express
cckexpress
endocrin
cell
howev
low
express
effici
transgen
mice
suggest
sequenc
outsid
also
contribut
cck
gene
regul
enteroendocrin
cell
background
previou
studi
gastroenterol
show
somatostatin
ss
mrna
express
pancreat
content
increas
rat
streptozotocininduc
diabet
return
control
upon
insulinotherapi
observ
suggest
insulin
neg
control
pancreat
mrna
express
content
studi
undertaken
demonstr
neg
control
insulin
ss
mrna
express
method
streptozotocin
mg
kgl
diabet
rat
without
insulin
cell
use
exclus
presenc
ss
rin
cell
determin
confoc
microscopi
ss
mrna
purifi
rat
islet
rin
cell
estim
rtpcr
effect
insulin
ss
mrna
express
rin
cell
test
accord
variou
glucos
insulin
concentr
cultur
medium
result
diabet
glycemia
reach
mm
day
return
mm
normal
upon
day
insulinotherapi
day
diabet
ss
mrna
isol
islet
increas
fold
return
normal
day
insulin
confoc
microscopi
imag
clearli
indic
rin
cell
contain
without
insulin
glucagon
cell
mm
glucos
increas
mrna
mm
valu
within
nm
insulin
reduc
ss
mrna
mm
glucos
respect
final
increas
concentr
insulin
lnm
mm
glucos
medium
result
progress
reduct
ss
mrna
express
cell
decreas
rang
nm
insulin
nm
insulin
summari
studi
clearli
show
diabet
associ
increas
pancreat
ss
mrna
express
content
effect
total
revers
insulin
cell
exquisit
synthes
ss
hormon
ss
mrna
express
cell
overexpress
mm
glucos
inhibitori
eftect
insulin
ss
mrna
express
seem
independ
glucos
total
depend
insulin
concentr
insulin
glucos
effect
rapid
observ
within
exposur
conclus
insulin
definit
involv
neg
control
pancreat
ss
mrna
express
independ
glucos
support
nserc
canada
xiaofu
wang
qingd
wang
b
mark
ever
neurotensin
nt
gut
tridecapeptid
multipl
physiolog
patholog
effect
gi
tract
stimul
prolifer
intestin
mucosa
certain
colon
pancreat
cancer
proteas
system
identifi
import
regul
intracellular
activ
includ
apoptosi
two
promin
cytoplasm
proteas
system
identifi
ubiqintinproteasom
pathway
calpaincalpastein
system
purpos
studi
examin
role
proteas
system
human
nt
hnt
gene
regul
method
human
pancreat
carcinoid
cell
line
bon
express
high
level
hnt
mrna
treat
variou
proteas
inhibitor
h
northern
rnase
protect
assay
use
determin
hnt
apoptot
gene
express
hnt
promot
construct
transfect
bon
cell
treat
proteas
inhibitor
luciferas
activ
assess
dualluciferas
assay
bon
cell
apoptosi
measur
cell
death
detect
elisa
result
proteasom
inhibitor
significantli
decreas
hnt
mrna
express
dosedepend
manner
contrast
dramat
induc
apoptot
gene
dnsterin
littl
effect
express
famili
gene
similar
effect
obtain
use
anoth
proteasom
inhibitor
lactacystin
effect
pronounc
contrast
calpain
inhibitor
calpeptin
effect
hnt
apoptot
gene
express
consist
result
rna
express
hnt
promot
activ
reduc
lactacystin
calpeptin
region
bp
proxim
hnt
promot
appear
respons
proteasom
pathway
regul
consist
effect
hnt
express
lactacystin
induc
bon
cell
apoptosi
greater
effect
note
howev
effect
calpeptin
bon
cell
death
conclus
find
identifi
proteasom
pathway
critic
constitut
express
gut
peptid
nt
increas
bon
cell
apoptosi
correl
inhibit
hnt
express
apelin
recent
discov
peptid
endogen
ligand
apj
receptor
apelin
express
stomach
apelin
stimul
cholecystokinin
cck
secret
gi
epitheli
cell
prolifer
purpos
studi
clone
human
apelin
promot
order
elucid
molecular
mechan
underli
regul
apelin
express
method
region
human
ape
fin
gene
clone
pcr
use
human
genom
dna
templat
bp
fragment
human
apelin
sequenc
delet
bp
subdon
upstream
luciferas
gene
basic
order
identifi
element
essenti
activ
transcript
activ
transient
transfect
experi
done
identifi
cell
type
express
specif
effect
dna
methyl
transferas
mhibitordnmt
trichostatin
tsa
nm
histon
deacetylas
inhibitor
hdac
activ
human
apelin
gene
express
test
human
mammari
gland
cell
line
realtim
pcr
experi
result
human
apelin
region
isol
sequenc
verifi
approxim
promot
activ
retain
within
first
bp
sequenc
construct
activ
promoterless
construct
highest
transcript
activ
measur
breast
kidney
cell
core
promot
activ
lofold
greater
compar
activ
colon
stomach
cell
respect
breast
cell
transcript
activ
yflank
region
includmg
sequenc
upstream
bp
fragment
significantli
lower
suggest
repressor
element
region
tsa
increas
apelin
gene
express
wherea
exposur
increas
apelin
express
conclus
discuss
bp
fragment
suffi
cient
drive
human
apelin
gene
express
find
apdin
core
promot
activ
higher
breast
kidney
cell
compar
colon
stomach
cell
indic
transcript
regul
apelin
gene
celltyp
specif
agre
level
apdin
gene
express
bodi
repressor
element
may
present
region
upstream
core
promot
find
hdac
inhibitor
increas
apelin
express
suggest
histon
acetyl
regulatori
step
apelin
gene
express
character
gene
express
profil
kupffer
cell
stimul
ifn
alpha
gamma
maria
zocco
emilia
carloni
mario
pescatori
michel
c
santoro
enrico
c
nista
giovanni
gasbamni
giufiano
ramadori
antonio
gasbarrini
kupffer
cell
kc
intrasinusoid
locat
tissu
macrophag
pronounc
endocyt
phagocyt
capac
kc
secret
potent
mediat
inflammatori
respons
thu
control
earli
phase
inflamm
play
import
role
innat
immun
defens
locat
strateg
posit
insid
liver
clearanc
foreign
particl
includ
virus
play
import
role
prevent
tumor
develop
interferon
famili
cytokin
antivir
antiprofif
immunomodulatori
activ
ifn
alpha
gamma
involv
regul
larg
number
gene
crucial
macrophag
activ
aim
studi
evalu
kc
gene
express
basal
condit
stimul
ifn
alpha
gamma
order
suggest
possibl
mechan
action
cytokin
macrophag
activ
method
rat
kc
isol
collagenas
perfus
centrifug
elutri
cultur
hour
divid
three
differ
group
unstimul
stimul
ifn
alpha
stimul
ifn
gamma
uiml
hour
incub
period
total
rna
extract
process
accord
affymetrix
protocol
biotinil
crna
hybrid
microarray
gene
set
data
analys
perform
use
ma
softwar
gene
show
remark
differ
express
microarray
analysi
select
confirm
real
time
pcr
result
nearli
gene
repres
array
express
kc
among
ifn
alpha
upregul
gene
twofold
downregnl
gene
upregul
gene
belong
broad
rang
function
pathway
includ
effector
protein
strong
antivir
activ
gene
involv
antigen
prcess
present
tumor
suppressorproapoptot
gene
ifn
gamma
hand
upregnl
twofold
gene
downregnl
gene
gene
induc
ifn
alpha
also
induc
ifn
gamma
downregnl
gene
includ
gene
cytoskelet
regul
like
marker
prolifer
like
cyclin
rtpcr
confirm
result
array
conclus
studi
show
ifn
directli
target
rat
kc
involv
regul
wide
varieti
gene
analysi
express
profil
shed
light
onto
molecular
mechan
kc
activ
specif
pathway
antivir
antitumor
process
ghrelin
origin
discov
stomach
stimul
food
intak
trigger
secretori
motor
respons
involv
peptid
gastroprotect
littl
studi
compar
effect
ghrefin
appli
intraperitonealfi
ip
intracerebroventricularli
icv
gastric
secret
rat
chronic
gastric
fistula
gastric
lesion
induc
h
water
immers
restraint
stress
wr
ischemiareperfus
ir
without
inhibit
cyclooxygenas
cox
indomethacin
rofecoxib
inhibitor
b
suppress
nitric
oxid
sfathas
lnna
c
blockad
sensori
nerv
capsaicin
mgkg
sc
cgrp
releas
gkg
ip
cut
vagal
nerv
bilater
vagotomi
area
gastric
lesion
measur
plainmetri
gastric
blood
flow
gbf
determin
clearanc
techniqu
gastric
lumin
nox
level
measur
griess
method
blood
mucos
biopsi
sampl
collect
assess
plasma
ghrelin
level
ria
mrna
ghrelin
rtpcr
wr
produc
typic
gastric
bleed
eros
significantli
rais
plasma
ghrelin
level
mrna
ghrelin
gastric
mucosa
ghrelin
gkg
ip
increas
gastric
acid
secret
compar
basal
dosedepend
attenu
gastric
lesion
induc
wr
ir
dose
reduc
lesion
pgkg
gkg
respect
ghrefin
ngrat
icv
attenu
significantli
gastric
lesion
induc
wr
ir
gastroprotect
effect
central
peripher
ghrefin
accompani
signific
rise
plasma
ghrelin
level
increas
gbf
lumin
nox
content
protect
hyperem
effect
ghrelin
appli
ip
icv
complet
abolish
vagotomi
significantli
attenu
suppress
indomethacin
rofecoxib
sensori
denerv
capsaicin
cgrp
antagonist
lnna
attenu
significantli
ghrelininduc
protect
hyperemia
addit
lnna
largiinn
darginin
restor
protect
hyperem
effect
hormon
conclud
central
peripher
ghrelin
exert
potent
gastroprotect
action
stomach
depend
upon
vagal
activ
sensori
nerv
involv
hyperemia
mediat
prostaglandin
unrel
acid
secretori
effect
orexin
oxa
novel
neurupeptid
increas
food
intak
inhibit
fast
small
bowel
motil
rat
aim
studi
investig
effect
intraven
iv
oxa
endogen
oxa
acid
secret
gastric
empti
distribut
orexin
immunoreact
rat
stomach
additon
halflif
oxa
rat
plasma
studi
rat
equip
gastric
fistula
subject
iv
infus
oxa
praolkgmin
select
receptor
antagonist
salin
pentagastin
pmol
rainl
infus
administr
polyethylen
glycol
peg
radioact
marker
liquid
nutrient
gastric
retent
measur
infus
oxa
immunohistochemit
tri
oxa
oxb
orexin
receptor
oxr
gastrin
neuron
no
nno
gtomach
perform
anoth
group
rat
given
oxa
pmolkgmin
differ
time
interv
order
calcul
plasma
halflif
antagonist
inhibit
basal
p
pentagastrininduc
ixmo
rain
p
gastric
acid
secret
decreas
gastric
retent
iquid
nutrient
salin
nutrient
respect
nonnutri
liquid
peg
oxa
alon
effect
either
basal
acid
secret
gastric
empti
plasma
halflif
oxa
min
stepwis
increas
infus
rate
oxa
confirm
linear
concentrationtim
curv
thu
firstord
kinet
plasma
oxa
decreas
nutrient
intak
infus
pmoll
respect
salin
nurient
antagonist
p
orexin
orexin
receptorimmunoreactivitiy
found
mncosa
myenter
nerv
cell
bodi
varicos
nerv
fiber
ganglia
circular
muscl
stomach
subset
structur
coexpress
vip
gastrin
nno
conclus
use
antagonist
endogen
oxa
seem
influenc
gastric
acid
secret
gastric
empti
nutrient
liquid
pineal
gland
secretori
product
melatonin
exhibit
gastroprotect
activ
mucos
damag
induc
strong
irrit
whether
central
applic
hormon
precursor
ltryptophan
influenc
gastric
mucos
defens
remain
elucid
studi
effect
intracerebroventricular
icv
administr
melatonin
ltryptophan
acid
gastric
secret
rat
gastric
fistula
h
water
immers
restraint
stress
wr
induc
gastric
lesion
without
remov
pineal
gland
pinealectomi
b
luzindol
mgkg
ip
antagonist
ofmelatonin
c
function
ablat
sensori
nerv
capsaicin
mgkg
sc
within
three
day
number
gastric
lesion
determin
planimetri
gastric
blood
flow
gbf
assess
clearanc
method
plasma
melatonin
gastrin
level
measur
specif
ria
exposur
wp
produc
gastric
lesion
accompani
increas
gastric
acid
output
fall
gbf
compar
baselin
effect
augment
pinealectomi
capsaicindenerv
melatonin
ltryptophan
ixgkg
ixgkg
icv
rais
plasma
melatonin
level
fold
basal
significantli
decreas
gastric
secret
melatonin
dosedepend
reduc
wrsinduc
gastric
lesion
dose
inhibit
lesion
ixgkg
produc
signific
rise
gbf
plasma
immunoreact
gastrin
level
protect
hyperem
effect
melatonin
significantli
reduc
luzindol
complet
abolish
capsaicindenerv
restor
exogen
cgrp
ggkg
sc
ad
melatonin
lrtyptophan
capsaicindenerv
anim
pinealectomi
exagger
wrsinduc
lesion
significantli
decreas
accompani
fall
gbf
deleteri
effect
counteract
icv
supplement
pinealectom
rat
melatoinn
ixgkg
ltryptophan
ixgkg
abolish
concurr
treatment
luzindol
conclud
central
melatoinn
deriv
ltryptophan
inhibit
gastric
secret
exhibit
gastroprotect
activ
wr
damag
via
mechan
involv
activ
receptor
gastric
hyperemia
possibl
mediat
sensori
neuropeptid
cgrp
gastrin
known
exert
gastroprotect
vasodilatatori
trophic
action
sensori
inform
transmit
vagal
affer
larg
fail
reach
level
consciou
percept
recent
human
studi
indic
high
frequenc
low
energi
gastric
pace
enhanc
toler
gastric
distens
patient
diabet
gastroparesi
similar
eleertostimul
also
reduc
dyspept
symptom
independ
gastric
empti
anoth
group
diabet
patient
observ
implic
vagal
affer
modul
noeicept
pain
anterior
cingul
cortex
acc
function
relat
cognit
emot
affect
process
sensori
inform
hypothes
vagal
stimul
modul
acc
activ
lead
enhanc
toler
viscer
stimul
record
electrophysiolog
respons
singl
acc
neuron
grade
crd
mm
hg
control
rat
rat
viscer
hypersensit
vii
induc
intracolon
instil
acet
acid
follow
day
period
crd
vtl
show
gross
colon
patholog
none
acc
neuron
control
respond
crd
contrast
basal
fire
rate
acc
neuron
vh
rat
higher
compar
control
vs
spikessec
grade
crd
evok
respons
acc
neuron
test
vagotomi
perivag
applic
capsaicin
alter
acc
respons
crd
investig
vagal
affer
role
modul
acc
activ
studi
effect
electr
subdiaphragmat
vagai
stimul
ev
acc
activ
crd
ram
hg
ac
rat
lowintens
ev
ix
hz
activ
vagal
fiber
reduc
basal
crdinduc
fire
respect
inhibitori
action
affect
perivag
applic
capsaicin
contrast
highintens
ev
ix
hz
activ
vagal
c
fiber
effect
intracellular
record
nodos
ganglia
neuron
follow
immunohistochem
label
show
nodos
neuron
activ
lowintens
ev
gabaimmunoreact
ir
one
neuron
glutamateit
none
contain
substanc
p
first
report
activ
vagal
affer
fiber
reduc
acc
neuron
activ
stimul
noxiou
crd
fiber
nodos
neuron
mainli
gabair
activ
vagal
affer
pathway
may
decreas
nocicept
reduc
pa
n
dyspept
symptom
evok
viscer
stimul
modul
acc
activ
inhibit
lumbar
splanchnic
affer
mechanosensit
galanin
benjamin
philli
l
ashley
ashley
blackshaw
background
galainn
gal
amino
acid
neuropeptid
present
central
peripher
nervou
system
other
shown
may
act
peripher
inhibit
mechanosensit
primari
affer
end
skin
joint
stomach
esophagu
eg
page
et
al
ddw
flatter
et
al
neurosci
aim
investig
effect
gal
mechanosensit
high
threshold
colon
primari
affer
view
role
colon
hypersensit
method
use
vitro
rat
colon
affer
prepar
distal
colon
lumbar
splanchnic
nerv
lsn
remov
intact
specialis
organ
bath
colon
open
longitudin
offcentr
pin
fiat
lsn
guid
oil
fill
chamber
singl
unit
record
six
seros
mesenter
affer
classifi
accord
locat
mechanorecept
field
respons
mechan
stimuli
blunt
probe
applic
calibr
yon
frey
hair
drug
ad
metal
ring
surround
recept
field
result
incub
human
gal
minut
found
sigmficantli
chang
spontan
discharg
n
comparison
incub
bsakreb
vehicl
repeat
measur
anova
number
action
potenti
gener
respons
probe
reduc
unit
result
dose
depend
reduct
mean
peak
instantan
frequenc
p
oneway
anova
galanin
induc
concentr
depend
excitatori
effect
one
unit
inhibitori
excitatori
effect
revers
select
galanin
receptor
antagonist
galantid
washout
time
control
show
effect
unrel
drug
administr
conclus
result
suggest
gal
may
reduc
mechan
sensit
subpopul
colon
primari
affer
lack
gal
specif
antagonist
make
difficult
determin
galanin
receptor
subtyp
involv
inhibitori
effect
candid
support
astrazeneca
studi
focus
brain
local
receptor
situ
hybrid
analysi
mrna
rat
brain
indic
intens
label
cell
contain
dorsal
motor
nucleu
vagu
dmv
molec
endocrinol
endocrinol
within
dmv
mrna
intens
medial
part
rustral
twothird
nucleu
ie
region
project
stomach
j
comp
neurol
purpos
studi
determin
effect
activ
medialrostr
dmv
gastric
motil
perform
unilater
microinject
two
dose
potent
cyclic
agonist
rostral
dmv
anesthet
rat
monitor
gastric
activ
intragastr
balloon
lglutam
use
tool
identifi
rostral
dmv
subsequ
mtii
microinject
sinc
previous
shown
microinject
lglutam
region
dmv
rostral
obex
rat
caus
increas
intragastr
pressur
neurogastroenteroi
mot
dose
mtii
produc
increas
gastric
motil
mmhgsec
area
curv
n
effect
occur
immedi
upon
mtii
administr
last
second
fourfold
higher
dose
mtii
n
also
increas
gastric
motil
mmhgsec
area
curv
effect
also
occur
immedi
last
second
excitatori
effect
mtii
gastric
motil
close
resembl
observ
lglutam
could
reproduc
minut
excitatori
lglutam
effect
repeat
minut
interv
microinject
find
indic
activ
rostral
dmv
increas
gastric
motil
presum
excit
cholinerg
motor
neuron
dmv
synaps
postganglion
cholinerg
neuron
innerv
stomach
support
nih
grant
aga
abstract
characteris
antagonist
slv
vitro
viva
holger
saan
daniel
jasserand
reinhard
brueckner
dania
reich
eric
ronken
andrew
mccreari
herman
van
stinvenberg
chri
eeckhout
ulf
prenschoff
substanc
p
sp
neurokinin
receptor
known
involv
intestin
nocicept
antagonist
effect
predin
model
viscer
nocicept
pain
report
vitro
viva
activ
newli
develop
antagonist
slv
slv
specif
exhibit
high
bind
affin
human
receptor
less
activ
rat
receptor
pki
affin
human
rat
receptor
much
lower
pki
pki
function
cell
assay
use
chines
hamster
ovari
cell
express
recombin
human
receptor
slv
potent
inhibit
spinduc
increas
camp
inositoltrisphosph
valu
respect
furthermor
slv
concentrationdepend
inhibit
sp
induc
relax
phenylephrin
precontract
guineapig
aorta
vitro
valu
nm
investig
antagonist
potenc
slv
viva
abil
antagonis
sp
induc
hypotens
investig
anaesthetis
guinaapig
iv
administr
nmol
kg
oral
administr
slv
inhibit
respons
long
durat
action
determin
h
administr
pmolkg
slv
also
test
rat
model
viscer
hypersensit
pain
sensitis
colon
affer
previou
instil
dilut
acet
acid
colon
distens
induc
nocicept
behaviour
respons
abdomin
cramp
writh
use
pmol
kg
slv
sc
long
last
effect
could
demonstr
test
period
minut
drug
administr
mean
inhibit
rain
administr
maxim
inhibit
achiev
data
demonstr
slv
potent
oral
activ
antagonist
abil
drug
reduc
viscer
hypersensit
suggest
slv
might
benefici
irrit
bowel
syndrom
peptid
given
either
ici
ip
thirthi
min
later
gastric
lesion
induc
intragastr
administr
ethanol
mlrat
rat
sacrif
min
ethanol
exposur
individu
hemorrhag
lesion
measur
along
greatest
length
overal
total
lesion
design
lesion
index
result
lcv
inject
nofq
g
dosedepend
inhibit
format
gastric
mucos
lesion
caus
ethanol
maxim
reduct
p
vs
vehicl
n
follow
nofq
pg
timecours
studi
show
peak
effect
exert
nofq
bg
inject
min
ethanol
challeng
declin
rain
n
absent
rain
ufp
rang
pg
icv
ineffect
given
alon
dosedepend
antagon
protect
effect
nofq
complet
blockad
observ
follow
upf
pg
ip
inject
nofq
pgkg
similarli
effect
prevent
develop
gastric
mucos
lesion
maxim
reduct
p
vs
vehicl
n
lower
achiev
nofq
icv
inject
protect
effect
peripher
inject
n
ofq
antagon
ufp
pgkg
ip
conclus
present
result
indic
nofq
act
central
peripher
protect
gastric
mucosa
damag
effect
shortlast
line
pharmacokinet
featur
protect
nofq
appear
mediat
activ
nap
receptor
add
support
hypothesi
nofq
may
partecip
regul
gastrointestin
function
roxan
peddl
ingersofi
selmer
elizabeth
c
colley
mark
chen
robert
h
riddel
ronald
h
stead
background
intermedi
conduct
calciumactiv
potassium
ik
channel
implic
control
digest
tract
process
myenter
neuron
mucos
epitheli
cell
ik
channellik
immunoreact
report
human
rat
dorsal
root
ganglia
drg
boettger
et
al
brain
human
enter
neuron
arnold
et
al
neuroreport
howev
describ
normal
human
tract
use
routin
fix
tissu
specimen
method
formalinfix
paraffinembed
ffpe
tissu
block
human
gastrointestin
tract
drg
n
patient
undergo
surgeri
varieti
condit
autopsi
specimen
obtain
local
hospit
follow
appropri
ethic
procedur
ffpe
rodent
tissu
also
studi
immunohistochemistri
perform
section
use
rabbit
antihuman
lk
gsk
rais
amino
acid
ggdlvlglgalrrrkc
ntermin
human
channel
detect
perform
use
zyme
nba
kit
south
san
francisco
colour
develop
aec
mount
aqueou
medium
nonimmun
serum
adsorpt
immun
peptid
use
controi
result
ikir
present
myenter
submucos
ganglia
major
ganglion
cell
appear
posit
although
intens
stain
vari
cell
cell
nerv
fibr
plexi
also
proport
ganglion
cell
label
vari
tissu
tissu
ikir
also
local
epithelia
albeit
rel
weakli
occasion
epitheli
cell
resembl
enteroendocrin
ceil
express
ikir
equival
intens
posit
neuron
occasion
mononuclear
cell
also
stain
mucosa
submucosa
serosa
rat
mous
enter
ganglia
also
ikir
epithelium
speci
strongli
stain
human
rat
mous
drg
express
strong
ikir
intens
smaller
diamet
neuron
ikir
also
observ
axon
ikir
abolish
antiserum
preadsorb
antigen
peptid
conclus
distribut
ikir
human
g
sampl
drg
consist
seen
rodent
earlier
work
local
ikir
routin
ffpe
patholog
sampl
allow
studi
distribut
ion
channel
variou
human
intestin
diseas
richard
young
nicol
cooper
l
ashley
blackshaw
background
recent
show
potent
inhibitori
effect
grouplii
metabotrop
glutam
receptor
mglur
peripher
gastric
vagal
affer
mechanosensit
central
gastric
affer
input
nt
groupi
mglur
evok
synapti
excit
cn
action
gastric
vagal
affer
signal
unknown
aim
studi
aim
determin
whether
mpep
select
antagonist
could
modul
gastric
affer
input
within
ferret
nt
ii
identifi
express
ferret
nt
extrins
input
retrograd
trace
proxim
stomach
method
singleunit
respons
phasic
isobar
distens
stomach
record
use
glass
microelectrod
nt
anaesth
tize
adult
male
ferret
immunohistochemistri
perform
combin
retrograd
trace
gastric
input
nt
proxim
stomach
day
ctbfitc
result
administr
mpep
ici
attenu
respons
nt
unit
excit
gastric
distens
min
unit
contrast
mfep
effect
unit
inhibit
gastric
distens
unit
immunohistochemistri
fix
cryostat
section
ferret
nt
reveal
heavi
fiber
label
later
border
medial
subnucleu
intermedi
subnucleu
nt
region
neuron
respons
distens
record
low
level
label
also
seen
fiber
later
portion
subnucleu
gefatinosn
trace
soma
dorsal
motor
vagal
nucleu
dmv
conclus
find
indic
gastric
input
ferret
nt
mediat
combin
local
fiber
medial
nt
suggest
promin
central
role
viscer
input
may
prove
suitabl
target
reduc
affer
input
therapeut
background
appetitemodul
peptid
hormon
ghrelin
predominantli
produc
secret
stomach
endogen
ligand
growth
hormon
secretagogu
receptor
subtyp
la
seem
transduc
chang
food
intak
central
nervou
system
elev
ghrelin
level
patient
anorexia
nervosa
shown
retum
normal
partial
weight
gain
aim
studi
investig
postprandi
plasma
ghrelin
concentr
weight
gain
method
fast
plasma
ghrelin
level
measur
femal
patient
anorexia
nervosa
year
follow
psychotherapeut
treatment
intervent
psychosomat
institut
month
standard
test
ml
fluid
meal
g
protein
g
carbohydr
g
fat
perform
patient
three
differ
time
admiss
partial
weight
gain
kg
kg
respect
plasma
ghrelin
level
basal
minut
postprandi
measur
commerci
avail
radioimmunoassay
phoenix
pharmaceut
usa
result
anorect
patient
bodi
mass
index
bmi
kgm
plasma
ghrelin
level
significantli
suppress
pgml
pgml
minut
postprandi
p
partial
weight
gain
bmi
kgm
meamnduc
plasma
ghrelin
concentr
decreas
pgml
pgml
p
hospit
therapi
bmi
reach
kg
postprandi
ghrelin
level
felt
pgml
p
postprandi
plasma
ghrelin
decreas
admiss
median
significantli
differ
suppress
weight
gain
respect
conclus
studi
show
signific
postprandi
suppress
plasma
ghrelin
level
patient
anorexia
nervosa
weight
gain
basal
plasma
ghrelin
level
significantli
decreas
howev
rel
mealinduc
ghrelin
decreas
significantli
differ
find
indic
acut
chang
energi
balanc
anorect
patient
independ
chronic
chang
energi
balanc
recent
six
homologu
ph
identifi
name
systemat
nadph
oxidas
nox
dual
oxidas
duox
famili
among
famili
member
noxl
thought
respons
gener
superoxid
anion
hydrogen
peroxid
tumorigen
angiogen
function
mice
inject
noxltransfect
nih
cell
primari
cultur
guinea
pig
gastric
pit
cell
express
noxl
spontan
produc
superoxid
anion
consider
high
rate
expos
helicobactor
pylori
hp
lipopolysaccharid
lp
type
type
strain
suggest
art
import
role
noxl
hptrigger
rosmedi
carcinogenesi
stomach
studi
precis
examin
mechan
prime
hp
lp
guinea
pig
pit
cell
cultur
lpsfree
condit
constitut
express
new
homologu
racl
mrna
well
noxl
respons
hp
lp
cell
induc
express
noxl
novel
p
homologu
mrna
level
compon
mrna
chang
actinomycin
cycloheximid
complet
bdcked
prime
effect
hp
rna
interfer
target
noxl
x
significantli
suppress
upregul
superoxid
gener
furthermor
found
hp
lp
increas
gtpbound
racl
within
min
activ
continu
h
confirm
pulldown
assay
human
protein
phosphoinositid
inhibitor
complet
block
hp
lpsinduc
activ
racl
superoxid
gener
without
affect
lpstrigger
express
noxl
mrna
final
confirm
transfect
constitutiev
activ
racl
adenoviru
vector
direct
activ
racl
phorboi
complet
revers
inhibit
snperoxid
gener
result
suggest
noxl
may
induc
respons
hp
infect
studi
also
demonstr
first
time
racl
play
indispens
role
full
activ
noxl
jun
sun
anjali
rao
jame
l
madara
becom
increasingli
appar
dynam
molecular
cross
talk
exist
microflora
mucos
epitheli
cell
gut
patient
inflammatori
bowel
diseas
ibd
higher
amount
bacteria
attach
epitheli
surfac
healthi
peopl
evid
indic
ibd
result
aberr
immun
activ
intestin
mucosa
normal
usual
commens
host
bacteri
flora
andor
product
laboratori
previous
report
bacterialepitheli
interact
involv
proinflammatori
nfkappab
pathway
studi
defin
novel
bacteria
effector
protein
avra
regul
nfkappab
pathway
regul
betacatenin
pathway
import
control
epithelia
prolifer
also
find
interest
cross
talk
nfkappab
betacatenin
pathway
use
human
epitheli
cell
vitro
model
found
avra
express
epitheli
cell
directli
regul
express
betacatenin
target
gene
cmyc
cell
prolifer
enhanc
nonvirul
salmonella
phopc
colon
cell
compar
colon
wildtyp
salmonella
avra
mutant
strain
immnunoprecipit
result
show
physic
interact
nf
appab
betacatenin
polar
cell
model
nfkappab
antibodi
brought
betacatenin
protein
nonvirul
salmonella
phopc
colon
ceil
betacatenin
bound
compar
colon
wildtyp
salmonella
avra
mutant
strain
avra
express
regul
physic
interact
betacatenin
nfkappab
result
indic
cross
talk
exist
nfkappab
betacatenin
pathway
bacterialhost
interact
might
induc
longterm
cellular
respons
addit
transient
inhibit
acut
inflammatori
respons
util
bacteriaderiv
factor
activ
host
machineri
previous
shown
iec
respond
differenti
fashion
bacteri
dna
unknown
iec
interact
bacteri
dna
inflammatori
condit
aim
aim
studi
determin
effect
bacteri
dna
iec
immun
respons
presenc
proinflammatori
cytokin
tnfa
assess
effect
oral
administr
probiot
bacteri
dna
anim
model
coliti
method
cell
pretreat
dna
gg
salmonella
dublin
probiot
compound
prior
incub
tnfa
ngml
secret
measur
elisa
ikb
protein
mrna
level
western
blot
rtpcr
nfkb
activ
report
assay
proteasom
activ
proteasom
assay
kit
vivo
studi
adult
svev
z
mice
receiv
vsl
dna
oral
ixg
sacrific
colon
remov
analyz
tnfa
mrna
level
protein
secret
result
tnf
treatment
stimul
mrna
product
protein
secret
pretreat
dublin
dna
addit
effect
secret
respons
tnfcc
associ
enhanc
nfkb
activ
increas
mrna
contrast
pretreat
cell
vsl
dna
result
signific
inhibit
secret
delay
nfkb
activ
stabil
ikb
paral
reduct
proteasom
activ
interestingli
tnfcinduc
increas
mrna
level
significantli
alter
vsl
dna
suggest
possibl
inhibitori
effect
probiot
dna
chemokin
translat
secretori
process
abil
vsl
dna
downregul
inflammatori
respons
mirror
vivo
studi
treatment
mice
vsl
dna
oral
gavag
result
signific
reduct
colon
ifnand
tnfa
secret
mrna
level
attenu
histolog
inflamm
conclus
inflammatori
environ
dna
pathogen
bacteria
augment
epitheli
immun
respons
enhanc
nfkb
signal
contrast
dna
probiot
bacteria
given
oral
benefici
effect
treatment
coliti
possibl
act
limit
inflamm
specif
downregul
epitheli
chemnkin
secret
commens
bacteria
elicit
integr
respons
innat
immun
system
mucos
interfac
intestin
vivo
sue
keilbaugh
romain
banchereau
nadiya
boiko
john
j
cebra
gari
wu
background
grow
evid
suggest
pathogenesi
ibd
involv
dysregul
mucos
immun
respons
commens
bacteri
flora
regard
bacteria
byproduct
elicit
cellular
respons
primarili
activ
innat
immun
system
current
littl
inform
regard
innat
immun
respons
elicit
bacteri
colon
intestin
tract
vivo
method
result
order
develop
databas
innat
immun
respons
gene
alter
bacteri
colon
colon
rna
isol
three
group
cb
mice
studi
use
affymetrix
microarray
germfre
colon
alter
schaedler
flora
asp
defin
flora
gut
commens
monoassoci
schaedler
e
coll
target
gene
interest
confirm
quantit
rtpcr
mine
databas
alter
epitheli
gene
identifi
singl
famili
consist
robustli
activ
gfold
commens
colon
rag
iii
famili
autocrin
growth
factor
studi
sever
differ
tissu
shown
famili
gene
activ
immun
stimulatori
cytokin
subsequ
analysi
databas
identifi
singl
immun
modul
cytokin
interferon
gamma
strongli
induc
sod
mice
upon
commens
colon
induct
ifni
observ
chronic
colon
formerli
germfre
well
convent
hous
scid
mice
compar
germfre
scid
mice
previou
studi
shown
reglli
express
activ
ifni
vitro
immunohistochemistri
colon
e
coli
monoasssoci
sod
mice
identifi
intraepitheli
mononuclear
cell
sole
sourc
ifn
dual
immunofluoresc
show
express
coloc
marker
natur
killer
nk
cell
conclus
result
provid
first
demonstr
colon
intestin
tract
commens
bacteria
result
activ
uniqu
popul
innat
immun
effector
cell
mucos
interfac
intraepitheli
nk
cell
ienk
turn
ifni
product
ienk
may
modul
characterist
intestin
epithelium
interfac
activ
express
reglli
autocrin
epitheli
growth
factor
cultur
supemat
run
sd
page
gel
impregn
gelatin
without
heat
reduct
gelatinolyt
band
develop
h
c
presenceabs
specif
proteas
inhibitor
pi
im
murin
close
loop
model
use
studi
rrv
infect
balbc
mice
loop
construct
tie
junction
stomach
duodenum
cecum
termin
ileum
prior
tie
distal
knot
tx
pb
mix
serin
pi
aprotinin
leupeptin
aebsf
inject
intralumin
mice
sacrif
loop
weight
express
mgcm
net
fluid
secret
total
loop
weight
less
tissu
weight
result
zymogram
cultur
supemat
infect
uninfect
cell
show
proteolyt
band
kd
cystein
aspart
metalloproteas
inhibitor
affect
band
develop
howev
serin
pi
pefabloc
benzamidin
aprotonin
pmsf
cation
chelat
complet
inhibit
band
loop
weight
increas
rrv
infect
loop
treat
pi
mgcm
vs
mgcm
pi
p
differ
express
net
fluid
secret
tabl
effect
pi
uninfect
mice
conclus
rv
infect
caus
increas
releas
serin
proteas
intestin
epitheli
cell
serin
proteas
inhibitor
significantli
increas
intestin
secret
occur
murin
model
rv
infect
thu
specif
enhanc
proteolyt
activ
may
modul
host
fluid
loss
infect
attenu
activ
may
caus
excess
secret
sever
diseas
outcom
background
aim
epitheli
ceil
sensor
microbi
environ
prime
host
immun
respons
elabor
chemokin
respons
bacteri
signal
enter
lumen
previous
demonstr
probiot
confer
protect
invas
salmonella
infect
therefor
aim
studi
examin
influenc
lactobacilln
salivariu
epitheli
cell
respons
invas
salmonella
typhimurium
method
epitheli
cell
stimul
l
salivarin
salmonella
typhimurium
hour
addit
l
salivariu
preincub
epitheli
cell
hour
ad
simultan
ad
hour
addit
typhimurium
tnf
coincub
hour
supemat
level
measur
use
elisa
number
typhimurium
cell
adher
epitheli
ceil
measur
plate
tryptic
soya
agar
tsa
follow
wash
apic
surfac
result
contrast
typhimurium
tnf
induc
signific
secret
doseand
timedepend
manner
l
salivariu
significantli
reduc
basal
secret
epitheli
cell
p
furthermor
respons
typhimurium
significantli
reduc
prior
simultan
exposur
epithelia
l
salivarina
due
competit
exclus
pathogen
probiot
epitheli
surfac
number
adher
typhimnrium
unalt
probioticassoci
reduct
respons
less
evid
tnf
substitut
salmonella
stimulu
signific
reduct
observ
l
salivariu
preincub
epitheli
cell
expect
tnf
typhimurium
associ
activ
nfkb
l
salivariu
activ
nfkb
conclus
l
salivariu
reduc
epitheli
cell
respons
direct
action
epitheli
cell
rather
exclus
pathogen
epitheli
bind
site
mechan
unclear
may
directli
involv
nfkb
michel
pietzak
elixa
chakraborti
enter
abl
transloc
intestin
barrier
dissemin
caus
sepsi
mening
suscept
human
host
neonat
rat
previous
shown
induc
small
intestin
villou
damag
area
directli
contact
bacteria
aim
studi
determin
whether
induc
damag
via
apoptosi
method
spmguedawiey
rat
pup
oral
inocul
nonpathogen
e
coli
sacrif
hour
routin
histolog
tunel
assay
tdtmediat
dutpbiorin
inckend
label
perform
rat
intestin
tissu
cell
apoptosi
cell
quantifi
annexin
vfitc
av
express
loss
propridium
iodid
pi
exclus
incub
moi
track
cell
avpi
viabl
measur
apoptosi
av
earli
apoptosi
membran
integr
av
end
stage
apoptosi
death
caspas
measur
vad
muhicaspas
substrat
surfac
express
fa
verifi
use
specif
monoclon
ab
cell
underw
fac
analysi
bectondickinson
facscalibur
flow
cytomet
analyz
cellquest
softwar
result
tunel
rat
enterocyt
confluent
villou
tip
directli
contact
rat
fed
show
rare
diffus
tunel
base
crypt
incub
hour
tunel
cell
increas
uninfect
cell
demonstr
averag
av
pi
av
pi
baselin
hour
incub
av
cell
increas
pi
cell
increas
avpi
seen
cell
time
point
respect
p
compar
baselin
caspas
upregul
cell
express
increas
cell
incub
hour
conclus
induc
damag
human
rat
intestin
epitheli
cell
via
apoptosi
perhap
activ
pathway
induct
apoptosi
e
coli
may
explain
abil
success
transloc
intestin
barrier
dissemin
understand
mechan
host
microbi
interact
take
place
may
lead
novel
prevent
therapeut
treatment
gram
neg
sepsi
mening
well
inflammatori
bowel
diseas
epitheli
cell
akiko
sato
masahiro
lizuka
osamu
nakagomi
manabu
suzuki
fasuo
hori
shtho
konno
kenji
sasaki
sumio
watanab
background
aim
toll
like
receptor
tlr
innat
immunerecognit
receptor
recogn
molecular
pattern
associ
bacteri
viral
antigen
recent
studi
show
recogn
doubl
strand
rna
dsrna
induc
immun
respons
rotavirna
darna
genom
infect
epitheli
cell
small
intestin
caus
acut
gastroenter
young
children
aim
studi
clarifi
whether
rotaviru
dsrna
modul
wound
repair
iec
method
express
cell
express
tlpo
mrna
cell
assess
rtpcr
ampfifi
dna
fragment
subject
sequenc
analysi
wound
assay
confluent
rnonolay
cell
wound
cultur
hour
absenc
presenc
variou
concentr
trgml
rotaviru
strain
rrv
rna
migrat
cell
assess
count
cell
observ
across
wound
border
induct
cytokin
express
tnfa
interferon
ib
ifn
mrna
cell
assess
rtpcr
hour
stimul
rotaviru
rna
activ
signal
pathway
activ
mapk
stimul
rotavim
rna
assess
western
blot
result
intensifi
express
mrna
observ
rtpcr
epitheli
migrat
wound
area
diminish
time
p
time
p
time
p
exposur
ml
rotaviru
rna
express
mrna
ceil
induc
hour
stimul
rotaviru
rna
mapk
activ
stimul
rotaviru
rna
iconclnaion
rotaviru
dsrna
induc
express
inflammatori
cytokin
significantli
diminish
wound
repair
iec
effect
probabl
given
emmanuel
coron
philipp
sansonetti
eric
letessi
eric
espaz
jeanpaul
galmich
michel
neunlist
introduct
recenti
shown
enter
nervou
system
en
target
infect
shigella
flexneri
flexneri
coronet
al
gastroenterolog
flexneri
induc
acut
chang
neurochem
phenotyp
ii
morpholog
alter
suggest
neuron
damag
human
submucos
neuron
therefor
goal
studi
investig
mechan
involv
effect
use
pharmacolog
approach
ex
vivo
human
colon
model
method
segment
colon
patient
undergo
surgeri
cancer
mount
modifi
uss
chamber
invas
non
invas
strain
fiexneri
ad
mucos
side
chamber
hour
cultur
tissu
fix
microdissect
obtain
whole
mount
meissner
plexu
neuron
form
nitric
oxid
synthas
nno
neuron
specif
enolas
nse
detect
use
immunohistocherak
cal
method
pharmacolog
studi
perform
use
itthibitor
no
lname
antagonist
nmda
receptor
ixmol
result
modifi
total
number
neuron
per
ganglia
vs
respect
p
n
nevertheless
proport
neuron
express
nno
significantli
decreas
presenc
compar
vs
p
n
effect
block
preincub
tissu
lname
addit
induc
signific
decreas
nse
label
enter
neuron
n
p
alter
neuron
morpholog
compar
latter
effect
block
lname
conclus
result
confirm
fiexueri
alter
en
induc
chang
neurochem
phenotyp
submucos
neuron
alter
neuron
phenotyp
mediat
least
part
via
b
name
depend
pathway
alter
nse
label
might
mediat
nmda
receptor
previous
character
pattern
express
tlr
primari
human
intestin
epitheli
ceil
identifi
small
highli
differenti
popul
human
iec
distinct
tlrneg
enterocyt
coexpress
current
studi
potenti
role
tlrposit
innat
immun
respons
enteroinvas
bacteri
pathogen
evalu
specif
three
distinct
tlr
complex
detect
gramposit
gramneg
speci
analyz
util
iec
line
ceil
constitut
express
lp
peptidoglycan
pgn
unrespons
measur
activ
nfkbluciferas
report
overexpress
sensit
ceil
lp
commerci
pgn
respect
fashion
tranfect
inhibit
lpsor
pgninduc
activ
via
format
complex
contrast
transfect
sens
lp
pgn
independ
util
compar
three
model
intracellular
enter
pathogen
gramposit
l
monocytogena
gramneg
fiexnerii
paratyphi
recogn
gramneg
bacteria
specif
depend
upon
partner
associ
tlri
recogn
gramneg
pathogen
specif
gramposit
listeria
intracellulr
presenc
bacteria
requir
outer
bacteri
cell
wall
compon
suffici
activ
tlr
repurifi
commerci
lp
well
wild
type
lpsfree
mutant
n
meningitidi
confirm
lp
specif
recogn
ligand
differ
lp
recogn
lpsdepend
fashion
contrast
detect
pgn
gramposit
bacteria
fiilafli
trigger
tlr
complex
led
inflammatori
chemokin
express
illb
product
wherea
pb
monocyt
unabl
produc
mcpi
stimul
tlr
upreguf
illb
find
demonstr
tissu
specif
differ
tlrinduc
respons
may
repres
function
consequ
activ
tlrposit
iec
vivo
acut
bacteri
infect
gut
role
human
betadefensin
campylobacterjejuni
infect
matthia
zilbauer
nick
dorr
john
georg
parjeet
boughan
mona
bajajelfiott
introduct
campylobacterjejuni
c
jejuni
one
commonest
caus
infect
diarrhoea
world
wide
clinic
spectrum
vari
mild
wateri
bloodi
inflammatori
diarrhoea
frequent
associ
post
infecti
extraintestin
complic
syndrom
despit
seriou
health
problem
caus
bacterium
diseas
pathogenesi
remain
poorli
understood
present
studi
investig
role
epitheim
antimicrobi
peptid
betadefensin
cjejuni
infect
method
human
colon
intestin
cell
line
infect
cfuml
virul
strain
nctc
jejuni
defensin
gene
express
assess
rtpcr
bactericid
activ
recombin
human
betadefensin
hbd
test
strain
evalu
brothdilut
assay
result
conclus
mark
timedepend
induct
observ
maxim
express
hour
postinfect
contrast
gene
express
modest
importantli
bacterium
found
highli
suscept
antimicrobi
action
amongst
peptid
test
studi
suggest
like
contribut
selflimit
natur
infect
via
enhanc
bacteri
clearanc
bole
nadph
oxidas
oxid
burst
respons
tolllik
receptor
ignal
larg
intestin
epitheli
cell
iozuhito
rokutan
yuki
kuwano
tsukasa
kawahara
hisano
mino
shigetada
teshimakondo
llecent
two
famili
p
homologu
identifi
nadph
oxidas
nox
dual
oxidas
duox
famili
nox
famili
compris
noxl
initi
term
moxl
nohi
renam
renox
noxl
preferenti
express
colon
physiolog
role
noxl
start
investig
recent
nox
organ
refer
nox
activ
gene
encod
novel
homologu
respect
clone
new
adaptor
protein
thought
essenti
noxl
activ
establish
primari
cultur
guinea
pig
larg
intestin
epitheli
ceil
give
puriti
surfac
mucou
cell
cell
spontan
releas
superoxid
anion
nmolmg
proteinh
express
noxl
racl
mrna
gpgl
mrna
also
express
human
colon
cancer
cell
line
cell
express
noxl
racl
mrna
nadph
compon
mrna
secret
aall
amount
superoxid
anion
nmolmg
proteinh
cotransfect
psl
cdna
cell
enhanc
pmastimul
superoxid
releas
treatment
transfect
cell
recombin
flagelfin
rfiic
salmonella
enteritidi
augment
superoxid
releas
associ
induct
noxl
protein
ila
enhanc
superoxid
product
cotransfect
x
vector
gment
rfbcstimuiat
releas
cell
cell
express
tolllik
receptor
rflic
rapidli
phosphoryl
transform
growth
factorbactiv
idnas
bind
protein
potent
inhibitor
nfkb
pyrrofidin
dithiocarbam
significantli
block
rflicprim
increas
superoxid
produclion
induct
noxl
protein
result
suggest
involv
noxl
activ
surfac
mucou
cell
colon
besid
epitheli
cell
discern
pathogenec
among
bacteria
appropri
oper
noxl
host
defens
hand
probiot
report
vitro
antiinflammatori
effect
howev
whether
mucos
bacteria
f
varium
caus
inflamm
intestin
mucosa
determin
method
human
colon
epitheli
cell
cocultur
mucos
bacteria
isol
uc
speci
probiot
speci
cell
cultur
infect
bacteria
resuspend
mem
contain
fb
bacteriumcel
ratio
incub
h
allow
bacteri
entri
occur
remov
extracellular
bacteria
cultur
incub
h
presenc
imipenem
kill
remain
extracelhilar
bacteria
subsequ
supemat
remov
cell
lyse
sd
salin
number
viabl
bacteria
releas
determin
cultur
day
agar
plate
concentr
supemat
determin
elisa
kit
result
mucos
bacteria
includ
f
vanum
eubacterium
aerofacien
e
colt
enterococcu
feacium
staphylococcu
epidermidi
streptococcu
sangui
recov
cell
cfuml
bacteria
includ
probiot
strain
l
delbrueckii
subsp
bulgaricu
str
thermophilu
l
gasseri
b
longum
enter
cell
concentr
exposur
bacteria
strain
pgml
contrast
mean
concentr
exposur
f
varium
highest
level
pgml
concentr
exposur
b
vulgatu
st
epidermidi
eubacteriam
lentum
eubacterium
aerofacien
sir
sangui
arid
respect
howev
concentr
exposur
probiot
pgml
conclus
probiot
invad
colon
epitheli
ceil
induc
secret
cell
hand
mucos
bacteria
especi
f
varium
isol
uc
invad
colon
epitheli
cell
induc
secret
background
gitr
member
tumor
necrosi
factor
receptor
famili
induc
dexamethason
murin
ceil
molecul
also
known
highli
express
cell
involv
regulatori
function
cell
also
express
membranebound
tgfb
might
mediat
suppress
cellcel
contact
express
gitr
membranebound
tgfb
characterist
marin
cell
aim
present
studi
sought
determin
whether
human
ceil
also
express
gitr
membranebound
tgfb
well
murin
cell
next
sought
analyz
differ
ceil
patient
ibd
healthi
volunt
method
peripher
blood
lymphocyt
obtain
ulcer
coliti
uc
crohn
diseas
cd
healthi
volunt
control
centrifug
fresh
blood
fcoil
paqu
cytometr
analysi
cell
stain
approxim
dilut
antibodi
antibodi
includ
hladrp
harm
ngen
antihuman
gitr
genzymetechn
antihuman
lap
r
system
result
express
gitr
significantli
higher
cell
control
cell
gitr
posit
gitr
posit
sire
arli
membranebound
tgf
express
higher
level
cell
respect
signific
differ
uc
cd
control
ratio
respect
ratio
respect
ratio
respect
howev
signific
differ
activ
uc
inact
uc
ratio
respect
conclus
human
cell
also
express
gitr
membranebound
well
murin
cell
number
cell
express
tgp
significantli
increas
patient
inact
uc
compar
activ
uc
tgf
may
involv
induct
sustain
remiss
uc
louis
ocallaghan
barbara
shell
john
macsharri
john
k
collin
liam
omafioni
fergu
shanahan
background
prophylact
efficaci
coliti
follow
bifidobacterium
consumpt
knockout
ko
mice
report
molecular
mechan
underpin
unclear
previous
show
chang
cytokin
product
therefor
aim
studi
comprehens
examin
system
mucos
immunolog
respons
vitro
challeng
defin
stimuli
probioticand
placebof
ko
mice
method
illoko
mice
fed
bifidobacterium
infanti
per
day
ident
placebo
week
sacrific
spleen
peyer
patch
intestin
mucosa
peyer
patchfre
remov
singl
cell
suspens
gener
cell
phenotyp
examin
use
flow
cytometri
singl
cell
suspens
stimul
monoclon
antibodi
salmonella
typhimurium
bifidobacterium
infanti
heterolog
faecal
flora
lysat
hour
tnfa
ifni
tgf
mipla
rant
cytokin
level
measur
use
elisa
result
signific
alter
cytokin
respons
observ
probioticf
mice
particularli
within
peyer
patch
cell
spontan
product
tnfc
ifn
peyer
patch
cell
vitro
significantli
reduc
probint
fed
mice
p
addit
ifn
secret
significantli
reduc
peyer
patch
cell
isol
probioticf
anim
stimul
vitro
salmonella
bifidohacteria
flora
lysat
contrast
spontan
stimul
rant
secret
enhanc
peyer
patch
cell
probioticf
mice
enhanc
rant
product
also
note
cell
deriv
mucosa
intriguingli
spontan
secret
significantli
reduc
splenocyt
cultur
deriv
probioticl
mice
secret
enhanc
mucosa
peyer
patch
cell
predomin
ilioko
mous
howev
ratio
normal
probiot
fed
mice
conclus
consumpt
b
infanti
induc
immunolog
alter
host
chemokin
proinflammatori
cytokin
signal
affect
howev
alter
sitespecif
observ
system
compart
extrapol
intestin
immun
ceil
sensit
dss
coliti
ki
li
lauren
kmideni
tizong
miao
lan
r
sanderson
ping
wang
suppressor
cytokin
signal
protein
regul
respons
immun
cell
cytokin
studi
group
shown
lymphocyt
overexpress
increas
metabol
prolifer
investig
impact
intestin
mucos
immun
respons
induc
moder
dextran
sodium
sulphat
dss
coliti
constitut
overexpress
mice
typic
symptom
coliti
loos
stool
rectal
blood
loss
loss
bodi
weight
appar
transgen
mice
n
earli
day
dss
administr
wild
type
litterm
n
symptom
first
observ
day
result
transgen
anim
lost
significantli
bodi
weight
end
experi
day
wild
type
mice
p
subsequ
histopatholog
assess
tissu
injuri
inflam
proxim
distal
colon
area
reveal
gross
differ
transgen
wild
type
mice
howev
immunohistochem
analysi
area
show
increas
number
lamina
propria
lymphocyt
transgen
addit
colon
tnfa
mrna
level
transgen
mice
significantli
increas
moreov
spleen
lympbocyt
isol
transgen
mice
exhibit
higher
prolif
activ
cell
wild
type
litterm
p
find
provid
first
vivo
evid
involv
intestin
inflamm
suggest
sensitis
gut
inflammatori
insult
stimul
chinal
expans
local
lymphocyt
novel
cytokin
thl
properti
upregul
inflam
intestin
mucosa
patient
paul
guarino
muhammadzeza
sachedina
sharon
hoang
margarita
mishina
giorgo
bamia
brian
k
reuter
fabio
cominelfi
theresa
pizarro
background
novel
heterodimer
cytokin
relat
share
subunit
well
abil
induc
th
mediat
immun
respons
preferenti
express
recent
report
normal
mous
gastrointestin
tract
ileal
dendrit
cell
implic
potenti
role
sitespecif
manifest
crohn
diseas
cd
prototyp
thlmediat
inflammatori
disord
aim
determin
rel
express
cellular
local
intestin
mucosa
patient
ibd
noninflam
control
method
involv
inv
noninvolv
ninv
intestin
mucos
biopsi
patient
cd
ulcer
coliti
uc
well
noninflam
tissu
control
cont
process
total
cellular
rna
revers
transcrib
result
cdna
analyz
real
time
pcr
rtpcr
transcript
level
use
sequencespecif
probe
primer
human
result
normal
rna
cellular
local
determin
immunohistochemistri
util
recombin
human
receptorhuman
igg
fc
chimera
primari
detect
antibodi
result
mrna
levd
significantli
increas
cd
lnv
uc
inv
compar
cont
lp
although
increas
level
mrna
detect
cd
inv
compar
uc
lnv
increas
cd
ninv
compar
cont
trend
reach
statist
signific
statist
signific
differ
transcript
level
uc
ninv
versu
cont
tissu
addit
protein
local
lamina
propria
mononuclear
cell
morpholog
consist
tissu
histiocyt
macrophag
inflam
ileal
tissu
cd
patient
conclus
taken
togeth
studi
indic
present
higher
level
inflam
tissu
patient
cd
compar
noninflam
noncd
patient
tissu
given
abil
elicit
thl
immun
respons
memori
tcell
local
lamina
propria
affect
tissu
data
suggest
may
play
pivot
role
pathogenesi
chronic
intestin
inflamm
characterist
cd
variant
human
receptor
cytoplasm
domain
render
cell
insensit
paul
gmndmer
christoph
gasch
background
target
disrupt
gene
gene
involv
signal
mice
caus
chronic
intestin
inflamm
similar
ibd
human
two
variant
allel
cytoplasm
domain
extracellular
domain
allel
present
caucasian
protect
uc
previous
lab
show
monocyt
individu
carri
variant
less
sensit
inhibit
tnfot
product
vitro
ramunol
studi
elucid
molecular
basi
function
differ
snp
method
code
sequenc
cdna
obtain
differ
individu
three
common
haplotyp
wildtyp
egfp
gene
control
clone
result
construct
transfect
mous
pro
bcell
line
carri
select
puromycin
clone
check
express
construct
flow
cytometri
western
blot
induc
prolifer
test
mttassay
without
addit
result
stabl
clone
grown
hour
plate
variou
concentr
induc
moder
prolifer
within
hour
less
none
clone
figur
effect
consist
within
hour
prolifer
period
overrul
proiifer
cumul
effect
seen
suboptim
concentr
conclus
data
indic
exchang
glycin
arginin
cytoplasm
domain
human
render
ceil
unrespons
simultan
presenc
variant
partial
counteract
effect
yet
poorli
understood
mechan
background
mediat
nfkb
activ
respons
proinflammatori
cytokin
express
tcra
activ
memori
cell
although
implic
ibd
regul
receptor
system
remain
unclear
method
human
splice
variant
express
assess
intestin
mucosa
crohn
diseas
ulcer
coliti
control
patient
rtpcr
intracellular
receptor
traffick
secret
signal
transduct
assess
use
full
length
mutant
gfp
flagtag
express
construct
cell
cell
line
lack
full
length
express
confoc
microscopi
util
character
activ
depend
membran
compart
associ
result
encod
exon
stretch
bp
chromosom
clone
human
observ
potenti
splice
variant
lack
transmembran
domain
encod
exon
analysi
inflam
noninflam
intestin
tissu
mrna
confirm
express
contain
complet
extracellular
bind
domain
cytoplasm
tail
lack
aa
encod
exon
ii
isoform
concomitantli
express
tissu
similar
ratio
howev
mrna
express
upregul
crohn
diseas
compar
normal
control
splice
variant
appear
constitut
express
furthermor
ratio
mrna
express
vari
differ
intestin
hematopoet
cell
line
correspond
respons
lack
transmembran
domain
result
distinct
vesicular
sort
isoform
integr
enrich
cell
surfac
membran
rapidli
transloc
earli
endosom
compart
upon
stimul
contrast
observ
golgi
network
secretori
vesicl
minim
overlap
contain
compart
indic
earli
differenti
cellular
target
receptor
isoform
consequ
could
isol
cell
supemat
conclus
discoveri
solubl
demonstr
signal
system
includ
least
one
addit
secret
regul
differenti
control
mrna
splice
may
respons
modul
adapt
respons
ubiqu
express
cytokin
receptor
system
heme
oxygenas
regul
balanc
inflammatori
cytokin
dextrau
sodium
sulfateinduc
coliti
tomohisa
takagi
fuji
naito
kaauhiro
katada
yutaka
isozaki
masaaki
kuroda
hisato
tsuboi
toshimitau
okuda
satoshi
kokura
hiroshi
ichikawa
norimasa
yoshida
toshikazu
yoshlkawa
background
hein
oxygenas
ho
ratelimit
enzym
hein
degrad
catalyz
cleavag
hein
ring
form
carbon
monoxid
co
ferrou
iron
biliverdin
three
ho
isoform
identifi
one
play
protect
role
process
inflamm
present
studi
investig
possibl
role
regul
inflammatori
process
use
dextran
sodium
sulfat
dss
induc
coliti
mice
materi
method
acut
coliti
induc
dss
male
balb
c
mice
diseas
activ
index
dad
determin
daili
basi
anim
consist
calcul
score
base
chang
bodi
weight
stool
consist
intestin
bleed
rnrna
protein
express
determin
western
blot
rtpcr
differ
point
dss
induct
colon
mrna
express
proand
antiinflammatori
eytokin
tnfa
ifng
determin
elisa
rtpcr
mrna
express
thl
marker
marker
also
measur
moreov
evalu
enhanc
treatment
inhibitor
zinc
protoporphyrin
ix
znpp
ip
daili
result
dss
administr
dai
score
express
mrna
protein
increas
timedepend
manner
express
tnfa
ifng
mrna
increas
dss
administr
express
enhanc
dss
administr
compar
express
coadministr
znpp
enhanc
increas
dai
score
increas
express
tnfa
ifng
enhanc
znpptreat
group
domin
express
also
enhanc
contrast
increas
express
ilio
inhibit
znpptreat
group
conclus
result
indic
play
protect
role
intestin
mucos
injuri
induc
dss
effect
probabl
result
regul
cytokin
balanc
intestin
tissu
introduct
ulcer
coliti
uc
character
immun
respons
lead
mucosai
inflamm
epitheli
barrier
dysfunct
howev
typic
cytokin
affect
intestin
barrier
recent
identifi
key
cytokin
oxazaloncof
mous
model
uc
present
studi
aim
character
role
epitheli
barrier
function
uc
method
lymphocyt
isol
biopsi
uc
patient
product
measur
monolay
use
cell
cultur
model
studi
effect
barrier
function
investig
measur
resist
ussingtecbniqu
tight
junction
protein
quantifi
immunohlot
densitometr
epitheli
apoptosi
detect
tunel
stain
epitheli
restitut
assess
monolay
closur
lociti
um
defect
result
uc
lymphocyt
releas
higher
eontrol
cell
longml
decreas
rt
parallel
apoptot
ratio
upregul
p
interferong
effect
poreform
tight
junction
protein
increas
control
p
wound
heal
assay
repair
veloc
reduc
umh
final
uc
mucosa
studi
similar
alter
observ
cell
expos
name
increas
express
epitheli
apoptot
ratio
conclus
key
cytokin
ulcer
coliti
thc
induc
epitheli
bamer
dysfunct
affect
epitheli
tight
junction
epitheli
apoptosi
epitheli
restitut
thiazolidenedion
background
crohn
diseas
character
recurr
episod
intestin
inflamm
associ
thl
cytokin
cell
chemoattract
nuclear
transcript
factor
ppargamma
pparg
highli
express
normal
crohn
diseas
intestin
epithelium
activ
receptor
demonstr
reduc
gener
inflamm
murin
coliti
model
howev
littl
known
regard
specif
effect
pparg
activ
intestin
cell
migrat
test
whether
pparg
activ
reduc
secret
thlassoci
chemokin
intestin
epithelium
whether
reduct
associ
reduc
cell
migrat
coliti
method
effect
specif
tzd
pparg
agonist
rosiglitazon
pioglitazon
chemokin
level
measur
vitro
vivo
vitro
experi
intestin
epitheli
cell
preincub
vari
level
agonist
follow
addit
ifng
tnfa
hour
chemokin
rna
protein
level
measur
qpcr
elisa
coliti
experi
mice
given
acut
dextran
sodium
sulfat
dss
mediat
coliti
without
pretreat
pioglitazon
day
chemokin
level
colon
number
colon
cell
measur
quantit
pcr
elisa
immunohistochemistri
anoth
set
experi
splenocyt
congeinc
express
mice
given
dss
day
earlier
inject
intraperiton
mice
given
coliti
day
previous
chemokin
rna
protein
level
number
cell
asssess
hour
posttransf
result
four
tzd
test
significantli
decreas
mrna
protein
level
thlassoci
chemokin
activ
intestin
epitheli
cell
dose
depend
manner
similarli
dss
coliti
level
signflcantli
reduc
reduct
thlassoci
chemokin
parallel
decreas
colon
cell
infiltr
evidenc
adopt
transfer
label
ceil
conclus
tzd
reduc
level
thlassoci
chemokin
cell
traffick
overal
intestin
inflamm
compound
attract
candid
mainten
adjuv
therapi
thl
diseas
like
crohn
diseas
arvind
batra
lnka
fedk
bianca
wittig
martin
zeitz
georg
ku
john
randl
britta
siegmund
introduct
demonstr
upregul
lesion
patient
crohn
diseas
ulcer
coliti
express
constitut
inact
precursor
cleav
therebi
activ
interleukinl
convert
enzym
ice
demonstr
previous
ice
ko
mice
protect
acut
chronic
dssinduc
coliti
pna
pna
sinc
act
strong
synerg
ifn
induct
hypothes
inhibit
ice
would
also
offer
protect
coliti
model
method
trinitrobenzen
sulfon
acid
tnb
induc
coliti
oxazoloneinduc
coliti
model
employ
mice
treat
bid
pralnacasan
via
oral
garag
start
initi
coliti
mortal
weight
loss
histolog
score
evalu
end
experi
colon
cultur
perform
cytokin
evalu
well
analysi
apoptosi
lamina
propria
lymphocyt
lpl
flow
cytometri
result
vehicletr
wt
mice
mortal
observ
coliti
induct
tnb
pralnacasantr
mgkg
mice
die
addit
pralnacasan
treatment
prevent
weight
loss
histolog
sign
inflammati
significantli
reduc
compar
vehicletr
group
vs
p
inflamm
maximum
diseas
consist
reduc
macroscop
histolog
diseas
sever
ifnand
concentr
markedli
suppress
supernat
total
colon
cultur
pralnacasantr
anim
releas
antiinflammatori
cytokiu
remain
unchang
tnbsinduc
coliti
associ
decreas
apoptosi
lpl
vehicletr
wt
mice
contrast
lpl
pralnacasantr
tnbsexpos
mice
present
apoptot
rate
similar
one
detect
healthi
control
mice
oxazoloneinduc
coliti
pralnacasan
mgkg
po
treatment
reduc
colon
tissu
content
ili
dosedepend
summari
inhibit
ice
specif
inhibitor
pralnacasan
current
phase
rheumatoid
arthriti
protect
thla
well
coliti
provid
therefor
interest
target
human
diseas
background
hydroxyeicosatetraeno
acid
hete
import
paracrin
signal
modul
cancer
inflamm
hete
synergist
enhanc
iklainduc
express
human
colon
myofibroblast
cmf
ilia
induc
transcript
via
erk
activ
pkcz
zeta
mediat
ro
gener
activ
also
enhanc
mrna
stabil
aim
studi
determin
hete
enhanc
express
method
cmf
treat
illa
pgml
hetb
ram
protein
isol
subject
western
blot
analysi
erk
analysi
immunoprecipitationkinas
assay
pkcz
activ
mrna
stabil
assess
ad
drb
ram
h
illa
addit
subject
rna
isol
variou
time
northern
blot
analysi
singl
cell
ro
gener
determin
dcf
fluoresc
result
r
hete
enhanc
express
fold
yet
affect
express
primari
effect
level
messag
stabil
although
modest
fold
transcript
enhanc
seen
hete
affect
erk
pkcz
activ
increas
activ
hour
compar
alon
hete
alon
induc
ro
gener
fold
combin
hete
significantli
increas
ro
compar
ili
alon
vs
respect
ram
also
enhanc
express
antioxid
dpi
ndga
block
effect
hete
conclus
data
demonstr
hete
enhanc
express
cmf
via
enhanc
ro
gener
result
increas
messag
stabil
shortterm
hour
enhanc
activ
heteinduc
ro
involv
increas
pkcz
activ
suggest
differ
mechan
ro
gener
illa
result
demonstr
depend
sourc
ro
affect
express
transcript
posttranscript
level
studi
support
gulf
coast
ddc
role
membran
nuclear
prostaglandin
receptor
ulcer
hiromi
bamba
shinichi
ota
kenji
fujimori
akira
kato
hiroypki
miyatani
shinichi
ban
chiaki
kawamoto
michio
shimizu
yukio
yoshida
kenji
fujiwara
prostaglandin
pg
product
induc
isoform
pg
synthetas
shown
induc
growth
factor
hepatocyt
growth
factor
hgf
vascular
endotheli
growth
factor
vegf
contribut
repair
process
gastric
mucosa
gastro
recent
studi
demonstr
pg
may
play
import
role
prevent
intestin
mucos
inflamm
membran
receptor
pge
receptor
andor
peroxisom
proliferatoractiv
receptor
nuclear
pg
receptor
ppar
j
clin
invest
gastro
present
studi
determin
target
role
pg
ulcer
coliti
uc
examin
local
effect
pg
hgf
vegf
product
macrophag
colon
flbroblast
method
three
specimen
human
uc
immunostain
specif
antibodi
macrophag
myofibroblast
pmadifferenti
cell
use
human
macrophag
model
hmac
human
colon
fibroblast
obtain
resect
colon
surgeri
cultur
medium
fetal
bovin
serum
pge
agonist
pge
receptor
agonist
ppar
use
hgf
vegf
camp
measur
mrna
express
pg
receptor
cell
assess
rtpcr
result
immunoreact
predominantli
strongli
express
interstiti
cell
locat
around
microvessel
sever
inflam
area
stain
pattern
macrophag
myofibroblast
similar
observ
uc
mrna
pge
receptor
express
hmac
colon
fibroblast
hmac
pge
dramat
increas
vegf
product
significantli
increas
camp
format
membraneperm
form
camp
cholera
toxin
camp
elev
agent
also
significantli
increas
vegf
product
dramat
increas
vegf
product
camp
format
fibroblast
dramat
increas
hgf
vegf
product
significantli
increas
camp
format
cholera
toxin
also
significantli
increas
hgf
vegf
product
increas
hgf
vegf
product
conclus
result
suggest
pggrowth
factor
pathway
membran
receptormedi
process
may
defens
role
human
uc
studi
requir
establish
role
ppari
area
background
mesenter
adipos
tissu
hypertrophi
fat
wrap
one
characterist
crohn
diseas
cd
find
suggest
adipocyt
secret
specif
protein
could
play
function
role
pathogenesi
cd
adiponectin
adipocytespecif
secretori
protein
identifi
group
human
adipos
tissu
adiponectin
belong
famili
protein
includ
c
l
q
report
adiponectin
may
antiinflammatori
properti
especi
macrophag
may
suppress
phagocyt
activ
tnfaproduct
therefor
investig
adiponectin
express
mesenter
adipos
tissu
contigu
intestin
cd
method
mesenter
adipos
tissu
specimen
obtain
cd
patient
n
ulcer
coliti
uc
patient
n
control
n
undergo
intestin
resect
immunohistochemistri
adiponectin
perform
adiponectin
concentr
tissu
homogen
adiponectin
releas
vitro
shortterm
cultur
determin
elisa
adiponectin
mrna
concentr
tissu
homogen
determin
competit
rtpcr
moreov
associ
adiponectin
concentr
laboratori
data
investig
result
adiponectin
concentr
mesenter
adipos
tissu
contigu
involv
intestin
cd
patient
adiponectin
releas
significantli
higher
mesenter
adipos
tissu
contigu
healthi
intestin
cd
patient
p
p
respect
intestin
uc
patient
p
p
intestin
control
p
p
increas
adiponectin
mrna
level
found
mesenter
adipos
tissu
contigu
involv
intestin
cd
patient
compar
healthi
intestin
cd
patient
p
furthermor
adiponectin
concentr
mesenter
adipos
tissu
contigu
involv
intestin
invers
correl
serum
crp
level
cd
patient
p
conclus
result
suggest
adipocyt
hypertrophi
mesenter
adipos
tissu
fat
wrap
produc
secret
lot
adiponectin
may
regul
inflammatori
reaction
cd
character
cytokin
upregul
oligopeptid
transport
peptl
human
cell
stephan
r
vavricka
mark
w
musch
laura
chang
keri
kle
ken
drabik
didier
merlin
eugen
b
chang
background
r
aim
ditripeptid
transport
intestin
epitheli
cell
highli
express
small
intestin
minim
express
colon
state
chronic
colon
inflamm
express
upregul
colon
epitheli
cell
contrast
transportand
barrierrel
protein
dowrtregul
ifn
one
cytokin
stimul
activ
appear
potenti
mediat
increas
express
chronic
inflamm
low
dose
ml
known
increas
activ
cell
absenc
increas
protein
express
studi
examin
potenti
role
differ
cytokin
mediat
inflammationassoci
increas
activ
express
method
cell
grown
collagen
oat
transwel
treat
tnfc
cell
function
determin
measur
jh
glycosylsarcosin
transport
classic
hpeptl
substrat
protein
determin
total
biotinyl
sampl
repres
apic
western
blot
result
basolater
treatment
cell
tnfa
concentr
hour
hour
hour
reveal
upregul
protein
total
biotinyl
portion
earli
time
point
apic
total
express
increas
parallel
chang
activ
later
time
point
increas
activ
observ
correl
induct
express
apic
membran
increas
total
express
concentr
tnfa
show
concentrationdepend
upregnl
hpeptf
total
biotinyl
sampl
detect
concentr
hour
cytokin
like
fail
increas
hpeptf
function
hpeptf
express
conclus
tnfcl
two
import
cytokin
may
modul
intestin
inflamm
upregul
activ
protein
cell
increas
express
may
respons
enhanc
express
function
express
chronic
inflam
colon
mucosa
tomoaki
ando
john
elrod
merilyn
jen
paul
jordan
takashi
joh
makoto
ltoh
j
background
aim
although
mucos
addressin
cell
adhes
associ
ibd
vitro
studi
examin
colon
endotheli
cell
therefor
studi
focus
express
regul
function
cultur
murin
colon
endotheli
cell
method
establish
colon
endotheli
cell
line
immortomous
mice
express
temperaturesensit
larg
antigen
mice
immortomic
express
cell
examin
respons
tnfc
ili
ifni
signal
pathway
involv
express
examin
use
signal
blocker
proteasom
pare
tyrosin
kinas
genistein
map
kinas
pkc
pkg
also
examin
lymphocyteendotheli
adhes
use
cell
express
without
satur
level
mab
result
tnfx
induc
dosedepend
time
point
induct
pkc
tyrosin
kinas
mapk
nfkbparp
depend
ili
ifni
induc
express
lymphocyt
endotheli
adhes
increas
tnfc
significantli
inhibit
antibodi
p
vs
tnfc
treatment
conclus
express
respons
cytokin
thought
import
event
ibd
induc
colon
endotheli
cell
tnfa
act
determin
lymphocyt
recruit
therefor
system
may
provid
use
model
form
ibd
vitro
defici
nk
specif
nk
tcell
crohn
diseas
ulcer
coliti
randal
h
grose
adrian
cummin
fiona
thompson
subset
immunoregnlatori
tcell
surfac
pfienotyp
vijll
tcell
predominantli
nk
cell
cdld
restrict
tcell
defici
autoimmun
disord
aim
studi
investig
whether
regulatori
tcell
defici
crohn
diseas
ulcer
coliti
blood
collect
flow
cytometri
subject
crobn
diseas
n
ulcer
coliti
n
control
subject
n
number
circul
cd
nk
cell
v
ifn
product
measur
vitro
antibodi
stimul
rel
duplex
pcr
ileal
colon
biopsi
sampl
use
determin
mrna
express
nk
cell
reduc
crohn
diseas
level
normal
control
similarli
nk
cell
reduc
ulcer
coliti
subject
v
tcell
nr
tcell
reduc
level
normal
control
respect
crohd
diseas
v
v
xgalactosylceramidecdld
tcell
crohn
ulcer
coliti
compar
normal
control
subject
product
tcell
defect
intestin
mrna
express
crohn
diseas
ulcer
coliti
respect
level
normal
subject
conclud
nk
cell
defici
crohn
diseas
ulcer
coliti
v
tcell
defici
function
defect
crohn
diseas
select
mucos
defici
ulcer
coliti
v
cgalactosylceramidecdld
tetram
cell
defici
crohn
diseas
ulcer
coliti
decreas
immunoregnlatori
ceil
may
contribut
pathogenesi
ibd
clinic
benefit
activ
ulcer
coliti
patient
demonstr
recent
phase
trial
present
studi
pharmacolog
effect
tumor
necrosi
factoralpha
tnfa
product
eukocyt
vitro
vivo
evalu
method
whole
blood
aliquot
hepariinz
human
porcin
whole
blood
incub
without
variou
concentr
min
room
temperatur
lipopolysaccharid
lp
ad
incub
hr
cultur
supernat
collect
elisa
isol
peripher
blood
monocyt
human
porcin
monocyt
isol
steril
condit
whole
blood
use
dextran
sediment
follow
ficollhypaqu
centrifug
adhes
well
cultur
plate
monocyt
either
treat
variou
concentr
rain
left
untreat
stimul
lp
incub
hr
human
monocyt
hr
porcin
monocyt
cultur
supernat
collect
elisa
vivo
porcin
endotoxemia
model
anesthet
pig
receiv
iv
infus
gkgmin
vehicl
prior
lp
infus
gkghr
plasma
sampl
collect
sever
time
point
use
elisa
result
without
lp
stimul
tnfa
product
vitro
experi
except
porcin
whole
blood
human
whole
blood
isol
human
monocyt
inhibit
tnfx
product
concentrationdepend
manner
respect
also
inhibit
tnfu
product
porcin
monocyt
vivo
model
transient
increas
plasma
level
observ
peak
min
lp
infus
pretreat
suppress
increas
plasma
tnfa
level
doserel
manner
gkgmin
significantli
suppress
increas
compar
vehicl
control
group
conclus
inhibit
tnfa
product
monocyt
inhibitori
effect
demonstr
vitro
vivo
fkn
endotheli
cell
surfac
chemokin
mediat
leukocyt
adhes
uniqu
receptor
fknr
investig
potenti
role
fkn
ibd
assess
product
function
crohn
diseas
cd
ulcer
coliti
uc
fkn
express
rest
activ
control
ibd
human
intestin
microvascular
endotheli
cell
himec
studi
flow
cytometri
western
blot
secret
solubl
fkn
measur
elisa
himec
supemat
fknr
express
assess
flow
cytometri
peripher
blood
tcell
cd
uc
control
well
tcell
line
role
fkn
leukocytehlmec
adhes
investig
antibodi
blockad
control
ibd
unstimul
himec
display
low
fkn
express
moder
upregul
tnfa
illjj
howev
combin
tnfa
ifni
reduc
mark
synergist
effect
significantli
p
stronger
cd
uc
control
himec
contact
jurkat
tcell
also
upregnl
fkn
express
increas
significantli
p
higher
cd
uc
control
himec
fkn
secret
parallel
himec
surfac
express
cd
uc
produc
significantli
p
control
fknr
express
significantli
p
higher
cdj
tcell
activ
cd
uc
patient
inact
diseas
control
adhes
jurkat
cell
cd
uc
himec
significantli
p
higher
control
himec
fkn
blockad
substanti
decreas
adhes
interestingli
fkn
blockad
result
greater
inhibit
vcamlmedi
adhes
induc
alon
combin
enhanc
fkn
product
mucos
microvasculamr
upregnl
express
fknr
peripher
tcell
provid
possibl
explan
enhanc
endothelialtcel
adhes
cd
uc
suggest
specif
mechan
tcell
recruit
inflam
mucosa
contribut
ibd
pathogenesi
viva
regul
solubl
cytokin
receptor
infliximab
steroid
crohn
diseas
thierri
gustot
andr
van
gossum
charl
nicais
eric
quertinmont
sandrin
roland
jacqu
devier
deni
franchimont
background
acutephas
respons
apr
selffimit
phenomenon
initi
product
sever
negativefeedback
factor
solubl
cytokinereceptor
scr
stnfri
stnfrii
scr
cytokinescaveng
inhibit
bind
cytokin
membran
receptor
major
except
complex
activ
cellular
subunit
driven
signal
transduct
howev
solubl
form
prevent
interact
inhibit
signal
pathway
pharmacolog
block
tnfa
offer
uniqu
opportun
understand
tnfamedi
offer
regul
scr
compar
modul
steroid
method
prospect
examin
activ
cd
patient
acd
treat
lnfliximab
mgkg
intraven
methylprednisolon
mp
mgkg
n
patient
cd
clinic
remiss
rcd
cdai
normal
crp
wo
immunosuppress
n
healthi
subject
n
circul
level
tnf
stnfri
stnfrii
illb
measur
use
quantit
sandwich
enzym
immunoassay
baselin
week
treatment
result
higher
level
stnfri
p
p
stnfrii
p
p
p
p
p
p
p
ns
observ
acd
compar
rcd
healthi
subject
importantli
solubl
decoy
receptor
vs
p
p
p
p
decreas
acd
compar
rcd
healthi
subject
emphas
defici
product
two
import
antiinflammatori
ssr
acd
infliximab
mp
induc
signific
decreas
cdai
p
crp
p
p
alreadi
week
interestingli
lnfliximab
induc
signific
decreas
stnfrii
week
p
surprisingli
enhanc
express
week
p
invers
mp
clearli
increas
week
week
p
p
respect
conclus
differ
profil
scr
product
observ
acd
rcd
induct
therapi
tnfliximab
steroid
differ
regul
scr
acd
background
aim
activ
ulcer
coliti
uc
associ
elev
peripher
blood
granulocyt
monocytesmacrophag
show
activ
behaviour
produc
proinflammatori
cytokin
resist
apoptosi
level
neutrophil
mucosa
parallel
intestin
inflamm
predict
uc
relaps
accordingli
adsorpt
granulocyt
monocyt
apheresi
gma
patient
sever
uc
associ
dramat
sustain
clinic
efficaci
hanai
h
et
al
clin
gastroenterol
hepatol
howev
full
efficaci
gma
appear
due
reduct
peripher
blood
granulocyt
monocyt
per
se
method
interest
see
gma
chang
plasma
level
substanc
might
exert
antiinflammatori
effect
fortysix
patient
steroid
depend
uc
mean
cai
clinic
activ
index
dai
diseas
activ
index
treat
gma
use
adacolumn
remov
granulocyt
monocyt
small
fraction
lymphocyt
fci
complement
receptor
bear
leukocyt
first
treatment
session
measur
plasma
level
receptor
antagonist
solubl
tnfa
receptor
li
lselectin
express
index
leukocyt
inlet
column
blood
return
patient
column
outflow
result
column
outflow
level
illra
tnfa
receptor
ii
increas
respect
togeth
downmodul
l
selectin
test
sampl
tnfa
virtual
undetect
lllra
report
strong
antiinflammatori
effect
solubl
tnfc
receptor
known
block
effect
viva
conclus
major
sourc
illra
ilio
tnfa
receptor
ii
believ
adsorb
rnonocyt
neutrophil
column
came
effect
togeth
reduct
circulaung
level
granulocyt
monocyt
allevi
inflamm
promot
remiss
activ
uc
result
increas
understand
mechan
clinic
efficaci
associ
adsorpt
granulocyt
monocyt
apheresi
introduct
clinic
outcom
ulcer
coliti
uc
shown
correl
vitro
measur
lymphocyt
steroid
sensit
lss
small
studi
implic
overproduct
steroid
resist
report
benefici
effect
receptor
treatment
upon
steroid
resist
uc
aim
studi
relationship
vitro
lss
product
cytokin
lymphocyt
larger
studi
method
peripher
blood
lymphocyt
healthi
volunt
isol
lss
assess
measur
antiprolif
effect
dexamethason
dex
follow
stimul
phytohaemagglutinin
pha
result
count
per
minut
cpm
mean
triplic
cultur
present
percentag
inhibit
moll
dex
cpm
pha
alon
cpm
dexcpm
pha
alon
x
cultur
supemat
post
pha
stimul
assay
ilio
tnfa
ifn
use
flow
cytometrymultiplex
bead
array
correl
spearman
rho
result
median
im
pha
stimul
median
cytokin
level
pgml
absenc
dex
low
high
tnfa
ifni
strong
neg
correl
tnfa
none
level
p
p
receptor
blockad
basiliximab
result
rise
median
level
decreas
level
tnfa
ifn
presenc
basiliximab
steroid
resist
individu
overproduc
signific
neg
correl
l
level
p
p
conclus
lymphocyt
steroid
sensit
correl
secret
vitro
neg
correl
product
tnfa
ifni
especi
previous
shown
receptor
blockad
improv
lss
thu
low
level
present
must
play
least
permiss
role
steroid
resist
overproduct
cytokin
may
account
variat
lss
repres
target
intervent
excess
rise
presenc
evid
dysregnl
cytokin
product
steroid
resist
individu
effect
nicotin
cytokin
human
ldefensin
respons
organ
cultur
model
ibd
marian
c
aldhou
jack
satsangi
introduct
effect
smoke
ibd
well
establish
mechan
occur
unknown
affect
innat
acquir
immun
respons
cytokin
dysregnl
featur
cd
uc
mucos
human
produc
epitheli
cell
may
contribut
innat
defenc
microorgan
shown
rais
uc
investig
effect
nicotin
spontan
lpsinduc
cytokin
product
method
use
hour
organ
cultur
method
incub
colon
pinch
biopsi
obtain
endoscopi
patient
cd
n
uc
n
control
hc
n
differ
concentr
nicotin
lp
lp
nicotin
cytokin
ill
tgp
tnfa
measur
cultur
supernat
commerci
inhons
elisa
respect
result
signific
differ
cytokin
level
obtain
product
highest
unstimul
biopsi
hc
pgml
compar
cd
median
pgml
uc
median
pgml
similar
pattern
seen
lpsstimul
biopsi
hc
median
pgml
cd
median
pgml
uc
median
pgml
comparison
product
stimul
across
diseas
group
gave
signific
differ
p
anova
although
comparison
stimul
turn
signific
consist
pattern
product
respons
nicotin
alon
diseas
group
howev
comparison
biopsi
stimul
lp
alon
lpsnicotin
patient
increas
product
seen
cd
uc
hc
x
p
highest
unstimul
biopsi
uc
patient
median
pgml
compar
cd
median
pgml
hc
median
pgml
quit
reach
signific
oneway
anova
p
littl
chang
respons
stimul
discuss
increas
uc
level
affect
stimul
nicotin
andor
lp
product
reduc
cd
uc
compar
hc
level
significantli
chang
respons
nicotin
alon
differenti
chang
seen
nicotin
combin
lp
chang
product
may
enough
offset
fine
tune
local
inflammatori
respons
gut
may
underli
diseas
differ
respons
smoke
solubl
galectin
strong
colon
epitheli
cell
cec
deriv
fibroblast
stimul
factor
elisabeth
lippert
werner
falk
thflo
kaehn
juergen
schoelmerich
gerhard
rogler
background
intestin
fibroblast
play
import
role
pathogenesi
fibrosi
stenosi
crohn
diseas
cd
themechan
factor
affect
activ
flbroblast
cd
still
subject
research
therefor
tri
identifi
iecderiv
factor
activ
method
primari
human
cec
isol
control
mucosa
supernat
cultur
readout
activ
quantifi
elisa
transloc
nfkappab
inhibit
domin
neg
ikbexpress
adenoviru
activ
nfkappab
demonstr
immunfluoresc
proteindna
array
major
activ
induc
protein
purifi
use
fplc
hiprep
sephacryl
high
resolut
column
sd
gel
electrophoresi
sequenc
result
signific
increas
secret
stimul
ceccondit
media
compar
uncondit
media
versu
pgml
found
denatur
medium
minut
reduc
activ
suggest
effect
caus
protein
dilut
condit
media
still
induc
detect
level
indic
strong
stimul
effect
ieccondit
media
nfkappab
depend
overexpress
domin
neg
ikappab
reduc
secret
level
untreat
cell
transloc
nfkappab
nucleu
higher
stimul
compar
nonstimul
proteindna
array
confirm
result
fplc
analysi
suggest
exist
protein
molecular
weight
kda
mainli
respons
activ
purif
fplc
sdspage
subsequ
sequenc
reveal
solubl
galectin
strong
activ
factor
produc
cec
conclus
classic
biochem
approach
identifi
solubl
galectin
strong
activ
produc
cec
galectin
induc
nfkappab
activ
secret
cell
support
dfg
sfb
proangiogen
profil
mucos
microenviron
inflammatori
bowel
diseas
ibd
silvio
danes
miquel
san
brenda
rivera
rey
gall
west
manijeh
h
phillip
antonio
gasbarrini
claudio
fiocchi
neoangiogenesi
growth
new
blood
vessel
critic
neoplast
growth
also
chronic
inflamm
like
rheumatoid
arthriti
psoriasi
atherosclerosi
recent
demonstr
occurr
intens
neoangiogenesi
crohff
diseas
cd
ulcer
coliti
uc
mucosa
local
mediat
new
vessel
format
identifi
vivo
level
key
proangiogen
molecul
bfgf
vegf
cellular
sourc
examin
whether
could
promot
angiogenesi
vitro
test
human
intestin
microvascular
endotheli
cell
himec
elba
immunoblot
measur
bfgf
vegf
mucos
extract
cultur
human
intestin
fibroblast
hif
lamina
propria
mononuclear
cell
lpmc
stimul
tnfa
lf
respect
chemotaxi
test
extract
capac
induc
himec
migrat
contribut
individu
angiogen
factor
assess
antibodi
blockad
compar
control
pgmi
level
ibd
extract
remark
p
higher
uc
cd
true
bfgf
uc
cd
control
vegf
show
increas
ibd
compar
normal
mucosa
unstimul
hif
produc
neglig
amount
low
high
amount
bfgf
vegf
respect
tnfa
stimul
product
vegf
increas
dramat
bfgf
remain
unchang
contrast
lpmc
spontan
produc
larg
amount
three
mediat
increas
lp
stimul
lp
enhanc
bfgf
vegf
cd
uc
extract
induc
increas
himec
migrat
inhibit
primarili
block
less
bfgf
vegf
result
demonstr
immun
nonimmun
cell
significantli
contribut
creation
proangiogen
microenviron
ibd
mucosa
understand
domin
angiogen
factor
cellular
sourc
provid
materi
conceptu
base
develop
novel
antiangmgen
therapi
ibd
role
sparc
extraceuular
matrix
chang
lan
c
lawranc
franci
lloyd
warren
ray
background
crohn
diseas
cd
ulcer
coliti
uc
chronic
inflammatori
bowel
diseas
ibd
unknown
aetiolog
cd
unlik
uc
present
transmur
inflamm
may
lead
fibrosi
intestin
obstruct
sparc
protein
secret
protein
acid
rich
cystein
transient
express
inflam
tissu
associ
wound
heal
mrna
express
invers
relat
presenc
fibrosi
aim
aim
studi
correl
sparc
express
intestin
inflamm
fibrosi
human
ibd
determin
alter
express
sparc
influenc
fibrosi
tnb
model
murin
intestin
fibrosi
method
section
control
intestin
fibros
cd
nonfibros
uc
diseas
control
fibros
diverticular
diseas
nonflbros
ischaem
coliti
stain
haemotoxylin
eosin
trichrom
sparc
collagen
iii
analys
murin
model
chronic
intestin
inflamm
establish
weekli
intrarect
administr
trinitrobenzen
sulfon
acid
tnb
week
group
mice
treat
oral
ra
stimul
sparc
express
indomethacin
block
downstream
signal
sparc
neither
colon
tissu
obtain
stain
mrna
isol
sparc
express
determin
realtim
pcr
result
sparc
protein
constitut
express
neural
tissu
fibroblastlik
ceil
colon
tissu
sparc
express
inflammatori
cell
infiltr
inflam
fibms
intestin
murin
model
indomethacin
induc
retino
acid
inhibit
inflamm
fibrosi
week
determin
trichrom
collagen
stain
sparc
mrna
express
invers
relat
develop
fibrosi
week
except
indomethacintr
mice
sparc
level
significantli
elev
p
protect
fibrosi
differ
group
lost
week
find
demonstr
sparc
express
level
invers
correl
level
intestin
fibrosi
increas
sparc
level
protect
intestin
fibrosi
protect
block
indomethacin
conclus
sparc
express
level
play
role
develop
intestin
fibrosi
backgroumd
emerg
concept
matrix
biolog
suggest
upon
tissu
injuri
provision
ha
matrix
form
time
infamm
occur
time
ha
replac
perman
tissuerepair
matrix
element
egcollagen
elastin
inflamm
reced
recent
teder
et
al
scienc
show
lung
injuri
model
hyaluronan
must
clear
perman
matrix
deposit
inflamm
resolv
macmphag
via
receptor
respons
clear
ha
observ
upregul
ha
colon
mucosa
activ
ibd
report
treatment
mucos
smooth
muscl
ceil
msmc
vire
agent
induc
endoplasm
reticnlum
stress
vitro
caus
elabor
ha
matrix
adhes
mononuclear
leukocyt
via
receptor
aim
investig
whether
monocyt
cell
popul
cell
pbml
lpmc
preferenti
bind
adhes
ha
matrix
vitro
abl
clear
ha
addit
follow
fate
hyaluronan
exposur
monocyt
measur
chang
msmc
monocyt
cultur
medium
compart
method
human
msmc
lpmc
deriv
resect
colon
tissu
lpmc
monocyt
cell
bind
unstimul
poli
cstimul
msmc
assess
use
leukocyt
confoeal
microscopi
ha
measur
fluorophoreassist
carbohydr
gel
electrophoresi
face
result
ha
mediat
leukocyt
adhes
favor
bind
monocyt
lineag
leukocyt
adhes
monocyt
leukocyt
ha
result
cap
ha
intern
cell
ha
deplet
msmc
surfac
rapidli
rain
rise
ha
monocyt
cultur
medium
observ
conclus
hyaluronanmedi
mononuclear
leukocyt
adhes
repres
noncytokineinduc
pathway
leukocyt
retent
msmc
favor
interact
monocyt
bind
induc
chang
leukocyt
appar
rapid
cap
ha
degrad
intern
imbal
synthesi
degrad
pathway
could
account
observ
accumul
ha
inflam
colon
mncosa
may
contribut
chronic
ibd
flare
effect
enter
microflora
tolllik
receptor
colon
epitheli
cell
ulcer
coliti
hamhiko
ogata
nobuhiko
kamada
osamu
hitotsumatsu
nagamu
inou
masahiro
takaishi
yasushi
lwao
hiromasa
ishii
takanori
kanai
mamom
watanab
toshifumi
hibi
background
aim
activ
nfkb
signal
transduct
pathway
result
phosphoryl
subsequ
ubiquitin
lkba
nfkb
play
critic
role
inflammatori
process
intestin
mucosa
ulcer
coliti
uc
also
suggest
enter
microflora
act
import
pathophysiolog
role
activ
uc
aim
studi
investig
effect
enter
microflora
inflammatori
action
analyz
proinflamamtori
cytokin
tollfik
receptor
tlr
express
colon
epitheli
cell
uc
subject
method
colon
mucosa
obtain
surgic
oper
biopsi
specimen
uc
patient
crohn
diseas
cd
patient
normal
subject
western
blot
analysi
perform
use
monoclon
antibodi
mab
ubiqnitin
protein
ikb
protein
lmmunohistochem
stain
also
perform
use
antiubiquitin
mab
cocultur
bacteri
product
normal
flora
proinflammatori
cytokin
secret
tlr
mrna
express
colon
mucosa
isol
epitheli
cell
analyz
elisa
rtpcr
result
western
blot
analysi
polyubiquitin
protein
express
upregul
activ
uc
mucosa
furthermor
total
ikb
protein
express
downregul
ubiqnitin
phosphoryl
ikba
protein
express
upregul
activ
uc
mucosa
exvivo
organ
cultur
condit
bacteri
product
bacteroid
group
protein
secret
proinflammatori
cytokin
tnfa
significantli
enhanc
activ
uc
mucosa
compar
normal
subject
elba
immunohistochem
stain
reveal
ubiquitin
protein
strongli
express
colon
epitheli
cell
uc
compar
cd
normal
subject
isol
colon
epitheli
cell
bacteroid
upregul
also
mrna
express
colon
epitheli
cell
activ
uc
mrna
express
enhanc
bacteri
product
conclus
result
suggest
commens
microb
bacteroid
might
respons
acceler
inflammatori
process
colon
epitheli
cell
could
lead
mucos
damag
produc
proinflammatori
cytokin
ulcer
coliti
extend
lifespan
long
telomer
fibroblast
older
ulcer
coliti
patient
katherin
getliff
carmen
martinruiz
thoma
von
zgfinicki
chuka
nwokolo
ulcer
coliti
uc
characteris
damag
intestin
epithelium
underli
connect
tissu
cellular
caus
damag
unknown
could
includ
chang
prolif
abil
epitheli
layer
either
decreas
overact
wound
heal
activ
latter
lead
fibrosi
three
process
regul
least
part
colon
fibroblast
present
stmma
colon
mucosa
recent
studi
shown
cell
function
alter
uc
cell
lack
telomeras
telomer
shorten
cell
divis
reach
critic
length
prolifer
ceas
cell
undergo
replic
senesc
sinc
senesc
fibmblast
function
defici
possibl
telomer
shorten
senesc
could
acceler
uc
thu
play
role
etiolog
diseas
support
idea
provid
previou
observ
chang
telomeras
activ
telomer
shorten
rate
genom
instabl
uc
fact
telomeras
knockout
mous
suffer
colitisfik
ulcer
bowel
test
hypothesi
isol
colon
fibroblast
uc
patient
noncol
control
measur
prolif
lifespan
vitro
telomer
length
measur
quantit
real
time
pcr
found
age
control
patient
correl
neg
lifespan
rectal
fibroblast
p
linear
correl
absent
uc
fibroblast
fact
cell
older
uc
patient
underw
significantli
popul
doubl
senesc
compar
agematch
control
vs
p
trend
toward
longer
telomer
explant
slower
rate
telomer
shorten
also
observ
fibroblast
older
uc
patient
unexpectedli
studi
show
replic
senesc
delay
rectal
fibroblast
deriv
older
uc
patient
could
reflect
increas
risk
cancer
progress
biomark
differ
diseas
process
individu
studi
find
evid
connect
tissu
abnorm
colon
uc
glycoprotein
mediat
colon
inflamm
torsten
kucharzik
andrea
luger
xia
lin
andrew
gewirtz
shanthi
sitaraman
didier
merlin
background
aim
anomali
integrin
regul
function
implic
etiolog
variou
patholog
condit
includ
inflammatori
disord
ibd
sever
class
cell
surfac
glycoprotein
includ
shown
play
role
integrinmedi
event
present
studi
investig
protein
express
induc
proinflammatori
cytokin
interferon
gamma
monolay
ii
cell
signal
event
induc
figat
monolay
iii
intestin
effect
ligat
mous
coliti
model
method
intestin
epitheli
cell
line
intestin
mucosa
human
mice
use
present
studi
vivo
studi
perform
mice
administ
dss
result
show
express
normal
human
mice
small
larg
intestin
demonstr
cytokin
interferon
gamma
increas
express
protein
monolay
increas
express
interferon
gamma
transcript
level
show
ligat
protein
mous
anti
antibodi
induc
increas
intraceflular
calcium
protein
phosphoryl
eg
fak
phosphoryl
monolay
demonstr
administr
mice
induc
visibl
colon
inflamm
howev
dextran
sulfat
sodiuminduc
murin
coliti
significantli
enhanc
ligat
conclus
data
collect
indic
upregnl
intestin
inflamm
ii
activ
protein
worsen
intestinalinflamm
propos
inflamm
upregul
natur
bind
molecul
releas
combin
event
might
play
import
role
induct
perpetu
intestin
inflamm
introduct
aimscrohn
diseas
chronic
inflammatori
gastrointestin
disord
characteris
abnorm
mucos
immun
respons
probabl
trigger
compon
intestin
bacteri
flora
genet
suscept
host
first
suscept
gene
identifi
crohn
diseas
thought
interact
bacteri
muramyldipeptid
intracellularli
lead
activ
nfkappab
pathway
constitut
express
monocyt
paneth
cell
small
intestin
possibl
explain
mutat
particularli
associ
crohn
diseas
termin
ileum
paneth
cell
special
secretori
epitheli
cell
locat
base
crypt
lieberktihn
small
intestin
produc
import
antbacteri
protein
lysozym
secretori
alphadefensin
studi
investig
paneth
cell
morpholog
gene
express
crohn
diseas
relat
genotyp
methodspcr
restrict
fragment
length
polymorph
sequenc
use
genotyp
termin
ileal
surgic
resect
specimen
use
immunohistochemistri
western
blot
analysi
detect
express
lysozym
alphadefensin
result
conclusionswhil
histochemicafli
appar
differ
number
distribut
paneth
cell
correl
genotyp
paneth
cell
antimicrobi
product
test
detect
sampl
regardless
genotyp
product
includ
lysozym
alphadefensin
suggest
although
mutat
could
alter
aspect
paneth
cell
function
differenti
caus
absolut
defici
antibacteri
protein
peptid
uncoup
eno
activ
chronic
inflam
human
intestin
microvascular
endotheli
cell
contribut
acquir
microvascular
dysfunct
ibd
parvaneh
rafie
ossama
hatoum
kirkwood
prichard
jr
david
g
bininn
introduct
microvacular
endotheli
dysfunct
found
chronic
inflam
ibd
intestin
may
contribut
impair
heal
enhanc
leukocyt
recruit
thrombot
complic
loss
endotheli
deriv
nitric
oxid
increas
superoxid
gener
affect
gut
microvessel
underli
dysfunct
known
eno
may
switch
product
superoxid
gener
base
activ
statu
hsp
associ
found
endotheli
cell
expos
chronic
stress
ie
atherosclerosi
diabet
mellitu
hypothes
uncoupl
eno
activ
preferenti
gener
superoxid
contribut
microvascular
endotheli
dysfunct
ibd
method
himec
involv
ibd
crohn
diseas
uc
normal
control
assess
unstimul
follow
tnfalp
activ
eno
express
assess
use
western
blot
himec
lysat
immunoprecipit
antieno
antibodi
analyz
western
blot
sdspage
antieno
phosphoryl
eno
ser
thr
associ
demonstr
eno
activ
state
himec
superoxid
gener
assess
use
hydroethidin
intravit
stain
sepiapterirl
use
ensur
adequ
store
tetrahydobiopterin
result
equival
hspgo
express
control
himec
increas
follow
tnfalp
control
ibd
himec
demonstr
equival
amount
eno
protein
phosphoryl
ser
contrast
associ
eno
phosphoryl
eno
thr
diminish
chronic
inflam
ibd
himec
compar
control
sepiapterin
administr
effect
control
ibd
superoxid
gener
suggest
mechan
independ
tetrahydrobiopterin
defici
conclus
data
suggest
eno
activ
state
alter
chronic
inflam
himec
uncoupl
eno
chronic
inflam
ibd
endotheli
cell
result
diminish
thr
phosphoryl
lack
associ
previous
shown
elev
sigmoid
circular
muscl
uc
patient
scaveng
catalas
restor
decreas
ca
signal
uc
sigmoid
muscl
cell
cell
shorten
normal
level
support
hypothesi
contribut
sigmoid
motor
dysfunct
uc
addit
reduc
nkainduc
ca
signal
cell
shorten
ca
free
medium
caus
switch
signal
transduct
pathway
nkainduc
contract
calmodulinand
protein
kinas
c
pkc
depend
untreat
normal
cell
pkcdepend
cell
similar
chang
observ
uc
suggest
ili
contribut
motor
dysfunct
uc
illibinduc
reduct
ca
signal
shorten
isol
circular
muscl
cell
restor
catalas
suggest
illindnc
motor
dysfunct
occur
least
part
product
studi
test
sigmoid
smooth
muscl
cell
possibl
sourc
uc
intraceflular
measur
use
fluoresc
diacet
stronger
oxid
signal
detect
enzymat
isol
uc
sigmoid
circular
smooth
muscl
ceil
control
cell
oxid
gener
sinc
preincub
muscl
cell
catalas
significantli
reduc
fluoresc
signal
data
suggest
isol
uc
muscl
cell
contain
excess
confirm
observ
control
uc
sigmoid
circular
smooth
muscl
cell
cultur
hour
level
cultur
medium
measur
uc
muscl
cell
spontan
secret
normal
cell
data
indic
sigmoid
smooth
muscl
cell
may
sourc
uc
treatment
uc
mucos
homogen
hour
significantli
increas
secret
normal
muscl
cell
wherea
normal
mucos
homogen
suggest
inflammatori
mediat
secret
uc
mucosa
stimul
muscl
cell
produc
similarli
exposur
tnfc
ngml
u
ml
elev
mucosa
muscl
uc
patient
significantli
increas
secret
normal
muscl
cell
conclud
tnfct
secret
uc
mucosa
stimul
sigmoid
circular
smooth
muscl
ceil
produc
support
niddk
differenti
neuropeptid
express
pediatr
patient
crohn
diseas
dolar
sidpra
lee
boyer
alison
j
buchan
kevan
jacobson
inflammatori
bowel
diseas
ibd
chronic
recurr
intestin
inflammatori
disord
adult
associ
chang
neuropeptid
express
distribut
purpos
present
studi
determin
whether
similar
chang
observ
children
ibd
full
thick
section
tissu
collect
fresh
surgic
specimen
area
inflam
colon
noninflam
margin
children
ileocoloinc
n
colon
n
crohn
diseas
mean
age
year
age
rang
year
male
diseas
durat
prior
surgeri
month
mean
month
tissu
fix
paraformaldehyd
cryostat
section
immunostain
vasoact
intestin
peptid
vip
nitric
oxid
synthas
no
neural
abund
quantifi
use
morphometr
analysi
system
inflam
region
submucon
plexu
signific
increas
number
vip
immunoreact
ir
neuronsplexu
observ
noninflam
margin
neuronsganglion
vs
inflam
tissu
neuronsganglion
contrast
chang
seen
neuron
inflam
submuc
plexu
compar
normal
margin
noninflam
margin
neuronsganglion
vs
inflam
tissu
neuronsganglion
wherea
myenter
plexu
number
nosir
neuron
significantli
increas
inflam
area
noninflam
margin
neuronsganglion
vs
inflam
tissu
neuronsganglion
chang
vipir
neuron
number
noninflam
margin
neuronsganglion
vs
inflam
tissu
neuronsganglion
contrast
adult
data
littl
evid
coloc
vip
no
colon
data
demonstr
import
differenti
express
subpopul
neuron
inflam
tissu
vip
no
respond
differ
two
major
enter
plexi
chang
neuropeptid
express
distribut
might
contribut
pathogenesi
ibd
ongo
symptom
even
absenc
activ
diseas
support
ccfc
canada
suppress
endotheli
nfkb
activ
may
candid
therapeut
target
patient
ulcer
coliti
kenji
ina
kazuo
knsugami
tsuyoshi
nishiwaki
ryuichi
furuta
osamu
watanab
takahisa
suzuki
takafumi
ando
hidemi
goto
background
aim
activ
inflam
intestin
mucosa
affect
ulcer
coliti
uc
character
intens
infiltr
polymorphonuclear
neutrophil
activ
endothelium
may
play
central
role
recruit
leukocyt
examin
effect
solubl
factor
gener
intestin
mucosa
human
umbil
vein
endotheli
cell
huvec
better
character
possibl
regulatori
mechan
enhanc
recruit
circulatori
neutrophil
affect
mucosa
uc
method
colonoscop
mucos
biopsi
tissu
cultur
cultur
insert
h
organ
cultur
supernat
use
follow
experi
endotheli
activ
uc
n
crohn
diseas
n
coutro
n
paramet
endotheli
activ
includ
product
elisa
express
flow
cytometri
nfkb
activ
immunohistochemistri
western
blot
luciferas
report
assay
interact
neutrophii
huvec
examin
bind
migrat
assay
result
local
gener
solubl
factor
uc
mucosa
could
activ
endotheli
nfkb
subsequ
product
express
neutral
experi
specif
block
ing
antibodi
suggest
endogen
lllb
uc
mucosa
may
larg
respons
enhanc
neutruphil
migrat
increas
bind
huvec
therapeut
agent
prednisolon
psl
cyclosporn
csa
sa
sig
nificandi
inhibit
illbinduc
endotheli
nfkb
activ
conclus
activ
inflam
mucosa
uc
local
gener
illb
could
attract
neutrophil
nfkbmediat
express
product
phenomena
uppr
ssed
presenc
psl
csa
suggest
suppress
endotheli
activ
may
candid
therapeut
target
patient
uc
format
leukocyteplatelet
complex
patient
ulcer
coliti
novel
marker
diseas
activ
respons
granulocytapheresi
yuji
koik
nagamu
inou
makoto
naganuma
yuichi
morohoshi
atsushi
sakuraba
shigeo
yoshizawa
haruhiko
ogata
yasnshi
iwao
noriyuki
shiobara
katsuya
hiraishi
hiromasa
ishii
toshifumi
hibi
background
aim
recent
demonstr
activ
plateleta
bind
leukocyt
implic
inflammatori
process
variou
disord
aim
studi
investig
import
leukocyteplatelet
leuplt
complex
mechan
format
pathogenesi
ulcer
coliti
uc
evalu
effect
granuloeytapheresi
gcap
plateletsleukocyt
complex
method
peripher
blood
obtain
patient
ulcer
coliti
uc
healthi
control
hc
anticoagul
red
blood
ceil
hemolyz
ammonium
chlorid
white
blood
cell
stain
control
antibodi
conjug
fluorescein
isothiocyan
phycoerythrin
platelet
isol
peripher
blood
stain
pselectin
cell
analyz
flow
cytomet
sever
uc
assess
clinic
activ
index
cai
score
accord
lichtig
present
relat
leuph
complex
score
analyz
uc
patient
fiftynin
patient
uc
treat
gcap
studi
patient
receiv
five
apheresi
session
consecut
week
peripher
blood
obtain
session
session
session
leuplt
complex
analyz
result
number
percentag
neutrophdeplatelet
nplt
complex
monocyteplatelet
mpit
complex
significantli
increas
patient
uc
compar
hc
although
express
neutrophil
monocyt
uc
patient
hc
express
higher
platelet
uc
patient
hc
relat
number
leuph
complex
cai
score
uc
patient
howev
patient
treat
prednisolon
psi
day
number
leuplt
complex
significantli
relat
cai
score
patient
treat
ragday
less
psl
nplt
complex
significantli
decreas
andor
treatment
gcap
respond
group
conclus
result
suggest
leupit
complex
play
import
role
pathogenesi
ulcer
coliti
complex
reflect
sever
diseas
respons
gcap
therapi
tlr
express
macrophag
dc
lymphocyt
integr
compon
innat
immun
respons
similar
tlr
cd
famili
member
capabl
recogn
bacteri
compon
although
vivo
microbi
ag
cdld
unknown
cdld
activ
nkt
cefl
shown
mediat
import
innat
immun
respons
aim
studi
character
interact
tlr
cdld
examin
depend
tlr
express
cdld
follow
oral
listeria
infect
cdldand
wild
type
wt
mice
infect
po
listeria
monocytogen
lm
pmbc
lymphocyt
lung
intestin
isol
express
flow
analysi
hr
infect
result
indic
number
cd
lb
blood
macrophag
decreas
hr
cd
compar
wt
mice
differenti
express
observ
follow
lm
infect
cdldmice
lb
ceil
increas
baselin
fold
hr
macrophag
express
wt
increas
baselin
fold
time
level
cell
surfac
express
wt
cdld
mice
compar
blood
cell
hr
cdldmice
show
fold
increas
express
compar
wt
mice
hr
addit
observ
express
increas
cell
lung
fold
decreas
cell
compar
iel
small
intestin
fold
wt
mice
differ
increas
lung
fold
compar
iel
small
intestin
cell
analyz
data
suggest
express
lb
macrophag
depend
cdld
effici
listeria
clearanc
absenc
cdld
induc
upregul
possibl
compensatori
mechan
activ
innat
immun
lm
activ
earli
infect
follow
cell
may
regul
express
cell
ni
intestin
wllll
mek
ls
key
regul
gene
express
nontransform
human
colonocyt
sang
hoon
rhee
andrew
c
keat
eoin
c
kelli
charalabo
pothoulaki
background
object
pathophysiolog
ibd
involv
lumin
bacteria
exagger
mucos
immun
respons
character
increas
express
cytokin
macropbag
inflammatori
protein
tolllik
receptor
tlr
involv
innat
immun
respons
infect
flagellin
specif
ligand
molecular
pattern
associ
sever
bacteri
speci
although
proinflammatori
signal
demonstr
colon
adenocarcinoma
cell
line
express
signal
nontransform
colonocyt
studi
determin
whether
flagellin
increas
cytokin
express
nontransform
human
colon
cell
identifi
signal
mechan
involv
method
cell
treat
flageflin
ngml
cell
lysat
obtain
expos
human
cytokin
array
membran
compos
differ
captur
antibodi
mechan
flageflin
increas
cytokin
level
investig
domin
neg
construct
pharmacolog
inhibitor
result
cytokin
array
experi
show
hr
flagellin
exposur
increas
express
confirm
elisa
flagellin
increas
promot
activ
block
domin
neg
mutant
western
blot
analys
show
flagelfin
activ
jnk
degrad
ikba
flageflininduc
promot
activ
protein
product
alter
transfect
cell
domin
neg
jnk
mutant
preincub
jnk
inhibitor
respect
howev
flageflinstimul
promot
activ
block
domin
neg
kinas
involv
activ
mutant
mek
inhibitor
flagellinmedi
express
suppress
exposur
mek
inhibitor
wherea
increas
promot
activ
partial
inhibit
domin
neg
mutant
concinaion
nontransform
human
colonocyt
mek
activ
mediat
express
respons
engag
support
grant
dk
cp
nation
institut
health
ccfa
lack
structur
molecular
mechan
mutat
associ
crohn
diseas
bissan
daniel
j
b
mark
anthoni
w
segal
thought
act
receptor
muramyl
dipeprid
mdp
compon
bacteri
cell
wall
mutat
gene
associ
chronic
inflammatori
granulomaton
diseas
includ
crohn
diseas
blau
syndrom
littl
known
protein
normal
structur
function
precis
mutat
alter
characterist
use
bioinformat
method
structur
annot
model
domain
card
focus
region
associ
diseas
ctermin
domain
canon
leucin
rich
repeat
lrr
similar
seen
ribonucleaseh
inhibitor
model
structur
wildtyp
mutat
lrr
domain
propos
interact
anoth
protein
domain
interfac
span
least
includ
approxim
half
face
lrr
impli
bind
mdp
isol
suggest
either
receptor
mdp
intermediari
downstream
signal
pathway
mdp
must
present
bound
protein
partner
also
explain
mutat
associ
crohn
diseas
disrupt
interfac
normal
signal
function
next
model
nucleotid
bind
domain
homolog
expect
function
catalyt
atpas
sinc
possess
key
residu
implic
atp
hydrolysi
contrast
mutat
lrr
demonstr
mutat
involv
blau
syndrom
characteris
arthriti
uveiti
cutan
inflamm
overt
bowel
diseas
directli
affect
atp
bind
specif
mutat
imped
deactiv
kinet
either
atp
hydrolysi
releas
would
explain
constitut
activ
describ
cell
transfect
construct
contain
blau
mutat
use
bioinformat
predict
methodolog
provid
valuabl
insight
normal
function
furthermor
precis
explain
mechan
mutat
lrr
caus
lossoffunct
associ
crohn
diseas
found
nbd
caus
constitut
activ
wit
blau
syndrom
tolllik
receptor
induc
apic
seal
zonula
occludenst
via
protein
kinas
c
pkc
intestin
epitheli
monolay
elk
cario
guido
gerken
daniel
k
podolski
background
intestin
epitheli
barrier
function
modul
complex
interplay
sever
protein
within
rightjunct
tj
complex
recent
demonstr
ligandinduc
activ
significantli
enhanc
intestin
transepithefi
resist
ter
mediat
via
pkc
independ
aim
identifi
specif
tjassoci
protein
target
activ
pkc
modul
ter
materi
method
subceflular
distribut
tjassoci
protein
increas
ter
assess
laser
confoc
microscopi
highli
differenti
monolay
exposur
synthet
fipopeptid
known
ligand
result
stimul
membraneassoci
redistribut
apic
tj
area
form
distinct
consolid
later
cellcel
contact
comparison
samedepth
neg
control
analyz
xy
zsection
confoc
immunofiuoresc
alter
distribut
correl
timedepend
manner
transient
increas
ter
pretreat
specif
pkc
inhibitor
rottlerin
minut
block
alter
distribut
correl
inhibit
ter
increas
via
pkc
howev
stimul
result
tj
junctionalassoci
morpholog
chang
occludin
ecadherin
actin
cytnskeleton
suggest
specif
effect
via
contrast
stimul
phorbol
ester
pma
activ
sever
differ
pkc
isoform
led
disrupt
line
suggest
stimulusspecif
effect
divers
morpholog
alter
via
broad
pkccomplex
conclus
present
studi
suggest
pkccomplex
essenti
compon
signal
pathway
directli
enhanc
intestin
epitheli
integr
transloc
upon
activ
activ
reprogram
macrophag
ttelicobact
hepaticu
hilda
holcomb
issel
lira
jame
g
fox
david
b
schauer
helicobact
hepaticu
use
model
ibd
colon
cancer
certain
genet
engin
line
mice
well
hepat
liver
cancer
mice
suscept
inbr
strain
aj
mice
resist
diseas
becom
colon
higher
number
h
hepaticu
suscept
strain
compar
activ
bone
marrowderiv
macrophag
aj
mice
h
hcpatku
order
determin
role
innat
immun
respons
suscept
resist
diseas
addit
studi
compar
cytokin
product
macrophag
wild
type
tolllik
receptor
defici
mice
also
perform
character
role
receptor
macrophag
recognit
h
hepaticu
cell
stimul
vitro
increas
number
h
hepaticu
activ
determin
measur
proinflammatori
cytokin
nitric
oxid
cultur
supernat
aj
macrophag
produc
proinflammatori
cytokin
respons
h
hepaticu
stimul
howev
macrophag
mice
produc
fold
higher
level
aj
macrophag
p
aj
macrophag
produc
time
higher
level
p
prior
treatment
h
hepaticu
render
macrophag
aj
mice
incap
produc
restimul
organ
contrast
product
remain
high
even
hour
initi
stimul
level
increas
upon
restimul
result
tlrdefici
macrophag
demonstr
involv
activ
macrophag
h
hepaticu
although
defect
consist
result
dramat
decreas
eytokin
product
compar
wildtyp
macrophag
defect
find
suggest
chronic
exposur
h
hepaticu
may
result
reprogram
macrophag
decreas
cytokin
product
thu
allow
pathogen
establish
persist
infect
diseas
suscept
may
correl
level
continu
produc
reprogmm
macrophag
respons
h
hepaticu
addit
studi
necessari
determin
differ
tlr
express
macrophag
susecept
restist
strain
mice
correl
differ
cytokin
product
joo
sung
kim
brigitt
aflard
christian
jobin
backgroundaim
nfkb
transcript
system
major
effector
pathway
intestin
inflamm
innat
immun
respons
flavonoid
luteolin
found
variou
herbal
extract
shown
antiinflammatori
properti
vitro
vivo
howev
mechan
action
impact
luteolin
innat
immun
still
unclear
investig
effect
luteolin
lpsinduc
nfkb
activ
intestin
epitheli
dendrit
cell
method
rat
nontransform
cell
bone
marrowderiv
dendrit
cell
bmdc
isol
mice
pretreat
luteofin
ixm
b
stimul
lp
gml
variou
time
addit
bmdc
isol
novel
transgen
mice
express
gfp
transcript
control
nfkb
kbgfp
use
studi
tnfc
express
determin
realtim
rtpcr
elisa
cell
infect
adenovir
vector
encod
kbluciferas
report
gene
treat
lp
luteolin
ikb
phosphorylationdegrad
rela
phosphoyl
evalu
western
blot
rela
recruit
icami
promot
assess
chromatin
immunoprecipit
assay
chip
ldh
assay
use
measur
cytotoxtc
effect
luteofin
gfp
express
measur
use
fluoresc
microscopi
spectrofluorometri
result
lpsindue
ikb
phosphorylatioddegrad
rela
phosphoryl
block
luteolintr
cell
luteolin
significantli
block
lpsinduc
nfkb
transcript
activ
cell
addit
lpsinduc
rela
recruit
promot
inhibit
luteolin
inhibit
lpsinduc
gene
express
luteolin
associ
cytotox
cell
lpsinduc
gfp
express
significantli
inhibit
luteolintr
bmdc
isol
bgfp
mice
moreov
luteolin
suppress
lpsinduc
tnf
u
mrna
acculnul
protein
seer
tion
inhibit
n
bmdc
der
ved
race
conc
son
data
indic
ae
luteolin
block
kpsinduc
nfkb
signal
gene
express
bmdc
modul
innat
immun
natur
plant
product
may
repres
attract
strategi
prevent
intestin
inlqamm
associ
dysregu
ate
innat
immun
respons
lesley
e
smytbi
ronald
h
clement
meg
mosteflarbamum
phillip
smith
background
shown
human
intestin
macrophag
downregul
product
proinflammatori
cytokin
retain
phagocyt
baeteriocid
capabl
investig
mechan
underli
profound
downregul
intestin
macrophag
cytokin
releas
method
intestin
macrophag
obtain
patient
undergo
gastrojejunostomi
isol
enzym
digest
homolog
blood
monocyt
purifi
elutri
condit
medium
deriv
stroma
small
intestin
mucosa
scm
nuclear
cytoplasm
extract
mrna
extract
prepar
intestin
macrophag
monocyt
incub
without
lp
mgml
ifnf
uml
heatkil
staphylococcu
aureu
hksa
cfu
minut
extract
also
made
stimul
monocyt
presenc
scm
scm
plu
antitgfb
signal
transduct
capabl
assess
determin
nfkb
ikba
pikba
level
western
blot
mrna
rtpcr
cultur
supernat
evalu
tnfa
tgfb
result
stumul
intestin
macrophag
releas
nfkbinduc
cytokin
ill
tnfa
express
signal
transduct
protein
fail
activ
nfkb
monocyt
releas
cytokin
express
signal
transduct
protein
activ
nfkb
sinc
intestin
macrophag
deriv
blood
monocyt
investig
intestin
rnacrophag
lose
abil
express
activ
nfkb
monocyt
stimul
presenc
cm
releas
nfkbdepend
cytokin
activ
nfkb
ident
intestin
macrophag
howev
scmtreat
monocyt
releas
tgfb
nfkbindepend
process
importantli
preincub
scm
antitgfb
antibodi
inhibit
scm
mrregul
monocyt
nfkb
activ
releas
nf
kbdepend
proinflammatori
cytokin
conclus
intestin
macrophag
downregul
proinflammatori
cytokin
releas
blockad
key
protein
nfkb
activ
pathway
moreov
abil
stromal
cellderiv
tgfb
inhibit
monocyt
nfkbdepend
cytokin
product
suggest
mechan
wherebi
monocyt
newli
recruit
lamina
propria
undergo
regul
proinflammatori
cytokin
product
mimi
takami
jung
park
keilla
hemati
mucos
injuri
h
pylori
nsaidinduc
gastriti
directli
correl
extent
neutrophil
pmn
infiltr
activ
although
grow
data
suggest
neuropeptid
somatostatin
sum
modul
innat
immun
respons
thu
may
impact
natur
histori
gut
mucos
inflamm
effect
sum
biochemistri
cellular
physiolog
integrinmedi
neutrophii
recruit
studi
purifi
human
pmn
isol
whole
blood
fluomsceinlabel
bind
assay
perform
plate
coat
human
fibrinogen
fib
ligand
specif
predomin
integrin
receptor
pmn
macl
human
ligand
recogn
inhibit
pmn
adhes
fib
n
p
sum
may
impact
function
interrupt
key
interact
two
integrin
ceil
adhes
inhibit
pmn
adher
pmn
prime
ifnf
import
proinflammatori
cytokln
inflammatori
condit
gut
mucosa
augment
respons
adhes
assess
augment
revers
presenc
sum
sum
inhibit
activ
mapk
pancreat
cancer
cell
possibl
activ
serin
phosphatas
mapk
activ
essenti
mediat
activ
figand
bind
pmn
examin
effect
sum
mapk
pmn
lysat
western
blot
activationspecif
antibodi
sum
inhibit
mapk
activ
n
se
p
similarli
preserv
protein
kinas
c
pkc
activ
import
integrinmedi
pmn
adhes
previous
identifi
isoform
pkc
rapidli
activ
stimul
pmn
sum
decreas
activ
pkc
isoform
p
sum
receptor
identifi
human
murin
lymphocyt
monocyt
macrophag
dendrit
cell
pmn
incub
presenc
unlabel
sum
cold
sum
displac
label
dose
depend
manner
unstimul
pmn
well
pmn
addit
preliminari
flow
cytometri
experi
show
specif
bind
ab
human
pmn
stimul
pma
data
indic
sum
direct
impact
integrin
function
cell
signal
human
pmn
specif
receptor
background
aim
aid
defect
condit
acquir
immun
system
innat
immun
mainli
involv
gastric
microenviron
characterist
gastric
mucos
chang
aid
report
hypertroph
gastric
fold
usual
associ
opportunist
infect
cytomegaioviru
cryptospondium
toxoplasma
helicobact
pylorineg
patient
howev
mechan
gastric
chang
still
unclear
clarifi
studi
pathophysiolog
gastric
mucos
lesion
impair
acquir
immun
use
mhc
class
ii
defici
mice
suppos
similar
aid
patient
materi
method
mhc
class
ii
defici
mice
background
serial
sacrif
month
group
wild
type
wt
mice
serv
control
mice
bred
spf
condit
immunohistochemistri
use
cdf
lb
gastrin
regi
protein
antibodi
semiquantit
rtpcr
tlr
ino
tnfa
inff
tgfb
mpo
assay
serum
gastrin
level
bacteri
cultur
stomach
gastric
acid
studi
moreov
investig
effect
gastrin
gastric
hyperplast
chang
inhibitor
gastrin
receptor
administ
mice
three
month
result
cell
cell
decreas
spleen
mhc
class
ii
defici
mice
gastric
mucosa
show
hyperplasia
preserv
pariet
cell
infiltr
lb
polymorphonuclear
cell
express
mpo
gastric
mucosa
significantli
upregul
suggest
chronci
actvat
innat
immun
respons
bacteri
cultur
stomach
show
nonpathogenet
bacteria
gemeua
haemolysan
mice
gastric
acid
mhc
class
ii
defici
mice
normal
although
serum
gastrin
level
regposit
cell
ecl
chief
cell
significantli
increas
compar
wtmice
month
treatment
thick
hyperplast
gastric
mucosa
mhc
class
defici
mice
significantli
reduc
serum
gastrin
level
gastrinposit
cell
g
cell
significantli
increas
compar
nontreat
mice
conclus
chronic
activ
innat
immun
gastric
microencironmem
induc
hyperplast
gastric
muco
secondari
upregnl
gastrin
synthesi
stimul
releas
polymorphonudear
cell
ca
cdna
gener
use
mmlv
revers
transcriptas
invitrogen
carlsbad
ca
gamma
gene
amplifi
pcr
reaction
use
taq
dna
polymeras
lnvitrogen
carlsbad
ca
analyz
agaros
gel
electrophoresi
amount
pcr
product
sampl
compar
rna
ratio
intens
gamma
rna
quantifi
kodak
gel
document
system
use
measur
express
gamma
gene
base
statist
analysi
mean
sd
hs
ratio
cut
valu
demarc
express
level
gamma
uc
hs
observ
hs
ratio
higher
uc
patient
ratio
less
differ
express
gamma
gene
healthi
subject
uc
patient
statist
highli
signific
p
valu
conclus
first
report
express
normal
lymphocyt
postul
regul
uc
may
associ
alter
immun
balanc
autoimmun
respons
uc
background
aim
entericbacteri
interact
appear
play
central
role
develop
coliti
antibacteri
molecul
demonstr
possess
benefici
effect
pathogenesi
inflammatori
bowel
diseas
ibd
studi
undertaken
character
natur
occur
host
molecul
modul
ibd
method
dna
microarray
perform
use
total
colon
mucos
rna
obtain
wt
mice
day
administr
dss
day
messeng
rna
show
fold
increas
dssday
compar
dssday
select
express
confirm
quantit
q
pcr
immunohistochemistri
anim
model
acut
chronic
coliti
well
human
ibd
includ
uc
cd
result
chitinas
mammalian
homologn
plant
chitinas
play
major
role
defens
mechan
fungal
pathogenesi
fold
increas
recoveri
phase
day
compar
acut
phase
day
dss
coliti
express
homologn
mous
human
highli
upregnl
colon
epitheli
cell
cec
lamina
propria
lp
cell
tcell
receptor
alpha
chain
knockout
tcra
ko
mice
domin
coliti
b
cell
defici
tcra
tripl
ko
ap
tko
mice
thl
domin
coliti
compar
wt
mice
express
absent
cec
lp
cell
qpcr
mrna
express
significantli
upregul
human
uc
cd
compar
normal
individu
ihc
analysi
use
affin
purifi
rabbit
polyclon
antibodi
show
cec
apic
basal
side
lp
cell
mainli
macrophag
dendrit
like
cell
strongli
express
protein
tcrako
mice
mice
express
stronger
cec
lp
colon
tissu
patient
uc
cd
express
absent
wt
normal
individu
messag
protein
level
posit
associ
diseas
sever
especi
form
coliti
mous
human
conclus
significantli
upregul
recoveri
phase
acut
coliti
chronic
coliti
anim
model
coliti
well
human
ibd
possibl
molecul
might
act
benefici
factor
develop
coliti
honwai
koon
dezheng
zhao
charalabo
pothoulaki
background
object
report
substanc
p
sp
particip
acut
intestin
inflamm
via
bind
gprotein
coupl
receptor
activ
transcript
factor
nfkappa
b
lead
releas
proinflammatori
cytokin
colon
epitheli
cell
also
report
sp
stimul
cell
prolifer
critic
event
tissu
restor
heal
chronic
coliti
via
transactivatiml
epiderm
growth
factor
receptor
egfr
activ
mitogenactiv
protein
kinas
mapk
howev
mechan
involv
spinduc
egfr
mapi
activ
complet
understood
examin
mechan
sp
induc
egfr
activ
normal
human
colonocyt
determin
whether
mechan
involv
mapk
nfkappa
b
signal
method
nontransform
human
colon
cell
normal
express
low
level
stabli
transfect
human
cell
use
retrovir
express
system
cell
incub
sp
differ
time
point
phospfioryl
egfr
determin
western
blot
analysi
result
found
exposur
cell
sp
pm
stimul
egfr
activ
min
follow
activ
min
spinduc
egfr
activ
block
pretreat
matrix
metalloproteinas
mmp
inhibitor
batimastat
specif
egfr
phosphoryi
inhibitor
pretreat
antibodi
potenti
egfr
ligand
suggest
tgf
alpha
epiderm
growth
factor
egf
heparinbind
egf
amphiregnfin
major
mediat
spinduc
egfr
transactiv
also
demonstr
spinduc
kappa
b
phosphoryl
inhibit
either
batimastat
gml
pretreat
moreov
sp
induc
secret
promot
activ
significantli
alter
batimastat
pretreat
conclus
sp
induc
egfr
activ
involv
mmpmediat
releas
tgf
pha
lead
subsequ
egfr
transactiv
cell
prolifer
signal
proinflammatori
pathway
involv
spinduc
nfkappa
b
activ
gene
transcript
relat
mmp
releas
egfr
transactiv
increas
interstiti
pressur
characterist
inflammatori
bowel
diseas
chang
tissu
pressur
also
occur
infect
inflammatori
condit
hypothes
increas
interstiti
pressur
might
modul
macrophag
function
examin
effect
extracellular
pressur
macrophag
phagocytosi
examin
use
human
monocyt
cell
line
undifferenti
monocytelik
pmadifferenti
macrophagelik
ceil
incub
serum
opson
fiuorescem
label
latex
bead
hour
ambient
mmhg
increas
pressur
bead
uptak
monocyt
affect
pressur
howev
bead
uptak
macrophag
significantli
increas
exposur
pressur
vs
n
p
macrophag
constitut
express
activ
fak
erk
src
exposur
macrophag
pressur
decreas
erk
fak
phosphoryl
n
p
alter
fak
src
phosphoryl
transfect
fak
sirna
reduc
fak
express
well
amount
phosphoryl
fak
significantli
increas
basal
macrophag
phagocytosi
p
pressur
inhibit
fak
phosphoryl
mocktransfect
macrophag
macrophag
transfect
scrambledsirna
phosphoryl
fak
significantli
reduc
pressur
cell
transfect
fak
sirna
pressur
increas
phagocytosi
three
group
howev
fak
sirna
transfect
cell
exhibit
pressur
effect
phagocytosi
observ
scrambl
sirna
transfect
cell
phagocytosi
invers
parallel
fak
activ
pretreat
macrophag
ram
inhibit
erk
activ
increas
basal
bead
uptak
cell
vs
n
p
pressur
increas
bead
uptak
cell
pressur
also
inhibit
erk
activ
mocktransfect
macrophag
macrophag
transfect
serambledsirna
transfect
fak
sirna
abolish
inhibit
erk
pressur
cell
express
fak
exhibit
minim
phagocytosi
pressur
fail
increas
phagocytosi
data
suggest
tissu
pressur
inflammatori
edema
may
activ
macrophag
inhibit
fak
consequ
inhibit
erk
extracellular
pressur
may
contribut
effect
addit
link
alter
muscl
contractil
evict
parasit
therebi
contribut
host
defens
critic
differenti
naiv
cell
cen
howev
sourc
earli
immun
respons
remain
unclear
nkt
cell
unusu
popul
ceil
coexpress
receptor
nk
cell
cell
consid
earli
sourc
murin
implic
develop
function
nkt
cell
studi
investig
intestin
muscl
contractil
host
protect
immun
trichinella
spirafi
infect
cdldl
mutant
mice
defici
nkt
cell
method
cdldl
mutant
cdldl
wildtyp
cdldl
mice
infect
spirali
sacrif
variou
time
point
investig
worm
recoveri
carbacholinduc
intestin
muscl
contractil
product
vitro
con
stimul
spleen
cell
result
intestin
worm
expuls
delay
cdldl
mce
significantli
higher
number
worm
recov
cdldl
mice
compar
cdldl
mice
day
postinfect
pi
worm
count
day
pi
day
pi
vs
day
pi
day
pi
cdldl
cdldl
infect
mice
respect
delay
worm
expuls
cdldl
mice
associ
mark
attenu
intestin
muscl
contract
muscl
contract
mgmm
cdldl
infect
mice
compar
mgmm
cdldl
infect
mice
day
pi
correl
downregul
product
splenocyt
cdldl
mice
compar
cdldl
mice
infect
pgml
vs
pgml
cdldl
vs
cdldl
infect
mice
day
pi
conclus
studi
demonstr
cdldl
contribut
least
part
infectioninduc
muscl
contractil
worm
expuls
gener
immun
respons
spirali
infect
absenc
nkt
cell
infect
cdldl
mice
associ
reduct
product
subsequ
interf
host
protect
immun
nematod
infect
leptin
ghrelin
involv
control
food
intak
recent
detect
gastric
mucosa
implic
gastroprotect
variou
noxiou
agent
lheir
antiinflammatori
effect
lower
gut
littl
studi
studi
compar
effect
vehicl
leptin
ghrelin
appli
subcutan
sc
dose
ggkg
heal
colon
damag
induc
wistar
rat
intrarect
administr
trinitrobenzen
sulfon
acid
tnb
mgkg
without
suppress
nosynthas
lnna
mgkg
ip
b
inactiv
sensori
nerv
mgkg
sc
within
three
day
appli
without
treatment
leptin
ghrelin
week
upon
tnb
treatment
colon
blood
flow
cbf
assess
clearanc
techniqu
plasma
leptin
ghrelin
level
assess
radioimmunoassay
rim
distal
cm
colon
remov
colon
tissu
weight
area
colon
lesion
pfainmetri
myeloperoxidas
mpo
activ
elisa
leptin
ghrefin
mrna
rtpcr
evalu
administr
tnb
result
macroscop
lesion
accompani
increas
tissu
weight
rise
mpo
activ
express
leptin
ghrelin
mrna
colon
significantli
enhanc
tbnstreat
rat
compar
intact
colon
mucosa
leptin
ghrelin
dosedepend
attenu
area
colon
lesion
dose
reduc
lesion
respect
produc
signific
fall
tissu
weight
decreas
mpo
activ
acceler
colon
heal
evok
hormon
accompani
signific
rise
cbf
fold
increas
plasma
leptin
ghrelin
level
inhibit
nosynthas
activ
lnna
capsaicindeactiv
sensori
nerv
prolong
heal
colon
lesion
significantli
attenu
leptin
ghrelininduc
acceler
heal
colon
damag
elimin
accompani
rise
cbf
evok
peptid
conclud
leptin
ghrelin
appli
exogen
express
releas
endogen
exert
antiinflammatori
properti
acceler
heal
ulcer
coliti
heal
effect
hormon
depend
upon
hyperemia
colon
probabl
mediat
capsaicinsensit
affer
fiber
releas
vasoact
neuropeptid
trefoil
factor
increas
express
intestin
epitheli
cell
jacqu
van
huyss
pieter
demett
ine
truyen
klaa
vandenbrouck
debbi
lauken
lothar
steidler
pieter
rottier
claud
cuveli
trefoil
ctor
member
trefoil
famili
peptid
constitut
express
gastrointestin
tract
experi
use
recombin
protein
variou
anim
model
gastric
injuri
demonstr
role
repair
process
enhanc
mucos
heal
restitut
vivo
promot
migrat
intestin
epitheli
cell
vitro
previous
describ
shed
membran
ecadherin
use
invitro
cell
cultur
system
deriv
enterocyt
administr
recombin
mous
aim
studi
investig
possibl
way
ecadherin
shed
enterocytelik
cell
treat
hour
total
rna
isol
cdna
synthesis
cdna
probe
hybridis
human
unigen
set
coloni
filter
rzpd
contain
known
unknown
est
spot
duplo
filter
cover
human
genom
spot
intens
measur
signal
qualiti
evalu
vivo
induct
evalu
murin
dextran
sodium
sulfat
dss
induc
model
acut
coliti
dss
administr
drink
water
supplement
weight
volum
dss
two
group
mice
receiv
daili
inocula
vector
control
intragastr
cathet
mocktreat
anim
receiv
daili
btl
healthi
control
mice
receiv
normal
drink
water
throughout
experi
express
level
evalu
colon
day
treatment
use
quantit
pcr
immunohistochemistri
macroarray
result
deriv
enterocyt
show
increas
express
mous
model
treatment
secret
l
lacti
augment
level
express
time
compar
water
control
rel
express
level
four
time
high
mocktreat
mice
suffer
acut
coliti
administr
vector
control
led
sevenfold
increas
immunohisthochem
stain
express
mice
show
signific
increas
express
crypt
epithelium
mice
treat
conclus
show
administr
lead
increas
transcript
protein
express
data
provid
new
insight
work
mechan
trefoil
factor
protect
capac
glycoprotein
gp
endoplasmat
reticuhimlocaf
chaperon
link
innat
adapt
immun
peptidebind
site
bind
peptid
occur
cell
proteasom
degrad
bound
peptid
releas
extracelhifar
space
cell
stress
necrosi
bind
intemalis
peptid
transfer
major
histocompatibif
complex
class
present
tcell
therebi
immun
toler
induc
recent
show
express
imac
method
mrna
vitro
differenti
macrophag
imac
norrnl
mucosa
isol
affymetrix
ofigonudeotid
array
analysi
perform
multicellular
spheroid
mc
specif
differenti
imac
occur
gener
cultur
cell
day
agaros
freshli
isol
blood
monocyt
cocultur
mc
stain
h
day
immunohistochem
murin
transfer
coliti
model
scid
mice
express
analyz
result
imac
noninflam
mucosa
mrna
express
higher
vitro
differenti
macrophag
support
earlier
result
mrna
induct
subtract
screen
express
induc
mc
day
cocultur
wherea
stain
absent
day
background
protein
c
potent
natur
antithrombot
antiinflammatori
substanc
whose
activ
regul
endotheli
express
thrombomodulin
tm
endotheli
protein
c
receptor
epcr
inflammatori
bowel
diseas
character
chronic
inflamm
increas
preval
thrombosi
aim
aim
present
studi
evalu
express
epcr
tm
intestin
resect
mucos
biopsi
specimen
patient
inflammatori
bowel
diseas
control
solubl
form
receptor
also
measur
plasma
materi
method
resect
specimen
patient
ulcer
coliti
crohn
diseas
studi
immunohistochemistri
immunofluoresc
peritumor
tissu
specimen
patient
colon
cancer
resect
specimen
patient
diverticul
use
control
rna
frozen
tissu
ibd
control
undergo
colonoscopi
extract
rtpcr
solubl
receptor
measur
plasma
ibd
patient
control
statist
analysi
perform
mean
nonparametr
test
result
endotheli
protein
c
receptor
thrombomodulin
express
mucos
endothelium
normal
specimen
intens
signal
decreas
inflammatori
bowel
diseas
surprisingli
epcr
also
express
bydendriticlik
cell
also
stain
posit
coloc
verifi
immunofluoresc
number
dendriticlik
ceil
decreas
ulcer
coliti
patient
compar
control
cell
per
high
power
field
vs
decreas
less
evid
section
crohn
diseas
patient
messeng
rna
epcr
parallel
protein
express
median
solubl
thrombomodulin
epcr
plasma
level
higher
ibd
patient
control
vs
ugml
p
vs
ngml
p
respect
conclus
epcr
express
dendriticlik
cell
bear
key
complement
receptor
suggest
role
epcr
innat
immun
ibd
reduc
mucos
express
tm
epcr
well
high
solubl
tm
epcr
plasma
level
suggest
derang
protein
c
activ
possibl
lead
decreas
antithrombot
activ
pathway
epitheli
ino
diminish
enterocyt
parasit
earli
c
parvum
infect
neonat
piglet
jodi
gookin
jessica
allen
sophia
chiang
martha
armstrong
c
parvum
parasit
epithelium
intestin
villi
result
enterocyt
injuri
inflammatori
cell
influx
electrolyt
fluid
loss
decreas
barrier
function
previous
shown
induc
nitric
oxid
synthas
ino
express
infect
epithelium
nitric
oxid
metabolit
increas
urin
infect
piglet
inhibit
ino
shortterm
effect
barrier
function
uss
chamber
sheet
ileal
mucosa
obtain
infect
piglet
hypothes
epitheli
ino
induct
may
serv
promot
parasit
clearanc
thu
examin
vivo
mechan
ino
action
c
parvum
infect
onedayold
fitterm
piglet
randomli
alloc
treatment
group
infect
c
parvum
oocyst
day
locat
amount
ino
protein
determin
ihc
immunoblottmg
ileal
mucosa
control
infect
piglet
synthesi
measur
urinari
excret
nox
mucos
myeloperoxidas
mpo
activ
measur
quantifi
nentrophil
infiltr
piglet
treat
ino
inhibitor
lnil
mgkg
ip
salin
ml
ip
sever
infect
determin
daili
bodi
weight
fecal
consist
number
excret
oocyst
piglet
euthan
peak
infect
quantit
histolog
ileal
mucos
sheet
mount
uss
chamber
measur
transeptiheli
resist
flux
clsecret
c
parvum
infect
result
intens
express
ino
parasit
enterocyt
along
apic
villi
significantli
increas
urinari
excret
nox
mucos
mpo
activ
compar
uninfect
piglet
infect
piglet
treat
lnil
significantli
decreas
urinari
excret
nox
significantli
increas
excret
oocyst
fece
significantli
greater
number
parasit
per
villu
enterocyt
compar
salinetr
infect
piglet
differ
bodi
weight
sever
diarrhea
mucos
barrier
function
mucos
mpo
activ
salin
lniltreat
piglet
result
studi
demonstr
epitheli
express
ino
significantli
diminish
earli
enterocyt
parasit
c
parvum
infect
contrast
model
defin
nonspecif
mucos
inflamm
ino
activ
result
intestin
infect
c
parvum
contribut
disrupt
barrier
function
sever
associ
inflamm
diarrhea
introduct
dendrit
cell
dc
occupi
central
posit
immun
system
cell
respons
prime
naiv
ceil
prime
naiv
ceil
critic
event
induct
adapt
immun
respons
differenti
cell
determin
natur
adapt
respons
whether
thl
regulatori
cell
respons
differ
outcom
influenc
effect
microbi
product
includ
dna
dc
oligonucleotid
either
stimulatori
inhibitori
effect
immun
system
therefor
assess
effect
dna
deriv
commens
bifidobacteria
lactobacilh
streptococcu
salivariu
subsp
thermophilu
abil
dc
stimul
naiv
cell
method
matur
dc
obtain
overnight
cultur
human
peripher
blood
mononuclear
cell
separ
nonadher
cell
metrizamidegradi
enrich
dc
expos
dna
commens
bacteria
probiot
prepar
vsl
lactobacilh
strain
bifidobacteria
strain
streptococc
strain
cell
wall
prepar
probiot
bacteria
medium
alon
control
respons
allogen
naiv
cell
measur
incorpor
flow
cytometri
use
assess
dc
phenotyp
viabil
detect
apoptot
cell
annexinv
propidinm
iodid
stain
result
irrespect
differ
treatment
metrizamidesepar
dc
express
high
level
costimulatori
molecul
matur
marker
howev
significantli
lower
prolifer
observ
cocultur
naiv
cell
bacteri
dnatreat
dc
compar
either
cultur
contain
dc
expos
medium
alon
dc
expos
cell
wall
compon
bacteria
respons
stimul
dc
expos
medium
cell
wall
differ
significantli
viabil
dc
affect
treatment
indic
bacteri
dna
prepar
toxic
anuexinv
stain
neg
cell
cultur
hour
hour
suggest
lower
prolifer
seen
dnatreat
cultur
unlik
due
induct
apoptosi
conclus
dna
probiot
bacteri
prepar
vsl
inhibit
abil
matur
dc
stimul
naiv
cell
possibl
indic
inhibitori
cpg
motif
domin
genom
commens
bacteria
neither
precis
function
rest
intestin
eosinophfl
immunopathogen
mechan
drive
rest
ceil
activ
clearli
understood
eosinophil
esophag
ee
hypothes
eosinophil
infihrat
ing
esophagu
activ
eosinophil
popul
present
intestin
rest
aim
better
understand
mechan
eosinophil
activ
healthi
individu
patient
ee
express
potenti
activ
marker
cytokin
determin
use
immunofluoresc
confocai
microscopi
tissu
specimen
esophagu
intestin
blood
sampl
healthi
control
ee
patient
analyz
healthi
individu
intestin
eosinophil
blood
eosinophil
express
suggest
physiolog
activ
process
digest
tract
ee
patient
intestin
eosinophil
express
indic
inflammatori
respons
may
restrict
esophagu
ee
patient
approxim
eosinophil
infiltr
inflam
esophag
mucosa
express
indic
increas
proport
activ
cell
compar
physiolog
situat
howev
number
posit
intestin
eosinophil
differ
ee
patient
control
origin
hypothesi
rest
eosinophil
normal
intestin
mucosa
activ
eosinophil
inflam
esophagu
prove
simpl
current
data
indic
heterogen
among
eosinophil
noninflammatori
inflammatori
condit
base
find
would
like
suggest
follow
three
pattern
activ
mucos
eosinophil
baselin
activ
pattern
seen
intestin
mucosa
healthi
subject
indic
eosinophil
may
activ
involv
barrier
function
primari
activ
pattern
observ
inflamm
site
reflect
eosinophil
pivot
involv
inflammatori
process
remot
activ
pattern
note
far
inflammatori
process
consist
system
activ
background
aim
alter
import
mucos
modul
innat
mucos
immun
defensin
toll
like
receptor
tlr
may
involv
disrupt
innat
immun
studi
express
variou
defensin
tlr
quantifi
immunohistochem
intestin
epithelium
lamina
proprla
submucos
leukocyt
method
surgic
specimen
patient
crohn
diseas
cd
ulcer
coliti
uc
control
fix
cryostat
section
cut
endogen
peroxidas
activ
inactiv
antihuman
betadefensin
betadefensin
alfadefensin
alfadefensin
use
primari
antibodi
section
stain
appropri
sedondari
antibodi
either
peroxidaseconjug
rabbit
antigoat
immunoglobulin
goat
antirabbit
antimous
immunoglobulin
conjug
peroxidaselabel
dextran
polym
posit
express
assess
region
crypt
basal
mid
superfici
semiquantifi
follow
none
region
crypt
region
crypt
region
crypt
lamina
propria
submucos
leukocyt
count
express
posit
cell
result
alfadefensin
significantli
regul
cd
epithelium
compar
control
p
p
respect
number
alfadefensin
posit
cell
significantli
larger
lamina
propria
patient
uc
control
p
cd
p
number
posit
lamina
propria
leukocyt
significantli
larger
patient
cd
control
p
uc
p
express
molecul
submucos
leukocyt
show
signific
differ
cd
uc
control
conclus
differenti
express
defensin
tlr
repres
alter
innat
immun
cd
uc
mucosa
epitheli
express
betadefensin
lamina
propria
leukocyt
express
character
alter
innat
immun
patient
cd
propionibacterium
lymphocyt
subpopul
express
determin
immunohistocbemistri
tnfalpha
mrna
level
colon
determin
rtpcr
addit
bacteri
flora
cecum
examin
select
medium
number
coloni
quantifi
result
dss
treatment
induc
shorten
colon
length
histolog
mark
cell
infiltr
eros
observ
colon
mucosa
increas
proinflammatori
cytokin
express
also
observ
dss
mice
hand
histolog
chang
includ
cell
infiltr
significantli
attenu
dhnatreat
mice
increas
infiltr
cell
increas
vascular
express
colon
mucosa
submucosa
induc
dss
also
significantli
attenu
dhna
administr
addit
examin
bacteri
flora
reveal
enterobacteriacea
lactobacillu
decreas
dsstreat
mice
alter
intestin
flora
significantli
revers
dhna
conclus
dss
treatment
induc
signific
colon
inflamm
accompani
lymphocyt
infiltr
upregul
adhes
molecul
reduct
use
bacteria
data
suggest
dhna
attenu
colon
inflamm
suppress
lymphocyt
infiltr
also
balanc
intestin
bacteri
flora
helminth
background
grow
bodi
data
indic
excess
amount
reactiv
oxygen
metabolit
role
mediat
intestin
damag
ibd
therefor
elimin
may
benefici
superoxid
dismutas
sod
key
antioxid
enzym
use
inflammatori
diseas
hamper
short
circulatori
halflif
aim
aim
determin
whether
bacten
suppli
sod
colon
might
improv
experiment
coliti
compar
effect
oral
treatment
wild
type
engin
lactococcu
lacti
lactobacflln
plantamm
produc
differ
amount
sod
also
test
effect
continu
infus
bovin
sod
colon
lumen
method
male
wistar
rat
fit
cathet
proxim
colon
coliti
induc
administr
tnb
mgkg
colon
cathet
two
group
rat
receiv
continu
intracolon
infus
bovin
sod
uratday
salin
day
tnb
five
group
treat
oral
live
lactic
acid
bacteria
cfuday
bacteri
buffer
day
day
tnb
lactic
acid
bacteria
wild
type
recombin
strain
overexpress
sod
sod
sod
activ
bacteri
extract
unitslo
cfu
wild
type
l
plantamm
wild
type
l
lacti
l
plantamm
sod
l
lacti
sod
respect
rat
sacrif
day
tnb
sampl
colon
tissu
taken
evalu
macroand
microscop
damag
score
myeloperoxidas
mpo
activ
result
tnb
induc
weight
loss
macroand
microscop
colon
damag
score
respect
increas
mpo
activ
ug
protein
vs
control
alter
significantli
reduc
p
bovin
sod
colon
infus
oral
treatment
wild
type
l
lacti
l
lacti
sod
l
plantamm
sod
signific
differ
p
effect
three
bacteria
exampl
decreas
mpo
activ
treatment
wild
type
l
lacti
l
lacti
sod
l
plantamm
sod
respect
wild
type
l
plantamm
produc
sod
signific
effect
tnbsinduc
alter
conclus
lactic
acid
bacteria
produc
sod
even
small
amount
wild
type
l
acti
effect
reduc
sever
tnb
coliti
rat
bacteria
consid
promis
therapeut
agent
ibd
recent
studi
shown
probiot
effect
remiss
mainten
pouehin
mechan
probiot
exert
ist
activ
still
unknown
aim
investig
composit
microflora
bacteri
divers
pouchiti
biopsi
probiot
therapi
method
mucosaassoc
pouch
microflora
probiot
therapi
investig
use
rdnabas
singlestrand
confirm
polymorph
sscp
fingerprint
clone
experi
realtim
pcr
result
bacteri
divers
low
pouchiti
simplif
flora
appear
hallmark
activ
ibd
ottet
al
ddw
divers
restor
treatment
probiot
p
comparison
divers
score
total
number
bacteri
cell
pouch
biopsi
significantli
increas
probiot
therapi
comparison
untreat
remiss
p
identif
band
demonstr
probiot
induc
divers
anaerob
flora
mucos
growth
strain
contain
prepar
conclus
pouchiti
seem
associ
loss
bacteri
divers
normal
anaerob
flora
probiot
therapi
may
restor
normal
anaerob
flora
may
import
obtain
noninflammatori
barrier
function
placebo
day
prior
treatment
serum
collect
mice
sacrif
hour
anticd
inject
tissu
obtain
mrna
extract
use
semiquantit
rtpcr
result
histolog
examin
small
intestin
reveal
significantli
decreas
mucos
damag
score
character
decreas
apoptot
bodi
lb
anticd
vs
anticd
alon
p
improv
villouscrypt
ratio
lb
anticd
vs
anticd
alon
p
mice
pretreat
lactobacillu
spp
serum
level
interferonf
tnfa
alter
lb
howev
mrna
isol
small
intestin
mice
treat
lb
reveal
significantli
decreas
rel
express
interferonf
hour
fold
differ
compar
anticd
alon
p
hour
fold
compar
anticd
alon
hour
p
hour
p
conclus
oral
feed
lactobacillu
spp
prior
initi
tcell
mediat
bowel
damag
amelior
aga
abstract
mucosai
damag
diminish
apoptot
respons
small
intestin
associ
decreas
express
proinflammatori
cytokin
mrna
fund
ccfc
abbottcagcihr
fellowship
hiroki
tanab
yoshinori
shirafuji
kaiin
thoreux
miguel
freita
raphael
bourdetsicard
andr
ouellett
background
probiot
live
microb
confer
health
benefit
host
contribut
increas
resist
intestin
pathogen
paneth
cell
locat
base
small
intestin
crypt
contain
abund
microbicid
adefensin
secretori
granul
role
molecul
innat
immun
demonstr
studi
mice
express
human
adefensin
transgen
gram
gram
pathogen
bacteria
antigen
induc
releas
paneth
cell
adefensin
crypt
lumen
howev
potenti
influenc
intestin
microflora
particularli
prohiot
speci
paneth
cell
investig
aim
investig
influenc
probiot
strain
lactobacillu
casei
l
casei
paneth
cell
secretori
respons
investig
sensit
l
casei
adefensin
method
crypt
isol
edta
treatment
small
intestin
segment
adult
mice
expos
live
l
casei
bactericid
assay
perform
secret
collect
crypt
expos
l
casei
use
defensinsensit
phopstrain
typhimurium
surviv
bacteria
count
plate
mous
adefensin
crp
prepar
gel
permeat
chromatographi
intestin
acid
extract
purifi
homogen
rpiiplc
recombin
rhesu
macaqu
adefensin
human
adefensin
defensinrel
peptid
express
e
coil
purifi
hplc
surviv
bacteria
expos
peptid
h
solut
determin
count
cfu
plate
result
l
casei
induc
secret
paneth
cell
isol
crypt
extent
induc
speci
bacteria
eg
typhimurium
l
casei
sensit
mixtur
crp
logphas
l
casei
sensit
stationari
phase
cell
sensit
l
casei
rhesu
macaqu
adefensin
approxim
similar
crp
sensit
two
mous
adefensinrel
gene
product
exclus
paneth
cell
bactericid
aureu
e
coli
l
casei
conclus
l
casei
induc
adefensin
releas
crypt
paneth
cell
sensit
adefensin
mous
rhesu
macaqu
human
paneth
cell
observ
may
reflect
one
mechan
probiot
may
increas
resist
intestin
pathogen
probiot
agent
ecoli
heal
effect
proxim
inflamm
small
bowel
samuel
adler
harold
jacob
rami
eflakim
introduct
e
coil
shown
anim
studi
decreas
diarrhea
death
rate
util
agent
patient
proxim
inflamm
small
bowel
report
ongo
result
method
patient
symptom
consist
inflammatori
bowel
diseas
neg
gi
evalu
underw
capsul
endoscopi
reveal
inflammatori
chang
mostli
proxim
small
bowel
patient
receiv
cc
po
bid
ecoli
contain
seventh
live
bacteria
per
cc
probactrix
biobal
corp
week
two
patient
discontinu
probiot
agent
day
place
asa
prepar
patient
experi
improv
probactrix
three
patient
underw
follow
capsul
endoscopi
studi
remain
patient
report
improv
signific
improv
follow
treatment
probactrix
patient
underw
followup
capsul
endoscopi
complet
week
cours
probiot
agent
ce
studi
initi
read
nonblind
fashion
two
experienc
capsul
endoscopist
ce
studi
read
blind
fashion
anoth
experienc
capsul
endoseopist
blind
reader
given
case
pair
deidentifi
respect
ident
date
order
respect
pre
posttreat
random
well
result
patient
good
good
clinic
respons
probiot
agent
mark
reduct
abdomin
symptom
improv
well
patient
initi
ce
reveal
inflamm
proxim
small
bowel
signific
improv
posttreat
respond
normal
small
bowel
biopsi
posit
celiac
serolog
screen
celiac
serolog
return
normal
cours
probactrix
two
patient
improv
ce
unchang
pre
post
treatment
one
report
progress
symptom
ce
reveal
worsen
inflamm
post
therapi
find
consist
among
three
reader
conclus
ecoil
demonstr
endoscop
heal
effect
small
bowel
mucosa
patient
proxim
inflamm
small
bowel
ce
valuabl
tool
measur
therapeut
respons
small
bowel
inflammatori
diseas
clostridium
butyricum
cultur
supernat
downregulatn
tolllik
receptor
mrna
level
human
colon
epitheli
cell
atsushi
isono
tatsuro
katsuno
hidekazu
morita
naoki
sato
genichiro
seo
yasushi
saito
yasuo
suzuki
background
intestin
epithelium
show
mark
upregul
tolllik
receptor
activ
inflammatori
bowel
diseas
ibd
suggest
upregul
may
play
role
continu
inflamm
intestin
mucosa
ibd
howev
littl
known
factor
suppress
express
intestin
epitheli
cell
aim
studi
perform
examin
whether
probiot
affect
express
human
colon
epitheli
cell
method
effect
cultur
supernat
heatkil
bacteria
bacillu
mesentericu
toa
bm
strcptococca
faecali
sf
clostridium
butyricutn
toa
cb
human
colon
epitheli
cell
examin
colon
epitheli
cell
treat
cultur
supemat
heatkil
bacteria
without
thl
cytokin
mrna
gapdh
mrna
evalu
realtim
pcr
activ
agent
cultur
supemat
determin
hplc
result
treatment
cb
supemat
significantli
reduc
mrna
level
compar
untreat
control
wherea
bm
sf
supemat
induc
signific
chang
mrna
level
none
heatkil
bacteria
alter
mrna
level
ifnat
p
gml
upregul
mrna
interestingli
cb
supemat
significantli
reduc
mrna
level
even
presenc
lfn
cb
supemat
analyz
determin
activ
element
respons
mrna
downregul
hplc
show
cb
supernat
includ
mm
formic
acid
mm
acet
acid
mm
butyr
acid
colon
epitheli
cell
treat
organ
acid
separ
combin
mrna
significantli
suppress
cell
treat
solut
contain
butyr
acid
conclus
cultur
supernat
clostndiam
butyricum
heatkil
bacteria
reduc
mrna
level
human
colon
epitheli
cell
butyr
acid
produc
clostndium
butyricum
activ
agent
respons
suppress
mrna
result
indic
probiot
includ
clostridium
butyricum
effect
downregul
human
colon
epitheli
cell
probiot
e
coli
nissl
een
inhibit
activ
adhes
peripher
tcell
extracellular
matrix
andrea
sturm
klau
rill
joflarma
harderdheureus
daniel
baumgart
bertram
wiedenmann
axel
dignass
background
ecn
shown
serv
effect
mainten
treatment
ulcer
coliti
pouchiti
previous
demonstr
ecn
inhibit
cell
cycl
peripher
blood
tcell
pbt
lamina
propria
tcell
hypothes
ecn
inhibit
activ
recruit
activ
pbt
intestin
mucosa
downregul
activ
adhes
ecm
involv
recruit
ell
circul
blood
intestin
mucosa
method
pbt
stimul
crosslink
mab
cultur
absenc
presenc
steril
filter
ecn
supernat
flow
cytometri
analysi
use
assess
tcroelb
tcr
yb
integrin
express
cytokin
secret
measur
cba
analysi
adhes
pbt
ecm
compon
fibronectin
collagen
use
adhes
assay
base
luminometr
analysi
fiuoresc
label
cell
result
supernat
ecn
significantli
inhibit
activ
pbt
dosedepend
fashion
follow
stimul
vol
ecn
cell
vol
cell
vol
cell
addit
express
costimulatori
molecul
significantli
downregul
ecn
cultur
pbt
ecn
supemat
also
result
rel
increas
tcr
cell
tcell
popul
furthermor
synthesi
proinflammatori
tnfa
pbt
significantli
reduc
mean
secret
antiinflammatori
ilio
significantli
enhanc
mean
final
ecn
inhibit
adhes
pbt
collagen
fibronectin
mean
mean
respect
mayb
caus
downregul
integrin
express
ecn
mean
l
conclus
cellfre
snpernat
ecn
inhibit
activ
pbt
downregul
costimul
molecul
necessari
fulli
activ
tcell
modul
product
proand
antiinflammatori
cytokin
pbt
furthermor
decreas
express
may
result
reduc
adhes
pbt
collagen
fibronectin
may
ultim
caus
decreas
recruit
activ
pbt
side
intestin
inflamm
data
provid
evid
probiot
bacteria
broadli
influenc
human
immun
system
may
explain
benefici
effect
intestin
inflamm
analyz
cellular
respons
induc
gramneg
e
coli
nissl
ecn
gramposit
lactobacillu
acidophilu
cell
coincub
probiot
strain
gene
differenti
regul
express
gene
verifi
quantit
realtim
pcr
lightcycl
technolog
western
blot
probiot
effect
barrier
function
iec
monitor
measur
transepitheli
resist
ter
ecn
affect
transcript
gene
repres
nfkb
signal
pathway
ikb
alter
express
inflammatori
cytokin
sinc
express
gene
tight
junction
protein
piinn
involv
pkc
pathway
also
upregul
contact
ecn
colon
physiolog
function
barrier
integr
appear
posit
modul
probiot
vivo
l
acidophilu
similar
gene
effect
lesser
even
revers
extend
ikb
data
provid
insight
molecular
mechan
ecn
l
acidophilu
might
modul
clinic
characterist
inflammatori
bowel
diseas
ibd
crohn
diseas
ulcer
coliti
result
aggress
immun
respons
resid
microflora
furthermor
effect
ecn
gene
express
tight
junction
protein
may
explain
strain
exert
protect
effect
enteroinvas
pathog
n
cell
cultur
model
dna
micmarray
analys
gene
express
lead
develop
new
strategi
treatment
ibd
infecti
diseas
lactobacillu
probiot
appear
benefici
ibd
mechan
action
poorli
understood
lactobacillu
brevi
lb
streptococcu
thermophilu
st
two
pmbioric
high
level
sphingomyelinas
smase
enzym
lead
ceramidemedi
apoptosi
investig
whether
cd
lpmc
undergo
smasedepend
apoptosi
activ
immun
cell
suscept
cell
death
whether
form
apoptosi
depend
degre
cell
activ
lpmc
obtain
control
cd
patient
peripher
blood
mononuclear
cell
pbmc
healthi
volunt
fresh
pbmc
use
rest
activ
cell
stimul
bacteri
sonic
obtain
lb
st
nonpathogen
e
coli
ec
lpmc
pbmc
ceil
expos
bacteri
sonic
mg
proteinml
ceramid
gml
medium
alon
hour
experi
sonic
preincub
mm
glutathion
inhibit
smase
activ
apoptosi
assess
flow
cytometri
propidium
iodidestain
cell
express
apoptot
cell
lb
st
sonic
induc
significantli
p
apoptosi
cd
respect
control
lpmc
less
pbmc
respect
stimul
induc
timedepend
increas
lband
stinduc
apoptosi
lb
st
hour
respect
ec
sonic
fail
induc
apoptosi
cell
type
regardless
activ
state
ceramid
induc
apoptosi
cell
inhibit
smase
glutathion
markedli
reduc
lband
stinduc
apoptosi
lpmc
enhanc
apoptosi
cd
lpmc
appear
select
effect
probiot
lb
st
sinc
enter
bacteria
like
ec
fail
enhanc
apoptosi
probioticinduc
apoptosi
smasemedi
activationdepend
result
suggest
induct
immun
cell
apoptosi
one
mechan
mediat
therapeut
effect
probiot
e
colt
nissl
induc
human
beta
nfkb
depend
mechan
cell
miriam
schlee
jan
wehkamp
jnergen
harder
kai
wehkamp
jen
schroeder
ednard
f
introduct
e
coli
nissl
ahern
treatment
option
remiss
mainten
ulcer
coliti
mechan
action
probiot
strain
still
insuffici
understood
recent
demonstr
abil
e
coli
nissl
induc
human
beta
cell
aim
investig
e
coli
nissl
mediat
transcript
regul
gene
method
studi
activ
promot
put
bind
site
nfkb
e
coli
nissl
luciferas
report
gene
assay
appli
transfect
cell
respect
plasmid
h
cell
incub
e
coli
nissl
strain
whose
influenc
express
predefm
real
time
pcr
prove
direct
impact
nfkb
promot
plasmid
mutat
bind
site
nfkb
use
transfect
result
promot
activ
e
coli
nissl
well
uropathogen
e
coil
strain
analog
transcript
induct
real
time
pcr
remark
bacteri
supemat
prompt
fold
higher
promot
activ
compar
bacteri
pellet
nf
kb
report
plasmid
moder
activ
e
coli
nissl
addit
supemat
strongest
capac
activ
nfkb
mediat
transcript
mutat
two
nfkb
bind
site
promot
activ
complet
bacteria
bacteri
supernat
posit
control
beta
almost
complet
block
discuss
abrog
promot
activ
e
cofi
nissl
follow
insert
mutat
nfkb
site
indic
import
role
transcript
factor
induct
antimicrobi
peptid
moder
activ
nfkb
repres
novel
mode
probiot
action
bacteri
flora
inflammatori
bowel
diseas
fullautomat
bacteri
flora
analyz
system
genu
speci
specif
primer
base
rdna
gene
sequenc
detect
identif
bacteri
flora
human
fece
hiromasa
takaishi
ryuichiro
tanaka
koji
nomoto
takashi
asahara
takahiro
matsuki
katsuyoshi
matsuoka
nagamu
lnoue
haruhiko
ogata
yasushi
iwao
toshitumi
hibi
background
analysi
intestin
flora
import
elucid
pathogenesi
ibd
howev
bacteria
consist
intestin
flora
cultiv
convent
cultiv
techniqu
recent
research
led
rapid
advanc
applic
molecular
techniqu
base
ribosom
rnadna
rrnadna
gene
sequenc
studi
microbi
divers
method
fece
collect
patient
suffer
ulcer
coliti
crohn
diseas
fecal
pellet
immedi
place
anaerob
dilut
buffer
intestin
flora
analyz
use
select
media
anaerob
chamber
coloni
organ
count
bacteri
count
express
unit
cfu
per
gram
wet
weight
fece
moreov
dna
extract
fece
analyz
fullautomat
flora
analyz
system
use
dna
extract
pure
cultur
enumer
bacteria
extern
standard
sybr
green
use
fluoresc
substanc
abi
prism
use
detect
equip
pcr
result
bifidobactrerium
bacteroidacea
enterobacteriacea
decreac
lactobacillu
enterococcu
increas
ibd
patient
use
fullautomat
flora
analyz
system
bacteroid
fragili
group
quantit
decreas
contrari
previou
report
interestingli
although
b
vulgatu
b
ovatu
decreas
accord
decreas
b
fragtli
group
b
fraglli
affect
quantit
bacteroid
vulgatu
domin
bacteria
ibd
patient
also
healthi
control
activ
extent
diseas
uc
affect
bacteroid
speci
predomin
flora
quantit
similarli
corticosteroid
psl
daili
probior
bifidobacterium
andor
lactobacillu
daili
affect
bacteroid
speci
predomin
flora
quantit
conclus
develop
fullautomat
flora
analyz
system
use
quantit
pcr
genu
speci
specif
primer
base
rdna
gene
sequenc
use
system
bacteria
identifi
known
cluster
speci
within
hour
result
suggest
system
use
analysi
intestin
flora
intestin
flora
patient
differ
normal
subject
high
dose
probiot
effect
treatment
mild
pouchiti
pilot
studi
paolo
gionchettl
femando
rizzello
claudia
morselli
gilberto
pierang
filippo
pierang
rossella
romagnofi
federica
ugolini
silvio
laureti
massimo
campieri
background
pouchiti
major
longterm
complic
ilealpouch
anal
anastomosi
ipaa
ulcer
coliti
uc
broadspectrur
antibiot
mainstay
treatment
condit
recent
shown
efficaci
highli
concentr
probiot
prepar
vsl
billionsg
lyophilis
viabl
bacteria
prevent
relaps
chronic
pouchiti
prevent
pouchiti
onset
aim
evalu
efficaci
vsl
treatment
mildli
activ
pouchiti
method
twelv
consecut
patient
mild
pouchiti
defin
score
ponchiti
diseas
activ
index
pdai
includ
clinic
endoscop
histolog
criteria
treat
vsl
bid
month
pdai
qualiti
life
score
inflammatori
bowel
diseas
questionnair
ibdq
assess
end
studi
period
result
eight
patient
remiss
defin
score
signific
decreas
mean
total
pdai
score
rang
rang
p
unchang
mean
pdai
score
one
patient
drop
non
complianc
treatment
median
ibdq
score
improv
significantli
patient
remiss
rang
rang
p
conclus
high
dose
probiot
could
use
treatment
mild
pouchin
control
studi
warrant
intestin
epitheli
cell
motil
morphogenesi
requir
rho
kinas
activ
ann
hopkin
g
thoma
brown
adrian
pineda
brian
babbin
asma
nusrat
migrat
epitheli
cell
essenti
wound
repair
injuri
actin
restructur
cell
migrat
regul
p
ho
famili
gtpase
major
effector
rho
gtpase
rho
kinas
rock
aim
studi
character
mechan
rock
regul
epitheli
cell
motil
pharmacolog
rock
inhibitor
epitheli
cell
express
domin
neg
dn
rock
util
studi
restitut
morphogenesi
model
intestin
epitheli
cell
line
dnrock
induc
discontinu
aberr
basal
factin
aggreg
migrat
epithelium
accompani
aggreg
increas
detergentinsolubl
actinbind
protein
ezrin
increas
associ
ezrin
transmembran
protein
morphogenesi
model
rock
induc
analog
factin
aggreg
addit
abnorm
filopodialbk
protrus
treatment
evok
signific
reduct
diphosphomyosin
light
chain
mlc
level
migrat
epitheli
cell
actin
aggreg
filopodiallik
protrus
could
mimick
direct
inhibit
mlc
kinas
protrus
could
revers
cabl
tyrosin
kinas
inhibitor
ioim
follow
express
dominantneg
howev
rock
inhibit
associ
reduc
phosphoryl
thu
reduc
inactiv
cofilin
llmkinas
actinrich
protrus
induc
partial
revers
overexpress
limkinas
conclud
rock
effector
mlc
kinas
klmkinas
orchestr
distinct
respons
coordin
epitheli
cell
motil
primarili
regul
cdlmatx
adhes
protrus
respect
use
monolay
intestin
cell
report
activ
inflammatori
mediat
nfkb
degrad
modul
ikba
requir
oxidantinduc
disrupt
bf
egf
protect
injuri
molecular
mechan
unclear
isoform
pkc
key
monolay
integr
hypothes
activ
critic
egf
protect
oxidantinduc
nfkb
activ
consequ
activ
name
cytoskelet
disassembl
barrier
dysfunct
method
use
first
multipl
set
gi
clone
creat
stabl
transfect
overexpress
pkc
inhibit
express
clone
pretreat
egf
pkc
activ
eg
dag
analog
oag
oxid
assess
monolay
bf
stabil
molecular
dynam
f
gactin
cytoskeleton
subcellular
distribut
vitro
kinas
activ
isoform
level
phosphoryl
nuclear
transloc
activ
nfkb
subunit
n
result
rel
wild
wt
monolay
expos
oxid
alon
transfect
clone
stabli
overexpress
fold
protect
oxid
damag
low
previous
nonprotect
dose
egf
pkc
activ
indic
enhanc
nativ
isoform
activ
suppress
nfkb
subunit
nuclear
transloc
activ
reduc
degrad
phosphoryl
enhanc
factni
assembl
decreas
gactin
pool
increas
actin
cytoskelet
stabil
enhanc
bf
near
normal
b
overexpress
induc
stabil
ikbct
inactiv
nfkb
potenti
egp
oag
clone
low
dose
modul
led
increas
pkci
particul
fraction
indic
activ
isoform
c
antisens
transfect
stabli
inhibit
nativ
pkci
activ
substanti
inhibit
measur
egfmedi
protect
nfkb
activ
monolay
factin
barrier
dysfunct
show
first
time
activ
crucial
egfmedi
protect
oxid
stress
nfkb
activ
uniqu
intracellular
modul
ikbet
intestin
cell
thu
discov
novel
biolog
mechan
inhibit
dynam
nfkb
cytoskeletalbard
instabl
among
classic
subfamili
pkc
isoform
cell
intravit
observ
bone
marrow
cell
traffick
mous
small
intestin
koji
matsuzaki
yoshikazu
tsuzuki
junichi
miyazaki
yoshikiyo
okada
ryota
hokari
atsushi
kawaguchi
shigeaki
nagao
kazuro
itoh
soichiro
minra
background
bone
marrow
contain
hematopoiet
progenitor
cell
hpc
differenti
variou
type
matur
ceil
recent
report
indic
specif
fraction
bone
marrow
cell
contribut
regener
intestin
interstiti
ceil
epithelium
mucos
damag
process
hpc
home
intestin
mucosa
essenti
requir
adhes
interact
vascular
endothelinm
fulli
understood
studi
examin
bone
marrow
ceil
migrat
microvessel
small
intestin
mncosa
vivo
without
lipopolysaccharid
lp
treatment
investig
role
adhes
molecul
method
hpc
isol
cell
magnet
cell
sort
tibia
femur
male
mice
lp
administ
intraperiton
host
mice
three
hour
cell
administr
cell
label
carboxyfluorescein
snccinimidyl
ester
administ
control
mice
lp
treat
mice
via
tail
vein
ceil
migrat
postcapillari
venul
pcv
peyer
patch
pp
villu
microvessel
submucos
venul
monitor
use
intravit
microscop
roll
adher
ceil
quantifi
compar
experi
monoclon
antibodi
pselectin
nitegrinvascular
cell
adhes
moleculei
administ
rain
prior
cell
administr
result
number
adher
cell
significantli
increas
pcv
pp
submucos
venul
lpstreat
mice
villu
capillari
antibodi
significantli
attenu
lpsinduc
increas
cell
adhes
pcv
pp
submucos
venul
lp
treatment
also
significantli
increas
percentag
roll
cell
pcv
pp
pretreat
antibodi
significantli
suppress
roll
rate
cell
lp
treat
mice
conclus
data
demonstr
lp
treatment
result
signific
increas
recruit
bone
marrow
cell
microvessel
lymphoid
nonlymphoid
tissu
appear
play
import
role
cell
migrat
intestin
mucosa
chemotherapeut
role
intestin
paneth
cell
christoph
dekaney
susan
j
hen
paneth
cell
small
intestin
known
protect
intestin
epithelium
bacteri
invas
secret
antimicrobi
factor
includ
lysozym
cryptdin
addit
antimicrobi
role
posit
paneth
ceil
base
intestin
crypt
adjac
intestin
stem
ceil
lifespan
day
place
ceil
advantag
posit
act
sentinel
intestin
stem
cell
influenc
stem
cell
microenviron
hypothes
cytotox
damag
stem
cell
zone
elicit
secretori
respons
paneth
cell
hypothesi
test
assess
respons
paneth
cell
follow
administr
chemotherapeut
drug
adriamycin
method
adult
emal
mice
treat
ip
singl
inject
adriamycin
rag
kg
bodi
weight
jejun
tissu
collect
h
later
tissu
section
evalu
damag
score
number
paneth
apoptot
cell
incorpor
brdu
crypt
epithelium
quantit
h
result
evalu
h
e
stain
section
reveal
gross
mucos
damag
occur
h
singl
dose
adriamycin
persist
h
inject
newli
form
crypt
could
observ
earlier
respons
adriamycin
could
seen
epithelium
number
apoptot
cell
increas
earli
h
peak
h
return
near
normal
level
h
inject
addit
paneth
cell
increas
number
crypt
base
h
assess
h
e
lysozym
immunohistochemistri
panetb
cell
number
remain
elev
h
inject
found
crypt
base
along
side
crypt
paneth
cell
present
degener
crypt
b
could
also
found
base
newli
form
crypt
h
post
inject
h
paneth
cell
incorpor
brdu
conclus
rapid
increas
paneth
cell
number
lack
brdu
incorpor
consist
proliferationindepend
event
differenti
commit
precursor
cell
earli
respons
paneth
cell
cytotox
damag
presenc
degener
regener
crypt
suggest
novel
role
cell
protect
intestin
mucosa
manipul
stem
cell
nich
support
nih
grant
role
pkc
isoform
hypoxiareoxygenationlnduc
injuri
human
intestin
epitheli
cell
barri
tepperman
qing
chang
background
experiment
anim
ischemiareperfus
challeng
caus
increas
intestin
mucos
permeabl
enterocyt
apoptosi
similarli
hypoxiareoxygen
hr
intestin
ceil
vitro
impair
cellular
function
protein
kinas
c
pkc
shown
mediat
hypoxia
h
induc
damag
variou
cell
type
whether
pkc
play
similar
role
intestin
cell
unknown
present
studi
examin
role
variou
pkc
isoform
enterocyt
viabil
respons
h
hr
method
human
intestin
epitheli
cell
line
scbn
use
cell
subject
hypoxia
period
hr
group
cell
subsequ
reoxygen
exposur
room
air
furthermor
group
pretreat
either
select
pkc
inhibitor
agonist
peptid
prior
h
hr
challeng
viabil
estim
formazan
dye
reduct
apoptosi
determin
histochem
determin
degrad
polyadpribns
polymeras
parp
part
signal
cascad
apoptosi
cytochrom
c
transloc
index
mitochondri
injuri
result
h
hr
result
activ
pkcet
e
scbn
cell
cell
viabil
decreas
durat
h
increas
r
result
declin
viabil
pkc
activ
via
phorbol
ester
treatment
exacerb
injuri
respons
h
hr
inhibitor
pkca
e
reduc
degre
cell
injuri
antagon
exacerb
respons
treatment
select
agonist
decreas
extent
damag
h
associ
morpholog
chang
cell
includ
cell
shrinkag
nuclear
deform
r
increas
apoptosi
evidenc
increas
appear
nuclear
condens
fragment
treatment
specif
pkce
agonist
increas
earli
cellular
nuclear
deform
associ
hypoxia
alter
apoptot
chang
induc
r
contrast
agon
decreas
apoptosi
respons
hr
challeng
hinduc
cytochrom
c
releas
revers
pkce
antagonist
parp
degrad
hr
abolish
agonist
conclus
differ
pkc
isoform
appear
involv
cell
injuri
apoptosi
respons
hr
challeng
human
intestin
ceil
pkca
e
appear
involv
injuri
respons
hr
challeng
appear
play
protect
role
model
intestin
ceil
injuri
protect
effect
lactulos
dextran
sulfat
sodiuminduc
colon
inflamm
rat
gyorgi
rural
mitsuaki
okayama
ryoichi
tsubouchi
shinichi
kato
gyula
mozsik
koji
takeuchi
backgroundaim
intestin
microtlora
like
import
initi
factor
pathogenesi
ulcer
coliti
uc
promis
result
recent
obtain
probiot
therapi
uc
oral
administ
lactulos
shown
increas
colon
level
lactobactlln
speci
associ
probiot
activ
purpos
present
studi
examin
effect
lactulos
rat
uc
model
induc
dextran
sulfat
sodium
dss
method
experiment
coliti
induc
male
wistar
rat
dsssolut
ad
drink
water
day
lactulos
mgkg
administ
po
twice
daili
day
metrunidazol
mgkg
use
refer
drug
give
po
twice
daili
day
colon
ulcer
area
colon
length
bodi
weight
chang
diarrheabloodi
fece
colon
mucos
myeloperoxidas
activ
mpo
thiobarbitur
acid
reactiv
substanc
tbar
histolog
examin
result
dsstreatment
control
anim
result
sever
colon
lesion
accompani
diarrhea
bloodi
fece
decreas
bodi
weight
shorten
colon
length
increas
mpo
activ
well
tbar
due
ca
alon
crypt
perfus
ringer
expos
presenc
absenc
tpen
highaffin
chelat
heavi
metal
ka
zn
x
tpen
significantli
delay
increas
time
requir
achiev
maximum
respons
attenu
maximum
respons
control
condit
respons
n
nhzclinduc
chang
prevent
pretreat
mm
dtt
n
implic
thiol
group
nhci
target
crypt
perfus
ringer
expos
thapsigargin
deplet
major
intracellular
ca
store
endoplasm
reticulum
respons
attenu
n
background
aim
mechan
underli
damag
impair
heal
ulcer
coliti
uc
yet
defin
transglutaminas
tg
famili
enzym
catalyz
protein
crosslink
associ
increas
tissu
stabil
wound
heal
express
keratinocyt
transglntaminas
tgk
result
crosslink
protein
envelop
comifi
epiderm
cell
requir
barrier
function
termin
differenti
stratifi
squamou
epithelia
studi
look
possibl
role
isoenzym
intestin
mucosa
integr
uc
patient
patient
method
endoscop
histolog
indic
studi
patient
uc
activ
inact
normal
control
undergo
colonoscopi
tgk
protein
content
mrna
express
colon
evalu
western
blot
analysi
semiquantit
rtpcr
respect
colon
locat
tgk
evalu
immunohistochemistri
use
specif
monoclon
antibodi
result
show
first
time
presenc
tgk
normal
colon
mucosa
control
subject
increas
number
epitheli
cell
posit
tgk
observ
immunohistochemistri
base
upper
crypt
stain
less
pronounc
inact
patient
surprisingli
absent
activ
uc
keep
result
western
blot
rtpcr
show
protein
level
gene
express
tgk
downregul
activ
uc
compar
inact
diseas
control
conclus
demonstr
first
time
presenc
keratinocyt
form
transglutaminas
human
normal
colonocyt
wherea
express
activ
coliti
result
suggest
similarli
role
play
epidermi
keratinocyt
transghitaminas
may
promot
cell
cohes
colon
epithelium
find
damag
epithelium
increas
permeabl
bacteri
lumin
antigen
compon
show
impair
tgk
express
marker
reduc
cell
adhes
remain
consider
interest
novel
proapoptot
action
carbon
dioxid
cultur
intestin
epitheli
cell
selvi
krishnan
steven
borkan
john
h
schwartz
satish
k
singh
background
aim
previous
observ
apic
barrier
ga
weakelectrolyt
diffus
perfus
crypt
rabbit
colon
function
unknown
hypothes
barrier
protect
prolifer
cell
lumin
acidhas
extrem
colon
lumen
contain
elev
level
may
deleteri
prolifer
epitheli
ceil
use
cultur
cell
model
known
lack
appreci
barrier
sought
determin
elev
induc
apoptosi
andor
necrosi
method
colon
cancer
immort
intestin
cryptlik
cell
line
cultur
standard
bsasupplementeddmem
normox
condit
either
cell
analyz
flow
cytometri
surfac
annexinv
apoptosi
propidium
iodid
stain
necrosi
mitochondri
membran
potenti
awm
use
assay
fiuorimetr
confirm
apoptosi
result
cell
grown
col
condit
display
modest
gradual
increas
apoptosi
necrosi
consist
normal
cell
turnov
contrast
col
doubl
rate
apoptosi
annexin
posit
ceil
rose
tripl
annexin
posit
cell
activ
increas
cell
expos
col
vs
tripl
also
col
doubl
necrosi
pi
remain
normal
despit
prolong
exposur
either
col
ambient
cosre
condit
ph
measur
ph
standard
dmem
solut
col
condit
increas
apoptosi
necrosi
acut
decreas
awm
consist
earli
mitochondri
injuri
similar
result
observ
cell
line
conclus
exposur
elev
level
found
colon
caus
apoptosi
necrosi
sever
transform
nontransform
intestin
epitheli
cell
line
process
independ
ambient
ph
appear
due
permeant
weak
acid
effect
awm
apoptosi
appear
independ
earli
mitochondri
injuri
novel
apoptogen
action
may
due
alter
protein
apoptot
cascad
eg
via
carbamyi
diseas
impair
apic
col
barrier
function
may
predispos
colon
epitheli
cell
apoptot
necrot
cell
death
improv
reconstitut
intestin
epithelium
induct
epitheli
cell
migrat
tgfbeta
depend
effect
kerem
bulnt
peter
felderbau
nikolau
ansorg
frank
schmitz
peter
hoffmann
wolfgang
e
schmidt
backgroundaim
variona
studi
suggest
glucagonlik
peptid
secret
enteroendocrin
cell
gastrointestin
tract
food
intak
abl
decreas
mucos
injuri
set
human
disord
character
injuri
dysfunct
intestin
mucos
epithelium
evalu
potenti
epitheli
injuri
use
vitro
model
method
wound
induc
use
razor
blade
confluent
colo
monolay
afterward
supplement
media
wound
heal
investig
hour
microscop
quantif
number
cell
migrat
across
wound
edg
prolifer
assess
use
photometr
mitochondri
incorpor
measur
mtt
monoclon
ixgml
ad
wound
monolay
neutral
effect
induc
mediat
wound
heal
result
induc
signific
increas
migrat
monolay
compar
control
group
anova
posthoc
test
p
effect
observ
coloncanc
deriv
cell
hne
colo
mttprolifer
assay
reveal
signific
dose
depend
increas
prolifer
stimul
colo
coloncanc
cell
line
effect
detect
cell
neutral
experi
antitgf
lead
total
inhibit
induc
migrat
wound
small
intestin
monolay
conclus
result
indic
exert
repar
action
induct
secret
iec
cell
seem
respons
factor
improv
epitheli
wound
heal
thu
analogu
peptid
may
potenti
use
treatment
variona
gut
disord
character
injuri
inflamm
ineffect
repair
intestin
mucosa
induct
small
intestin
damag
select
cyclooxygenas
cox
inhibitor
defici
endogen
nitric
oxid
yujiro
hayashi
ryoko
ohno
aya
yokota
akiko
tanaka
koji
takeuchi
backgroundaim
recent
studi
demonstr
inhibit
requir
gastrointestin
ulcerogen
properti
nsaid
sinc
inhibit
accompani
express
assum
prostaglandin
pg
produc
contribut
mucos
integr
advers
condit
induc
inhibit
hand
produc
constitut
synthas
cno
play
import
role
maintain
mucos
integr
small
intestin
mimick
role
pg
produc
intestin
damag
might
induc
inhibit
cno
present
studi
examin
whether
intestin
damag
provok
inhibit
cno
whether
express
upregul
condit
defici
method
male
sd
rat
use
lname
mgkg
cnosino
inhibitor
aminognanidin
mgkg
ino
inhibitor
mgkg
select
inhibitor
rofecoxib
mgkg
select
inhibitor
given
po
either
alon
combin
anim
kill
h
later
analysi
mrna
perform
rtpcr
result
neither
lname
aminoguanidin
alon
provok
damag
small
intestin
within
h
yet
lname
administ
togeth
rofecoxib
produc
gross
lesion
largininesensit
manner
follow
administr
lname
express
mrna
upregul
intestin
mucosa
content
increas
h
later
rofecoxiband
largininedepend
manner
lname
enhanc
intestin
motil
decreas
mucu
secret
increas
bacteri
invas
mucosa
upregul
express
well
product
follow
lname
inhibit
prior
administr
atropin
dose
inhibit
intestin
hypermotil
caus
lname
addit
intestin
lesion
induc
lname
plu
rofecoxib
prevent
pretreat
ampicillin
atropin
well
aminognanidin
conclus
result
suggest
inhibit
cno
provok
intestin
damag
similar
inhibit
inhibit
cno
similar
upregul
express
intestin
process
associ
intestin
hypermotil
bacteri
invas
may
key
occurr
intestin
damag
associ
inhibit
role
endogen
prostaglandin
pg
cyclooxygenas
cox
isozym
heal
indomethacininduc
small
intestin
lesion
rat
ryoko
ohno
hikaru
nishio
akiko
tanaka
koji
takeuchi
backgroundaim
endogen
pg
play
import
role
modul
mucos
defens
stomach
well
heal
aspect
gastric
ulcer
believ
mainli
involv
former
latter
event
respect
recent
report
pg
produc
import
maintain
mucos
integr
small
intestin
nsaidinduc
damag
yet
role
pg
heal
intestin
ulcer
remain
unknown
present
studi
examin
role
pgcox
heal
indomethacininduc
intestin
ulcer
rat
use
select
inhibitor
method
male
sd
rat
use
intestin
ulcer
induc
singl
inject
indomethacin
mgkg
sc
anim
kill
day
administr
variou
cox
inhibitor
mgkg
rofecoxib
rag
kg
plu
rofecoxib
given
po
twice
daili
day
day
either
day
earli
stage
day
late
stage
ulcer
express
mrna
mucosa
examin
rtpcr
content
measur
result
intestin
ulcer
induc
indomethacin
heal
within
day
ulcer
area
decreas
less
drug
test
significantli
delay
heal
intestin
ulcer
given
day
howev
given
earli
day
heal
significantli
delay
indomethacin
rofecoxib
contrast
heal
impair
indomethacin
rofecoxib
given
late
day
mrna
upregnl
intestin
mucosa
day
ulcer
throughout
day
yet
intens
potent
day
diminish
thereaft
mucos
content
significantli
decreas
h
administr
indomethacin
recov
gradual
within
h
significantli
increas
normal
level
day
ulcer
increas
content
observ
day
ulcer
significantli
decreas
rafecoxib
day
suppress
rofecoxib
conclus
endogen
pg
produc
play
role
heal
intestin
ulcer
role
cox
isozym
activ
involv
process
may
differ
depend
stage
heal
earli
stage
late
stage
mitsuaki
okayama
ryoichi
tsubouchi
gyorgi
rumi
shinichi
kato
koji
takeuchi
backgroundaim
nonsteroid
antiinflamm
drag
nsaid
produc
damag
gastrointestin
mucosa
also
worsen
ulcerogen
respons
impair
heal
preexist
ulcer
tissu
recent
studi
demonstr
gastrointestin
ulcerogen
properti
account
inhibit
cyclooxygenas
cox
howev
effect
colon
lesion
much
studi
report
data
controversi
present
studi
examin
effect
variou
cox
inhibitor
dssinduc
ulcer
coliti
rat
investig
whether
drug
afford
protect
aggrav
colon
lesion
model
method
experiment
coliti
induc
male
wistar
rat
daili
treatment
dss
drink
water
day
indomethacin
non
select
cox
inhibitor
mgkg
select
inhibitor
mgkg
celecoxib
select
inhibitor
mgkg
given
po
twice
daili
dss
treatment
either
consecut
day
earli
day
late
day
express
mrna
colon
mucosa
examin
rtpcr
mucos
content
measur
eia
result
daili
treatment
dss
day
caus
mucos
lesion
colon
decreas
bodi
weight
gain
colon
length
well
increas
mpo
activ
daili
administr
indomethacin
celecoxib
day
worsen
sever
dgsinduc
colon
damag
increas
mpo
activ
likewis
damag
aggrav
given
earli
late
day
celecoxib
given
late
earli
day
dss
treatment
lndomethacin
given
either
earli
later
day
worsen
colon
lesion
express
mrna
upregul
colon
day
dss
treatment
signific
increas
product
content
normal
mucosa
inhibit
indomethacin
celecoxth
day
dss
treatment
suppress
indomethacin
cdecoxib
conclus
result
suggest
endogen
pg
produc
afford
protect
dssinduc
colon
lesion
involv
earli
period
develop
phase
later
period
extens
andor
repair
phase
thu
caution
paid
use
select
inhibitor
well
nsaid
patient
ulcer
coliti
michel
neunlist
philipp
aubert
stephani
bormaud
ann
ruehl
francoi
pari
isabdl
neveu
philipp
naveilhan
jeanpaul
galmich
introduct
recent
studi
reveal
neuron
enter
nervou
system
involv
regul
intestin
barrier
function
prolifer
paracellular
permeabl
tight
junction
protein
express
howev
role
enter
gfial
cell
egc
anoth
major
compon
en
control
harrier
function
current
unknown
therefor
goal
studi
character
use
cocuhur
model
role
egc
control
intestin
epitheli
cell
prolifer
materi
method
transform
primari
rat
egc
seed
well
plate
maintain
cultur
reach
confluenc
intestin
epitheli
cell
seed
transwel
filter
well
densiti
next
day
filter
place
cultur
egc
without
egc
control
maintain
cultur
three
day
prolifer
assess
thymidin
incorpor
measur
resist
tight
junction
associ
protein
assess
protein
immunohistochemistri
mrna
level
rtpcr
result
cocufiur
egc
induc
signific
increas
cell
prolifer
compar
control
cultur
alon
inde
cocultur
egc
increas
thymidin
incorpor
compar
control
p
n
concomitantli
number
cell
signlficandi
increas
n
compar
comrol
effect
also
associ
increas
resist
transwel
filter
n
caco
cultur
egc
compar
control
effect
cultur
egc
reproduc
condit
medium
egc
cultur
alon
addit
caco
cocuhur
egc
signific
decreas
mrna
compar
control
effect
associ
cytoplasm
redistribut
associ
actin
filament
conclus
result
suggest
egc
involv
regul
intestin
cell
prolifer
intestin
bamer
permeabl
mechan
factor
respons
effect
remain
unknown
could
involv
play
import
role
repair
process
intestin
barrier
follow
aggress
effect
pkc
activ
intracellular
ca
signal
integr
intestin
epitheli
cell
barri
tepperman
brian
dougla
soper
qing
chang
background
protein
kinas
c
pkc
activ
associ
tissu
injuri
includ
colon
inflamm
compromis
integr
isol
intestin
epitheli
cell
j
physiol
addit
increas
cytosof
ca
also
reduc
gastrointestin
cellular
integr
dig
di
sci
furthermor
demonstr
number
cellular
system
pkc
activ
alter
cellular
ca
homeostasi
increas
ca
level
j
physiol
j
biol
chem
therefor
present
studi
examin
effect
pkc
activ
intestin
cellular
integr
role
ca
respons
furthermor
also
examin
effect
specif
pkc
isoform
respons
method
rat
intestin
epitheli
cell
line
use
studi
cell
incub
presenc
pkc
activ
phorbol
myrist
acet
pma
im
experi
cell
incub
ca
medium
cell
viabil
assess
trypan
blue
uptak
alamar
blue
dye
exclus
cellular
ca
signal
assess
fluorimetr
cell
incub
indol
dye
result
pma
treatment
result
concentr
depend
increas
extent
cell
injuri
respons
significantli
attenu
addit
panspecif
pkc
inhibitor
gf
furthermor
cell
viabihti
maintain
cell
preincuh
pkc
isoformspecif
inhibitor
go
pkcx
rottlerin
pkc
pkc
cell
injuri
also
reduc
cell
incub
medium
presenc
either
ca
channel
antagonist
verapamil
intracellular
chelat
baptaam
pma
inact
phorbol
ester
induc
dosedepend
increas
cellular
ca
character
rapid
transient
spike
follow
tonic
plateau
phase
control
level
respons
elimin
addit
baptaam
furthermor
increas
ca
spike
reduc
elimin
coincub
antagonist
rottlerin
inhibit
pkca
pkc
less
effect
ineffect
regard
conclus
data
suggest
pkc
activ
via
pma
challeng
affect
integr
rat
intestin
epitheli
ceil
pkca
activ
appear
mediat
effect
via
increas
cellular
ca
moreov
known
produc
inflammatori
mediat
includ
prostaglandin
pg
pgfcc
wide
use
immunosuppressam
treatment
inflammatori
bowel
diseas
effect
intestin
myofibroblast
function
unknown
therefor
analyz
effect
metabolit
myofibroblast
prolifer
apoptosi
b
myofibroblast
product
pge
pgfc
c
myofibroblaststimul
intestin
epitheli
repair
method
primari
subepitheli
colon
myofibroblast
cmf
isol
human
colon
resect
stimul
either
concentr
hour
effect
cmf
prolifer
assess
thymidin
incorpor
apoptosi
evalu
histon
elisa
addit
pgf
concentr
cmf
supernat
determin
analysi
effect
cmfstimul
intestin
epitheli
repair
mechan
human
colon
epitheli
cell
incub
condit
media
collect
cmf
stimul
prolifer
apoptosi
cell
evalu
describ
cell
migrat
analyz
sheet
migrat
assay
result
neither
affect
prolifer
apoptosi
cmf
howev
substanc
effect
substanti
inhibit
well
pg
fla
concentr
cmf
cultur
supemat
maxim
effect
respect
observ
final
concentr
cultur
supem
cmfstimul
exert
signific
effect
migrat
prolifer
apoptosi
cell
compar
control
media
conclus
metabofit
decreas
pge
releas
colon
myofibroblast
vitro
contrast
modul
myofibroblaststimul
repair
mechan
intestin
epithelium
julia
tomfinson
anthoni
blikslag
shown
pg
elabor
import
recoveri
ischamicinjur
intestin
order
investig
role
mucos
recoveri
knockout
wildtyp
mice
subject
mm
jejun
ischemia
mucosaltoseros
flux
manintol
monitor
vitro
index
barrier
function
recoveri
jejun
tissu
subject
coxselect
inhibitor
measur
seros
solut
min
recoveri
denud
villou
surfac
area
calcul
ischemia
min
recoveri
index
restitut
western
analys
perform
cox
isoform
rain
recoveri
ischemicinjumd
tissu
significantli
less
permeabl
mannitol
control
tissu
wildtyp
mice
treatment
select
inhibitor
significantli
increas
permeabl
manintol
recov
tissu
compar
control
tissu
associ
signific
reduct
level
wherea
manintol
permeabl
significantli
differ
fi
om
control
tissu
follow
treatment
select
inhibitor
signific
effect
treatment
epitheli
restitut
suggest
chang
ill
mannitol
permeabl
paracellular
natur
knockout
mice
mannitol
permeabl
ischemicinjur
tissu
recov
control
level
min
signific
reduct
mannitol
permeabl
note
wildtyp
tissu
seen
similar
wildtyp
tissu
significantli
increas
permeabl
mannitol
associ
signific
reduct
level
chang
epitheli
restitut
protein
present
control
ischem
sampl
wildtyp
mice
wherea
present
knockout
mice
mucos
barrier
function
ischemicinjur
jejunum
recov
within
min
wildtyp
knockout
mice
overshoot
reduct
mannitol
permeabl
seen
wildtyp
mice
latter
also
block
wildtyp
tissu
suggest
process
altern
inhibit
prevent
recoveri
barrier
function
set
mice
suggest
import
role
acut
recoveri
ischemicinjur
jejunum
glucagonlik
mediat
protect
effect
tnb
induc
ileiti
lauri
e
wallac
gari
r
martin
david
l
sigalet
inflammatori
bowel
diseas
devast
caus
intestin
dysfunct
especi
patient
crohn
diseas
howev
pathogenesi
inflamm
regul
intestin
repair
poorli
understood
lab
previous
administ
glucagonlik
improv
nutrient
malabsorpt
follow
resect
note
peptid
put
antiinflammatori
effect
aim
examin
protect
role
rat
trinitrobenzen
sulfon
acid
tnb
induc
ileiti
crohn
diseas
model
method
fast
g
rat
given
intralumin
inject
tnb
solut
mgml
ethanol
site
cm
proxim
ileocec
valv
subset
tnb
treat
anim
receiv
ugkg
sc
bid
group
follow
day
bodi
weight
monitor
throughout
period
day
blood
sampl
determin
post
prandial
level
assess
elisa
addit
ileal
tissu
harvest
assay
myloperoxidas
activ
cytokin
express
tgfi
ino
western
blot
result
exogen
supplement
tnb
rat
demonstr
signific
increas
bodi
weight
post
prandial
blood
level
compar
tnb
alon
tabl
mpo
tissu
damag
score
marker
intestin
inflamm
significantli
reduc
treat
anim
tabl
conclus
upregul
marker
intestin
inflamm
moder
follow
administr
clearli
effect
rat
tnb
ileiti
howev
investig
requir
delin
antiinflammatori
properti
potenti
therapi
background
intestin
transplant
treatment
intestin
failur
requir
endoscop
surveil
patholog
confirm
identifi
acut
allograft
reject
advanc
endoscop
imag
allow
morpholog
featur
reject
identifi
readili
gastro
endosc
show
combin
improv
magnif
imag
methylen
blue
chromoscopi
earli
reject
graft
recoveri
intestin
adapt
villou
hypertrophi
visual
real
time
correl
reliabl
establish
patholog
featur
method
male
infant
underw
live
relat
ileal
allograft
transplant
gastroschisi
examin
graft
perform
fujinon
eg
videoscop
wit
h
magnif
intestin
stoma
postop
day
everi
week
next
week
follow
monthli
exam
addit
week
subject
biopsi
obtain
histolog
prolifer
intestin
succu
aspir
ria
analysi
total
examin
perform
cours
yr
result
earli
reject
villi
flatten
stain
intens
blue
intervillu
space
also
increas
appear
correl
crypt
apoptosi
villu
blunt
submucos
edema
inflamm
villu
recoveri
select
regener
villi
stain
select
denud
area
post
villu
slough
take
methylen
blue
regener
villi
shor
stain
intens
villi
reject
appear
correl
histolog
villi
thin
lack
enterocyt
differenti
crypt
repair
complet
inflamm
submucosai
edema
reduc
int
es
tinal
adapt
villi
elong
overlap
loss
intervil
space
stain
increas
enter
level
seen
surgic
adapt
low
reject
recoveri
prolifer
markedli
incr
eas
earli
recoveri
decreas
acut
reject
unchang
surgic
adapt
conclus
magnif
chromoendoscopi
use
manag
intestin
transplant
identifi
reject
recoveri
earlier
reduc
dur
ion
intens
immunosuppress
strategi
could
blunt
dilemma
reject
sepsi
post
transplant
lymphoprolif
disord
surgic
procedur
often
associ
regul
express
crohn
diseas
mucosa
giovanni
monteleon
giovanna
del
vecchio
blanco
sabrina
ballerini
piero
vavasson
ivan
monteleon
daniel
fina
sergio
bernardini
thoma
macdonald
francesco
pallon
background
aim
defect
tgfbl
signal
associ
high
mucosa
patient
crohn
diseas
cd
enhanc
contribut
maintain
mucos
inflamm
studi
examin
molecular
mechan
underli
induct
human
intestin
method
whole
intestin
mucos
lamina
propria
mononuclear
cell
lpmc
sampl
obtain
cd
patient
control
analys
rna
protein
realtim
light
cycler
rtpcr
western
blot
acetyl
interact
intrins
histon
acetyhransferas
examin
immunoprecipit
western
blot
determin
express
requir
de
novo
protein
synthesi
cd
lpmc
treat
cydoheximid
chx
hour
analys
ikba
bactin
western
blot
final
determin
acetyl
enhanc
express
normal
lpmc
treat
trichostatin
histon
deacetylas
inhibitor
hour
result
protein
express
increas
cd
sampl
comparison
control
contrast
control
exhibit
higher
level
rna
cd
suggest
regul
posttranscript
level
cd
inde
inhibit
de
novo
protein
synthesi
chx
reduc
ikba
protein
short
halflif
express
rais
possibl
high
caus
enhanc
protein
stabil
address
issu
first
examin
acetyl
cd
mucosa
given
acetyl
one
dynam
posttranstransl
mechan
enhanc
protein
stabil
coimmunoprecipit
assay
reveal
acetyl
lysin
residu
interact
importantli
inhibit
histon
deacetylas
trichostatin
enhanc
protein
rna
express
normal
lpmc
conclus
data
indic
cd
mucosa
high
cellular
level
sustain
dynam
posttranscript
mechan
suggest
acetyl
lysin
residu
enhanc
protein
express
make
protein
resist
ubiquitin
degrad
background
aim
peroxisom
proliferatoractiv
receptori
ppar
ligand
depend
nuclear
receptor
implic
regul
chronic
intestin
inflamm
previous
shown
nonpathogen
gram
neg
bactena
induc
nfkb
activ
proinflammatori
gene
express
primari
intestin
epitheli
cell
iec
line
studi
character
molecular
mechan
ppari
gram
neg
bacteriainduc
iec
activ
method
phosphorela
ppar
detect
iec
bacteroid
vulgatu
monoassoci
germfre
fisher
rat
use
immunohistochemistri
western
blot
analysi
cell
fine
constitut
express
ppari
stimul
gram
neg
b
wlgatnslp
presenc
absenc
ppari
agonist
rosiglitazon
ppari
specif
knockdown
cell
achiev
use
small
interfer
si
rna
techniqu
result
demonstr
nonpathogen
gram
neg
b
vulgatu
induc
persist
ppari
express
colon
epithelium
follow
bacten
co
oniz
day
consist
transient
induct
phosphorela
colon
epithelium
day
ppar
ligand
inhibit
b
vulgatuslpsinduc
rela
phosphoryht
ikba
degrad
nfkb
nuclear
transloc
nfkb
dna
bind
activ
cell
note
low
affin
ppar
ligand
inhibit
lpsinduc
ikbu
gene
express
cell
convers
high
affin
ligand
rosiglitazon
affect
rela
phosphoryl
proinflammatori
gene
express
iec
concordanfli
ppar
specif
knockdown
cell
fail
revers
inhibitori
effect
conclus
could
demonstr
metabolit
inhibit
gram
neg
bacteriainduc
rela
phosphoryl
gene
express
iec
via
ppari
independ
mechan
question
role
ppari
regul
chronic
inflamm
intestin
epithelium
background
aim
crohn
diseas
cd
mucosa
lamina
pmpria
lymphocyt
lpl
express
high
level
fa
resist
fasmedi
apoptosi
molecular
mechan
underli
resist
cd
lpl
fasmedi
apoptosi
still
remain
unclear
aim
present
studi
examin
express
role
fliceinhibitori
protein
flip
inhibitor
fa
signal
pathway
cd
materi
method
whole
intestin
mucosa
lamina
propna
mononuclear
cell
lpmc
lp
lymphocyt
lpl
obtain
cd
ulcer
coliti
uc
patient
normal
control
analyz
express
flip
western
blot
use
monoclon
antibodi
recogn
fulllength
short
form
flip
investig
mechan
underli
induct
flip
normal
lpmc
cultur
presenc
without
addit
cytokin
produc
excess
cd
mucosa
abl
enhanc
resist
cell
fasmedi
apoptosi
result
fulllength
form
flip
constitut
detect
sampl
express
higher
whole
biopsi
mucos
cell
cd
patient
comparison
uc
normal
control
addit
cd
sampl
exhibit
higher
level
short
form
flip
neg
regul
activ
initi
caspas
treatment
normal
lpl
enhanc
flip
express
thu
suggest
role
cytokin
induc
flip
